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The capacity for mammals to regulate breathing is critical to match 
ventilation to changes in oxygen availability and demand, for example during 
sleep or ascent to altitude. Acute falls in arterial PO2 activate specialised 
oxygen-sensing chemoreceptors, which relay this information to the 
cardiorespiratory centre of the brainstem, which then acts to restore blood 
gas homeostasis. While the role of the carotid bodies as peripheral 
chemoreceptors is undisputed, it has been proposed that a central oxygen 
sensor may exist. However, this view remains controversial. 
The work in this thesis built on recent findings which showed that the 
AMP-activated protein kinase (AMPK), a ubiquitously expressed cellular 
energy sensor, within catecholaminergic (tyrosine hydroxylase 
(TH)-expressing) cells is critical to the proper regulation of breathing during 
acute hypoxia. It was found that targeted deletion of AMPK within this 
subpopulation of respiratory neurons of the mouse brainstem led to 
decreases in ventilation and more frequent and prolonged apnoeas. The fact 
that this ventilatory deficit was hypoxia-specific and rescued by addition of 
hypercapnia showed that the capacity for neuronal activation was not 
affected per se, because central and peripheral chemosensors contributing 
to the hypercapnic response also express TH. Importantly, the activity of the 
carotid bodies in response to hypoxia remained fully intact, indicating that 
the respiratory deficits originated centrally.  
In light of these findings, the experiments carried out in this thesis further 
investigated how the deletion of both AMPK catalytic subunits in 
catecholaminergic cells (TH AMPK-α1/α2 dKO) impacts on hypoxic 
ventilation and where within the brainstem neuronal activation may be 
affected. By using whole-body plethysmography, I show that AMPK within 
the brainstem respiratory network is not only critical for appropriate 
ventilatory adjustments during acute hypoxia, but also during prolonged 
periods of low oxygen availability. Following the severe hypoventilation 
observed at the onset of hypoxia, ventilation remained attenuated relative to 
controls, even during periods lasting up to an hour. Moreover, some TH 




of hypoxia. In those mice where respiratory rhythmogenesis was retained, it 
was found to be interrupted at regular intervals by high frequency periods of 
spontaneous apnoeas. Immunohistochemical analyses of the brainstems of 
TH AMPK-α1/α2 dKO mice revealed a comparable number of 
catecholaminergic cells relative to controls, supporting the conclusion of a 
functional deficit within these neurons rather than hypo- or hyperplasia. This 
was further corroborated by the identification of a specific area within the 
brainstem that showed significant reductions in immediate early gene 
expression (cFos) and thus neuronal activation during hypoxia. Importantly, 
cardiovascular responses to hypoxia were unaltered in TH AMPK-α1/α2 
dKO mice relative to controls, indicating that this identified brainstem 
nucleus may separately control the respiratory and the cardiovascular 
responses to hypoxia through AMPK-dependent pathways. Finally, directing 
AMPK deletion to the adrenergic subset of catecholaminergic neurons 
revealed that the ventilatory deficit originated within the noradrenergic cells 
of the caudal brainstem, consistent with the location of the identified area of 
cFos deficiency.  
In summary, AMPK-dependent signalling is required within a specific group 
of noradrenergic neurons within the caudal brainstem to ensure appropriate 
signal integration and transduction during hypoxia in order to appropriately 
regulate ventilatory adaptations and protect from hypoventilation and 
respiratory instability. Therefore, AMPK may be a potential new therapeutic 
target to protect from sleep-disordered breathing associated with metabolic 






A reduction in available oxygen increases breathing frequency to supply 
more oxygen to our lungs. It is therefore crucial for mammals to be able to 
regulate breathing, for example during sleep or ascent to altitude. When 
blood oxygen levels fall, sensory organs within the carotid arteries – called 
the carotid bodies – detect these changes and relay signals to the brainstem. 
From there, the modulation of heart rate, blood pressure and more 
importantly increases in the drive to breathe are aimed to restore blood 
oxygen levels.  
Recent work demonstrated that the proper regulation of breathing during 
acute periods of low oxygen availability (hypoxia) is supported by a protein 
called AMP-activated protein kinase (AMPK). My studies support these 
findings and show that reduced levels of AMPK trigger conditions 
symptomatic of altitude sickness, namely sleep disordered breathing and 
apnoea. Importantly, I have shown that these symptoms can last for 
prolonged periods of hypoxia, with very little, if any, signs of recovery.  
Because the drive to breathe is generated within the brainstem I sought to 
explore how the activation of neurons during hypoxia is affected in the 
absence of AMPK. While the activation of the majority of respiratory neurons 
was unaltered, I found that a particular area within the brainstem showed a 
reduction in neuronal activity. It is therefore likely that this area controls the 
appropriate respiratory adaptations during periods of low oxygen availability.  
Obesity and type-2 diabetes also lower AMPK levels and are, like altitude 
sickness, strongly associated with sleep disordered breathing (1-3 million 
people in the UK). I therefore propose that AMPK deficiency within the 
brainstem causes these respiratory diseases and that it may also contribute 
to sudden infant death syndrome (cot death, 1 in 3200 UK births), which is 
associated with maternal obesity. These studies could lead to new 
therapeutic strategies for those who suffer from sleep apnoea and may help 






Eine Verringerung des verfügbaren Sauerstoffs erhöht die Atemfrequenz um 
mehr Sauerstoff in unsere Lungen zu bringen. Daher ist es für Säugetiere 
entscheidend dass die Atmung reguliert werden kann, zum Beispiel 
während des Schlafes oder beim Aufstieg in die Höhe. Wenn der 
Blutsauerstoffspiegel sinkt erkennen Sinnesorgane in den 
Halsschlagadern - die so genannten Karotiskörper - diese Veränderungen 
und leiten diese Informationen an den Hirnstamm weiter. Von dort aus zielt 
die Modulation der Herzfrequenz, des Blutdrucks und vor allem die 
Steigerung des Atemtriebs darauf ab, den Blutsauerstoffspiegel wieder 
herzustellen. 
Jüngste Arbeiten haben gezeigt dass die richtige Atmungsregulierung 
während akuter Perioden mit geringer Sauerstoffverfügbarkeit (Hypoxie) 
von einem Protein namens AMP-aktivierte Proteinkinase (AMPK) unterstützt 
wird. Meine Studien belegen diese Befunde und zeigen, dass reduzierte 
Proteinexpression von AMPK den Symptomen der Höhenkrankheit ähnelt, 
nämlich schlafbezogene Atmungsstörung und Apnoe. Wichtig ist dass ich 
gezeigt habe, dass diese Symptome über längere Zeiträume von Hypoxie 
anhalten, mit sehr wenigen, wenn überhaupt, Zeichen der Genesung. 
Da der Antrieb zum Atmen im Hirnstamm erzeugt wird wollte ich 
untersuchen, wie die Aktivierung von Neuronen während der Hypoxie in 
Abwesenheit von AMPK beeinflusst wird. Während die Aktivierung der 
Mehrheit der Atmungsneuronen unverändert war, fand ich dass ein 
bestimmter Bereich innerhalb des Hirnstamms eine Verringerung der 
neuronalen Aktivität zeigte. Es ist daher wahrscheinlich, dass dieser Bereich 
in Zeiten geringer Sauerstoffverfügbarkeit die entsprechenden 
Anpassungen der Atmung steuert. 
Adipositas und Typ-2-Diabetes senken auch den AMPK-Spiegel und sind, 
wie die Höhenkrankheit, stark mit schlafbezogenen Atmungsstörungen 
verbunden (1-3 Millionen Menschen in Großbritannien). Daher ist meine 
Annahme dass ein AMPK-Mangel im Hirnstamm diese 




Kindstod beitragen kann (1 von 3200 Geburten im Vereinigten Königreich), 
der mit mütterlicher Fettleibigkeit einhergeht. Diese Studien könnten zu 
neuen therapeutischen Strategien für diejenigen führen, die an Schlafapnoe 
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KO  Knock-out 
LKB1  Liver kinase beta 1 
Mv  Minute ventilation 
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pFRG  Parafacial respiratory group 
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PSA  Post-sigh apnoea 
rCPG  Respiratory central pattern generators 
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SolIM  Intermediate subnucleus of the NTS 
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SolM  Medial subnucleus of the NTS 
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1.1 The mammalian respiratory network 
Vertebrates have a very low capacity to store oxygen (Endeward et al., 2010; 
Gros et al., 2010), which means a constant oxygen (O2) supply is paramount 
for survival. Adequate delivery of O2 to all tissues in mammals is achieved 
by the periodic intake of air and exchange of O2 and carbon dioxide (CO2) 
between the lung alveoli and the blood stream, which carries them to and 
from all cells in the organism. In order to facilitate an appropriate degree of 
gas exchange, muscles of the ribcage and diaphragm need to be 
rhythmically activated in order to contract. This contraction increases the 
pleural cavity, which leads to lung inflation and air intake. Relaxation of these 
muscles is then followed by lung recoil and air outflow (Seeley, 2011).  
 
1.1.1 The anatomy of the brainstem respiratory network 
The mammalian drive to breathe is primarily generated in the pons and 
medulla oblongata of the brainstem, where several functionally distinct 
neuronal compartments form two bilaterally distributed ventral respiratory 
columns (VRC) that are necessary to generate respiratory rhythm (Figure 
1.1).  
In a caudal to rostral order, the medullary VRCs comprise the caudal and 
rostral ventral respiratory groups (cVRG and rVRG, respectively), the pre 
Bötzinger complex (preBötC), the Bötzinger complex (BötC), the 
post-inspiratory complex (PiCo), and the retrotrapezoid nucleus/parafacial 
respiratory group complex (RTN/pFRG). Within the pons, the bilateral 
pontine respiratory groups (PRG) consist of the Kölliker-Fuse nucleus (KF) 
and the dorsally adjacent lateral parabrachial region (LPBr) (Alheid & 
McCrimmon, 2008; Smith et al., 2013).  
The neural machinery that the VRCs form is robust, yet flexible, and 
integrates and coordinates physiology and behaviour based on modulations 
by neuronal inputs from the area postrema (AP) and the nucleus tractus 
solitarius (NTS), which are located medially and bilaterally in the dorsal 
medulla oblongata, respectively, as well as other supra-brainstem structures 




Pattinson et al., 2009b; King et al., 2013). Collectively, the VRC and its 
interneuron populations are known as the respiratory central pattern 





Figure 1.1: The anatomy of the brainstem respiratory network. 
Side view (left) and top view (right) of the brainstem showing the 
compartments of the respiratory centres in the dorsal (AP, NTS) and ventral 
medulla. LPBr: lateral parabrachial region, KF: Kölliker-Fuse nucleus, AP: 
area postrema, NTS: Nucleus tractus solitarius, 7N: facial nucleus, RTN: 
retrotrapezoid nucleus, PiCo: post-inspiratory complex, NA: nucleus 
ambiguus, BötC: Bötzinger complex, preBötC: pre-Bötzinger complex, 
rVRG: rostral ventral respiratory group, cVRG: caudal ventral respiratory 
group, RVL: rostral ventrolateral medulla, CVL: caudal ventrolateral medulla, 
LRt: lateral reticular nucleus. Figure adapted from Alheid et. al. (2011) and 




1.1.2 Functionality of individual compartments within the brainstem 
respiratory network 
As mentioned above, each compartment of the VRCs serves a functionally 
distinct role in respiratory pattern generation, which in concert shape 
respiration. Eupneic breathing consists of three phases: (1) inspiration, (2) 
post-inspiration and (3) late expiration. During inspiration, the lungs inflate 
due to contraction of the diaphragm, which receives innervation from the 
rVRG. At the same time, motor output from the preBötC coordinates muscles 
that open up the oropharyngeal airway to allow for airflow. Inspiration is 
terminated during post-inspiration, where the airflow is stopped by adduction 
of the larynx to allow for longer gas exchange in the lungs. Subsequent 
abduction of the larynx marks the beginning of exhalation, which is 
completed by minor innervation of intercostal and abdominal muscles from 
the BötC and the cVRG (Smith et al., 2013). The synaptic network of these 
respiratory neurons is a complex and delicate interplay of excitatory and 
inhibitory propriobulbar (projecting to medullary respiratory neurons) and 
bulbospinal (projecting to spinal motoneurons) interneurons (Horner, 2009) 
(Figure 1.2):  
(1) Breathing commences with the preBötC, which is densely populated 
by glutamatergic neurons that provide an excitatory inspiratory drive 
(Koizumi et al., 2013). Additionally, a subset of preBötC neurons have 
been found to have intrinsic bursting properties, similar to a 
pacemaker, in vitro and in situ (Koizumi & Smith, 2008; St-John et al., 
2009). The neurons within the preBötC are highly interconnected and 
also project to other structures such as the PiCo and the BötC, where 
some glycinergic and GABAergic neurons have been suggested to 
inhibit post-inspiratory and expiratory neurons during inspiration. In 
concert with the preBötC works the rVRG, which contains the main 
cluster of glutamatergic bulbospinal inspiratory premotor neurons that 
lead to innervation of the diaphragm (Dobbins & Feldman, 1994; 
Guyenet et al., 2002). Activity of the rVRG is determined by excitatory 
innervations from the inspiratory preBötC neurons, and the rVRG is 




(2) Following inspiration, post-inspiration is initiated by an increase in the 
bursting activity within the PiCo, which like the preBötC exhibits 
autonomous rhythm-generating properties that are necessary and 
sufficient for in vivo post-inspiratory activity. Post-inspiration is tightly 
coupled to occur immediately after inspiration, and the absence of 
GABAergic inhibitory input from the preBötC to the PiCo leads to 
synchronisation of bursting from both of these oscillators. This in turn 
disrupts the appropriate sequential phases that determine eupneic 
breathing and can lead to aspiration pneumonia (Anderson et al., 
2016). The overall signalling output from the PiCo is glutamatergic 
and hence excitatory, and this excitatory output appears to be 
increased by noradrenergic input from the pons. That said, the 
pontine respiratory structures appear to also deliver an additional 
inhibitory input to ventilation through noradrenergic A5 neurons, 
because transection studies have demonstrated increased phrenic 
nerve activity associated with increased respiratory frequency in the 
absence of the pons (Hilaire et al., 1989).  
(3) The transition from post-inspiration to expiration is primarily driven by 
glycinergic and GABAergic inhibitory projections from the BötC to the 
preBötC and rVRG, but also by excitatory inputs from the PRG to the 
BötC and pFRG/RTN (Ezure et al., 2003; Dutschmann & Herbert, 
2006). The pFRG/RTN is an interesting structure, which contains 
glutamatergic neurons expressing the transcription factor paired-like 
homeobox 2b (Phox2b), the mutation of which leads to congenital 
central hypoventilation syndrome that can lead to fatal respiratory 
arrest during sleep if left untreated (Weese-Mayer et al., 2005; 
Stornetta et al., 2006; Abbott et al., 2009). The pFRG/RTN is initially 
rhythmically active in perinatal rodents and at this point called the 
pFRG. Following developmental transformation the pFRG becomes 
tonically active and respiratory-modulated in adults, at which point it 
is referred to as the RTN (Thoby-Brisson et al., 2009; Abbott et al., 
2011; Depuy et al., 2011). Importantly, the RTN has been under 
intense investigation for its central chemoreceptor activity, as its 




pH (Kumar et al., 2015; Guyenet et al., 2016; Souza et al., 2018). 
Lastly, it has also been suggested to contribute to abdominal muscle 
contraction during active expiration (Feldman & Del Negro, 2006). 
Following the transition from post-inspiration, expiration is carried out 
through excitation of bulbospinal expiratory premotor neurons from 
the cVRG that receive innervations from BötC and pFRG/RTN (Smith 
et al., 2013).  
 
In addition to the respiratory modulation by the rCPGs of the brainstem, an 
essential contribution to the patterning of eupneic breathing also comes from 
the mechanoreceptors located in the lungs. Particularly in small mammals 
with high breathing frequencies, such as mice, feedback from slowly 
adapting mechanoreceptors is crucial in the modulation of respiratory 
rhythm (Milsom, 1990). During inspiration, mechanical feedback occurs 
when the lung volume exceedes the functional residual capacity during 
expansion of the pleural cavity. Afferent output by pulmonary 
mechanoreceptors travels via the vagus nerve and is conveyed to the rCPGs 
via so-called Pump cells of the NTS. These Pump cells excite 
post-inspiratory neurons and inhibit early-inspiratory neurons within the 
rCPGs, thereby advancing the termination of the inspiratory phase of 
eupneic breathing and allowing for the high respiratory frequencies 







Figure 1.2: Microcircuits that shape respiratory rhythm and pattern 
generation. 
The Post-inspiratoy complex (PiCo), Bötzinger complex (BötC) and 
pre-Bötzinger complex (preBötC) have been proposed to contain autonomic 
rhythmogenic properties. These circuits involve populations of excitatory 
(green) pre-inspiratory, inspiratory and inhibitory (blue) expiratory neurons. 
The inhibitory populations not only project to the excitatory population within 
the PreBötC, but also mutually inhibit each other via an ‘inhibitory ring’. 
Projections are also made from the rhythmogenic microcircuits to the 
transmission circuits, which contain the rostral and caudal ventral respiratory 
group (rVRG and cVRG, respectively). These premotor neurons then project 
to inspiratory or expiratory motor neurons (MN) within the spinal cord. 
Furthermore, all compartments receive tonic, phasic, or rhythmic input from 
the pons, nucleus tractus solitarius (NTS), and the retrotrapezoid 
nucleus/parafacial respiratory group (RTN/pFRG). Figure adapted from 




1.2 Oxygen-sensing by peripheral catecholaminergic cells 
The evolution of a respiratory system that was able to provide a continuous 
supply and delivery of O2 allowed for the development and maintenance of 
large, diverse, and complex animals, because respiration and mitochondrial 
oxidative phosphorylation sufficiently and consistently provided enough O2 
and energy, respectively. Nevertheless, the evolution of a monitor with the 
capacity to detect changes in O2 supply and the ability to respond 
accordingly in a manner that maintains O2 homeostasis, and thus 
mitochondrial function and energy supply, at a whole-body level was 
required. This was achieved by the development of specialised 
chemoreceptors, which have the ability to sense acute reductions in O2 
supply and trigger a respiratory response that acts to re-establish O2 levels. 
Interestingly, the location of the primary peripheral arterial chemoreceptors 
has changed throughout evolution from being dispersed amongst all 
respiratory passages (i.e. gills) in fish, to multiple sites within the carotid 
arteries in amphibians and reptiles, and finally to a single dominant receptor 
site at each carotid artery in mammals and birds called the carotid body (CB) 
(Milsom & Burleson, 2007). That said, other O2-sensitive sites also exist 
within mammals, which are able to trigger responses to hypoxia that 
maintain whole-body O2 supply in the absence of fully a functional CB. 
 
1.2.1 Neonatal adrenomedullary chromaffin cells 
Newborn mammals have a poorly developed respiratory network at birth 
(Lavezzi & Matturri, 2008) and in humans the proper drive to breathe only 
commences at around 6 months of age (Kinney et al., 1992). In addition, the 
environment in which the CB develops in utero is relatively hypoxic, which 
means that after birth the comparatively hyperoxic environment leads to 
initial silencing of the CB-mediated stimulation of breathing (Wasicko et al., 
1999; Donnelly, 2000). This leaves newborn infants vulnerable to ventilatory 





Maturation of the peripheral and central respiratory network starts at birth 
and is hypothesised to be triggered by a surge of catecholamines released 
from neonatal adrenal medullary chromaffin cells (nAMCs) as a response to 
the severe hypoxia experienced during birth (Lagercrantz & Bistoletti, 1977; 
Faxelius et al., 1983; Lagercrantz, 1996). nAMCs are derived from the neural 
crest and during the early postnatal life they are able to respond to 
reductions in O2 through inhibition of O2-sensitive K+ channels (for example 
large-conductance Ca2+-dependent K+ (BK) channels and delayed-rectifier 
type Kv channels), which leads to membrane depolarisation and 
voltage-gated Ca2+ entry via L-type and T-type Ca2+ channels. The increases 
in intracellular Ca2+ trigger the release of catecholamines into the blood 
stream (Mochizuki-Oda et al., 1997; Thompson et al., 1997; Thompson et 
al., 2002; Levitsky & López-Barneo, 2009; Nurse et al., 2018). The secretion 
of catecholamines, particularly noradrenaline, activates the sympathetic 
nervous system to increase heart rate and facilitate O2 delivery to the tissues 
(Ream et al., 2008). Therefore, the O2 sensitivity of nAMCs partly overcomes 
the lack of chemosensitivity of the CB (Donnelly, 2000). 
The non-neurogenic and direct O2 sensitivity of nAMCs is lost during 
postnatal development at a time that roughly coincides with the sympathetic 
innervation of the adrenal gland by the splanchnic nerve (for example 1-2 
weeks for rodents, 24 hours for sheep)  (Comline & Silver, 1961; Seidler & 
Slotkin, 1985; Slotkin & Seidler, 1988; Nurse et al., 2009). It is likely that 
cholinergic signalling from the splanchnic nerve is the underlying cause of 
this, as activation of α7 nicotinic acetycholine receptors has been shown to 
lead to upregulation KATP channels and membrane hyperpolarisation 
(Buttigieg et al., 2008; Nurse et al., 2009). It is therefore not surprising that 
denervation of the splanchnic nerve in adults has been shown to recover the 
direct hypoxia-sensing mechanism of chromaffin cells (Seidler & Slotkin, 
1986; Levitsky & López-Barneo, 2009).  
It should be mentioned at this point that the non-neurogenic O2 sensitivity of 
nAMCs may not be the only neonatal response system to hypoxia. At birth, 
so-called neuroepithelial bodies (NEBs) which are innervated cell clusters 




have also been suggested to act as peripheral hypoxia-sensitive airway 
sensors due to the following set of characteristics (Lauweryns & Cokelaere, 
1973; Lauweryns et al., 1977; Lauweryns et al., 1985; Cutz & Jackson, 
1999):  
- They are preferentially located at airway branching points and 
therefore strategically placed to directly monitor inspired O2 levels 
- They contain microvilli that are in direct contact with the airway lumen 
- They are in close proximity to blood capillaries 
- Their cellular content includes cytoplasmic neurosecretory granules 
that contain serotonin and other neuropeptides 
- They are innervated by afferent nerve fibres from the dorsal root and 
nodose ganglion 
Studies have shown that during airway hypoxia, but not blood hypoxaemia, 
NEBs release serotonin, which shunts blood flow from poorly to better 
ventilated areas of the lung (Lauweryns & Cokelaere, 1973; Lauweryns et 
al., 1978). The cellular signalling pathway that mediates release of serotonin 
is similar, but not identical, to other O2-sensing cells. In response to hypoxia, 
closure of K+ channels and subsequent membrane depolarisation leads to 
activation of voltage-gated Ca2+ channels, influx of extracellular Ca2+, and 
neurotransmitter secretion via exocytosis (Youngson et al., 1993). The 
cellular O2 sensor in the case of NEBs appears to be NADPH oxidase, which 
during hypoxia fails to maintain superoxide and hence hydrogen peroxide 
production. This leads to reductions in the oxidised redox state of a cysteine 
residue in the H2O2-sensitive K+ channel subunit, which triggers a 
conformational change that closes the channel and in the end results in 
neurotransmitter release (Ruppersberg et al., 1991). Importantly, the fact 
that both spinal and vagal afferent nerves arborise on NEBs highlights their 
potential to send afferent information to the central nervous system during 
periods of hypoxia (Kemp et al., 2003). Therefore, although not 
catecholaminergic, NEBs may also have a function in the control of 
respiration during the transition from the intrauterine environment to air 
breathing and thus complement CB activity during the neonatal period (Cutz 




1.2.2 Carotid body type I cells 
As mentioned earlier, the CBs have evolved as the primary mammalian 
peripheral arterial chemoreceptors, which are located at the bifurcation of 
the carotid artery in the neck (Figure 1.3 A). The CB is one of the most highly 
vascularised organs in the body and consists of two cell types: clusters of 
catecholaminergic O2-sensing glomus (type I) cells and more glial-like 
sustentacular (type II) cells, which associate with type I cells in an 
approximate ratio of 1:4 (Nurse, 2014). The glomus cells are highly 
fenestrated and receive their blood supply from a branch off the carotid 
artery, which allows them to sense even minor changes in the blood gas 
composition (Kumar, 2007; López-Barneo et al., 2008). In addition, a series 
of nerve innervations allow for rapid communication between the periphery 
and the central nervous system. Afferent sympathetic nerves from the CB 
petrosal ganglia join the carotid sinus branch of the glossopharyngeal nerve, 
which innervates the breathing centres located in the medulla oblongata 
(Mifflin, 1992; Gonzalez et al., 1994) to prompt ventilatory adjustments by 
increased afferent fibre discharge in response to even minor reductions in 
O2 availability, which, for other non-O2-sensing cells, would still lie within the 
“normal” physiological range of PO2 (Mills, 1972; Erickson & Millhorn, 1994; 
Donnelly, 2000; López-Barneo et al., 2008; Buckler & Turner, 2015).  
While eupneic breathing during normoxia is stable and rhythmic with a very 
low frequency of basal CB chemoafferent fibre discharge (Kumar & 
Prabhakar, 2012), exposures to hypoxia increase respiratory drive and 
precipitate a biphasic hypoxic ventilatory response (HVR). The first part of 
the response to an acute fall in arterial PO2 is a rapid and robust increase in 
ventilation, which is driven by increases in breathing frequency and tidal 
volume and termed the “Augmenting phase”. The Augmenting phase occurs 
within seconds of the onset of hypoxia, and, as mentioned above, is primarily 
driven by peripheral chemoreceptor afferent fibre discharge to the 
respiratory centres of the brainstem (Ramirez et al., 1998; Palmer et al., 
2013; Pamenter & Powell, 2016). Within the brainstem, CB afferents 
terminate and activate specific nuclei in the caudal portion of the NTS, as 




innervations of the NTS will be provided in the introduction to Chapter 4) 
(Finley & Katz, 1992). Furthermore, catecholaminergic neurons within the 
NTS provide additional afferent inputs to ventral catecholaminergic cells and 
the rCPGs of the ventrolateral medulla (Ross et al., 1985; Koshiya & 
Guyenet, 1996), which provides an opportunity for signal amplification. 
Importantly, due to the immediate nature of this response, the Augmenting 
phase is determined by neurotransmitter release (predominantly glutamate) 
and enhanced synaptic transmission mediated by the effects of excitatory 
amino acids, rather than de novo protein synthesis (Gozal et al., 2000; 
Pamenter & Powell, 2016). Thereafter, within seconds to minutes, the 
central effect of hypoxia leads to the second phase of the ventilatory 
response, which manifests as a reduction in ventilation called “Roll-Off”. This 
ventilatory decline is primarily driven by reductions in breathing frequency 
with a lesser degree of reductions in tidal volume (Palmer et al., 2013). Given 
the continuous chemoafferent fibre discharge that is maintained throughout 
the hypoxic period, ventilatory “Roll-Off” may be mediated downstream of 
the CB chemoafferent input by changes in neurochemical signalling 
pathways secondary to receptor activation during the Augmenting phase 
(Gozal et al., 2000), as well as due to the declining metabolic rates of non-O2 
sensitive neurons and activation of central chemosensitive sites within the 
brainstem that respond to the decreasing levels of CO2 subsequent to the 
hyperventilation that occurred during the Augmenting phase (Neubauer et 
al., 1990; LaManna et al., 1996). However, the fact that ventilatory “Roll-Off” 
is proportional to the degree of the Augmenting phase, and that “Roll-Off” 
does not occur following peripheral chemodenervation or blockage indicates 
that the CBs may still play a pivotal role in the development of both phases 
of the HVR (Teppema & Dahan, 2010).  
Historically, the first direct evidence for a role of the CB in mediating 
cardiorespiratory homeostasis was obtained in the late 1920’s, when 
hyperventilation was triggered in response to decreases in arterial PO2 of 
vascularly isolated carotid bifurcations from dogs (Heymans & Heymans, 
1927). Since then, several studies across species have corroborated the 




pressure (Lahiri et al., 1981; Timmers et al., 2003; Izumizaki et al., 2004; 
Mouradian et al., 2012; McBryde et al., 2016), as well as determining the 
morphology and proposing stimulus-response mechanisms that underlie 
chemoafferent fibre discharge (Biscoe & Silver, 1966; Biscoe & Stehbens, 
1966; Biscoe & Duchen, 1990b, a; Buckler, 1997; Buckler et al., 2000; 
Campanucci et al., 2006; Buckler & Turner, 2013; Murali & Nurse, 2016).  
 
1.2.2.1 Hypoxia-response coupling within the carotid bodies 
It is now understood that within type I cells, inhibition of TASK1/3 potassium 
(K+) channels leads to cell depolarisation and voltage-gated calcium (Ca2+) 
entry (Figure 1.3 B) (Buckler, 2015), which triggers the release of various 
neurotransmitter and neuromodulators that shape the subsequent afferent 
discharge (Gonzalez et al., 1994; Peers & Buckler, 1995; López-Barneo et 
al., 2008; Nurse, 2010; Kumar & Prabhakar, 2012; Nurse & Piskuric, 2013). 
The key neurotransmitter in this pathway is likely ATP, which has been 
shown to activate post-synaptic ionotropic P2X2/3 receptors on afferent 
nerve terminals (Nurse, 2010, 2014). Recently, evidence of ‘ATP-induced 
ATP release’ has emerged, which allows for signal amplification through the 
expression of purinergic P2Y2 receptors on type II cells. Within these cells, 
receptor activation by ATP has been shown to trigger increases in 
intracellular Ca2+, leading to further release of ATP via Panx-1 channels into 
the synaptic cleft. There, ATP from both type I and type II cells is broken 
down by extracellular 5’-ectonucleases into adenosine, triggering an 
additional activation of type I cells via adenosine A2A receptors on the 
presynaptic type I cells (Conde & Monteiro, 2004; Conde et al., 2009; Conde 
et al., 2012) leading to a secondary rise of Ca2+ within type I cells and, 
therefore, release of ATP (Xu et al., 2006).  
In addition to the ATP-dependent excitation of chemoafferent fibre 
discharge, acetylcholine (Ach) has also been proposed to be a major 
excitatory neurotransmitter within the CB (Nurse & Zhang, 1999; Fitzgerald, 
2000; Iturriaga & Alcayaga, 2004). Various nicotinic and muscarinic ACh 
receptors (AChR) are expressed in the CB of several species, and the 




cats, rabbits, and humans (Fitzgerald et al., 2000; Shirahata et al., 2007; 
Kahlin et al., 2014). Furthermore, the blockage of both nicotinic and 
purinergic receptors was needed in order to inhibit the postsynaptic 
response to hypoxia in co-cultures of rat CB and petrosal ganglia (Zhang et 
al., 2000), and dual blockage of these receptors resulted in inhibition of 
respiration in neonatal rats (Niane et al., 2012). As mentioned above, ATP 
release from type I cells induces increases in intracellular Ca2+ and Panx-1 
channel activation on CB type II cells. This effect has also been observed 
after application of ACh to CB cell cultures, which induced Ca2+ increases 
with similar potency and also activated Panx-1 channels on the same type 
II cells (Tse et al., 2012; Murali et al., 2015). However, whether or not these 
neuroactive agents functionally combine to enhance Ca2+ signalling within 







Figure 1.3: Chemosensing and signalling at the carotid body tripartite 
synapse.
(A) The anatomical location of the carotid body at the bifurcation of the 
common carotid arteries, which relays chemosensory information to the 
brainstem via afferent projections of the glossopharyngeal nerve. (B) The 
‘tripartite’ synapse of the carotid body is made up of type I glomus cells 
(white), type II sustentacular cells (green) and terminals of the petrosal nerve 
(blue). During hypoxia, inhibition of TASK1/3 K+ channels ([1], dark blue) 
depolarises the type I cell membrane, which leads to increases in 
intracellular Ca2+ via voltage-gated Ca2+ channels (VGCC, brown) and 
exocytotic release of ATP (red circles) into the synaptic cleft [2]. ATP then 
activates postsynaptic P2X2/3 receptors found on the petrosal nerve 
terminals causing excitation and action potential firing, as well as P2Y2 
receptors found on type II cells, where subsequent increases in intracellular 
Ca2+ activate signalling inositol triphosphase (IP3) pathways that release 
further ATP into the synaptic cleft. There, ATP is broken down into 
adenosine ([3], ADO, green half circle) by extracellular 5′-ectonucleotidase 
(5′ENT). ADO in turn activates A2A receptors (A2AR) located on type I cells 
and further inhibits TASK1/3 channels to enhance type I cell depolarization 
[4] and ATP release (ATP-dependent ATP release). Panel A adapted from 





1.2.2.2 O2-sensing mechanisms within the carotid bodies 
While the hypoxia-response pathways leading to chemoafferent discharge 
have been largely determined, the O2-sensing pathways within the CB still 
remain under debate. There are, however, several hypotheses that aimed 
to identify the ultimate O2-sensor of the CB, which could either be a single 
sensor, or multiple sensors with varying affinities for O2 and thresholds for 
activation. The most favourable hypotheses are the Mitochondrial 
Hypothesis and the Membrane Hypothesis (Figure 1.4).  
 
The Mitochondrial Hypothesis (Figure 1.4 A) is based on the assumption 
that K+ channel closure is secondary to the effect of hypoxia, with the primary 
effector being the mitochondria. This theory was first postulated when 
mitochondrial NAD(P)H:NA(P)D+ ratios increased with decreasing PO2, 
which triggered afferent fibre discharges over the range of physiological O2 
levels (Mills & Jobsis, 1970, 1972). In support of this, inhibitors of the 
mitochondrial electron transport chain in type I cells were later shown to 
increase afferent fibre discharge (Mulligan et al., 1981; Wilson et al., 1994; 
Ortega-Saenz et al., 2003). Therefore, mitochondria of O2-sensing cells 
appear to be unusually sensitive to even minor fluctuations in O2, which 
allows them to trigger chemoafferent fibre discharge during exposures to 
mild hypoxia.  
The primary candidate of the mitochondrial respiratory chain that determines 
O2 sensitivity was proposed to be the expression of a specific form of 
cytochrome a3 with an unusually low affinity for O2 (Mills & Jobsis, 1972). 
More recently, the constitutive expressions of NADH dehydrogenase 
(ubiquinone) 1 alpha subcomplex 4-like 2 (NDUFA4L2) and cytochrome C 
oxidase (COX) subunit 4 isoform 2 (COX4I2) have been demonstrated in CB 
type I cells, which in non-specialised cells have an ordinarily low expression 
profile, but may be increased during prolonged hypoxia (Huttemann et al., 
2001; Fukuda et al., 2007; Tello et al., 2011; Zhou et al., 2016). Important in 
the context of O2-sensing, ATP confers allosteric COX inhibition via COX4I1, 
but not COX4I2 (Huttemann et al., 2001; Horvat et al., 2006), which creates 




capacity in the CB during normoxia (Mills & Jobsis, 1972; Duchen & Biscoe, 
1992). Therefore, the COX4I2-dependent activity of COX may determine, at 
least in part, the capacity of O2-sensing cells to monitor and quickly respond 
to even minor reductions in arterial PO2 (Evans et al., 2016; Evans, 2018). 
In non-O2-sensing cells on the other hand, reductions in ATP supply during 
hypoxia would relieve COX4I1 inhibition, leading to increases in O2 
consumption to maintain ATP levels within the cell until mitochondrial 
oxidative phosphorylation is finally inhibited by a PO2 of <5mmHg (0-1% O2) 
(Duchen & Biscoe, 1992). By contrast, an acute fall in O2 availability would 
not be able to trigger increases in O2 consumption and ATP supply of 
O2-sensing cells, leading to the rapid induction of signalling pathways that 
will aim to restore tissue O2 homeostasis, namely CB afferent fibre discharge 
that mediates increases in ventilation to maximise O2 uptake. In addition, the 
high expression of NDUFA4L2 was shown to limit the production of 
mitochondrial reactive oxygen species (ROS) during hypoxia through 
reductions in the activity of the mitochondrial complex I (Tello et al., 2011), 
thereby further reducing the capacity for increases in mitochondrial oxygen 
consumption of O2-sensing cells during hypoxia. Overall, the constitutive 
expression of these two complexes in CB type I cells might thus determine 
the mitochondrial affinity for O2 and confer, at least in part, the capacity to 
monitor and respond to even minor reductions in arterial PO2. 
Finally, the signalling cascade that links mitochondrial inhibition to closure 
of K+ channels within the CB type I cells is still controversial, but several 
pathways have been suggested that include signalling via hydrogen sulfide, 
reactive oxygen species, lactate, or adenosine nucleotides (Buckler & 
Turner, 2013; Chang et al., 2015; Fernandez-Aguera et al., 2015; Chang, 
2017): 
Hydrogen sulfide production CB type I cell activation has been 
suggested to occur consequent to fall in carbon monoxide (CO) synthesis 
during hypoxia, which ultimately leads to the production of hydrogen sulfide 
(H2S) and activation of redox-sensitive L-type Ca2+ channels (Peng et al., 
2010; Yuan et al., 2015). However, the action of H2S may lie upstream of 




type I cells through direct inhibition of mitochondrial oxidative 
phosphorylation (Buckler, 2012). Additionally, mouse CB type I cell 
transcriptome analysis revealed few to no reads of haem oxygenase-2, or 
cystathionine-γ-lyase and cystathionine-β-synthase, which are responsible 
for the generation of CO and H2S, respectively (Zhou et al., 2016).  
Reactive oxygen species The incomplete transfer of electrons 
following hypoxia-mediated inhibition of the mitochondrial electron transport 
chain has been linked to increases in the concentration of reactive oxygen 
species (ROS) (Turrens, 2003; Gonzalez et al., 2007), which may directly or 
indirectly affect K+ channel function (Wyatt & Buckler, 2004). However, their 
functional role in hypoxia-response coupling of type I cells is still not well 
established and as mentioned above, the constitutive expression of 
NDUFA4L2 and COX4I2 by CB type I cells act to limit mitochondrial ROS 
production during hypoxia (Huttemann et al., 2001; Fukuda et al., 2007).  
ATP A direct role for ATP regulation of TASK1/3 channel activity 
within CB type I cells came from the observation that upon patch excision, 
channel activity ceased rapidly unless physiologically relevant 
concentrations of MgATP were supplied to the inside of the patch (Varas et 
al., 2007). Therefore, MgATP levels could, directly or indirectly, regulate 
channel activity, which close during hypoxia subsequent to falls in ATP 
supply. However, there are currently no identified ATP-binding domains in 
either TASK1 or TASK3 channels, and other cytosolic signalling compounds 
may be required to recover loss of channel activity caused by patch excision 
even after MgATP supplementation (Buckler & Turner, 2015). 
Lactate-dependent activation of olfactory receptor 78 Most recently, 
activation of the G-protein coupled olfactory receptor 78 (Olfr78) has been 
proposed to underpin CB type I cell activation following increases in lactate 
production subsequent to anaerobic glycolysis during hypoxia (Chang et al., 
2015). While this mechanism supports the mitochondrial hypothesis, it does 
not appear to comply with a role of TASK K+ channel inhibition in the 
determination of type I cell activation. Furthermore, the expression of Olfr78 
is not limited to CB type I cells and the study undertaken here utilised a 




identification of the cellular transduction pathways along with a targeted 
deletion strategy would be required to further substantiate the proposed role 
of lactate in the O2-sensing signalling cascade, especially because serious 
doubt for a role of Olfr78 in CB activity arose after a follow-up study was 
unable to replicate these findings and showed no differences in the 
ventilatory and CB responses to hypoxia between wild-type mice and those 
with deletion of Olfr78 (Torres-Torrelo et al., 2018). 
Clearly, the precise O2-sensing mechanism(s) within CB type I cells have 
still not been fully elucidated. However, an alternative hypothesis predicts 
K+ channels to be the ultimate O2 sensor within the type I cells. It is 
indisputable that closure of selective K+ channels is critical for the signal 
transduction process during hypoxia, which has been proven in a variety of 
species (Lopez-Barneo et al., 1988; Chou & Shirahata, 1996; Buckler, 1997; 
Yamaguchi et al., 2004). However, the expression patterns of K+ channel 
subtypes are highly variable within and between species, as well as between 
different developmental stages, making one type of channel as the ultimate 
O2 sensor unlikely. That said, several different channel types may depolarise 
the membrane equally, provided they are either directly or indirectly inhibited 
by hypoxia. The finding that hypoxia decreased – reversibly and selectively 
– a small conductance, fast inactivating delayed rectifier K+ current in the 
rabbit type I cells ultimately coined the Membrane Hypothesis (Figure 1.4  
B) and the existence of so-called KO2 channels (Lopez-Barneo et al., 1988; 
Lopez-Lopez et al., 1989; Lopez-Lopez et al., 1993), which have also been 
suggested to exist in the rat (Peers, 1990; Buckler, 1997; Buckler et al., 
2000) and mouse (Perez-Garcia et al., 2004). However, despite their 
subtype variability within and between species, some limitations of this 
hypothesis arose when direct K+ channel blockers failed to induce afferent 
fibre discharge or neurotransmitter release under basal conditions 
(Donnelly, 1997; Osanai et al., 1997), which led to speculations that closure 
of K+ channels was indirect and subsequent to another primary O2 sensing 
mechanism. The more recent findings on COX4I2 expression further 




the predictions of Mills and Jobsis regarding both the site and mechanism of 
O2 sensing within the CB type I cells.  
 
Generating further controversy within the field, the most recent studies from 
our laboratory have now questioned the view that the HVR is entirely driven 
by the peripheral chemoreceptors, i.e. increases in the CB chemoafferent 
fibre discharge frequency in response to a fall in arterial PO2. Acutely, a fall 
in ATP supply will be partially compensated for by the adenylate kinase 
reaction, which increases the cellular AMP:ATP ratio by converting two 
molecules of ADP into one molecule of AMP and one molecule of ATP 
(Dzeja & Terzic, 2009). AMP is a potent activator of the AMP-activated 
protein kinase (AMPK) (Hardie et al., 2016), so a role for AMPK in 
hypoxia-response coupling seemed highly plausible. Accordingly, deletion 
of both AMPK catalytic subunits in catecholaminergic cells blocked the HVR 
and precipitated hypoventilation and apnoea. However, it did so without 
affecting CB type I cells and chemoafferent input responses during hypoxia. 
Moreover, the degree of the ventilatory deficit precipitated by loss of AMPK 
was more severe than when conditional deletion of an AMPK upstream 
kinase completely blocked CB chemoafferent fibre discharge (Mahmoud et 
al., 2016). Therefore, these observations suggest that in addition to the 
peripheral control by the CB, a component of the HVR arises centrally and 
that the latter is determined by AMPK-dependent signalling pathways within 







Figure 1.4: Hypotheses of acute O2 sensing in the carotid body type I 
cell.
(A) The Mitochondrial Hypothesis proposes that inhibition of TASK1/3 K+ 
channels is subsequent to hypoxia-induced inhibition of mitochondrial 
oxidative phosphorylation. In this case, O2-sensitivity is determined by the 
expression of specific isoforms and subtypes of the NADH dehydrogenase 
and cytochrome c complexes of the respiratory chain. Downstream of the 
mitochondria, several pathways have been proposed to lead to afferent fibre 
discharge, for example increases in hydrogen sulfide (H2S) production 
subsequent to decreases in carbon monoxide (CO) levels, increases in the 
production of reactive oxygen species (ROS) due to the incomplete electron 
transfer of the respiratory chain, closure of K+ channels due to reductions in 
ATP levels, or production of lactate by anaerobic glycolysis and activation of 
the olfactory receptor 78 (Olfr78). (B) The Membrane Hypothesis proposes 
that O2-sensitivity is conferred by O2-sensitive KO2 K+ channels, which 
depolarise the membrane, leading to opening of voltage-gated Ca2+ channel 
(VGCC) and the release of neurotransmitter that increase afferent fibre 




1.3 The AMP-activated protein kinase  
As mentioned above, a reduction of ATP supply during hypoxia with a 
subsequent increase in the AMP/ATP ratios via the adenylate kinase 
reaction creates the possibility of a role for adenosine mono-/diphosphates 
and the ubiquitously expressed cellular energy sensor AMPK in mediating 
hypoxia-response coupling. Classically, AMPK monitors cellular adenosine 
phosphates (AMP, ADP and ATP) and prompts metabolic adjustments with 
the goal to maintain energy homeostasis during cellular stress (Hardie et al., 
2006; Hardie et al., 2011; Gowans et al., 2013; Hardie et al., 2016).  
 
1.3.1 The structure of AMPK 
AMPK is a ubiquitously expressed heterotrimeric serine/threonine kinase 
consisting of one catalytic (a) and two regulatory (b and g) subunits. Each of 
these subunits has multiple isoforms encoded by distinct genes: two for the 
a-subunit, (α1 and α2), two for the β-subunit (β1 and β2), and three for the 
γ-subunit (γ1, γ2 and γ3) (Stapleton et al., 1996; Thornton et al., 1998; 
Cheung et al., 2000). Although each heterotrimeric AMPK complex only 
contains one of each subunits, the expression of these seven isoforms can 
result in at least 12 different combinations into which AMPK can assemble 
(Ross et al., 2016). As such, certain subunit combinations are expressed in 
a tissue-specific manner. For example, skeletal muscle predominantly 
expresses the catalytic α2 subunit, whereas adipose tissue mainly 
expresses the α1 subunit. Other tissues, for example in the liver, have been 
found to express α subunits with no particular preference (Stapleton et al., 
1996; Woods et al., 1996; Daval et al., 2006). Importantly, recent findings 
suggest that different subunit combinations could also be targeted to 
different subcellular localisations, have different sensitivities to metabolic 
stress (i.e. changes in the AMP, ADP and ATP levels), and create specificity 
regarding differential phosphorylation of downstream targets and thus 
signalling outputs (Ross et al., 2016).  
The α-subunits Encoded within the α-subunit are three key structures 




found, whose activation loop contains a highly conserved threonine residue 
at position 172 (Thr172). Phosphorylation of Thr172 by an upstream kinase 
leads to increased AMPK activity (see section 1.3.2 below) (Hawley et al., 
1996). The KD is followed by an auto-inhibitory domain (AID), which can 
determine the activity of the KD through conformational changes and binding 
to the opposite side of the active site (Pang et al., 2007; Chen et al., 2009; 
Ross et al., 2016). Lastly, a linker domain connects the AID to the globular 
C-terminal domain (CTD), which is important in the regulation of activity via 
adenine nucleotides (Ross et al., 2016).  
The β-subunits The N-terminal region of the β-subunit contains a 
carbohydrate-binding module (CBM), which participates in glycogen binding 
and may thus co-localise AMPK with glycogen synthase (Koay et al., 2007; 
Bultot et al., 2012). The C-terminal domain (CTD) on the other hand forms 
the core of the heterotrimeric complex by binding to both the CTD of the 
α-subunit, as well as the γ-subunit (Iseli et al., 2005).  
The γ-subunits The majority of the γ-subunit is made up of four tandem 
repeats of cystathionine β-synthase (CBS) motifs (CBS1-CBS4). The 
assembly of these CBS repeats creates a disk-like shape with one repeat in 
each quadrant, thereby forming four pseudosymmetrical clefts that create 
adenine nucleotide (AMP, ADP, ATP) binding sites (Scott et al., 2004). 
However, not all of these binding sites participate in nucleotide exchange. 
Within the mammalian γ1 subunit, site 2 appears to be always empty, 
whereas sites 1, 3 and 4 competitively bind to the adenosine nucleotides 
based on the metabolic status of the cell (Xiao et al., 2007; Xiao et al., 2011; 
Xiao et al., 2013). This way, AMPK is able to monitor and respond to 






Figure 1.5: The structure of the AMPK subunits. 
The catalytic α-subunits contain a serine/threonine kinase domain within 
their N-terminus. This part contains the threonine residue at position 172 
(Thr172), which is phosphorylated by upstream kinases. The kinase domain 
is followed by an auto-inhibitory domain (AID) and lastly a C-terminal domain 
(CTD) for binding of the β-subunit. The β-subunits contain two conserved 
binding domains: a carbohydrate-binding module (CBM) in the N-terminus, 
and CTD that links the α-subunit with the γ-subunit. The γ-subunits’ 
corresponding binding domain lies within its N-terminus and is followed by 
four tandem repeats of cystathionine-β-synthase (CBS) motifs that act in 
pairs to form binding pockets for the adenine nucleotides. Figure adapted 





1.3.2 The regulation of AMPK 
The regulation of AMPK occurs via three key mechanisms that can act 
individually or simultaneously: (1) allosteric activation by adenosine 
nucleotide-binding to the g subunit, which is closely linked to (2) inhibition of 
dephosphorylation of Thr172, and (3) direct activation via phosphorylation 
of Thr172 (Figure 1.6).  
Metabolic stress increases the cellular AMP:ATP ratio through activity of the 
adenylate kinase reaction, which converts two molecules of ADP into one 
molecule of AMP and one molecule of ATP (Dzeja & Terzic, 2009). Under 
normal homeostatic conditions, ATP prevails in the cell and competitively 
occupies all the binding sites within the g subunit. Therefore, AMPK is 
subjected to dephosphorylation at Thr172 and thus inactivation. During 
metabolic stress, allosteric activation of AMPK is mediated by displacement 
of ATP and binding of the more abundant nucleotide AMP to the high-affinity 
domain of site 1 within CBS repeats of the γ subunit, which induces a 10-fold 
increase in activity. Additionally, binding of either AMP or ADP to the 
low-affinity site 3 of the g subunit results in a conformational change of the 
heterotrimer that hinders phosphatases, for example protein phosphatase 
2A (PP2A), from dephosphorylating AMPK  at Thr172 (Hardie, 2007; Wu et 
al., 2007; Hardie et al., 2011; Ross et al., 2016). This allows for an additional 
100-fold activation by phosphorylation, which is facilitated by the main 
upstream tumour suppressor kinase Liver Kinase B1 (LKB1) (Hawley et al., 
2003; Woods et al., 2003). Notably, LKB1 constitutively phosphorylates 
AMPK at Thr172 even during normal metabolic homeostasis, but inhibition 
of dephosphorylation leads to a more rapid and maintained phosphorylation 
of Thr172 (Sakamoto et al., 2004). Alternatively, a cytosolic increase in Ca2+ 
mediated by cellular activity, but not a reduction in ATP, activates the 
upstream Calcium2+/calmodulin-dependent protein kinase kinase 2 
(CaMKK2), which also acts to phosphorylate and activate AMPK (Hawley et 
al., 2005; Woods et al., 2005).  
As indicated above, ADP does not bind to the high affinity site 1 within the g 
subunit and therefore cannot activate AMPK allosterically (Xiao et al., 2007). 




to increases in ADP:ATP ratio with a >100-fold activation, whereas during 
more severe conditions of metabolic stress, additional increases of the 
AMP:ATP ratio and allosteric activation by AMP-binding to site 1 are able to 
increase the total activity of AMPK by >1000-fold. This shows how AMPK is 
able to monitor the cellular ADP:ATP and AMP:ATP ratios and prompt 
appropriate cellular responses that aim to increase ATP production and at 
the same time reduce ATP consumption. For example, AMPK-dependent 
signalling pathways increase glucose uptake via translocation of the glucose 
transporter type 4 (GLUT4) (Pehmoller et al., 2009), glycolysis and fatty acid 
oxidation via mitochondrial β-oxidation (Hardie et al., 2012), mitochondrial 
biogenesis via activation of the peroxisome proliferator-activated receptor-γ 
co-activator 1α (PGC1α) (Jager et al., 2007), and clearance of 
non-functional mitochondria via UNC-51-like kinase 1 (ULK1)-dependent 
mitophagy (Egan et al., 2011). On the other hand, AMPK-dependent 
signalling pathways decrease gluconeogenesis, lipogenesis, and fatty acid, 
cholesterol, and protein synthesis (Carling, 2004; Daval et al., 2006; Hardie 
et al., 2012) via phosphorylation of, for example, Acetyl-CoA carboxylase 
(ACC) (Davies et al., 1992) glycogen synthase (Jorgensen et al., 2004a), 
and regulatory associated protein of the mammalian target of rapamycin 





Figure 1.6: The regulation of AMPK by adenosine nucleotides and 
upstream kinases. 
(1) AMPK is activated by phosphorylation via the upstream kinases Liver 
kinase beta 1 (LKB1), or Calcium/Calmodulin Dependent Protein Kinase 
Kinase 2 (CaMKK2). (2) During metabolic stress-induced depletion of ATP, 
the ratios of ADP:ATP and AMP:ATP increase. Inhibitory binding of ATP is 
displaced by AMP or ADP, which changes the conformation of the 
heterotrimers and protects the Thr172 residue from dephosphorylation by 
protein phosphatases (PPT). (3)  Binding of AMP to the high affinity site in 
the γ-subunit also activates AMPK allosterically. Figure adapted from 




1.4 AMPK and the hypoxic ventilatory response 
As highlighted earlier, the cellular mechanisms of hypoxia-response 
coupling in the CB are still a highly controversial topic with no definite 
consensus. Moreover, the expression of COX4I2 likely leads to quick 
reductions of ATP levels during hypoxia, which would increase the 
AMP:ATP ratio subsequent to the activity of adenylate kinase (Dzeja & 
Terzic, 2003; Panayiotou et al., 2014). Given that activation of AMPK is 
tightly coupled to mitochondrial metabolism via increases in the 
AM(D)P:ATP ratio, the possibility of a connection between AMPK activity 
and hypoxia-response coupling in O2-sensing cells emerged. In this regard, 
being a serine/threonine kinase, AMPK may have the capacity for the 
regulation of processes outside of metabolic control. Indeed, AMPK may 
phosphorylate and thus regulate the activity of several ion channels, such 
as the Ca2+-activated potassium channels KCa1.1 and KCa3.1 (Klein et al., 
2009; Ross et al., 2011), the voltage-gated K+ channels Kv1.5 and Kv2.1 
(Ikematsu et al., 2011; Mia et al., 2012; Andersen et al., 2015; Moral-Sanz 
et al., 2016), or the ATP-inhibited KATP channel Kir6.2 (Chang et al., 2009). 
In addition, an emerging role for AMPK in the regulation of enzymes involved 
in transmitter biosynthesis (Zhang et al., 2018), receptors (Ahmadi & Roy, 
2016), and pumps and transporters (Schneider et al., 2015) further suggests 
that AMPK may have a crucial function in determining cell excitability and 
signal transduction. 
A pivotal role for AMPK in mediating the HVR was first suggested in 2005, 
when activators of AMPK were able to activate isolated CB type I cells and 
increase afferent fibre discharge, whereas AMPK inhibitors blocked these 
actions (Evans et al., 2005a; Wyatt et al., 2007). Additionally, conditional 
genetic deletion strategies of the upstream kinase LKB1 in the 
catecholaminergic cells of mice further supported these findings, in that the 
capacity for type I cell activation during hypoxia was virtually abolished 
following conditional LKB1 deletion, as were increases in afferent fibre 
discharge. Consistent with this, the HVR of these mice was significantly 
attenuated (Evans, 2012; Mahmoud et al., 2015). However, when another 




AMPK catalytic subunits to catecholaminergic cells, the off-target effects of 
the previously used pharmacological agents were uncovered, because 
against expectation, conditional deletion of AMPK in CB type I cells failed to 
attenuate CB afferent fibre discharge in response to hypoxia (Mahmoud et 
al., 2016).  
It is now clear that the initial outcomes were due to the off-target effects of, 
for example, the AMPK antagonist Compound C, which was found to inhibit 
at least 10 other kinases more potently than AMPK (Bain et al., 2007). The 
responses to the AMPK activator AICAR were also attributable to off-target 
effects, such as the AICAR-mediated inhibition of adenosine transporters 
which are key modulators of type I cell activity, and/or reductions in the 
adenylate pool and ATP (Gadalla et al., 2004; Hasenour et al., 2014; Lantier 
et al., 2014; Murali & Nurse, 2016). Therefore, it appears that unlike LKB1, 
AMPK activity is clearly not necessary for CB type I cell activation during 
hypoxia, which has since been corroborated by the pharmacological and 
genetic modulation of AMPK activity (Kim et al., 2014; Buckler, 2015; 
Mahmoud et al., 2016).  
That said, despite showing no effect on the chemoafferent discharge 
response of CB type I cells, targeted deletion of AMPK in catecholaminergic 
cells did precipitate a more severe attenuation of the HVR than targeted 
deletion of LKB1 did (Mahmoud et al., 2016). These findings therefore 
uncovered a split in the dependency of LKB1 and AMPK on the activation of 
the carotid body on one side, and the HVR or the other. In this regard, type 
I cell activation could be regulated in an LKB1-dependent manner by 
activation of one or more of the 12 AMPK-related kinases (Lizcano et al., 
2004; Evans et al., 2016; Evans, 2018). However, regardless of the 
LKB1-dependent signalling pathways that determine type I cell afferent 
discharge, AMPK activity clearly seems to serve a crucial function in 
facilitating appropriate ventilatory adjustments that shape the HVR, a 
component of which, according to these findings, must originate centrally 
within the brainstem respiratory network. Indeed, by using functional 
magnetic resonance imaging (fMRI), two well defined regions within the 




neuronal activity upon AMPK deletion in catecholaminergic cells relative to 
controls (Mahmoud et al., 2016), which were termed the ‘dorsal active 
region’ (DAR) and ‘ventral active region’ (VAR). Importantly, their anatomical 
locations were consistent with those of the dorsal nucleus tractus solitarius 
(NTS) and the ventrolateral medulla, respectively, which receive CB 
chemoafferent fibre inputs and harbour the dorsal catecholaminergic A2 and 
C2 cell groups and the ventral catecholaminergic A1 and C1 cell groups 
(Finley & Katz, 1992; Erickson & Millhorn, 1994; Li et al., 2008; Kline et al., 
2010). Therefore, the question arose whether specific brainstem 
catecholaminergic cells may be able to respond to hypoxia centrally and thus 
support the HVR in a manner that is dependent on AMPK activity. 
 
1.4.1 Central oxygen-responsive neurons of the brainstem 
Dominating within both the scientific and educational literature is the 
commonly held view that the central nervous system lacks a defined O2 
sensor capable of stimulating ventilation during periods of hypoxia. This may 
be the case for humans, as there appears to be no documented case of a 
retained HVR following bilateral carotid body resection (Timmers et al., 
2003; Gourine & Funk, 2017). By contrast, a variety of mammalian animal 
studies have demonstrated that the HVR can be partially or completely 
restored after either denervation or surgical removal of the CB (Davenport 
et al., 1947; Miller & Tenney, 1975; Bisgard et al., 1980; Martin-Body et al., 
1986; Daristotle et al., 1991; Roux et al., 2000a). Therefore, the existence 
of a central respiratory O2-sensitive network seems likely after all and, given 
that larger mammals appeared to require a considerably longer time period 
to recover evidence of a HVR, the possibility remains that due to the small 
number of cases and lack of long-term follow-up studies any degree of 
restoration of a HVR in humans may have simply remained undetected. 
Indeed, several hypoxia-responsive sites have been identified within the 
rodent brain, some of which were inhibitory and related to hypoxic ventilatory 
depression (thalamus and pons) (Martin-Body, 1988; Kramer et al., 1999), 
while others were excitatory and related to increased respiratory activity 




Horn & Waldrop, 1997; Pascual et al., 2002). Of these excitatory networks 
that increase ventilation, catecholaminergic neurons seem to be the likely 
candidate to modulate the ventilatory response to hypoxia. Catecholamines, 
in particular noradrenaline, often have a stimulating effect on the respiratory 
network and several studies have linked the activity of catecholaminergic 
A1/C1 neurons of the ventral medulla and A2/C2 neurons of the dorsal 
medulla to increases of ventilation (Teppema et al., 1997; Zanella et al., 
2006; Viemari, 2008; King et al., 2012; King et al., 2013; Burke et al., 2014; 
King et al., 2015). Furthermore, genetic mutations within catecholaminergic 
neurons have been related to mortality due to respiratory diseases such as 
Rett syndrome (Ide et al., 2005; Viemari et al., 2005; Weese-Mayer et al., 
2006; Roux et al., 2010) . Therefore, the catecholaminergic neurons of the 
medulla oblongata are attractive candidates for conferring an O2-sensing, 
hypoxia-responsive network within the brainstem.  
 
1.4.2 AMPK within the catecholaminergic cells of the brainstem  
If such a brainstem catecholaminergic network with central O2-sensitivity 
truly existed, then it may offer an explanation of how the deletion of AMPK 
could have had a more severe impact on the HVR than deletion of LKB1, 
while retaining a completely normal afferent discharge from the carotid 
bodies that was abolished upon LKB1 deletion. If the HVR was not solely 
determined by chemoafferent inputs to the respiratory centres of the 
brainstem, but also by the activity of a central hypoxia-sensitive network 
within the brainstem, then their coordinated action could determine its full 
extent. In support of this view, the HVR of amphibians is modulated by 
O2-sensing cells within the caudal brainstem while the role and the 
anatomical location of the peripheral chemoreceptors changes during the 
metamorphosis from the gill breathing tadpole to the lung-assisted, air 
breathing adult (Jia & Burggren, 1997; Porteus et al., 2011). It seems 
therefore entirely possible that throughout evolution the peripheral 
chemoreceptor inputs may have been periodically reconfigured about a 
common ancestral hypoxia sensor located within the caudal brainstem, 




of respiratory adjustments during hypoxia (Evans et al., 2016; Evans, 2018). 
Further support for this view comes from the fact that brainstem hypoxia 
alone may initiate increases in ventilation, given that there is continuous 
basal afferent input from the carotid bodies (Smith et al., 1993; Curran et al., 
2000). In addition, different aspects of the brainstem respiratory network 
may have different hypoxic sensitivities (Hill et al., 2011), and partial 
recovery of the HVR following CB resection may be derived from 
hypoxia-sensitive catecholaminergic neurons of the caudal brainstem in 
some animals (Smith & Mills, 1980; Roux et al., 2000a; Roux et al., 2000b). 
Furthermore, dysfunction of these catecholaminergic neurons has been 
shown to precipitate hypoventilation and apnoea associated with Rett 
syndrome, which worsens under hypoxic conditions (Roux & Villard, 2010).  
The evidence for a role of AMPK signalling in the central response to hypoxia 
came from the genetic deletion strategy which targeted AMPK deletion to 
catecholaminergic cells. As mentioned earlier, CB afferent discharge was 
retained during hypoxia, yet the HVR was severely attenuated. Furthermore, 
fMRI studies on these knockout mice revealed a reduction in activity of 
discrete dorsal and ventral nuclei of the caudal brainstem during hypoxia 
which matched the location of catecholaminergic neurons within the NTS 
(A2 and C2 neuronal groups) and VLM (A1 and C1 neuronal groups), which 
also represent the primary site of CB afferent input (Finley & Katz, 1992; 
Koshiya & Guyenet, 1996; Guyenet, 2000; Teppema & Dahan, 2010; 
Mahmoud et al., 2016).  
Therefore, these findings support a model of AMPK-dependent modulation 
of discrete nuclei within the caudal brainstem called DAR and VAR, which 
during hypoxia deliver increases in the drive to breathe via afferent 
projections to neural networks that modulate the ventral rCPG (see also 






Based on the assumption that a cluster of hypoxia-responsive neurons 
proximal to the NTS may form a nucleus that acts as a ‘gatekeeper’ of the 
HVR, I hypothesise that the LKB1-AMPK signalling pathway supports 
coincidence detection at either a single node or possibly multiple nodes 
within, and thus activation of, a hypoxia-responsive circuit that 
encompasses, at the very least, dorsal A2/C2 neurons of the NTS as 
suggested by the DAR, and ventrolateral A1 neurons as suggested by the 
VAR (Figure 1.7) (Evans et al., 2016; Mahmoud et al., 2016; Evans, 2018). 
Within this circuit, the capacity of AMPK activation may be determined by 
the co-action of ‘local hypoxic stress’ within the brainstem that increases the 
AM(D)P:ATP ratio via decreases in ATP supply (Hardie, 2014), coupled to 
‘applied metabolic stress’ via neuronal activation following afferent inputs 
from peripheral chemoreceptors and thus increases in ATP usage. 
Activation of AMPK, and thus the brainstem respiratory network, may 
therefore be determined by the coupling of chemoafferent fibre input and 
brainstem hypoxia. Thereafter, efferent output and increases in the drive to 
breathe may be facilitated by AMPK-dependent modulation of cellular 
metabolism, ion channel activity, neuronal firing frequency and/or 
neurotransmitter release in a manner that may be attenuated or augmented 
via regulation of AMPK expression (Lipton et al., 2001; Murphy et al., 2009; 





Figure 1.7: Schematic model of the AMPK-dependent integration of 
local hypoxic and applied metabolic stress that together determine the 
hypoxic ventilatory response.
Activation of AMPK within brainstem catecholaminergic A1 and C1 neurons 
corresponding to the ventral active region (VAR), as well as A2 and C2 
neurons corresponding to the dorsal active region (DAR), is determined by 
the synergistic effects of ‘local hypoxic stress’ (decreases in ATP supply) 
caused by brain hypoxaemia and ‘applied metabolic stress’ (increases in 
ATP usage) caused by increased neuronal activity subsequent to carotid 
body chemoafferent fibre input. AP: area postrema; NTS: nucleus tractus 
solitarius; rCPG: respiratory central pattern generators; LKB1: liver kinase 






1.6 Aims of the Thesis 
The studies performed in this thesis aimed to investigate whether 
AMPK-dependent signalling pathways originating within the DAR and VAR 
could modulate the HVR centrally. Given the retained CB chemoafferent 
fibre discharge, this involved utilising the mouse model of targeted dual 
deletion of the AMPK-α1 and -α2 catalytic subunits in catecholaminergic 
cells in order to: 
1) Investigate the effect of AMPK deletion in catecholaminergic cells on 
the ventilatory responses during acute and more prolonged 
exposures to mild and severe hypoxia by unrestrained whole-body 
plethysmography.  
2) Investigate the effect of AMPK deletion in catecholaminergic cells on 
the dorsal brainstem respiratory network activity by 
immunohistochemical staining for nuclear cFos expression as an 
index of neuronal activation following exposures to hypoxia.  
3) Investigate the effect of AMPK deletion in catecholaminergic cells on 
the apnoeic phenotype, with particular focus on the separation of 
spontaneous and post-sigh apnoeas. 
4) Investigate the effect of AMPK deletion in catecholaminergic cells on 
the ventilatory duty cycle during exposures to mild and severe 
hypoxia by using unrestrained whole-body plethysmography. 
5) Investigate the effect of AMPK deletion in catecholaminergic cells on 
the cardiovascular responses to hypoxia by tail cuff and pulse 
oximetry and comparing the hypoxia-induced cardiovascular 
responses of mice with AMPK deletion in catecholaminergic cells to 
those of mice with AMPK deletion in arterial smooth muscle cells. 
6) Compare the ventilatory responses during acute exposures to severe 
hypoxia of mice with AMPK deletion in catecholaminergic cells to 









2.1 Mouse models and colony management 
All experiments were performed in accordance with the regulations of the 
United Kingdom Animals (Scientific Procedures) Act of 1986. All studies and 
breeding schemes were approved by the University of Edinburgh and 
performed under UK Home Office project and personal licenses. Both adult 
male and female mice were used, and all were bred on a C57/Bl6 
background unless stated otherwise. Numbers of mice (≥3 per measure) 
used are indicated for each experiment. 
 
2.1.1 Mice containing transgenic loxP sites surrounding the catalytic 
α1 and α2 subunits of AMPK 
The foundation of the research undertaken for this thesis was based on 
transgenic mice carrying loxP sites which flank both of the AMPK catalytic 
α-subunits (Viollet et al., 2003; Jorgensen et al., 2004b). These genetic 
modifications were global, which means every cell of the entire organism 
carried a homozygously “floxed” AMPK-α1 and -α2 subunit.  
Because loxP sites were strategically placed in the introns surrounding the 
coding exons, the transcription and translation of the α-subunits was not 
disturbed, thus giving rise to phenotypically wild-type mice which throughout 
this thesis were used as genetic “wild-type” controls.  
 
2.1.2 Targeted deletion of AMPK-α1 and -α2 subunits by transgenic 
expression of Cre recombinase under the reporter of tyrosine 
hydroxylase 
In order to target AMPK-α1 and -α2 subunit deletion to only 
catecholaminergic cells, Cre recombinase was conditionally expressed 
under the promoter for tyrosine hydroxylase (TH), the rate-limiting enzyme 
in catecholamine biosynthesis which converts Tyrosine to L-DOPA 
(Karobath, 1971). Thus, all dopaminergic, noradrenergic, and adrenergic 
cells of the organism were targeted. Cre insertion into the 3’ UTR of the gene 
for TH was achieved by genetic knock-in of a vector encoding for an 




the gene for Cre recombinase (Lindeberg et al., 2004), thereby creating a 
bicistronic mRNA strand that allows for co-expression of both tyrosine 
hydroxylase and Cre recombinase.  
Repeated crossing of TH-Cre mice with AMPK-α1/α2 homozygous floxed 
(AMPK-α1/α2 Flx) mice resulted in offspring that carried heterozygous 
TH-driven Cre recombinase and global homozygous loxP sites for the AMPK 
catalytic α-subunits, thereby generating cell type-specific AMPK-α1/α2 
double knock-out (TH AMPK-α1/α2 dKO) mice. Confirmation of the 
presence of all target transgenes was done by genotyping, as described in 
section 2.1.6.  
Using this approach meant that conditional AMPK-α1/α2 deletion will occur 
from the first time expression of TH, and hence Cre, is initiated during 
development, even if this expression is only transient. Therefore, loss of 
AMPK activity in the adult could be, at least partially, compensated for by 
alternative metabolic coping strategies, which may extend to the way 
targeted cells respond to a hypoxic stimulus. One possibility to circumvent 
cellular compensatory mechanisms would be to utilise ligand-dependent 
chimeric Cre recombinases (CreER recombinases), which are inherently 
inactive but activated by administration (e.g. oral, intraperitoneal, 
intravascular) of tamoxifen (Feil et al., 2009). This method would therefore 
not only allow for spatial control of gene knockout, but also temporal. 
Moreover, it would allow us to test whether cellular mechanisms are 
engaged that could compensate for AMPK-α1/α2 subunit deletion. 
 
2.1.3 Targeted deletion of AMPK-α1 and -α2 subunits by transgenic 
expression of Cre recombinase under the reporter of 
Phenylethanolamine N-methyltransferase 
I also wished to further investigate the requirement of AMPK in 
catecholaminergic cells and sought to compare the phenotype of 
catecholaminergic AMPK-α1/α2 dKO mice to that of adrenergic 




This was achieved by utilising a transgenic mouse model whereby the gene 
encoding for Cre recombinase was inserted into exon 1 of the 
Phenylethanolamine N-methyltransferase (PNMT) gene (Ebert et al., 2004). 
PNMT is the final rate-limiting enzyme of catecholamine synthesis, which 
transfers a methyl-group from S-adenosyl-L-methionine onto noradrenaline, 
thereby converting it to adrenaline. By using this strategy, Cre was 
exclusively expressed in adrenergic cells.  
Once again, PNMT-Cre mice were crossed with AMPK-α1/α2 Flx mice, 
resulting in offspring that carried a heterozygous PNMT-driven Cre 
recombinase and global homozygous loxP sites for the AMPK catalytic 
α-subunits, thus generating adrenergic cell type-specific AMPK-α1/α2 
double knock-out (PNMT AMPKα1+α2 dKO) mice.  
Confirmation of the presence of all target transgenes was done by 
genotyping, as described in section 2.1.6.  
 
2.1.4 Targeted deletion of AMPK-α1 and -α2 subunits by transgenic 
expression of Cre recombinase under the reporter of transgelin   
Given the distinct possibility of Cre-leakage and ectopic expression of TH in 
the developing heart (Lindeberg et al., 2004), I also sought to assess the 
effects of AMPK deletion in the cardiovasculature. This was achieved by 
crossing AMPK-α1/α2 Flx mice with mice expressing Cre recombinase 
under the control of the SM22 promoter (Holtwick et al., 2002), a smooth 
muscle-specific gene encoding for transgelin. Because viability of mice with 
dual deletion of AMPK catalytic subunits in smooth muscle (Sm) cells is 
compromised (Moral-Sanz, J., awaiting publication), colonies were 
maintained as Sm AMPK-α1 KO and Sm AMPK-α2 KO, or as precursory 
breeders for Sm AMPK-α1/α2 dKO, whose AMPK catalytic subunits were 
heterozygously floxed and therefore retained a low level of AMPK-α1 and 
AMPK-α2 expression. 
Confirmation of the presence of all target transgenes was done by 





2.1.5 Breeding plan 
To maintain colonies, one male and two female AMPK-α1/α2 Flx mice were 
continuously crossed with each other. For the knockout lines, virgin 
AMPK-α1/α2 Flx mice were mated with either TH AMPK-α1/α2 dKO or 
PNMT AMPK-α1/α2 dKO mice. Although in-breeding of the mouse lines 
could not be circumvented, brother-sister matings were avoided by mating 
cousins. No fertility or viability problems were recorded. 
Breeding for the Sm AMPK-α1 KO, Sm AMPK-α2 KO, and Sm AMPKα1+α2 
dKO mice was carried out and managed by Dr Oluseye Ogunbayo 
independently of the other three colonies mentioned above. 
Pups were ear notched by the technicians within the animal facility for 
genotyping and identification at 14 days of age and weaned at 21 days of 
age. Whenever possible, male mice were kept alongside littermates and 
females in company of up to 5 other mice, which has been shown to promote 
well-being and reduce stress (Deacon, 2006).  
 
2.1.6 Genotype analysis 
Ear notch samples, between 1 to 3 pieces of approximately 4mm2 from each 
animal, were stored in DNAse free 1.5ml Eppendorf tubes at -20°C until 
addition of 120μl Direct PCR lysis buffer (Viagen Biotech, Inc.) and 6μl of 
20mg/ml Proteinase K (Thermo Fisher). Samples were incubated overnight 
at 55°C in a rotating hybridisation oven (Thermo Hybrid) and the activity of 
Proteinase K stopped by moving the samples into a waterbath at 85°C for 
45min. This step is crucial to ensure proper activity of Taq polymerase during 
the subsequent PCR. 
For the PCR reaction, a total reaction volume of 26μl per sample was used. 
Each reaction mix consisted of 2μl of sample lysate, 12.5μl of 2xGoTaq® 
Polymerase Green Master Mix (Promega), 1.6μl from a 10μM stock of each 
primer, as well as nuclease-free water to the final volume. All primers used 




The PCR was carried out using a SimpliAmpTM Thermal Cycler (Applied 
Biosystems) under the conditions illustrated in Table 2.2. 10μl of PCR 
products were run on a 2% agarose gel made with 10% SYBR®Safe DNA 
gel stain (Invitrogen) to visualise DNA bands, and a 100bp DNA Ladder 
(Promega). Each gel was run in a Sub-cell GT gel tank with a PowerPac™ 
Basic Power Supply (Bio-Rad) for 35-45min and imaged using a Genius Bio 














5’ TATTGCTGCCATTAGGCTAC 3’ 
α1-REV: 








5’ GCTTAGCACGTTACCCTGGATGG 3’ 
α2-REV: 







5’ CACCCTGACCCAAGCACT 3’ 
TH-REV: 
5’ CTTTCCTTCCTTTATTGAGAT 3’ 
Cre-UD: 







5’ CAGGCGCCTCATCCCTCAGCAGCC 3’ 
22: 










5’ GCGGTCTGGCAGTAAAAACTATC 3’  
79: 
5’ GTGAAACAGCATTGCTGTCACTT 3’  
80: 
5’ CTAGGCCACAGAATTGAAAGATCT 3’ 
81: 










Table 2.2: PCR protocols used for genotyping of transgenic mice. 




























































2.2  Unrestrained whole-body plethysmography 
To study ventilation during various degrees of hypoxia in conscious mice, an 
unrestrained whole-body plethysmography chamber (Buxco) was used. The 
advantages of this method are that each animal can be habituated to the 
environment, which on experimental days reduces stress levels and animals 
are generally calmer sooner. In addition, the animal can roam freely within 
a confined space and is allowed to explore and groom naturally until it has 
settled. The high sensitivity of the transducer to detect pressure differences 
during respiration ensures a high degree of accuracy for the measurements 
obtained.  
 
2.2.1 System setup 
The plethysmograph itself is made of Plexiglas and consists of a 450ml 
mouse chamber and a 100ml reference chamber (Figure 2.1). Linked to both 
chambers is a differential pressure transducer on one side, which is 
connected to a preamplifier, and a HalyconTM low noise pneumotachograph 
on the other side. Room air is drawn in through the pneumotachograph and 
is withdrawn at the bottom of the mouse chamber by the bias flow outlet at 
a rate of 1l/min. The gas inlet, which feeds into the mouse chamber and is 
connected to the transducer and pneumotachograph, is regulated by a valve 
at the top of the plethysmograph. An inlet rate greater than 1l/min (rate of 
bias flow outlet) must be ensured to avoid drawing in room air during gas 
challenges. A direct supply of gas was used which originated from a 
pre-mixed gas cylinder (BOC). Each cylinder was composed of 0.05% CO2 
(500ppm) and 12% or 8% O2 balanced in N2. The gas supply and flow were 
regulated via a pressure gauge on the gas cylinder, as well as a second 
distribution reservoir fitted with a pressure gauge (Buxco) to ensure air flow 
was constant. A gas flow of 2l/min was chosen for all experiments, including 






Figure 2.1: Schematic of the mouse whole-body plethysmography 
apparatus.  
During normoxia, air is drawn out of the mouse chamber (1) from the bias 
flow outlet (5). The negative pressure thereby created results in room air 
being drawn into the chamber via the pneumotachograph (4) air inlet. During 
experiments a single mouse would be placed on the platform (grey dashed 
lines) and the chamber closed. During animal ventilation within the sealed 
chamber, a pressure transducer (3) monitors the pressure changes that 
occur in the mouse chamber relative to the reference chamber (2) and relays 
the information to a preamplifier for subsequent analysis. Hypoxia is 
introduced by opening a valve (7) at the gas inlet (6) ensuring that the gas 





2.2.2 FinePointe acquisition software 
The foundation of data acquisition by this method is the occurrence of 
pressure changes during inhalation and exhalation within an enclosed 
environment (Chapin, 1954). During inhalation, the air becomes humidified 
and warmed by the animal’s lungs, thereby expanding in volume. This 
expansion within the lungs means the volume within the thorax is larger than 
the initially inspired volume, which increases the overall pressure in the 
sealed mouse chamber relative to the reference chamber that retains a 
constant pressure. During exhalation, air cools again and water vapor 
condensates, whereby the pressure decreases again. These pressure 
differences in relation to the reference chamber are measured by the 
transducer, which relays them to the acquisition software as a ‘box flow’ 
graph with a sampling frequency of 1kHz.  
The FinePointe software (DSI, version 2.4.6.9414) computes the received 
signals and displays the outcomes graphically and numerically. For the 
graphical box flow, a value of zero indicates no pressure differences 
between the mouse and reference chamber due to no respiratory activity. 
During inspiration the box flow crosses into negative pressure, whereas 
expiration is determined by positive pressures. Because the box flow is 
plotted over time, the data is displayed as a waveform from which several 
parameters are calculated. The duration of inspiration (Ti) and expiration 
(Te) are calculated as the time taken to cross the zero point, and the total 
breath duration (To) can be computed. From this, respiratory frequency per 
minute (60/To) can be deducted. A little more complex is the determination 
of the tidal volume, which takes into consideration the pressure changes 
within the chamber and the box flow amplitudes according to the formula by 
Drorbaugh and Fenn (Drorbaugh & Fenn, 1955). This formula accounts for 
body and ambient temperatures, humidity, and their subsequent influence 
on the pressure changes. Finally, the product of respiratory frequency and 
tidal volume allows for calculation of minute ventilation. Because pressure 
changes are also very sensitive to movement artefacts the software also 
incorporates a series of algorithms to reject periods that were considered 




Numerical data was acquired as averages of 2sec intervals, for which the 
software automatically computed the above mentioned values.  
 
2.2.3 Experimental protocols 
Prior to experimental procedures, naïve mice were habituated to the 
chamber environment on 5 consecutive days for 30 minutes 
(Plethysmography) or 60 minutes (cFOS expression analysis) at room air. 
 
2.2.3.1 Plethysmography measurements 
Following habituation, mice were placed in the plethysmography chamber 
and allowed to settle for 5 minutes before commencing measurements at 
room air. The duration of room air exposure would last until at least 3 or 4 
baseline measurements were obtained (see section 2.2.4.1). Room air 
exposures were followed by flushing and maintaining delivery of 12% or 8% 
O2 into the chamber. The FinePointe system automatically includes a 30s 
“washing” period, after which the 10min experimental period began. At the 
end of the hypoxic exposures, a 5min recovery period was recorded during 
which animals were breathing room air again. A full recovery indicated by 
activity, grooming, or sniffing must have been observed before the mice 
were placed back in their home cage and allowed to rest for at least 48 
hours.  
 
2.2.3.2 cFos expression analysis 
As described above, following habituation mice were placed in the 
plethysmography chamber and allowed to settle for 5 minutes before 
commencing measurements at room air. The duration of room air exposure 
would last for 15min, regardless of whether a baseline record has been 
obtained or not. Room air exposures were either maintained at 21% O2 for 
controls, or followed by flushing and maintaining delivery of 12% or 8% O2 
into the chamber for 60min. At the end of the 60min period, room air was 




were injected intraperitoneally with 2000mg/kg Pentobarbital Sodium 
(Merial) within a 5min period and immediately perfused thereafter (see 
section 2.5.1). 
 
2.2.4 Respiratory analysis 
In order to assess the ventilatory phenotypes of the genetic mouse models 
described above, ventilatory parameters such as respiratory frequency, tidal 
volume, minute ventilation, inspiration time and expiration time were 
computed by the FinePointe software over a 2s period and analysed for 
control and knockout mice according to the  criteria described below. 
 
2.2.4.1 Baseline measurements 
Each experiment of hypoxic exposures was preceded by a period of 
normoxic recordings. This period aimed to collect samples of baseline 
breathing, which were required to compute the percentage changes of 
breathing parameters during hypoxia. Baseline records were selected 
following a strict set of criteria: 1 – the animal had to be sitting quietly in the 
chamber without grooming, sniffing, or eating; 2 – the box flow pattern had 
to be regular and at least 4 breaths in length; 3 – the respiratory frequency 
and tidal volume should have been within the range of 150-250 breaths/min 
and 0.2-0.35ml, respectively (Palmer et al., 2013), even though 
subconscious bias often lead to a selection of baselines with frequencies 
close to 200 breaths/min and tidal volumes around 0.3ml. Example traces of 







Figure 2.2 Exemplary box flow records of baseline breathing.  
Raw box flow traces show exemplary periods selected as baselines. 
Respiratory values computed by the FinePointe software for these periods 
were: (A) 205.2breaths/min, 0.33ml, 68.91ml/min; (B) 209breaths/min, 
0.26ml, 55.2ml/min; (C) 202.42breaths/min, 0.30ml, 62.14ml/min; (D) 




2.2.4.2 Hypoxic ventilatory response during 5min exposures 
In order to assess the HVR during 5min exposures, the following points were 
chosen for analysis: 1 – the peak of the Augmenting phase (around 30s), 2 
– the nadir of the “Roll-Off”, (around 100s), and 3 – the plateau of the 
Sustained phase (around 300s). At or closest to each time point, a 2-8s 
period of ventilation was selected which was free of sighs, apnoeas, and 
movement.  
 
2.2.4.3 Minute-by-minute ventilatory response 
Respiratory frequency, tidal volume and minute ventilation were also 
analysed after every whole minute of hypoxia (i.e. in 60s intervals). The start 
point of hypoxia was chosen as the time point of the gas exchange, and not 
following the 30s “washing period” included by the FinePointe software. A 
6s breathing period was selected with the following criteria: 1 – free of sighs, 
2 – free of apnoeas unless unavoidable, 3 – free of movement artefacts, and 
4 – as close to the intended time point as possible. Occasionally, only a 2s 
or 4s period could be used. 
 
2.2.4.4 Whole minute ventilatory response 
For AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice respiratory data was 
also analysed as whole-minute averages (see Appendix 1). As above, the 
hypoxic start point was the moment of gas exchange and averages were 
taken for each full minute. For the first minute, however, values were only 
used for analysis once the animal started to respond to the hypoxic stimulus, 
which was evident by a cessation of sniffing and presentation of a more 
regular breathing pattern that usually occurred 25-35s after the onset of 
hypoxia. Thereafter, any occurrences of sighs, apnoeas, movements, or 





2.2.4.5 Duty cycle analysis 
In order to assess the time course of the ventilatory duty cycle in control and 
knockout mice, the values acquired by the FinePointe software for 
inspiration time (Ti), expiration time (Te), and total breath time (To, manually 
calculated as Ti+Te) were displayed as the ratiometric changes of 
hypoxia:normoxia. Each hypoxic value, starting 30s after the gas exchange, 
was divided by the total average of normoxic values, which were taken from 
the same time points as the baseline measurements described above. In 
addition, the ratios of tidal volume to inspiration time (Tv/Ti), expiration time 
(Tv/Te), and total breath time (Tv/To) were analysed in relation to normoxia.  
 
2.2.5 Apnoea and sigh analysis 
The raw box flow data from the point of gas exchange was extracted into 
CSV files and run through a Python script designed by Prof Mayank Dutia 
(University of Edinburgh). This script detects apnoeas as cessations of 
breathing that were greater than the average duration, including the interval, 
of 2 successive breaths (600ms) during normoxia, with a detection threshold 
of 0.25mmHg (SD of noise). Apnoeas were also separated manually based 
on whether or not they were immediately preceded by a sigh. All apnoeas 
were analysed in terms of frequency (apnoeic index, AI), duration, and the 
product of frequency and duration (apnoea-duration index, ADI). Sighs, 
regardless of whether they were accompanied by an apnoea or not, were 
also analysed, but only in terms of their frequency (sigh index, SI). 
 
2.3 Blood pressure 
Given that a subset of the catecholaminergic neurons targeted by our 
conditional AMPK deletion strategy employed have been heavily implicated 
in the control of the baroreflex, (Ross et al., 1984; Dampney et al., 2002; 
Guyenet, 2006; Guyenet et al., 2013), measurements of blood pressure and 
heart rate during exposures to hypoxia have been carried out by tail cuff and 





2.3.1 Kent CODA tail cuff system 
To measure blood pressure under normoxic and hypoxic conditions, the tail 
cuff method was chosen. The CODA™ Non-Invasive Blood Pressure 
System (Kent) works on the principle of volume pressure recording (VPR), 
whereby a VPR sensor measures the characteristics of returning blood flow 
from an occluded tail artery during deflation of an occlusion cuff (O-cuff). 
First, the VPR cuff inflates to push blood out of the tail. Immediately following 
this the O-cuff inflates to a maximum occlusion pressure of 250mmHg, which 
stops the flow of blood back into the tail. The O-cuff is then slowly deflated 
over a pre-set 20s period. Once blood flows back into the tail the VPR cuff 
senses the pulsations of the returning blood flow, and hence the “swelling” 
of the tail.  
On the graphic display, the returning blood flow can be seen as an increase 
in the VPR graph and at the first sign of “swelling” the systolic blood pressure 
(SBP) is measured (Figure 2.3 A). Diastolic blood pressure (DBP) is 
determined once the increasing rate of swelling first starts to cease. Once 
blood flow has been fully restored the graph on the monitor peaks and then 
declines as the cuff finishes its deflation.  
Mean blood pressure (MBP) is then calculated by the following formula: 
MBP = DBP + ()*+,)*
-
. 
An advantage of this method is that direct pressure changes are measured 
in the tail, as opposed to light emission and absorption, which is limited in 
animals with dark pigmentation such as our genetic background of 
C57BL/6J mice.  
The software also includes several exclusion criteria by which it assesses 
each measured cycle. The most commonly encountered reasons for 
exclusion were “wrong shape”, which was usually caused by animal 
movements that created dramatic artefacts in the graphs (Figure 2.3 B), and 
“no tail volume”, which meant blood flow in the tail could not be detected and 
the VPR graph was largely a straight line (Figure 2.3 C). Occasionally, the 




physiologically possible. However, subjective exclusion needed to also be 
applied in some cases, for example when sighs obviously influenced the 








Figure 2.3 Example records obtained during blood pressure 
measurements.  
Panels show examples of (A) a good cycle, where measurements for 
systolic (square) and diastolic (circle) pressures were obtained accurately; 
(B) a cycle that was affected by mouse movement; (C) a cycle where no 
blood flow was detected; (D) and a cycle where the detection of diastolic 




2.3.2 Experimental protocols 
Before commencing blood pressure experiments, all mice were habituated 
to the restraint of a mouse holder (Kent) to reduce stress-induced blood 
pressure responses. For this, mice were placed in the pre-warmed holder 
for 30mins on 5 consecutive days.  
On the day(s) of the experiment, each mouse was placed in the pre-warmed 
mouse holder and allowed to settle for 5mins with the cuffs attached to the 
tail.  
The first objective was to obtain measurements of resting blood pressure 
while breathing room air. For this, blood pressure was taken in 32 cycles 
with a 5s pause between each cycle, until 3 good records have been 
obtained (see section 2.3.3 for definition of “good records”). 
Blood pressure during hypoxia was measured on separate days after 
completion of all resting blood pressure measurements. For this protocol, 13 
cycles of measurements were taken during room air, which served as a 
baseline, followed by 16 cycles of hypoxia (12% or 8% O2 in 0.05% CO2, 
balanced in N2) and 8 cycles of recovery at room air. The durations of these 
cycles correspond to approximately 8mins room air, 10mins hypoxia, 5mins 
recovery. Hypoxic gas originated from a pre-mixed gas cylinder (BOC) and 
was delivered at a flow rate of 2l/min via a head cone that inserted into the 
mouse holder. 
 
2.3.3 Blood pressure analysis 
The tail cuff measurements are extremely sensitive to disturbances, such as 
animal movements or respiratory sighs. Such disturbances create artefacts 
in the VPR graph that interfere with appropriate detection of SBP and DBP 
points. Cycles that contained interferences were excluded from the analysis. 
If the disturbance only interfered with one of the measurements, then this 
value plus the mean blood pressure value were omitted from the analysis. 
The exclusion of cycles and data ultimately lead to a reduction in available 




of the data needed to be retained during hypoxic exposures in order for the 
experiment to be considered for group analyses.  
 
2.4  Peripheral arterial oxygen saturation and heart rate 
In order to measure peripheral arterial oxygen saturation (SpO2) and heart 
rate (HR) in mice during hypoxia, the PhysioSuite® MouseSTAT™ module 
(Kent) was used, which uses pulse oximetry for its measurements. 
 
2.4.1 Kent PhysioSuite® system 
The pulse oximeter is a Y-clip, which is attached to the tail of the mouse and 
contains a sensor that measures SpO2 and HR. One side of the sensor emits 
light at two different wavelengths – red and infrared. On the other side of the 
clip is a photosensor, which detects the light signals that have passed 
through the body tissue. Several factors influence the detection of light, such 
as tissue thickness, appropriate placement of the sensor, and, of course, the 
O2 content of arterial and venous blood, because the absorption rate is 
higher in O2-depleted blood than in O2-rich. It is very important to avoid 
restriction of blood flow, as the measurements depend on a pulsating 
vascular bed. It has previously been observed that measuring SpO2 in the 
tail is quite challenging and often leads to inaccurate readings. It was found 
that the perfusion rate varies greatly along the length of the tail, and warming 
of the animal increases perfusion rates at different degrees on the base, 
middle, and tip of the tail (Wu et al., 1995). Therefore, in order to ensure 
adequate blood flow and reproducibility, each animal was pre-warmed on a 
heating platform and the clip always placed at or as close as possible to the 
base of the tail. The sampling rate of the sensor was set to 0.5Hz. 
 
2.4.2 Experimental protocol 
As described in section 2.3.2, all animals were pre-habituated to the mouse 





Following 5min acclimation in the mouse holder, the tail clip was attached 
and repositioned until the SpO2 levels read between 95-99% (Ceylan et al., 
2016). After a 2min baseline, hypoxia (12% or 8% O2, 0.05% CO2, balanced 
in N2) was introduced via a head cone with an air flow of 2l/min for a duration 
of 10min. Exposures were then terminated and the animals allowed to 
recover for 3-5mins before being returned to their home cages.   
 
2.4.3 SpO2 and HR analysis 
The analysis for both SpO2 and HR was carried out identically, in that a total 
average was taken of the 2min baseline, the 10min exposure to hypoxia, 
and the entire recovery period.  
 
2.5  Brainstem immunohistochemistry 
In order to evaluate the activation of brainstem neurons after exposures to 
hypoxia, control and knockout mice were culled at the end of the experiment 
by an overdose of anaesthesia and the brains fixed for 
immunohistochemical processing. 
 
2.5.1 Perfusion, fixation and cryoprotection 
Following administration of an overdose of sodium pentobarbital as 
described in section 2.2.3.2, mice were checked for the absence of signs of 
breathing and withdrawal to pain by squeezing the paw with forceps. Once 
confirmed, the thoracic cavity was opened and the ribcage clamped back. 
The exposed heart, which at this point was still beating, was freed of the 
pericardium and any fat obstructing access before inserting the tip of a 
25mm StericanÒ 26-gauge needle (Braun) into the left ventricle. The needle 
had been previously attached to the tubing of an Autoclude peristaltic 
infusion pump (Verder) and filled with ice-cold heparinised saline (Table 
2.3). Immediately after switching on the peristaltic pump an incision was 
made to the right atrium of the heart to drain the fluid that flowed through the 




80-100ml of heparinised saline were passed before infusing approximately 
50-100ml of 4% paraformaldehyde (Table 2.3). A good perfusion resulted in 
the immediate and full clearance of the liver, no inflation of the lungs, no 
dripping of fluid from the mouth or nose, a robust ‘formalin dance’ and 
muscle twitching, and finally overall stiffness of the entire body of the mouse.  
Following transcardial perfusion and fixation, brains were carefully removed 
from the skull and placed overnight into Post-Fix solution (Table 2.3) at 4°C. 
Once sunken to the bottom of the vessel, brains were transferred into a 30% 
sucrose solution and stored at 4°C. For longer-term storage (several 
months), 0.01-0.05% sodium azide was added to the 30% sucrose solution 
to prevent fungal and bacterial growth.  
 
2.5.2 Sectioning of the brainstem 
To prepare for cryosectioning, brains were blotted dry on tissue paper and 
the brainstem separated from the forebrain roughly at the point of the optic 
chiasm using a sharp razor blade. A further incision was made to the right 
side of the brainstem in order to differentiate left and right sides during 
mounting. Brainstems were wrapped in aluminium foil and flash frozen in 
ground dry ice. Frozen brainstems were then mounted caudal side up onto 
a Frigomobil freezing microtome (Leica) set to -17°C to -18°C, covered in 
Cryo-M-Bed embedding compound (Bright) and allowed to freeze again.  
Sections were cut with a 33° blade at a thickness of 30μm and collection 
started as soon as the cerebellum became visible. Per vial, a series of 7 
alternating sections (A’s and B’s), each separated by 60μm, were collected 
in 0.1M phosphate buffer (PB) and later transferred into cryoprotecant (see 
Table 2.3) for storage at -20°C.  
One of the major problems arising with this procedure was that the brain 
would almost certainly be mounted at an angle onto the cryostat platform, 
which resultes in sections at slightly different anatomical planes 
(‘dorsoventral tilt’). Another challenge was the fragility of the sections during 
the cutting, as improper fixation, storage, or freezing could lead to tissue 




handling often tore apart. Fragility also arose from the thickness of the 
sections, as most commonly brains were cut at 40-44μm thick. However, I 
was unable to obtain double staining at this thickness and changes in the 
staining protocol did not overcome this issue. Only once I reduced the 
thickness to 30μm the double labelling was successful.  
 
2.5.3 Immunohistochemistry – fluorescence 
For immunostaining, several vials per animal from the same alternation 
(either all A’s or all B’s per animal) were used. All procedures were carried 
out at room temperature on a shaker.  
All sections per vial were drained into Falcon™ Cell Strainers (Fisher) with 
100μm pores and washed four times in a 6-well plate filled with 0.1M 
phosphate buffered saline (PBS, Table 2.3) for 10min each. To block 
non-specific binding sites for secondary antibodies, sections were then 
incubated in blocking solution (Table 2.3) for 2hr. The addition of Triton 
X-100 (Sigma) results in disruption of cell membranes, which allows for 
easier penetration of antibodies.  
Following a 10min rinse in 0.1M PBS, the sections were incubated overnight 
in primary antibodies prepared in a carrier solution (Table 2.3). The 
concentration of each primary antibodies needed to be tested upon first time 
use. All information on antibody origin and dilution can be found in Table 2.4.  
On the second day, primary antibodies were rinsed off by washing 10mins 
for four times in 0.1M PBS and secondary antibodies diluted in carrier 
solution were applied. Once again, sections were left overnight, but this time 
the incubation was covered to ensure dark conditions and avoid 
unnecessary photobleaching of the fluorophores on the secondary 
antibodies.  
Finally, on the third day all sections were washed in darkness four times for 
10min in 0.1M PBS and mounted on microscope slides (Fisher) in a 
caudo-rostral order. After a brief moment of air drying, Vision™ 




the slide and a coverslip carefully dropped. Slides were then stored in 
darkness at 4°C. 
 
2.5.4 Immunohistochemistry – Diaminobezidine staining 
As with fluorescent immunostaining, several vials from the same alternation 
were used for each animal undergoing Diaminobezidine (DAB) staining. All 
procedures were carried out on a shaker. 
Sections from each vial were drained into cell strainers and washed four 
times for 10min at room temperature in 0.1M phosphate buffered triton (PBT, 
Table 2.3). A 20min incubation in hydrogen peroxide immediately followed, 
which is important to block endogenous activity of neuronal peroxidase 
enzymes that can increase false positives during DAB staining. After another 
four 10min washes in 0.1M PBT, sections were incubated in blocking buffer 
(Table 2.3) for 30-60min. This step was immediately followed by incubation 
of sections in primary antibodies diluted in blocking buffer. It is important to 
note at this stage, that due to the cellular localisations and the nature of the 
colour development, primary antibodies targeting cFos (Table 2.4) were 
applied first. Sections were left to incubate for an initial 30-60min at room 
temperature before being transferred to 4°C for at least 36-48hr.  
After six 5min washes in 0.1M PBT to remove excess primary antibodies, a 
biotinylated IgG horse anti-rabbit secondary antibody diluted in blocking 
buffer was applied for 1hr at room temperature. The excess secondary 
antibodies were removed in four 5min washes, and an avidin-biotin complex 
(ABC; Vector Laboratories) applied to the sections for 1hr at room 
temperature. Avidin has an extremely high affinity for biotin and forms an 
incredibly strong non-covalent bond. The additional formation of complexes 
between avidin and horseradish peroxidase targets this construct to the 
antigen of interest. Following two 10min washes with 0.1M PB and one wash 
in 0.05M Tris buffer (Table 2.3), sections were incubated in a solution 
comprising 0.05M Tris buffer, DAB, Nickel II sulfate, ammonium chloride and 
hydrogen peroxide. Hydrogen peroxide is required for the oxidation of DAB 




peroxidase is present also. The addition of metallic ions such as nickel will 
turn a brown precipitant into a dark purple to black colour. For cFos 
visualisation, sections were incubated for 8min and the reaction stopped by 
washing in 0.05M Tris buffer for 5min. Longer incubations result in higher 
background precipitation of DAB, so for each staining a “test section” was 
incubated first and great care was taken that each sample was not incubated 
for longer periods. At the end, sections were washed in 0.1M PB twice for 
5min and once for 10min.  
At this point a single staining protocol would be completed, but because 
double labelling for cFos and TH was desired the protocol was immediately 
repeated, starting with four 10min washes in 0.1M PBT. This time, a mouse 
anti-TH primary antibody and biotinylated IgG horse anti-mouse (Table 2.4) 
were used. For the DAB colour development, the use of nickel II sulphate 
and ammonium chloride were omitted, so that cell bodies were stained in a 
brown precipitant, whereas cFos-positive cell nuclei were black in colour. 
For each primary and secondary antibody, negative controls were carried 
out by omission of said antibody in order to ensure binding specificity. None 
of the controls showed any immunoreactivity. In addition, incubations with 
pre-immunised serums specific for each primary antibody, and pre-absorbed 
cFos primary antibodies incubated with purified cFos peptide also showed 
no immunoreactivity (Hume, 2017; Hume et al., 2017). 
Once the immunohistochemistry had been completed, all sections were 
mounted on gelatine-coated glass microscope slides (Fisher) in a 
caudo-rostral order and air dried in a sealed container to protect from dust 
overnight. On the next day, the dried sections were dehydrated by 
submerging them in solutions of increasing concentrations of ethanol, 
namely 70% v/v, 90% v/v and 95% v/v for 5mins each, followed by three 
times 10mins at 100% v/v and finally two 10mins steps in xylene. A glass 
coverslip was quickly applied to the slides before the xylene had evaporated 
using DPX Mountant for histology (Sigma) and all slides were left to dry in a 




Table 2.3: Solutions used for immunohistochemistry. 
Immunofluorescence Solutions Ingredients 
Heparinised Saline 
0.9% w/v sodium chloride (VWR 
International) 
0.012% w/v heparin sodium salt from 
porcine intestinal mucosa (Sigma) 
Phosphate Buffer (PB), 1M 
11.5% w/v sodium phosphate 
dibasic dehydrate (Sigma) 
2.72% w/v sodium phosphate 
monobasic monohydrate (Sigma) 
pH 7.4 
4% Paraformaldehyde (PAF) 
4% paraformaldehyde (Sigma) in 
0.1M PB 
pH 7.4 
Post-Fix solution 15% w/v sucrose (Fisher) in 4% PAF 
Cryoprotectant 
20% v/v glycerol 
30% v/v ethylene glycol  
50% v/v 0.2M PBS 
Phosphate buffered saline (PBS), 
1M 
0.9% w/v sodium chloride in 1M PB 
pH 7.4 
Blocking solution 10% v/v normal serum in PBT 
Carrier solution 2% v/v normal serum in PBT 
DAB staining Solutions Ingredients 
Phosphate buffered triton (PBT) 
0.3% v/v TritonTM X-100 (Sigma) in 
0.1M PB 
pH7.4 
Hydrogen peroxide 0.3% v/v hydrogen peroxide (Sigma) in PBT 
Blocking buffer 3% v/v normal horse serum in PBT 
Avidin-biotin complex 0.2% v/v avidin 0.2% v/v peroxidase in PBT 
Tris buffer, 0.5M 6.1% w/v TrizmaÒ base (Sigma)  
pH 7.6 
Diaminobenzidine tetrachloride 
solution with nickel, ammonium 
chloride and hydrogen peroxide 
0.025% w/v diaminobenzidine 
tetrachloride (Sigma) 
2.5% w/v nickel II sulphate 
hexahydrate (Sigma) 
0.08% w/v ammonium chloride 
(Fisher) 
0.05% v/v hydrogen peroxide in 




Table 2.4: Antibodies used for immunohistochemistry. 
Immunofluorescence 
antibodies 
Host species Dilution Supplier 
Anti-cFos rabbit 

































































2.5.5 Image acquisition 
Images of each brainstem section were captured using a Leica DMR 
reflected light microscope and LAS V4.5.0 imaging software (Leica). A x5 
magnification was used to capture an overview the entire section, whereas 
a x20 magnification was used to capture images of the dorsal nucleus 
tractus solitarius (NTS) and area postrema (AP), and the ventrolateral 
regions that showed TH-positive cell bodies.  
For the dorsal regions of interest, three images were stitched together using 
the LAS imaging software in order to retain the original pixilation for 
subsequent image analysis.   
 
2.5.6 Image analysis 
Using an online tool, regions of the NTS present in the mouse brain atlas 
(Franklin & Paxinos, 2008) were selected and the background made 
transparent (Figure 2.4). These “templates” were then overlaid onto each 
immunohistochemical image using Inkscape version 0.48.2. The template 
with the best fit for the AP as a landmark was chosen, whereby the size of 
the template was increased or decreased proportionally to fit the underlying 
image (Figure 2.5 A). Templates were created for each brain map in the 
mouse brain atlas that included the AP, which encompassed the following 
Bregmas:  -7.76mm, -7.64mm, -7.56mm, and -7.48mm (Figure 2.4). Any 
sections that could not be clearly allocated to a specific Bregma from the 
brain atlas – due to smaller distances between sections cut (60µm) than 
those illustrated in the atlas (80µm) – were labelled 
as -7.70mm, -7.60mm, -7.52mm, -7.44mm.  
The images with the templates were then further analysed using (FIJI Is 
Just) ImageJ version 2.0.0-rc-43/1.51s. To measure the surface area for 
each subnucleus of the NTS, a global scale was set for each image 
according to the LAS specifications for x20 magnifications. Using the “ROI” 
plugin and a free-hand drawing tool, each NTS subnucleus and the AP were 
traced along the template lines and the surface areas measured. Each of 




thickness of each section. Cell counting was done with the help of the “Cell 
Counter” plugin and each subnucleus was counted manually by clicking on 
each target with a different corresponding number, and thus colour, for each 
subnucleus. Each target, be it a cFos-positive nucleus or a 
cFos-negative/TH-positive cell body, was confirmed by looking directly 
through the microscope, as this allowed for greater differentiation of 
background versus true staining and it enabled me to clearly visualise nuclei 
and cells at different depths of the sections by adjusting the focus. Staining 
was counted in the dorsal brainstem for total cFos per subnucleus (Figure 
2.5 Bi), TH-positive/cFos-negative, and TH-positive/cFos-positive cells 
(Figure 2.5 Bii). For the ventral brainstem only TH-positive cells were 
counted and separated for cFos-positive or cFos-negative labelling (Figure 







Figure 2.4 Template maps from the Mouse Brain Atlas used to identify 
subnuclei of the NTS.  
Four maps from the Franklin & Paxinos (2008) mouse brain atlas were used 
to identify regions of interest within the caudal nucleus tractus solitarius at 
Bregmas that encompassed the area postrema (AP). The individual nuclei 
that were used for Immunohistochemical studies are shown in the magnified 
top image. X = Dorsal motor nucleus of the vagus; SolC = commissural 
nucleus; SolM = medial nucleus; SolDM = dorsomedial nucleus; SolDL = 
dorsolateral nucleus; SolCe = central nucleus; SolIM = intermediate nucleus; 
SolI = interstitial nucleus; SolV = ventral nucleus; SolVL = ventrolateral 






Figure 2.5 Representative immunohistochemistry photomicrographs 
for double labelling of cFos and tyrosine hydroxylase.  
(A) shows exemplary templates from the mouse brain atlas superimposed 
onto acquired photomicrographs for approximate Bregmas -7.76mm (Ai) 
and -7.48mm (Aii); (B) shows an example of how each subregion of the NTS 
was counted using the Cell Counter plugin in FIJI (Bi), and the counting of 
TH-positive cell bodies classified into cFOS-positive (black arrows) and 
cFOS-negative (clear arrows) for the dorsal catecholaminergic A2 (Bii) and 
ventral catecholaminergic A1 (Biii) neurons. Scale bars are 100µm for (A) 





2.6  Metabolic measurements 
To confirm ventilatory outcomes, metabolic measurements of O2 
consumption (VO2) and CO2 production (VCO2) were carried out 
independently by David Burns at the University of Cork, Ireland.  
Naïve and untrained mice undergoing metabolic measurements were placed 
in a whole-body plethysmography chamber as described above (Buxco, 
USA). Airflow through the chamber was maintained at 1l/min. Fractional 
concentrations of O2 and CO2 were measured in air entering and exiting the 
plethysmography chamber by an O2 and CO2 analyser (ADInstruments, 
Colorado Springs, CO,USA) and transmitted to a computer software with a 
frequency of 0.1Hz.  
Two hypoxic protocols were used for each mouse – a step challenge and a 
graded hypoxia challenge. The step challenge introduced 8% O2 (0.05% 
CO2, balanced in N2) immediately following a 5min baseline period at 21% 
O2 (0.05% CO2, balanced in N2) and lasted for a total of 10min. The graded 
hypoxia challenge involved a 5min baseline period at 21% O2 (0.05% CO2, 
balanced in N2), which was then followed by 5min of decreasing O2 
concentrations (18% O2, 15% O2, 12% O2, 10% O2, 8% O2, all in 0.05% CO2, 
balanced in N2). 
For the hypoxic step challenge data are shown normalised for body mass 
(g) after 5min of hypoxia and presented in a minute-by-minute basis 
thereafter. For the graded hypoxic challenge, measurements were taken 
during the fifth minute of each given O2 concentration. 
 
2.7  Bioamine High Performance Liquid Chromatography 
Finally, the effect of AMPK deletion in catecholaminergic cells on the 
brainstem bioamine content was assessed by High Performance Liquid 
Chromatography (HPLC), which was carried out independently by David 
Burns at the University of Cork, Ireland.  
Following completion of all metabolic measurements, experimental mice 




minimum of 60min. Mice were culled by dislocation of the neck and trunk 
blood was collected immediately and placed on ice. In addition, the 
brainstems and part of the spinal cords were dissected. Samples were then 
analysed by HPLC at an independent facility within the University of Cork.  
 
2.8 Statistical analyses 
All data were presented as the mean±SEM for ‘N’ exposures and ‘n’ mice. 
The analyses, comparisons and generation of Figures were carried out 
using GraphPad Prism for Windows, Version 6.05 (US). If only two datasets 
were compared, an unpaired two-tailed t-test was conducted. If comparing 
between three or more groups of data, the analysis of variance (ANOVA) 
was tested. For the comparison of data sets with only one independent 
variable, for example across regions of interest, the analysis was carried out 
using a one-way ANOVA followed by a post-hoc Tukey multiple 
comparisons test. If the data set that had two independent variables, for 
example time and genotype, the comparisons between the groups were 
carried out using a two-way ANOVA followed by a post-hoc Sidak multiple 
comparisons test. Probability values less than 0.05 were considered to be 
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3.1.1 AMPK deficiency blocks the hypoxic ventilatory response and 
thus precipitates hypoventilation  
Recent studies have established that deletion of AMPK-α1 and -α2 catalytic 
subunits in tyrosine hydroxylase (TH)-positive cells (TH AMPK-α1/α2 dKO) 
attenuates the acute HVR to mild and severe hypoxia (Mahmoud et al., 
2016). Rather than hyperventilating, mice lacking AMPK-α1 and -α2 
subunits exhibited hypoventilation and more frequent, prolonged apnoeas 
during hypoxia. In fact, the HVR in response to 8% O2 was virtually 
abolished, and anaesthesia further exacerbated ventilatory depression 
observed during hypoxia. It was found that loss of AMPK-α1 expression was 
the primary precipitant of the phenotype. Deletion of AMPK-α2 appeared to 
have little effect, although the AMPK-α1/α2 dKO exhibited a more severe 
hypoxic phenotype than AMPK-α1 knockouts. Interestingly though, the 
carotid bodies of TH AMPK-α1/α2 dKO mice – which were also targeted by 
the conditional knockout –  remained exquisitely sensitive to hypoxia, 
contrary to the view that the HVR is determined solely by increased carotid 
body afferent input to the brainstem. It was therefore concluded that, at least 
in this context, deficits in the drive to breathe during hypoxia arose at the 
level of the brainstem. Importantly, dual deletion of AMPK-α1 and -α2 
catalytic subunits had no effect on the hypercapnic ventilatory response. In 
fact, the hypoxic phenotype of TH AMPK-α1/α2 dKO mice was completely 
rescued upon exposure to hypoxic hypercapnia, which highlights that AMPK 
deletion did not compromise the capacity for increased ventilation during 
hypoxia per se, but rather that AMPK deficiency specifically affects the HVR. 
AMPK activation may therefore selectively support hyperventilation and 
protect against hypoxia-induced ventilatory instability that can occur during 
sleep or ascent to altitude (Ainslie et al., 2013; Panossian & Daley, 2013).  
The proposed mechanism suggests a role for AMPK to support coincidence 
detection and signal integration within a subset of hypoxia-sensitive 
catecholaminergic neurons of the brainstem. In this setting, AMPK activation 




of mitochondrial oxidative phosphorylation and thus decreased ATP supply, 
and ‘applied metabolic stress’ delivered via increased ATP usage 
subsequent to peripheral chemoafferent input and neuronal activation 
(Evans et al., 2016; Mahmoud et al., 2016). Together, the sum of these two 
pathways may determine the magnitude of activation of AMPK and the 
brainstem respiratory network during hypoxia due to AMPK-related 
modulation of cell metabolism, ion channel activity, neuronal firing frequency 
and/or release of neurotransmitters (Lipton et al., 2001; Murphy et al., 2009; 
Ikematsu et al., 2011).  
 
3.1.2 The hypoxic ventilatory response is supported by the activation 
of LKB1-AMPK signalling pathways downstream of the carotid 
bodies 
As mentioned in Chapter 1, AMPK activation can occur through two distinct 
pathways, involving the upstream kinases LKB1 or Ca2+/CaMKK2 (Hardie et 
al., 2016). Our most recent investigations therefore considered the role of 
the LKB1-AMPK pathway and the Ca2+/CaMKKβ-AMPK pathway in 
mediating the HVR (Evans, 2012; Mahmoud et al., 2015). It was found that 
global deletion of Camkk2 was without effect on the HVR. By contrast, in 
mice with conditional deletion of Stk11 (the gene encoding LKB1) in 
catecholaminergic cells, inclusive of carotid body type I cells and brainstem 
respiratory network, outcomes were similar to those observed in TH 
AMPK-α1/α2 dKO mice, where hypoxia evoked hypoventilation and apnoea 
rather than hyperventilation. Furthermore, attenuation of the HVR, albeit less 
severe, was also conferred in mice carrying ~90% knockdown of LKB1. 
However, while Stk11 deletion markedly attenuated carotid body afferent 
discharge during normoxia, hypoxia, and hypercapnia, afferent input 
responses were retained following either ~90% knockdown of LKB1 or 
AMPK-α1/α2 deletion. Therefore, it seems that the LKB1-AMPK pathway, 
but not the Ca2+/CaMKK2-AMPK pathway, supports the HVR and that it 
does so as previously proposed (Mahmoud et al., 2016), by acting at a site 
downstream of the carotid body within brainstem catecholaminergic cells of 






Given the outcomes from the studies above I sought to test the hypothesis 
that AMPK activity in catecholaminergic cells continuously supports 
ventilation during hypoxia beyond the manifestation of the initial sustained 
phase of the HVR observed at 5min. Accordingly, mice with dual deletion of 
the AMPK-α1/α2 catalytic subunits in TH-expressing cells (as described in 
Chapter 2) were exposed to mild (12% O2, 10min) and severe (8% O2, 10min 
and 60min) hypoxia, and their ventilatory phenotype assessed using 






3.2.1 AMPK deletion in catecholaminergic cells attenuates ventilation 
throughout 10min exposures to hypoxia 
Consistent with previous studies (Mahmoud et al., 2016), deletion of 
AMPK-α1/α2 catalytic subunits in catecholaminergic cells was found to have 
no effect on normoxic baseline breathing (Appendix 1.1), but markedly 
attenuated the HVR during mild and severe hypoxia. However, the data 
presented here also show that this attenuation continues beyond 5min with 
no evidence of delayed compensation. Example records of changes in 
breathing frequency (Figure 3.1 Ai), tidal volume (Figure 3.3 Ai) and minute 
ventilation (Figure 3.4 Ai) illustrate the difference between AMPK-α1/α2 Flx 
and TH AMPK-α1/α2 dKO mice in response to 10min exposures to 12% O2 
or 8% O2. Whereas control AMPK-α1/α2 Flx mice responded to hypoxia with 
robust increases in ventilation which later stayed slightly above or returned 
to baseline values, TH AMPK-α1/α2 dKO mice were unable to maintain an 
equivalent level of ventilation. Notably, the severity of ventilatory depression 
observed in TH AMPK-α1/α2 dKO mice was PO2-dependent.  
 
3.2.1.1 Breathing frequency 
5min exposures to mild hypoxia As depicted in Figure 3.1 Ai, control 
AMPK-α1/α2 Flx mice responded to mild hypoxia (12% O2) with increases 
in breathing frequency. Following the onset of hypoxia, values reached 57.4 
± 3.9% relative to normoxia (n = 37 exposures from 14 mice) during the peak 
of the Augmenting phase (A) and then declined during ventilatory Roll-Off 
(RO) to 27.5 ± 2.4%. On average, this level of ventilation was maintained 
during the Sustained Phase (SP), where breathing frequency measured 
27.2 ± 3%.  
TH AMPK-α1/α2 dKO mice displayed a comparable response during the 
Augmenting phase, increasing breathing frequency by 47.9 ± 3.5% relative 




was significantly decreased during the RO (14.5 ± 3.1%, p<0.05) and SP 
(14.2 ± 2.8%, p<0.05).  
5min exposures to severe hypoxia During severe hypoxia (8% O2, Figure 
3.1 Bii), more pronounced differences were observed between genotypes. 
Both AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice increased their 
breathing frequency during the Augmenting phase. However, while control 
AMPK-α1/α2 Flx mice responded with an increase of 63.8 ± 4% (n = 54 
exposures from 21 mice), TH AMPK-α1/α2 dKO mice had a significantly 
attenuated augmenting phase, reaching only 47.1 ± 3.3% (n = 49 exposures 
from 21 mice, p<0.001). Thereafter, respiratory depression reduced 
breathing frequency in AMPK-α1/α2 Flx mice to 9.5 ± 2.4%, a level of 
ventilation that was maintained during the SP (11.9 ± 2.4%). In marked 
contrast, TH AMPK-α1/α2 dKO mice fell into hypoventilation relative to 
normoxia during RO (-15.8 ± 2.8%), where breathing frequency was 
significantly lower than for control AMPK-α1/α2 Flx mice (p<0.0001). This 
significant attenuation was still evident during the SP, when breathing 
frequency measured -9 ± 2.2% (p<0.0001 relative to AMPK-α1/α2 Flx). 
 
10min exposures to mild hypoxia Differences between genotypes in the 
HVR were also evident during more prolonged 10min exposures to hypoxia 
(Figure 3.2 A). Measurements taken at each full minute of hypoxia showed 
that breathing frequencies during mild hypoxia were higher for control 
AMPK-α1/α2 Flx mice than TH AMPK-α1/α2 dKO mice (Figure 3.2 Ai; 
controls n = 37 exposures from 14 mice, knockouts n = 28 exposures from 
11 mice). Although only statistically significant during the first half of the 
response (controls versus knockouts – at 1min: 49.6 ± 3.1% versus 24.7 ± 
2.3%, p<0.0001; at 5min: 26.3 ± 3.1% versus 12.6 ± 2.8%, p<0.01), average 
frequencies of TH AMPK-α1/α2 dKO mice remained attenuated throughout 
the exposure (controls versus knockouts – at 6min: 26.6 ± 2.8% versus 15.9 





10min exposures to severe hypoxia During severe hypoxia, breathing 
frequencies of TH AMPK-α1/α2 dKO mice were significantly attenuated 
relative to controls at each minute measured throughout the exposure 
(Figure 3.2 Aii; controls: n = 55 exposures from 21 mice versus knockouts: 
n = 40 exposures from 18 mice – at 1min: 28.4 ± 2.5% versus 0.9 ± 4.1%, 
p<0.0001; at 5min: 11.4 ± 2.4% versus -11.8 ± 2.7%, p<0.0001; at 10min: 
6.9 ± 2.4% versus -10.6 ± 3.3%, p<0.0001).  
These outcomes suggest that while TH AMPK-α1/α2 dKO mice are initially 
able to produce an, albeit reduced, augmentation of breathing frequency 
during hypoxia, they are unable to maintain normal hyperventilatory activity 
during severe hypoxia with breathing frequency very quickly dropping below 
normoxic baseline measurements throughout the remainder of the hypoxic 





Figure 3.1: The breathing frequency of TH AMPK-α1/α2 dKO mice is 
attenuated during acute hypoxia in a PO2-dependent manner. 
Left and middle panels show raw example records of breathing frequencies 
(breaths/min) during 10 minute exposures to (A) mild hypoxia (12% O2) and 
(B) severe hypoxia (8% O2) of (i) AMPK-α1 and -α2 floxed (AMPK-α1/α2 
Flx, black) and (ii) TH-driven AMPK-α1 and -α2 double knockout (TH 
AMPK-α1/α2 dKO, red) mice with a 2s sampling frequency. Dotted green 
lines indicate pre-hypoxic baseline frequencies, dashed lines the artefacts 
induced by gas exchange. Right panels (iii) show means ± SEM for 
percentage changes of breathing frequency during the peak of the 
Augmenting phase (A, approximately 30s), the nadir of the Roll-Off (RO, 
approximately 100s), and the plateau of the sustained phase (SP, at 300s) 
of the HVR in AMPK-α1/α2 Flx (12% O2: n = 37 exposures from 14 mice, 
8% O2: n = 54 exposures from 21 mice) and TH AMPK-α1/α2 dKO mice 
(12% O2: n = 28 exposures from 11 mice, 8% O2: n = 49 exposures from 21 
mice). * = p<0.05, *** = p<0.001, **** = p<0.0001. Significance tested by 






Figure 3.2: The PO2-dependent attenuation of breathing frequency, 
tidal volume, and minute ventilation in TH-driven AMPK-α1/α2 
knockout mice persists beyond the early hypoxic ventilatory response. 
Means ± SEM for percentage changes of (A) breathing frequency 
(breaths/min), (B) tidal volume (ml), and (C) minute ventilation (ml/min) 
during 10 minute exposures to (i) mild hypoxia (12% O2) and (ii) severe 
hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 
12% O2: n = 37 exposures from 14 mice, 8% O2: n = 55 exposures from 21 
mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, 12% O2: n = 28 exposures from 11 mice, 8% O2: n 
= 40 exposures from 18 mice) measured at each full minute of hypoxia. * = 
p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested by 





3.2.1.2 Tidal volume 
5min exposures to mild hypoxia In marked contrast to the hypoxia-induced 
increases in breathing frequency, only marginal changes in tidal volume 
were observed. During mild (12% O2) hypoxia (Figure 3.3 Aii), 
measurements for AMPK-α1/α2 Flx mice were 1.9 ± 2.5% relative to 
normoxia during the Augmenting phase, -1.7 ± 2% for RO, and 0.1 ± 1.7% 
during the SP. Interestingly, for TH AMPK-α1/α2 dKO mice measures 
(relative to normoxia) of tidal volume during hypoxia were lower at -3.1 ± 
1.6% during the Augmenting phase, -4.2 ± 2.3% for RO, and -5.3 ± 2.4% 
during the SP, but these differences did not reach significance relative to 
controls at any stage during 5 min exposures.  
5min exposures to severe hypoxia Changes in tidal volume of control 
AMPK-α1/α2 Flx mice during severe hypoxia (Figure 3.3 Bii) were 
comparable to those during mild hypoxia, with measurements of -2.1 ± 1.5% 
during the Augmenting phase, 1.2 ± 1.8% for RO, and -1.8 ± 1.7% during 
the SP. However, in TH AMPK-α1/α2 dKO mice measures of tidal volume 
during severe hypoxia were attenuated when compared to controls. Despite 
being more than twice the deficit, the reduction in tidal volume relative to 
normoxia during the Augmenting phase was not significantly different in TH 
AMPK-α1/α2 dKO mice compared to AMPK-α1/α2 Flx mice (-5.4 ± 1.4%, 
not significant). Following this, however, measurements during RO and the 
SP were significantly attenuated compared to controls (RO: -5.0 ± 2.1%, 
p<0.05; SP: -14.6 ± 1.9%, p<0.0001).  
 
10min exposures to mild hypoxia During slightly longer exposures to mild 
hypoxia, the changes in tidal volume of control AMPK-α1/α2 Flx mice were 
minimal compared to measures obtained during normoxia (Figure 3.2 Bi; at 
1min: -0.7 ± 2.1%; at 5min: 0.4 ± 1.5%; at 10min: 2 ± 2.4%). Despite being 
on average lower at each time point, the changes in tidal volume in TH 
AMPK-α1/α2 dKO mice during mild hypoxia were comparable to controls, 
but reached significance by the eighth and tenth minute of 10min exposures 
(Figure 3.4 Bi; at 1min: 1.3 ± 2.2%, not significant; at 5min: -4.9 ± 2.4%, not 




10min exposures to severe hypoxia During severe hypoxia, differences 
between genotypes were much more evident (Figure 3.2 Bii). Similar to 
outcomes for 5min exposures, increases in tidal volume in TH AMPK-α1/α2 
dKO mice were attenuated after 1min of hypoxia, although no significant 
different was apparent at this point between controls (3.3 ± 1.8%) and 
knockouts (-3.3 ± 2.2%). Thereafter, significant attenuation of tidal volume 
in TH AMPK-α1/α2 dKO mice compared to controls was observed for the 
remainder of the exposure (controls versus knockouts – at 2min: -0.8 ± 1.6% 
versus -11.6 ± 2.5%, p<0.01; at 5min: -2.9 ± 1.6% versus -17.6 ± 1.9%, 
p<0.0001; at 10min: -5.8 ± 1.5% versus -19.9 ± 1.8%, p<0.0001).  
From this, it would appear that TH AMPK-α1/α2 dKO mice do not only 
breathe slower, but also take smaller breaths during severe hypoxia than 





Figure 3.3: The tidal volume of TH AMPK-α1/α2 dKO mice is attenuated 
during acute hypoxia in a PO2-dependent manner. 
Left and middle panels show raw example records of tidal volumes (ml) 
during 10 minute exposures to (A) mild hypoxia (12% O2) and (B) severe 
hypoxia (8% O2) of (i) AMPK-α1 and -α2 floxed (AMPK-α1/α2 Flx, black) and 
(ii) TH-driven AMPK-α1 and -α2 double knockout (TH AMPK-α1/α2 dKO, 
red) mice with a 2s sampling frequency. Dotted green lines indicate 
pre-hypoxic baseline tidal volume, dashed lines the artefacts induced by gas 
exchange. Right panels (iii) show means ± SEM for percentage changes of 
tidal volume during the peak of the Augmenting phase (A, approximately 
30s), the nadir of the Roll-Off (RO, approximately 100s), and the plateau of 
the sustained phase (SP, at 300s) of HVR in AMPK-α1/α2 Flx (12% O2: n = 
37 exposures from 14 mice, 8% O2: n = 54 exposures from 21 mice) and TH 
AMPK-α1/α2 dKO mice (12% O2: n = 28 exposures from 11 mice, 8% O2: n 
= 49 exposures from 21 mice). * = p<0.05, **** = p<0.0001. Significance 





3.2.1.3 Minute ventilation 
5min exposures to mild hypoxia Adjustments of minute ventilation followed 
a similar trend to breathing frequency. During mild hypoxia (Figure 3.4 Aii), 
control AMPK-α1/α2 Flx mice responded with an increase of 58 ± 4% relative 
to normoxia during the Augmenting phase, which then declined to 23.5 ± 
2.8% during RO and 26.1 ± 3.5% for the SP. Compared to this, each of these 
measurements was significantly attenuated in TH AMPK-α1/α2 dKO mice, 
measuring 42.9 ± 3.8% during the augmenting phase (p<0.05), 8.6 ± 3% 
during RO (p<0.05) and 8.3 ± 4.1% for the SP (p<0.01).  
5min exposures to severe hypoxia During severe hypoxia (Figure 3.4 Bii), 
control AMPK-α1/α2 Flx mice responded with a similar initial augmentation 
to mild hypoxia, increasing minute ventilation to 58.8 ± 3.8% relative to 
normoxia. Thereafter, however, minute ventilation was slightly more 
depressed during severe hypoxia, reaching 10.5 ± 3.3% during RO and 9.2 
± 3% for the SP. As would be expected given the outcomes for frequency 
and tidal volume, minute ventilation was significantly attenuated in TH 
AMPK-α1/α2 dKO compared to control mice at each point measured (A: 38.2 
± 3.4%, p<0.0001; RO: -22 ± 2.8%, p<0.0001; SP: -23.8 ± 2.1%, p<0.0001).  
10min exposures to mild hypoxia In stark contrast to breathing frequency 
and tidal volume, each measurement of minute ventilation during 10min 
exposures to mild hypoxia was significantly attenuated in TH AMPK-α1/α2 
dKO mice compared to control AMPK-α1/α2 Flx mice (Figure 3.2 Ci; controls 
versus knockouts – at 1min: 47.5 ± 3.7% versus 25.7 ± 3%, p<0.001; at 
5min: 25.3 ± 3.1% versus 7.2 ± 3.9%, p<0.01; at 10min: 24 ± 3.8% versus 
2.3 ± 3.2%, p<0.001).  
10min exposures to severe hypoxia Not surprisingly, however, given the 
10min outcomes for breathing frequency and tidal volume during severe 
hypoxia described above, minute ventilation was also significantly 
attenuated in TH AMPK-α1/α2 dKO mice at every time point measured 
during exposures to severe hypoxia (8% O2, Figure 3.2 Cii; controls versus 
knockouts – at 1min: 31.8 ± 2.9% versus -3.1 ± 3.3%, p<0.0001; at 5min: 
7.8 ± 3% versus -28.2 ± 2.7%, p<0.0001; at 10min: 0 ± 2.4% versus -29.4 ± 





Figure 3.4: The minute ventilation of TH AMPK-α1/α2 dKO mice is 
attenuated during acute hypoxia in a PO2-dependent manner.  
Left and middle panels show raw example records of minute ventilation 
(ml/min) during 10 minute exposures to (A) mild hypoxia (12% O2) and (B) 
severe hypoxia (8% O2) of (i) AMPK-α1 and -α2 floxed (AMPK-α1/α2 Flx, 
black) and (ii) TH-driven AMPK-α1 and -α2 double knockout (TH 
AMPK-α1/α2 dKO, red) mice with a 2s sampling frequency. Dotted green 
lines indicate pre-hypoxic baseline minute ventilation, dashed lines the 
artefacts induced by gas exchange. Right panels (iii) show means ± SEM 
for percentage changes of minute ventilation during the peak of the 
Augmenting phase (A, approximately 30s), the nadir of the Roll-Off (RO, 
approximately 100s), and the plateau of the sustained phase (SP, at 300s) 
of the HVR  in AMPK-α1/α2 Flx (12% O2: n = 37 exposures from 14 mice, 
8% O2: n = 54 exposures from 21 mice) and TH AMPK-α1/α2 dKO mice 
(12% O2: n = 28 exposures from 11 mice, 8% O2: n = 49 exposures from 21 
mice). * = p<0.05, ** = p<0.01, **** = p<0.0001. Significance tested by 





3.2.2 The attenuation of hypoxic ventilation in mice with deletion of 
AMPK in catecholaminergic cells is not compensated for by 
changes in metabolism 
The fact that TH AMPK-α1/α2 dKO mice enter a torpor-like state during 
hypoxia (Mahmoud et al., 2016) along with the observed ventilatory 
depression of TH AMPK-α1/α2 dKO mice described above could be 
indicative of a hypometabolic response (Guppy & Withers, 1999). It was 
therefore of interest to assess the metabolic responses of control 
AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice during hypoxia, the 
experiments of which were carried out by Mr David Burns at the University 
of Cork (Prof Ken O’Halloran’s group).  
Metabolic rates during normoxia (21% O2) were comparable between 
control AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice, measuring 0.07 ± 
0.03ml/g/min (n = 11 mice) and 0.08 ± 0.02ml/g/min (n = 12 mice), 
respectively, for oxygen consumption (VO2), and 0.03 ± 0.009ml/g/min and 
0.03 ± 0.001ml/g/min, respectively, for carbon dioxide production (VCO2) 
(Figure 3.5 Ai and Bi).  
During 10min exposures to 8% O2 (Figure 3.5 Aii and Bii), control 
AMPK-α1/α2 Flx mice displayed a reduction of VO2 relative to normoxia 
which measured 0.038 ± 0.03ml/g/min (n = 9 mice) by 5min, and 0.038 ± 
0.02ml/g/min by 10min. Likewise, VCO2 was reduced relative to normoxia in 
control mice, measuring 0.028 ± 0.02ml/g/min by 5min, and 0.024 ± 
0.01ml/g/min at 10min. Compared to this, the VO2 of TH AMPK-α1/α2 dKO 
mice displayed minimal differences relative to controls, measuring 0.028 ± 
0.03ml/g/min (n = 10 mice) by 5min (not significant) and 0.027 ± 
0.02ml/g/min (not significant) at 10min. Similarly, VCO2 was not significantly 
different compared to control mice, measuring 0.022 ± 0.03ml/g/min by 5min 
(not significant) and 0.017 ± 0.02ml/g/min (not significant) by 10min. This 
shows that TH AMPK-α1/α2 dKO mice do not alter their metabolic rates 
relative to controls during sudden 10min exposures of 8% O2. 
Furthermore, O2 consumption and CO2 production were assessed during 
5min exposures to graded hypoxia (5min, each, of 21% O2, 18% O2, 15% 




in O2 availability that lasted for a total of 25min also revealed no differences 
between control (n = 11 mice) and TH AMPK-α1/α2 dKO mice (n = 12) with 
respect to the gradual reductions of VO2 and VCO2, respectively (Figure 3.5 
Aiii and Biii). 
Collectively, the data above show that the depressed ventilatory phenotype 
of TH AMPK-α1/α2 dKO mice during hypoxia is not compensated for by 
entering into a hypometabolic state. This therefore indicates that deletion of 
AMPK-α1 and -α2 catalytic subunits in catecholaminergic cells results in true 






Figure 3.5: Metabolic responses during hypoxia are unaffected in 
TH-driven AMPK-α1/α2 knockout mice.  
Means ± SEM for (A) oxygen consumption (VO2) and (B) carbon dioxide 
production (VCO2) during (i) normoxia (21% O2), (ii) 10min of 8% O2, and 
(iii) 5min exposures to graded hypoxia (21% O2, 18% O2, 15% O2, 12% 
O2, 10% O2, 8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, 
black, 21% O2: n = 11 mice; 8% O2: n = 9 mice; graded hypoxia: n = 11 
mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, 21% O2: n = 12 mice; 8% O2: n =10 mice; graded 
hypoxia: n = 12 mice). Significance tested by t-test for (i) and two-way 
ANOVA with Sidak post-hoc tests for (ii) and (iii). 
Collection of metabolic data was performed in collaboration with 





3.2.3 AMPK deletion in catecholaminergic cells attenuates ventilation 
throughout 60min exposures to hypoxia 
More prolonged 60min exposures to severe hypoxia (8% O2) were used to 
assess whether the ventilatory deficit of TH AMPK-α1/α2 dKO mice 
observed during 5min and 10min exposures to hypoxia in naïve mice might 
continue during longer exposures or show a delayed recovery during later 
phases of the HVR. During the experiments it quickly became obvious that 
a subset of experimental TH AMPK-α1/α2 dKO mice (3 out of 7, Figure 3.6 
Bi-iii)) had to be excluded from the group analysis due to their highly 
disordered breathing patterns, as shown in Figures 3.6 B and 3.7 B. The raw 
box flow records showed that the respiratory pattern in these mice started to 
become increasingly disordered around 20-30min of hypoxia, indicated by 
failure to clearly identify inspiratory and expiratory peaks in the box flow 
traces (Figure 3.7). Moreover, by the end of the exposure these mice had 
lost all ventilatory rhythmicity, whereas all of the control AMPK-α1/α2 Flx 
mice (6 out of 6) retained rhythmicity until the end of the 60min exposure. 
Furthermore, observations of the animal behaviour (chest movements) 
during the experiment did not match the ventilatory values computed by the 
FinePointe plethysmography software. For example, breathing frequencies 
for the raw box flow record shown in Figure 3.7 B were computed as an 
average of 356 ± 92 breaths per minute, which is in the range of breathing 
frequencies obtained during periods of sniffing or grooming. Yet all TH 
AMPK-α1/α2 dKO mice were observed to be exquisitely quiet throughout the 
exposures with minimal movements sparsely scattered throughout the 
hypoxic period. In the end, 4 out of 7 TH AMPK-α1/α2 dKO mice could be 
analysed for their ventilatory phenotype during 60min of 8% O2 and were 
compared to 5 control AMPK-α1/α2 Flx mice (one control mouse did not 














Figure 3.6: Example records showing the breathing patterns of control 
and TH-driven AMPK-α1/α2 knockout mice during prolonged 
exposures to severe hypoxia.  
Raw box flow traces of ventilatory activity in (A) six (i – vi) AMPK-α1 and -α2 
floxed (AMPK-α1/α2 Flx, black) and (B) seven (i – vii) TH-driven AMPK-α1 
and -α2 double knockout (TH AMPK-α1/α2 dKO, red) mice during the 60th 
minute of severe hypoxia (8% O2). Boxed regions in records Aii and Biii were 






Figure 3.7: Expanded view of the disordered breathing pattern in 
TH-driven AMPK-α1/α2 knockout mice during prolonged exposures to 
severe hypoxia. 
 Expanded box flow traces from boxed-in records in Figure 3.6 showing the 
individual breaths of one (A) AMPK-α1 and -α2 floxed (AMPK-α1/α2 Flx, 
black, Figure 3.6 Aii) and one (B) TH-driven AMPK-α1 and -α2 double 
knockout (TH AMPK-α1/α2 dKO, red, Figure 3.6 Biii) mouse during the 60th 





3.2.3.1 Breathing frequency 
As shown in Figure 3.8 A, the sustained phase of breathing frequencies in 
naïve AMPK-α1/α2 Flx (n = 5) mice appeared to only last for 10min. 
Thereafter, frequency declined slightly but remained augmented relative to 
normoxia. Importantly, breathing frequencies remained stable from 10min 
until the end of the exposure at 60min, measuring 6.1 ± 0.9% by 10-15min, 
8.4 ± 1.1% by 30-35min, and 7.6 ± 1.6% by 55-60min.  
Compared to controls, the breathing frequencies of naïve TH AMPK-α1/α2 
dKO mice (n = 4) were significantly attenuated throughout the entire 60min 
period. That said, the most severe ventilatory deficiency appeared to occur 
during the first 10-15min of hypoxia, where breathing frequencies in TH 
AMPK-α1/α2 dKO mice declined to -21.4 ± 1.7% by 5-10min (p<0.01 
compared to controls) and -19.5 ± 0.7% by 10-15min (p<0.001 compared to 
controls). Curiously, a recovery of frequency occurred after 10-15min of 
hypoxia, whereby values slowly increased for approximately 20min and then 
plateaued slightly below normoxic values (30-35min: -6.1 ± 1.2%, p<0.001 
compared to controls; 55-60min: -3.4 ± 0.7%, p<0.01 compared to controls).  
Overall, however, TH AMPK-α1/α2 dKO mice did not recover their 
respiratory frequency to the level observed for controls and instead 
continued to display an attenuated breathing frequency and hypoventilation 
for the entire duration of the hypoxic exposure.  
 
3.2.3.2 Tidal volume 
Measurements for control AMPK-α1/α2 Flx mice showed a time-dependent 
reduction in tidal volume (Figure 3.8 B). Consistent with outcomes from 
10min exposures, tidal volume fell below normoxic values within 5-10min 
(-10.5 ± 0.8%), but then continued to decline to -20.9 ± 1.2% by 15-20min 
before decreasing at a slower rate for the remainder of the 60min exposure 
(30-35min: -24.5 ± 0.2%; 55-60min: -29.4 ± 1.1%).  
The tidal volume response of TH AMPK-α1/α2 dKO mice from these 
experiments was somewhat unexpected. Unlike outcomes from previous 




for this cohort of mice were comparable to the response of controls (0-5min: 
3.9 ± 1.5%, not significant; 15-20min: -25.3 ± 2.1%, not significant). Even 
more surprising was the fact that, although reduced relative to normoxia, the 
tidal volume of these TH AMPK-α1/α2 dKO mice was significantly higher 
compared to controls between 5-10min (-4.3 ± 2%, p<0.05). Following this 
period, however, TH AMPK-α1/α2 dKO mice exhibited a faster decline of 
tidal volume which slowed around 25mins of hypoxia and thereafter 
remained significantly lower than that of control mice (30-35min: -31 ± 1.3%, 
p<0.01; 55-60min: -37.9 ± 0.6%, p<0.001).  
Therefore, the overall attenuation of tidal volume in TH AMPK-α1/α2 dKO 
mice that has been described previously (Mahmoud et al., 2016) and during 
5min and 10min exposures described above remained exacerbated relative 
to controls during prolonged 60min exposures to 8% O2 without any signs of 
recovery.  
 
3.2.3.3 Minute ventilation 
Changes in breathing frequency and tidal volume of control AMPK-α1/α2 Flx 
mice translated into a time-dependent reduction in minute ventilation that fell 
below normoxic values after 10min of 8% O2 (10-15min: -13 ± 0.8%). From 
then on, minute ventilation continued to decline at a very low rate, 
measuring -21.3 ± 0.5% by 30-35min and -28.5 ± 1.9% by 55-60min (Figure 
3.8 C).  
As expected, minute ventilation of TH AMPK-α1/α2 dKO mice was 
significantly attenuated compared to controls throughout the entire 60min 
period. Following the onset of hypoxia, minute ventilation fell below normoxic 
values within 5min and continued to rapidly decrease until the 15min mark 
(10-15min: -34.1 ± 2.4%, p<0.001 compared to controls). However, unlike 
controls the minute ventilation of TH AMPK-α1/α2 dKO mice plateaued at 
this point and while it did not decline much further until the end of the 
exposure, it remained significantly attenuated relative to controls 
(15-20min: -39.9 ± 0.8%, p<0.0001; 30-35min: -37.9 ± 1.6%, p<0.001; 





Collectively, these data strongly suggest that deletion of AMPK-α1 and -α2 
catalytic subunits in catecholaminergic cells results in a PO2-dependent 
ventilatory depression during hypoxia that extends beyond the 5min period 
measured previously. Notably, deficits observed in exposures to severe 
hypoxia lasting up to 60min showed no delayed recovery of ventilation and 
that the degree of hypoxic ventilatory depression observed in control mice 
is further exacerbated. Therefore, AMPK activity is required in 







Figure 3.8:  Deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells attenuated breathing frequency, tidal volume, 
and minute ventilation over a 60min period of severe hypoxia.  
Means ± SEM for the % change relative to normoxia (green dotted line) in 
(A) breathing frequency, (B) tidal volume, and (C) minute ventilation during 
60min exposures to severe hypoxia (8% O2) for whole minute averages in 
AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, n = 5 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, n = 4 mice). ns = not significant, * = p<0.05, ** = p<0.01, *** = p<0.001, 
**** = p<0.0001. Significance tested for each 5min block by Student’s paired 






3.3.1 Summary of findings 
Chapter 3 shows that the appropriate modulation of the respiratory response 
to hypoxia requires AMPK activity in catecholaminergic cells regardless of 
the duration of exposure to hypoxia, highlighted by the fact that there was 
no time-dependent or delayed compensation for the ventilatory deficiency 
reported previously. Importantly, the hypoxic respiratory depression 
triggered by AMPK deficiency was not only sustained, but increased in a 
manner proportional to the severity of hypoxia. During prolonged 60min 
exposures to severe hypoxia, the loss of both AMPK-α1 and -α2 catalytic 
subunits attenuated the ventilatory response to hypoxia and further 
exacerbated the hypoxic ventilatory decline observed in controls. Therefore, 
AMPK activity in catecholaminergic cells governs the maintenance of 
whole-body O2 supply throughout periods of acute hypoxia by continuously 
supporting appropriate ventilatory adjustments. 
 
3.3.2 AMPK activity in brainstem catecholaminergic cells supports 
increases in ventilation during hypoxia 
Firstly, and consistent with previous reports, deletion of AMPK-α1 and -α2 
catalytic subunits in catecholaminergic cells did not affect breathing during 
normoxia. In contrast, upon exposure to mild and severe hypoxic gas, 
increases in the drive to breathe were significantly attenuated (see also 
Appendices 1.2 to 1.4).  
By extending the duration of hypoxic exposures from 5min to 10min and then 
up to 60min, it became apparent that AMPK activity is not only required to 
support modulation of ventilation during the initial phases of the HVR, but 
also beyond and throughout more prolonged exposures to hypoxia. 
Classically, the HVR of mice and other mammals is biphasic. The first 
response to an acute fall in PO2 is a rapid and robust increase in ventilation, 
which is termed the “Augmenting phase” and primarily driven by carotid body 




(Ramirez et al., 1998; Palmer et al., 2013; Pamenter & Powell, 2016). 
Thereafter, the central effect of hypoxia leads to a reduction in ventilation 
called “Roll-Off”, which may be partially driven by declining metabolic rates 
of non-O2 sensitive neurons, as well as activation of central chemosensitive 
sites within the brainstem in response to increasing levels of hypocapnia 
subsequent to hyperventilation during the Augmenting phase. As has been 
demonstrated before (Mahmoud, 2014; Mahmoud et al., 2016), components 
of the classical biphasic HVR were retained in TH AMPK-α1/α2 dKO mice, 
albeit in an attenuated manner. These outcomes are entirely consistent with 
the view that – despite the fact that carotid body chemoafferent input 
responses remained unaffected – AMPK-α1/α2 deletion in 
catecholaminergic neurons blocked the HVR beyond the initial ventilatory 
augmentation during hypoxia for which afferent inputs may be responsible 
(Teppema & Dahan, 2010; Mahmoud et al., 2016; Wilson & Teppema, 
2016). That said, the attenuation of the Augmenting phase, particularly at 
8% O2, indicates that while chemoafferent inputs were most likely received 
within the brainstem, the appropriate physiological responses could not be 
executed sufficiently in the absence of AMPK activity within central 
catecholaminergic cells. This is entirely consistent with the proposal that 
AMPK-dependent signalling pathways within brainstem catecholaminergic 
cells support signal integration and thus modulation of ventilatory output via 
the respiratory central pattern generators (rCPGs) (Evans et al., 2016; 
Mahmoud et al., 2016; Evans, 2018). The rCPGs adjust ventilation by 
coordinating the rhythmic patterns of motor activity for the diaphragm, 
ribcage, and upper airway muscles (von Euler, 1983; Dobbins & Feldman, 
1994; Guyenet et al., 2002). During hypoxia, motor output from the rCPGs 
is modulated by signals from peripheral and central O2-sensing cells, which 
increase ventilation and thus protect against metabolic stress and tissue 
hypoxaemia at the whole-body level. It is now apparent that such modulation 
of rCPGs is reliant on AMPK-dependent signalling pathways for the entire 
duration of a hypoxic exposure, because significant deficits in ventilatory 
drive within TH AMPK-α1/α2 dKO mice were observed during exposures to 




The fact that AMPK-dependent signalling pathways are continuously 
required to support ventilatory drive became especially apparent during the 
acute hypoxic ventilatory decline, or “Roll-Off”, which was significantly 
attenuated in TH AMPK-α1/α2 dKO mice to the point where these mice 
entered a state of hypoventilation during severe hypoxia. Similar to the 
findings of others (Palmer et al., 2013), ventilatory efforts of control 
AMPK-α1/α2 Flx mice declined progressively until ventilatory activity 
approximated that observed during normoxia at the end of the 10 minute 
exposure. By contrast, TH AMPK-α1/α2 dKO mice maintained a fairly stable 
level of hypoventilation between 6 to 10 minutes of hypoxia. It may be 
possible for these mice to have reached a “minimum of ventilation”, not too 
dissimilar to patients suffering from central congenital hypoventilation 
syndrome (Healy & Marcus, 2011). Indeed, outcomes from hypoxic 
exposures lasting 60 minutes revealed no further decreases in ventilation of 
TH AMPK-α1/α2 dKO mice after approximately 15 minutes of severe 
hypoxia, whereas control AMPK-α1/α2 Flx mice still exhibited a minor 
decline in ventilation. This decline was mostly driven by continuous 
time-dependent reductions in tidal volume, consistent with the manifestation 
of hypoxic ventilatory depression/decline (HVD) (Pamenter & Powell, 2016). 
That said, control AMPK-α1/α2 Flx mice continued to maintain an 
augmented breathing frequency relative to normoxia throughout the 60min 
exposures, whereas breathing frequencies of TH AMPK-α1/α2 dKO mice 
remained attenuated relative to both controls and normoxia.  
Similar to the ventilatory phenotype of TH AMPK-α1/α2 dKO mice, a marked 
HVD has also been observed in neonatal mammals, whose oxygen-sensing 
network comprising the catecholaminergic cells of the peripheral carotid 
body and central nucleus tractus solitarius (NTS) are still immature at birth 
(Bissonnette, 2000; Teppema & Dahan, 2010; Koos & Rajaee, 2014). The 
neonatal response to hypoxia is characterised by a reduced augmentation 
phase and a quick decline into hypoventilation, which is, at least partially, 
equalised by a decrease in metabolism and hence O2 demand (Mortola & 
Maskrey, 2011). Given that catecholaminergic deletion of AMPK-α1 and -α2 




index of the metabolic status relative to controls was required to determine 
whether these mice compensated their minimal ventilatory output by 
decreases in metabolic demand, or whether they truly entered a 
hypoventilatory state. Neither an immediate exposure to severe hypoxia, nor 
graded intensities of increasing environmental hypoxia revealed any 
differences in the metabolic rates of TH AMPK-α1/α2 dKO mice relative to 
controls, confirming that deletion of AMPK-α1 and -α2 catalytic subunits in 
catecholaminergic cells results in true hypoventilation during hypoxia with 
no compensatory reductions in metabolism.  
On the whole, these findings add further weight to the hypothesis that 
AMPK-dependent signalling pathways have been adapted to regulate O2 
supply, and thus energy homeostasis, at the whole-body level. Deficiencies 
in AMPK expression may therefore compromise the appropriate modulation 
of breathing during hypoxic stress, for example during sleep or ascent to 
altitude (Ainslie et al., 2013; Panossian & Daley, 2013).  
 
3.3.3 Conclusion 
In conclusion, mice with dual deletion of the AMPK-α1 and -α2 catalytic 
subunits in catecholaminergic cells are unable to sustain an increase in 
ventilation during hypoxia and exhibit a severely disordered ventilatory 
phenotype during prolonged exposures. Given the normal increases of 
carotid body chemoafferent input and yet an attenuated HVR, 
AMPK-dependent signalling pathways are critical within the brainstem 
catecholaminergic network for signal integration and coordination of the 
appropriate ventilatory responses to hypoxia, which are modulated via 
afferent projections to the rCPGs within the ventral medulla. Therefore, in 
addition to the primary peripheral chemosensors of the carotid body, it 
seems quite plausible that AMPK-dependent modulation of a group of 
central oxygen-sensing catecholaminergic cells within the caudal brainstem 
may determine the overall degree of the ventilatory responses to hypoxia 
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neuronal activation 
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The nucleus tractus solitarius (NTS), located bilaterally within the dorsal 
medulla oblongata, contains undoubtedly one of the most complex neuronal 
aggregates of the brainstem. The NTS has been implicated in the control of 
a variety of respiratory, autonomic, emotional, volitional, appetitive, and 
gustatory functions (Geerling et al., 2006; Rinaman, 2010; Roussin et al., 
2012; Zoccal et al., 2014; Hume, 2017; Venkatraman et al., 2017). It is 
therefore not surprising that the NTS is the subject of a wide range of afferent 
innervations from the periphery and forms a vast network of neuronal 
projections within the brainstem, and to the spinal cord and forebrain 
(Andresen & Kunze, 1994; Horner, 2009; Kline et al., 2010; King et al., 2012; 
Zoccal et al., 2014; King et al., 2015).  
Important in the context of this thesis, sensory afferent innervations from the 
carotid bodies (chemoreceptors), pulmonary stretch receptors 
(mechanoreceptors) and arterial baroreceptors innervate the caudal 
portions of the NTS (Finley & Katz, 1992; Mendelowitz et al., 1992; Kubin et 
al., 2006) and mediate, through innervation of the ventrolateral medulla 
(VLM), cardiorespiratory changes in response to homeostatic threats such 
as hypoxia.   
 
4.1.1 The functional compartmentalisation of the NTS 
Several studies have sought to determine the precise neuronal connections 
between the NTS and VLM that modulate the control of breathing, and to 
separate innervations from specific compartments (subnuclei) of the NTS to 
the individual compartments of the VLM that form the ventral respiratory 
central pattern generators (rCPGs [bilateral symmetry]) (Ellenberger & 
Feldman, 1990; Nunez-Abades et al., 1993; Ellenberger & Feldman, 1994; 
Rosin et al., 2006; Alheid et al., 2011). Using retrograde tracer injections into 
individual compartments of the rCPGs, it was found that particular subnuclei 
of the NTS differentially innervate the VLM (Ross et al., 1985; Alheid et al., 
2011). Figure 4.1 illustrates these findings schematically, whereby 




left, and the cardiorespiratory (hearts and lungs, respectively) functions and 
carotid body afferent innervations (arteries) are illustrated on the right. 
Within the NTS, carotid body afferent inputs terminate within the portions 
that are mostly caudal to the level of the area postrema (AP), but also at the 
level of the AP (Finley & Katz, 1992), where afferent inputs from the 
baroreceptors and mechanoreceptors mostly terminate as well (Kubin et al., 
2006). With respect to the individual subnuclei of the NTS that receive these 
innervations, the most prominent afferent chemoreceptor projections were 
found to terminate within the commissural (SolC) and medial (SolM) 
subnuclei, while less prominent projections arrive at the interstitial (SolI), 
intermediate (SolIM), dorsolateral (SolDL), and ventrolateral (SolVL) 
subnuclei (Figure 4.1, right). In addition, few terminals also terminated in the 
area postrema (AP) and the dorsal motor nucleus of the vagus (10N), the 
latter of which contains parasympathetic preganglionic neurons that 
innervate the thorax and abdomen (Finley & Katz, 1992; Watson et al., 
2012). Vagal afferents arising from the pulmonary stretch receptors, on the 
other hand, were found to terminate within the NTS subnuclei of SolIM, SolI, 
SolV (ventral subnucleus), and SolVL (Kubin et al., 2006). Finally, densely 
projecting baroreceptor afferent terminals project to the SolM, caudal to and 
at the level of the AP, coinciding with the afferent innervations from the 
chemoreceptors (Mendelowitz et al., 1992).  
A picture began to emerge whereby the regulation of the respiratory and 
cardiovascular systems appeared to be synergistic. In support of this view, 
the majority of NTS neurons that project to the VLM were found to 
simultaneously innervate compartments of rCPG and the rostral and caudal 
ventrolateral medulla (Figure 4.1 left; RVL and CVL, respectively, red), 
which contain pre-sympathetic catecholaminergic C1 neurons (Alheid et al., 
2011). Therefore, it appears that within the NTS, networks that control 
cardiovascular responses are closely linked with those that modulate the 
respiratory responses. Nonetheless, there appears to also be a degree of 
selectivity with respect to the afferent innervation from the NTS subnuclei to 
the rCPGs. For example, while most subnuclei project broadly to each of the 




well as the bilaterally located SolM were found to completely avoid 
innervations of the inspiratory pre-Bötzinger complex (preBötC, green) and 
expiratory Bötzinger complex (BötC, yellow). Therefore, at least some of the 
reflex pathways that shape cardiorespiratory responses via caudal NTS 
nuclei appear to do so by directly innervating motor pattern forming 
compartments of the VLM (such as the rostral ventral respiratory group; 
Figure 4.1 left, purple), while indirectly acting on compartments that 





Figure 4.1: Schematic of the projections from the nucleus tractus 
solitarius to the ventral respiratory column.  
Top panel shows the anatomical organisation of the nucleus tractus 
solitarius (NTS) according to the Mouse Brain Atlas (Franklin & Paxinos, 
2008) at Bregma -7.48mm. Middle panel shows the functional organisation 
of the NTS according to findings from Alheid et. al. (2011) with respect to 
their afferent innervations to the ventral medulla (left) and their physiological 
control (right). Lower panel shows the compartmentalisation of the ventral 
respiratory column (VRC), which is colour coded according to the 
physiological function of each compartment (border colour – respiratory: 
blue, cardiovascular: red) and the connection to each NTS subnucleus (fill 
colours). Larger circles within the NTS subnuclei indicate strong innervation 
of each colour coded compartment of the VRC, smaller circles indicate 
weaker innervation. Schematic based on the findings of Alheid et. al. (2011). 




Abbreviations for Figure 4.1: 
Lungs: respiratory control, heart: cardiovascular control, artery: received 
afferent input from carotid bodies, AP: = area postrema; SubP: 
sub-postrema; 10N = dorsal motor nucleus of the vagus; SolC = 
commissural nucleus; SolM = medial nucleus; SolDM = dorsomedial 
nucleus; SolDL = dorsolateral nucleus; SolCe = central nucleus; SolIM = 
intermediate nucleus; SolI = interstitial nucleus; SolV = ventral nucleus; 
SolVL = ventrolateral nucleus; SolL = lateral nucleus 7N: facial nucleus, 
RTN: retrotrapezoid nucleus, NA: nucleus ambiguus, BötC: Bötzinger 
complex, preBötC: pre-Bötzinger complex, rVRG: rostral ventral respiratory 
group, cVRG: caudal ventral respiratory group, RVL: rostral ventrolateral 





4.1.2 cFos as a marker for neuronal activation 
In order to study the stimulus-dependent activation of particular neurons of 
the central nervous system in vivo, the use of cFos labelling became highly 
popular. Being part of the immediate-early gene family, the expression of 
the proto-oncogene cFos is rapidly activated and/or increased in response 
to a variety of extracellular stimuli and subsequent cellular activation, 
including the firing of action potentials within neurons of the central nervous 
system (Dragunow & Faull, 1989). Following membrane depolarisation and 
entry of extracellular Ca2+ via voltage-gated Ca2+-channels, activation of the 
Ca2+/calmodulin-dependent protein kinase (CaMK) allows for 
phosphorylation of the cyclic AMP response element binding protein (CREB) 
at Ser133, which induces its activity as a transcription factor for 
immediate-early genes such as cFos (Sheng et al., 1990). Therefore, any 
increases in cFos expression relative to unstimulated controls can be related 
back to any given stimulus-induced strong neuronal activation. 
Its latency of maximal expression after 20-90 minutes and long half-life made 
the cFos protein an ideal target for immunohistochemical experiments 
(Morgan et al., 1987; Johnstone et al., 2006; Perrin-Terrin et al., 2016). In 
addition, due to its functional role in regulating gene expression, cFos is 
localised to the nucleus (Sambucetti & Curran, 1986) and therefore allows 
for co-labelling of cytoplasmic structures in order to distinguish between 
activated cell types.  
Using this technique, a number of studies have aimed to identify the central 
respiratory network involved in the ventilatory responses to hypoxia. 
Invariably, systemic hypoxia was found to induce cFos expression bilaterally 
within the NTS and defined regions of the rCPG in the cat (Larnicol et al., 
1994), rabbit (Hirooka et al., 1997), rat (Erickson & Millhorn, 1994; Smith et 
al., 1995; Teppema et al., 1997; Bodineau & Larnicol, 2001; Cruz Jde et al., 
2010; Kline et al., 2010; King et al., 2012; King et al., 2013; Wakai et al., 
2015), and the neonatal mouse (Joubert et al., 2016). Importantly, 
increasing intensities of the hypoxic stimulus resulted in increased cFos 
expression within these animal models. Therefore, cFos expression is a 




to study alterations within the central respiratory network activity following a 
variety of pharmacological treatments or genetic modifications. 
 
4.1.3 AMPK deletion in catecholaminergic cells led to attenuations in 
brainstem cFos expression 
As described in Chapter 3, mice with dual deletion of AMPK-α1 and -α2 
catalytic subunits in tyrosine hydroxylase-expressing cells (TH AMPK-α1/α2 
dKO mice) exhibited marked hypoventilation during acute and prolonged 
periods of hypoxia. Functional magnetic resonance imaging (fMRI) revealed 
that during hypoxic exposures, TH AMPK-α1/α2 dKO mice also displayed 
reduced neuronal activity relative to controls within particular areas of the 
NTS and the VLM, which aligned well with the anatomical location of dorsal 
catecholaminergic A2/C2 and ventral A1/C2 neurons that were targeted by 
the TH-driven deletion of AMPK (Mahmoud et al., 2016). These regions were 
termed the “dorsal active region” (DAR) and “ventral active region” (VAR), 
respectively, and their anatomical location within the brainstem was found 
to span across several Bregma along the neuraxis. Analysis of cFos 
expression was subsequently used to identify the subpopulations of cells 
within the brainstems of TH AMPK-α1/α2 dKO mice that exhibited in vivo 
deficits of neuronal activation during hypoxia. A significant reduction in 
hypoxia-induced cFos expression was proposed to occur within the dorsal 
NTS subnuclei of SolM and SubP (sub-postrema), as well as the more 
rostrally located catecholaminergic C2 cell group. Significant reductions in 
cFos expression within TH-positive cells targeted by AMPK deletion were 
also observed within the dorsal catecholaminergic A2 neurons confined to 
the SubP, the dorsal C2 cell group, and the ventral A1 cell group. By 
contrast, significant increases in cFos expression were found within 
TH-positive cells of NTS subnuclei SolC, SolV, and SolVL, as well as the 






From the findings in the study described above, it was unclear whether 
AMPK-dependent reductions in the hypoxia-induced cFos expression 
spanned the entire neuraxis of the NTS or whether the deficits were confined 
to a particular rostrocaudal region as indicated by fMRI. Furthermore, the 
number and size of individual subnuclei of the NTS changes throughout its 
rostrocaudal length, and not all subnuclei were included in the cFos counts. 
I therefore sought to re-visit these outcomes and to provide a more detailed 
analysis by assessing the cFos expression in response to hypoxia within all 
subnuclei of the NTS, and to additionally separate my counts by individual 
Bregmas along the neuraxis of the caudal mouse brainstem.  
Accordingly, mice with dual deletion of the AMPK-α1 and -α2 catalytic 
subunits were exposed to hypoxia and their neuronal activation analysed by 






4.2.1 Ventilatory outcomes of experimental animals 
As shown in Figure 4.2 A, control AMPK-α1/α2 Flx mice used for analysis of 
cFos expression displayed a typical HVR, presenting as robust increases in 
ventilation at the onset of hypoxia, followed by a time-dependent roll-off until 
a sustained plateau was reached. Consistent with my previous studies 
(Chapter 3), analysis of TH AMPK-α1/α2 dKO mice used to compare cFos 
expression demonstrated that increases in minute ventilation during hypoxia 
were attenuated compared to controls (Figure 4.2 B, p<0.01), thereby 
confirming that ventilatory outcomes described in Chapter 3 were also 
observed in single exposures of naïve mice used for experiments carried out 
in this chapter. 
 
4.2.2 Immunohistochemical co-staining for the expression of cFos 
and tyrosine hydroxylase 
Fluorescence-based immunohistochemistry Previously published data on 
the expression of cFos and tyrosine hydroxylase (TH) within AMPK-α1/α2 
Flx and TH AMPK-α1/α2 mice utilised a fluorescence approach (Mahmoud 
et al., 2016), which I sought to emulate in order to confirm proof of principle 
by directly comparing outcomes from my experiments with those carried out 
by others and to ultimately analyse the data in more detail. Unfortunately, I 
found that the use of fluorescent secondary antibodies did not produce the 
desired qualitative outcomes during imaging. The staining of 
catecholaminergic (TH-positive) cell bodies was poor to absent for ventral 
A1/C1 neurons, and indistinguishable between individual cell bodies for 
dorsal A2/C2 neurons due to high background fluorescence proximal to the 
area postrema (Figure 4.3). Furthermore, labelling of cFos-positive nuclei 
resulted in a high degree of overall background fluorescence and additional 
unexpected labelling of cell bodies. Due to these technical difficulties an 
alternative method of immunohistochemical staining was employed that 




3,3′-Diaminobenzidine (DAB)-based immunohistochemistry The chosen 
alternative approach was to use DAB staining, a technique commonly used 
and described within the literature on cFos expression within the central 
nervous system following exposures to hypoxia (Erickson & Millhorn, 1994; 
Smith et al., 1995; Hirooka et al., 1997; King et al., 2012; Wakai et al., 2015). 
It was an immediate success regarding the specific detection of nuclear cFos 
expression. However, in initial trials TH labelling appeared entirely absent 
regardless of the primary and secondary antibody concentration used for 
incubations. In the end, reducing the section thickness from 40µm to 30µm 
finally allowed for visualisation of brown cell bodies of TH-positive neurons 
(see Figure 4.9). That said, the final working concentration for the anti-TH 
antibodies was 1/2,000 whereas the anti-cFos antibodies were used at a 
final concentration of 1/100,000. Therefore, there is a strong possibility that 
using a mouse primary antibody with an anti-mouse secondary antibody on 
mouse tissue may have resulted in non-specific detection of  endogenous 
mouse immunoglobulin within the sections. However, this should have 
resulted in increased background levels, rather than poor overall staining. 
One way to resolve this issue would be to use a genetic reporter, such as 
LacZ or tdTomato fluorescent protein fused to Cre. This way, any cells that 
conditionally express Cre leading to AMPK-α1 and -α2 catalytic subunit 
deletion would co-express one of these two markers. In the end, this method 
does not only provide more specificity regarding identification of the target 





Figure 4.2:  Attenuations of minute ventilation were confirmed in 
TH-driven AMPK-α1/α2 knockout mice used for analysis of cFos 
expression.  
(A) Example 10min records of minute ventilation (ml/g/min) for one 
AMPK-α1 and -α2 floxed mouse (AMPK-α1/α2 Flx, black) and one TH-driven 
AMPK-α1 and -α2 double knockout mouse (TH AMPK-α1/α2 dKO, red) used 
for cFos analysis after exposure to severe hypoxia (8% O2).  (B) Means ± 
SEM for minute ventilation during both halves of the 10min exposures to 8% 
O2 in AMPK-α1/α2 Flx (n = 7) and TH AMPK-α1/α2 dKO mice (n = 5). ** = 





Figure 4.3: Fluorescence photomicrographs following a 10min 
exposure to severe hypoxia.  
Representative photomicrographs of tyrosine hydroxylase (TH)-positive 
(red) cell bodies and cFos-positive (green) nuclei in the caudal brainstem of 
an AMPK-α1 and -α2 floxed (AMPK-α1/α2 Flx) mouse following 10min 






4.2.3 Assessment of catecholaminergic cell numbers following 
deletion of AMPK-α1 and -α2 catalytic subunits 
Within different systems and pathologies, AMPK has been shown to either 
promote or protect from cell death (Mihaylova & Shaw, 2011; Merlen et al., 
2014; Evans et al., 2015; Hardie, 2015). Importantly, neuronal AMPK has 
been proposed to be required within the rodent brain to promote survival 
following metabolic stress (Culmsee et al., 2001) and reductions in 
brainstem catecholaminergic neurotransmission may underlie, at least in 
part, the hypoventilatory and apnoeic phenotypes associated with Rett 
Syndrome (Ide et al., 2005; Viemari et al., 2005; Stettner et al., 2007; Katz 
et al., 2009; Roux & Villard, 2010). On the other hand, breathing irregularities 
and apnoeas during hypoxia have also been shown to be triggered by 
increases in catecholaminergic neurotransmission (Zanella et al., 2014). 
Therefore, it was important to firstly assess whether the deletion of AMPK-α1 
and -α2 catalytic subunits in TH-positive cells may have affected ventilatory 
stability during hypoxia through alterations in the overall number of 
brainstem catecholaminergic cells or the total bioamine content. 
 
4.2.3.1 Deletion of AMPK-α1 and -α2 catalytic subunits does not alter 
the number of TH-positive cells in the brainstem  
Total counts – dorsal and ventral As can be seen in Figure 4.4, counts for 
TH-labelled cells revealed no differences in the total number of 
catecholaminergic neurons within the dorsal (left panels) or ventral (right 
panels) brainstems of AMPK-α1/α2 Flx (n = 16) and TH AMPK-α1/α2 dKO 
(n = 11) mice. These outcomes were retained regardless of whether the 
counts were grouped into total counts for both hemispheres (Figure 4.4 A), 
or separated into the right side (Figure 4.4 B) and left side (Figure 4.4 C) of 
the brainstem (see Appendix 2.1 for data tables).  
Dorsal counts per Bregma Comparable counts between controls and TH 
AMPK-α1/α2 dKO mice were also obtained when separating the number of 
catecholaminergic neurons within the dorsal NTS by each identified Bregma, 




the right and left divisions of the NTS (Figure 4.5, Appendix 2.2). Notably, 
the number of TH-positive cells decreased slightly in a caudo-rostral 
direction, consistent with the reported location and density of the 
catecholaminergic A2 cell group that is primarily located in the caudal and 
medial portions of the NTS (Rinaman, 2011).  
Dorsal counts per subnucleus Additionally, no differences in TH cell counts 
between controls and TH AMPK-α1/α2 dKO mice were found when 
comparing the total, right-, and left-sided numbers of TH-positive cells found 
within each subnucleus of the NTS spanning the entire length of the caudal 
brainstem (Figure 4.6, Appendix 2.3). Notably, the highest density of 
TH-labelling following DAB staining was obtained within the mediolateral 
parts of the NTS (SolIM, SolV, SolVL, SolCe), however the presence of 
TH-positive cells was observed in every subnucleus.  
Ventral counts per cell group Total counts for TH labelled cells within the 
ventral medulla were also comparable between AMPK-α1/α2 Flx and TH 
AMPK-α1/α2 dKO mice after separation of ventral catecholaminergic cells 
into their neuronal cell groups, namely A1 cells at the level of the area 
postrema, C1 cells at the level of the 4th ventricle, and the mixed population 
of A1/C1 cells at the level of the obex (Figure 4.7, Appendix 2.4). That said, 
cell counts indicated a significant increase in the number of TH labelled 
neurons in the rostral ventrolateral medulla following AMPK deletion 
(p<0.05), where C1 neurons are predominant. However, this was only 
evident on the right side of the brainstem, with counts comparable for TH 
AMPK-α1/α2 dKO mice and controls for the left side alone and when both 
sides were added together. Separation of the more caudally located A1/C1 
and A1 neurons into the right and left sides of the ventrolateral medulla did 
not reveal any changes in the number of TH-positive cells following deletion 







Figure 4.4: Targeted deletion of AMPK-α1/-α2 catalytic subunits in 
catecholaminergic cells did not alter total brainstem 
catecholaminergic cell counts.  
Means ± SEM of tyrosine hydroxylase-positive cell counts (per 1000µm3) for 
all identified Bregma within the (A) total, (B) right side, and (C) left side of 
the dorsal brainstem within the nucleus tractus solitarius (left panels) and 
ventral brainstem (right panels) of AMPK-α1 and -α2 floxed mice 
(AMPK-α1/α2 Flx, black, n = 16 mice) and TH-driven AMPK-α1 and -α2 
double knockout mice (TH AMPK-α1/α2 dKO, red, n = 11 mice). Significance 





Figure 4.5: Targeted deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells did not alter dorsal brainstem 
catecholaminergic cell counts within any Bregma.  
Means ± SEM of tyrosine hydroxylase-positive cell counts (per 1000µm3) for 
all identified Bregma within the (A) total, (B) right-sided, and (C) left-sided 
nucleus tractus solitarius of AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n 
= 16 mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, n = 11 mice). Significance tested by Student’s t-test 





Figure 4.6: Targeted deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells did not alter dorsal brainstem 
catecholaminergic cell counts within any region of interest. 
 Means ± SEM of tyrosine hydroxylase-positive cell counts (per 1000µm3) 
for each subnucleus of the (A) total, (B) right-sided, and (C) left-sided 
nucleus tractus solitarius of AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n 
= 16 mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, n = 11 mice). SolC = commissural nucleus, SubP = 
sub-postrema, 10N = hypoglossal nucleus, SolM = medial nucleus, SolDM 
= dorsomedial nucleus, SolDL = dorsolateral nucleus, SolI = interstitial 
nucleus, SolIM = intermediate nucleus, SolV = ventral nucleus, SolVL = 
ventrolateral nucleus, SolL lateral nucleus, SolCe = central nucleus. 
Significance tested by Student’s t-test between genotypes for each region 





Figure 4.7: Targeted deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells did not alter ventral brainstem 
catecholaminergic cell counts.  
Means ± SEM of tyrosine hydroxylase-positive cell counts (per 1000µm3) for 
all identified Bregma within the (A) total, (B) right-sided, and (C) left-sided 
ventral brainstem corresponding to the catecholaminergic A1 neurons (left 
panels), A1/C1 neurons (middle panels), and C1 neurons (right panels) in 
AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n = 16 mice) and TH-driven 
AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, red, n = 11 
mice). * = p<0.05. Significance tested by Student’s t-test between genotypes 






4.2.3.2 Deletion of AMPK-α1 and -α2 catalytic subunits does not alter 
brainstem bioamine content 
Consistent with the outcomes for TH-positive cell counts, measurements of 
bioamine levels within the brainstems (Figure 4.8 A) and spinal cords (Figure 
4.8 B) of control AMPK-α1/α2 Flx (n = 11) and TH AMPK-α1/α2 dKO (n = 
12) mice carried out by David Burns at the University of Cork revealed no 
differences in the amounts of catecholamines (noradrenaline and serotonin), 
the catecholamine precursor L-DOPA, or the serotonin metabolite 
5-hydroxyindoleacetic acid (5-HIAA; see Appendix 2.5 for data tables).  
It would appear, therefore, that deletion of AMPK-α1 and -α2 catalytic 
subunits in catecholaminergic neurons did not result in any hyper- or 
hypoplasia of TH-positive cells and did not alter the catecholamine content 
within the brainstem. Therefore, the breathing irregularities, hypoventilation 
and apnoeas observed in TH AMPK-α1/α2 dKO mice during hypoxia were 
unlikely to be due to aberrant catecholaminergic biosynthesis and 
availability. It seems most likely, therefore, that ventilatory dysfunction 
resulted from inappropriate signal integration and transduction within the 
catecholaminergic respiratory network of the brainstem, ultimately leading 







Figure 4.8: Deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells did not alter bioamine content.   
Means ± SEM of bioamine levels within the (A) brainstems and (B) spinal 
cords of AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n = 11 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, n = 12 mice). 5-HIAA = 5-hydroxyindoleacetic acid. Significance tested 




4.2.4 The expression of nuclear cFos following 10min exposures to 
severe hypoxia 
In order to match experimental outcomes to plethysmography experiments 
described in Chapter 3 and to previously published data (Sunday Udoh, 
2015; Mahmoud et al., 2016), naïve mice were exposed to 10min of severe 
hypoxia (8% O2) and sacrificed 90min later to study the cFos expression 
within the brainstem.  
 
4.2.4.1 10min exposures to severe hypoxia are not sufficient to evoke 
hypoxia-dependent increases in cFos expression 
cFos expression in control mice Analysis of cFos expression in control 
AMPK-α1/α2 Flx mice following 10min exposures to 8% O2 showed a highly 
variable expression profile between animals, both with respect to the 
number of cFos-positive nuclei stained and their distribution within the NTS 
(Figure 4.9). These observations were further corroborated by the fact that 
there was no significant increase in the number of cFos-positive cells 
compared to mice exposed to room air (Figure 4.10; 21% O2: 0.007 ± 0.0005 
nuclei/1000µm3, 8% O2: 0.0186 ± 0.003 nuclei/1000µm3). This finding was 
contrary to outcomes described previously, which suggested that increasing 
intensities of hypoxia evoke increased expression of cFos within the rodent 
brainstem (Erickson & Millhorn, 1994; Smith et al., 1995; Hirooka et al., 
1997; King et al., 2012; Wakai et al., 2015). However, these previous studies 
of others generally used a much longer stimulus protocol, whereby hypoxia 
was administered for at least 60min and up to 3 hours.  
Considering the various methods described in the literature and following 
very kind guidance and advice from Prof Roger Dampney (University of 
Sydney), another stimulus protocol was tested where hypoxia (8% O2) was 
given for a period of 60min, with mice sacrificed after a 15min recovery 
period. This prolonged stimulus resulted in significant increases in cFos 
expression within the NTS of control mice (0.0624 ± 0.006 nuclei/1000µm3) 
when compared to either 21% O2 (p<0.0001) or 10min exposures to 8% O2 




hypoxia (8% O2) increased cFos expression within the NTS consistent with 
previously reported outcomes, while 10min exposures appeared to be of 
insufficient duration to do so. 
 
The effect of AMPK deletion on cFos expression Counts for cFos expression 
in TH AMPK-α1/α2 dKO mice following 10min hypoxia followed the same 
trend as control AMPK-α1/α2 Flx mice. There was no significant increase in 
the number of cFos-positive nuclei in TH AMPK-α1/α2 dKO mice exposed 
to severe hypoxia (8%O2) when compared to TH AMPK-α1/α2 dKO mice 
exposed to room air (Figure 4.10; 21% O2: 0.009 ± 0.002 nuclei/1000µm3, 
8% O2: 0.0182 ± 0.007 nuclei/1000µm3). Furthermore, the average 
expression of cFos following 10min hypoxia was almost identical within the 
NTS of TH AMPK-α1/α2 dKO mice compared to control AMPK-α1/α2 Flx 
mice exposed to 10min of 8% O2 (p=0.999).  
By contrast, and consistent with outcomes for control mice, prolonged 60min 
exposures to 8% O2 significantly increased the number of cFos-positive 
nuclei in TH AMPK-α1/α2 dKO mice compared to TH AMPK-α1/α2 dKO 
mice exposed to room air (0.0469 ± 0.0086 nuclei/1000µm3; p<0.05). 
Importantly, average counts revealed a small reduction in the total number 
of cFos positive nuclei when compared to control AMPK-α1/α2 Flx mice that 
were also exposed to 60min of 8% O2 (p=0.336).  
These findings highlight that 60min of hypoxia is an appropriate stimulus, 
which was therefore used for further, more detailed analyses of cFos 






Figure 4.9: 10min exposures to severe hypoxia resulted in highly 
variable expression of cFos within the dorsal brainstem.  
Representative photomicrographs of tyrosine hydroxylase (TH)-positive 
(brown) cell bodies and cFos-positive (black) nuclei in the caudal brainstem 
of four different AMPK-α1 and -α2 floxed mice following 10min exposures to 
8% O2. Approximate Bregma -7.56mm. AP = area postrema, cc = central 
canal, SolM = medial nucleus, SolDL = dorsolateral nucleus, SolIM = 
intermediate nucleus, SolI = interstitial nucleus, SolV = ventral nucleus, 





Figure 4.10: 60min of severe hypoxia are required to evoke 
PO2-dependent changes in total dorsal brainstem cFos expression.  
Means ± SEM for changes in whole NTS cFos counts (per 1000µm3) in 
AMPK-α1 and -α2 floxed (AMPK-α1/α2 Flx, black) and TH-driven AMPK-α1 
and -α2 double knockout mice (TH AMPK-α1/α2 dKO, red) exposed to room 
air (21% O2, shaded bars; controls: n = 4, knockouts: n = 4), 10min of 8% 
O2 (lined bars; controls: n = 7, knockouts: n = 4), or 60min of 8% O2 (empty 
bars; controls: n = 6, knockouts: n = 7). ns = not significant, * = p<0.05, **** 






4.2.5 PO2-dependent increases in cFos expression of control 
AMPK-α1/α2 Flx mice following 60min exposures to hypoxia 
From this point forward, cFos expression was assessed as an index of 
neuronal activation following 60min exposures to hypoxia.  
As illustrated in Figure 4.11, the overall intensity of cFos expression in 
control AMPK-α1/α2 Flx mice increased with decreasing PO2, consistent 
with outcomes previously described in the adult rabbit and rat (Erickson & 
Millhorn, 1994; Hirooka et al., 1997; King et al., 2012), as well as neonatal 
mice (Joubert et al., 2016).  
My further analyses incorporated subdivisions of brainstem regions by 
Bregma, given that previous studies have assessed cFos expression per 
Bregma (Erickson & Millhorn, 1994; Smith et al., 1995; Hirooka et al., 1997; 
King et al., 2012; King et al., 2015; Joubert et al., 2016). However, in my 
opinion this is not an ideal method of analysis, because for each 
experimental animal a number of sections could not be precisely allocated 
to one or the other of the ‘major’ Bregma presented in the brain atlas 
(-7.76mm, -7.64mm, -7.56mm, -7.48mm) and were therefore classified as 
sections of ‘minor’ or ‘intermediate’ Bregma 
(-7.70mm, -7.60mm, -7.52mm, -7.44mm). This means that ultimately the 
total number of counted sections varied for each Bregma within each O2 
concentration and genotype, and therefore resulted in an unbalanced 
dataset. One way to circumvent this issue was to summarise cFos outcomes 
for each subnucleus of the NTS across all Bregmas. This way, the number 
of counted sections per group remained consistent, as each subnucleus was 
present in at least one identified Bregma per animal. Normalisation of cFos 
counts by surface area and section thickness ensured that differences in 
subnuclei spanning multiple Bregmas were accounted for. In order to take 
the most thorough approach possible, however, outcomes were assessed 
using both approaches and presented throughout this chapter. Finally, in 
order to assess the bilaterality of hypoxia-induced cFos expression, counts 
will be presented as the total counts of cFos-positive nuclei (per 1000µm3) 
for both sides of the NTS combined, and with the NTS separated into right 




which in rodents and lagomorphs are midline structures and therefore were 







Figure 4.11: 60min exposures to hypoxia increased dorsal brainstem 
cFos expression in a PO2-dependent manner. 
Representative photomicrographs of tyrosine hydroxylase-positive (brown) 
and cFos-positive (black) cells in the caudal brainstem of AMPK-α1 and -α2 
floxed mice following 60min exposures to 21% O2 (top panel), 12% O2 
(middle panel), and 8% O2 (bottom panel). Approximate Bregma -7.56mm. 
AP = area postrema, cc = central canal, SolM = medial nucleus, SolDL = 
dorsolateral nucleus, SolIM = intermediate nucleus, SolI = interstitial 
nucleus, SolV = ventral nucleus, SolVL = ventrolateral nucleus, SolL = lateral 




4.2.5.1 PO2-dependent increases in cFos expression of control 
AMPK-α1/α2 Flx mice within each Bregma 
Mild hypoxia Consistent with observations made by others (Hirooka et al., 
1997; King et al., 2012), 60min exposures to 12% O2 increased the average 
expression of cFos in control AMPK-α1/α2 Flx mice relative to room air (21% 
O2). These increases in cFos expression from 21% O2 to 12% O2 reached 
significance within the right and left side of the NTS at Bregma -7.56mm, 
and when both sides of the NTS were added together (Figure 4.12, Table 
4.1 and Appendix 2.6; p<0.05 for each grouping). In addition, the NTS at the 
more rostrally located Bregma -7.48mm also displayed a significant increase 
in cFos expression (p<0.05), but only on the right side, with non-significant 
increases on the left side and when both sides were added together. These 
outcomes were slightly surprising, given that chemoafferent discharge from 
the carotid body increases during periods of mild hypoxia (Kumar, 2007). 
Therefore, afferent chemoreceptor discharge during exposures to 12% O2 
was expected to preferentially increase the activation of brainstem neurons 
within the caudal portions of the NTS, rather than the rostral portions. 
However, these Bregma align well with the rostrocaudal extent of the DAR, 
the area of the brainstem which, compared to controls, exhibited reduced 
activity during hypoxia following deletion of AMPK-α1/α2 catalytic subunits 
in catecholaminergic cells.  
 
Table 4.1: Bregma-specific responses of neuronal activation of 
AMPK-α1/α2 Flx mice following exposures to 12% O2. 
 
✖ = no activation, ✔ = mild activation 
 
Severe hypoxia In contrast to mild hypoxia, significant increases in cFos 
expression from 21% O2 to 8% O2 were observed for both sides of the NTS 
 - 7.76 mm  - 7.70 mm  - 7.64 mm  - 7.60 mm  - 7.56 mm  - 7.52 mm  - 7.48 mm  - 7.44 mm
Both sides ✖ ✖ ✖ ✖ ✔ ✖ ✖ ✖
Right side ✖ ✖ ✖ ✖ ✔ ✖ ✔ ✖




in all clearly identified ‘major’ Bregma along the caudo-rostral axis (Figure 
4.10 A, Table 4.2 and Appendix 2.6; Bregma: -7.76mm, p<0.05; -7.64mm, 
p<0.05; -7.56mm, p<0.01; -7.48mm, p<0.001). Importantly, a similar level of 
cFos expression after exposures to 8% O2 was also obtained in sections that 
fell between two of the major Bregma (‘minor’ 
Bregma: -7.70mm, -7.60mm, -7.52mm, and -7.44mm), but the numbers of 
sections per minor Bregma were too low to test for or reach statistical 
significance. That aside, the degree of activation during 8% O2 was clearly 
strongest in more rostral Bregma of the caudal brainstem, which may point 
to activation of these regions as being critical in the response to hypoxia. 
Analysis of the right side of the brainstem alone revealed that significant 
increases from 21% O2 to 8% O2 were retained in all major Bregmas (Figure 
4.10 B, Appendix 2.6; -7.76mm, p<0.05; -7.64mm, p<0.05; -7.56mm, 
p<0.01; -7.48mm, p<0.001). In addition, significance was reached at 
Bregma -7.52mm (p<0.05), while the level of cFos expression in all other 
‘minor’ Bregmas after exposures to 8% O2 was comparable to those 
obtained in ‘major’ Bregmas.  
Outcomes for cFos expression within the left side of the brainstem alone 
revealed that the increase of cFos expression from 21% O2 to 8% O2 did not 
quite reach significance at Bregma -7.76mm (Figure 4.10 C; p=0.0536). In 
all other Bregmas, however, outcomes were identical to those of the right 
side alone and when both sides were added together (-7.64mm, 
p<0.05; -7.56mm, p<0.01; -7.48mm, p<0.001). 
 
Table 4.2: Bregma-specific responses of neuronal activation in 
AMPK-α1/α2 Flx mice following exposure to 8% O2. 
✖ = no activation, ✔ = mild activation, ✔✔ = moderate activation, ✔✔✔ = 
strong activation 
 - 7.76 mm  - 7.70 mm  - 7.64 mm  - 7.60 mm  - 7.56 mm  - 7.52 mm  - 7.48 mm  - 7.44 mm
Both sides ✔ ✖ ✔ ✖ ✔✔ ✖ ✔✔✔ ✖
Right side ✔ ✖ ✔ ✖ ✔✔ ✔ ✔✔✔ ✖





Mild versus severe hypoxia Increases in the average cFos expression of 
control mice were also observed between 12% O2 and 8% O2 (Table 4.3), 
but once again these only reached significance within both sides of the NTS 
at the more rostral Bregma, namely -7.48mm (p<0.05), and -7.44mm 
(p<0.001). Significant increases in cFos expression at Bregma -7.48mm 
and -7.44mm were also retained when cFos-positive counts were separated 
into the right side (-7.48mm: p<0.05; -7.44mm: p<0.001) and left side 
(-7.48mm: p<0.05; -7.44mm: p<0.01) of the NTS.  
 
Table 4.3: Bregma-specific responses of neuronal activation in 
AMPK-α1/α2 Flx mice between exposures to 12% O2 and 8% O2. 
✖ = no activation, ✔ = mild activation, ✔✔ = moderate activation, ✔✔✔ = 
strong activation 
 
As described above, the significant increases in rostral, but not caudal, parts 
of the NTS were unexpected, given the termination of carotid body afferent 
innervations within the caudal portions of the NTS. However, the possibility 
remains that the rostral portions of the caudal NTS may contain a central 
O2-responsive neuronal network, which determines – in concert with CB 
afferent fibre input – the overall degree of respiratory drive during hypoxia.   
 - 7.76 mm  - 7.70 mm  - 7.64 mm  - 7.60 mm  - 7.56 mm  - 7.52 mm  - 7.48 mm  - 7.44 mm
Both sides ✖ ✖ ✖ ✖ ✖ ✖ ✔ ✔✔✔
Right side ✖ ✖ ✖ ✖ ✖ ✖ ✔ ✔✔✔





Figure 4.12: 60min exposures to hypoxia increased brainstem cFos 
expression in a PO2-dependent manner in every identified Bregma.  
Means ± SEM of cFos-positive cell counts per 1000μm3 in identified Bregma 
of the (A) total, (B) right-sided, and (C) left-sided nucleus tractus solitarius 
of AMPK-α1/α2 floxed mice after 60min exposures to 21% O2 (n = 4 mice), 
12% O2 (n = 6 mice), or 8% O2 (n = 6 mice). * = p<0.05, ** = p<0.01, *** = 
p<0.001, **** = p<0.0001. Significance tested by one-way ANOVA with 
Tukey post-hoc tests (long brackets) and Student’s t-test (short brackets). 





4.2.5.2 PO2-dependent increases in cFos expression of control 
AMPK-α1/α2 Flx mice within each subnucleus of the NTS 
Mild hypoxia Analyses of both sides of the NTS as a whole revealed that 
60min exposures of control AMPK-α1/α2 Flx mice to 12% O2 increased the 
average cFos expression relative to room air (21% O2) in every subnucleus 
of the NTS (Figure 4.13 A, Appendix 2.7). These increases reached 
significance within the medioventral subnuclei 10N (p<0.01), SolC (p<0.05), 
SolM (p<0.05), and SolCe (p<0.05) (Table 4.4). While the afferent 
projections from SolCe to the ventral medulla were found to be restricted to 
the facial nucleus (7N) and the nucleus ambiguus (NA), 10N, SolC, and 
SolM have been implicated in the control of cardiorespiratory responses due 
to their afferent projections to the rostral and caudal ventral respiratory 
groups (rVRG and cVRG, respectively), and the rostral and caudal 
ventrolateral medulla (RVL and CVL, respectively; see also Figure 4.1) 
(Alheid et al., 2011). Therefore, these nuclei might be primarily implicated in 
delivering the mild increases in ventilation described in Chapter 3.  
Considering the right side of the NTS alone (Figure 4.13 B, Appendix 2.7), 
12% O2 still induced significant increases in cFos expression relative to room 
air within 10N (p<0.01) SolM (p<0.05) and SolCe (p<0.05), consistent with 
outcomes for both sides together. Although findings so far have consistently 
demonstrated bilateral increases in cFos expression within the NTS 
following hypoxic stimulation (Erickson & Millhorn, 1994; Hirooka et al., 
1997; Teppema et al., 1997), additional significance within the right NTS was 
reached within the mediolateral NTS subnuclei SolDM (p<0.05) and SolIM 
(p<0.05). Both SolDM and SolIM were found to have prominent ipsilateral 
afferent projections to the respiratory compartments of the cVRG, rVRG and 
the retrotrapezoid nucleus (RTN), and SolIM also weakly projects to the 
cardiovascular compartments of the RVL and CVL (Alheid et al., 2011).  
Within the left side of the NTS (Figure 4.13 C, Appendix 2.7), significant 
increases in cFos expression from 21% O2 to 12% O2 were retained within 
10N (p<0.05) and SolCe (p<0.05), consistent with outcomes for both sides 




significance was reached within any other subnuclei on the left side of the 
NTS, and significance was lost within SolM (p=0.0519).  
It is possible, therefore, that the drive to breathe during mild hypoxia is 
modulated by a hemisphere-specific activation of specific NTS subnuclei. 
 
Table 4.4: NTS subnucleus-specific neuronal activation in AMPK-α1/α2 
Flx mice following exposure to 12% O2. 
✖ = no activation, ✔ = mild activation, ✔✔ = moderate activation 
 
Severe hypoxia Robust increases in cFos expression were observed 
following exposures to 8% O2, which significantly augmented cFos 
expression in every single subnucleus of the NTS relative to 21% O2, 
irrespective of whether the counts were grouped together for both sides of 
the NTS, or separated into its right and left divisions (Figure 4.13, Appendix 
2.7).  
 
Table 4.5: NTS subnucleus-specific neuronal activation of AMPK-α1/α2 
Flx mice following exposure to 8% O2. 
✖ = no activation, ✔ = mild activation, ✔✔ = moderate activation, ✔✔✔ = 
strong activation, ✔✔✔✔ = very strong activation 
 
Mild versus severe hypoxia Within both sides of the NTS of control 
AMPK-α1/α2 Flx mice, further hypoxia-dependent increases were observed 
between 12% O2 and 8% O2 within the majority of cardiorespiratory NTS 
AP SubP 10N SolC SolM SolDM SolDL SolI SolIM SolV SolVL SolL SolCe
Both sides ✖ ✖ ✔✔ ✔ ✔ ✖ ✖ ✖ ✖ ✖ ✖ ✖ ✔
Right side / ✖ ✔✔ / ✔ ✔ ✖ ✖ ✔ ✖ ✖ ✖ ✔
Left side / ✖ ✔ / ✖ ✖ ✖ ✖ ✖ ✖ ✖ ✖ ✔
AP SubP 10N SolC SolM SolDM SolDL SolI SolIM SolV SolVL SolL SolCe
Both sides ✔✔ ✔✔✔ ✔✔✔✔ ✔✔✔ ✔✔ ✔✔ ✔✔✔ ✔✔ ✔✔✔ ✔✔✔ ✔✔✔ ✔✔ ✔✔✔
Right side / ✔✔ ✔✔✔✔ / ✔✔ ✔✔ ✔✔✔ ✔✔ ✔✔✔ ✔✔ ✔✔ ✔✔✔ ✔✔✔




subnuclei (Table 4.6; SubP: p<0.05; 10N: p<0.05; SolC: p<0.05; SolDL: 
p<0.05; SolI: p<0.05; SolV: p<0.01; SolVL: p<0.05; SolL: p<0.05).  
Consistent with these outcomes, significant increases within the right side of 
the NTS alone were also observed within SubP (p<0.05), SolC (p<0.05), 
SolDL (p<0.05), SolI (p<0.05), SolV (p<0.05), SolVL (p<0.05), and SolL 
(p<0.01), but almost within 10N (p=0.0549). However, additional 
significance was gained within SolIM (p<0.05) and SolCe (p<0.05).  
Considering the left side of the NTS alone, the significant differences 
observed for both sides of the NTS combined were retained at 10N (p<0.05), 
SolC (p<0.05), SolI (p<0.05), SolV (p<0.001) and SolVL (p<0.05), whereas 
SubP (p=0.07), SolDL (p=0.156) and SolL (p=0.0816) did no longer show a 
significant increase in cFos expression between 12% O2 and 8% O2.   
 
Table 4.6: NTS subnucleus-specific responses of neuronal activation 
of AMPK-α1/α2 Flx mice between exposures to 12% O2 and 8% O2. 
✖ = no activation, ✔ = mild activation, ✔✔ = moderate activation, ✔✔✔ = 
strong activation 
 
Overall, the three-point assay described above showed that 60min of 
hypoxia was of sufficient duration to induce PO2-dependent increases in 
cFos expression within the caudal brainstems of AMPK-α1/α2 Flx mice, 
regardless of whether the data were presented for the entire brainstem 
(Figure 4.10), categorised as the whole NTS per Bregma (Figure 4.12), each 
NTS subnucleus in entirety along the full length of the caudal brainstem 
(Figure 4.13), as the total for both sides of the NTS, or divided into bilateral 
components of the NTS found within the right and left sides of the brainstem. 
Additionally, further separating these categories into outcomes for each 
subnucleus at each Bregma (see Appendices 2.8-2.11) also supported the 
above described findings. Therefore, although only more rostral Bregma of 
AP SubP 10N SolC SolM SolDM SolDL SolI SolIM SolV SolVL SolL SolCe
Both sides ✖ ✔ ✔ ✔ ✖ ✖ ✔ ✔ ✖ ✔✔ ✔ ✔ ✖
Right side / ✔ ✖ / ✖ ✖ ✔ ✔ ✔ ✔ ✔ ✔ ✔




the caudal brainstem were primarily activated in a PO2-dependent manner, 
each nucleus within the NTS of AMPK-α1/α2 Flx mice was responsive to 
hypoxia with robust increases in cFos expression during severe hypoxia. 
These outcomes are consistent with the PO2-dependent increases in 
ventilation of control mice described in Chapter 3, as well as the 
PO2-dependent attenuation of the HVR observed in TH AMPK-α1/α2 dKO 
mice. Therefore, a subset of neurons within NTS subnuclei may form a 
central hypoxia-responsive neural circuit within the rostral portion of the 
caudal brainstem that determines the degree of ventilatory drive. 
Additionally, the findings described above indicate for the first time that 
separation of the NTS into its individual subnuclei may have revealed a 
degree of specificity for some subnuclei to be differentially activated in a 






Figure 4.13: 60min exposures to hypoxia increased brainstem cFos 
expression in a PO2-dependent manner in every subnucleus of the 
NTS.  
Means ± SEM of cFos-positive cell counts per 1000μm3 in specific regions 
of interest over all identified Bregma of the (A) total, (B) right-sided, and (C) 
left-sided nucleus tractus solitarius of AMPK-α1/α2 floxed mice after 60min 
exposures to 21% O2 (n = 4 mice), 12% O2 (n = 6 mice), or 8% O2 (n = 6 
mice). AP = area postrema, SolC = commissural nucleus, SubP = 
sub-postrema, 10N = hypoglossal nucleus, SolM = medial nucleus, SolDM 
= dorsomedial nucleus, SolDL = dorsolateral nucleus, SolI = interstitial 
nucleus, SolIM = intermediate nucleus, SolV = ventral nucleus, SolVL = 
ventrolateral nucleus, SolL lateral nucleus, SolCe = central nucleus. * = 
p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested by 




4.2.6 The impact of AMPK-α1 and -α2 catalytic subunit deletion in 
catecholaminergic cells on the cFos expression in response to 
60min of severe hypoxia  
Given the fact that the ventilatory deficit in mice with TH-driven deletion of 
AMPK-α1 and -α2 catalytic subunits appeared to be due to a functional 
deficit rather than alterations in catecholaminergic cell numbers or bioamine 
content, the expression of cFos in TH AMPK-α1/α2 dKO mice was compared 
to control AMPK-α1/α2 Flx mice following 60min exposures to severe 
hypoxia. A stimulus of 8% O2 was chosen for this comparison because it 
induced significant increases in cFos expression within every Bregma and 
every subnucleus of AMPK-α1/α2 Flx mice and also precipitated the most 
severe ventilatory deficit within TH AMPK-α1/α2 dKO mice relative to 
controls. 
 
The effect of AMPK deletion on NTS cFos expression within each Bregma 
Analyses of both sides of the NTS at any given Bregma as a whole revealed 
no significant changes in cFos expression (normalised as counts per 
1000µm3) following 60min exposures to 8% O2 in TH AMPK-α1/α2 dKO mice 
relative to controls, even though on average cFos expression was mildly 
reduced in the more rostral parts of the caudal brainstem (Figure 4.14 A, 
Appendix 2.12; Bregmas -7.56mm to -7.44mm). A non-significant reduction 
in cFos expression within the rostral Bregma of TH AMPK-α1/α2 dKO mice 
relative to controls was also observed when the NTS was separated into its 
right and left divisions (Figure 4.14 B and C, respectively). 
It would therefore appear that any reductions in cFos expression that might 
have occurred arose within more rostral regions of the NTS and not the 
caudal portion, which is the primary site of carotid body afferent innervation 
(Finley & Katz, 1992). In support of this, deficits within the more rostral 
Bregma of TH AMPK-α1/α2 dKO mice would be consistent with the 
anatomical location of the DAR, the decrease in neuronal “activity” during 
severe hypoxia that was identified by fMRI, and the unaltered response of 
increased carotid body chemoafferent discharge during exposure to hypoxia 





The effect of AMPK deletion on cFos expression within each NTS 
subnucleus When considering each subnucleus from both sides of the NTS 
along their entire length, TH AMPK-α1/α2 dKO mice had, on average, fewer 
cFos counts per 1000µm3 than control AMPK-α1/α2 Flx mice did (Figure 
4.15 A). However, as shown in Figure 4.10, these individual reductions did 
not reach significance relative to controls when all subnuclei were added 
together. Furthermore, none of the individual subnuclei on their own 
revealed a significant reduction in cFos expression for TH AMPK-α1/α2 dKO 
mice relative to controls (Appendix 2.13), regardless of whether each 
subnucleus of the NTS was taken as a total of both sides, or divided into its 
bilateral components (Figure 4.15 B and C, respectively).   
 
From these data it seemed that deletion of AMPK-α1 and -α2 catalytic 
subunits in catecholaminergic cells did not have an impact on neuronal 
activation sufficient enough to explain the severe ventilatory deficits 
described in Chapter 3. That said, outcomes from our previous fMRI study 
(Mahmoud et al., 2016) revealed that the functional deficit in neuronal 
activity (measured via decreases in O2 consumption) during hypoxia was 
confined to a few Bregma and did not span the entire caudal brainstem. This 
area, i.e. the DAR, and its location could be consistent with the average, 
albeit non-significant, reductions in cFos expression observed in more 
rostral, but not caudal Bregma of TH AMPK-α1/α2 dKO brainstems. If true, 
this would suggest that the analyses of cFos-positive counts per subnucleus 
for the entire length of the NTS may have diluted any Bregma-specific 
differences within the more rostral portions. Therefore, these data were 
reanalysed to compare the cFos responses after 60min of 8% O2 in 







Figure 4.14: Targeted deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells did not alter dorsal brainstem cFos counts 
within any Bregma.  
Means ± SEM of cFos counts (per 1000µm3) for all identified Bregma within 
the (A) total, (B) right-sided, and (C) left-sided nucleus tractus solitarius of 
AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n = 16 mice) and TH-driven 
AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, red, n = 11 
mice). Significance tested by one-way ANOVA with Tukey post-hoc test. 
Highlighted in purple is the approximate location of the DAR (Mahmoud et 





Figure 4.15: Targeted deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells did not alter dorsal brainstem cFos counts 
within any subnuclei of the NTS.  
Means ± SEM of cFos counts (per 1000µm3) for each subnucleus within the 
(A) total, (B) right-sided, and (C) left-sided nucleus tractus solitarius of 
AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n = 6 mice) and TH-driven 
AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, red, n = 7 




4.2.6.1 Identification of a Bregma- and subnucleus-specific deficit in 
cFos expression following deletion of AMPK-α1 and -α2 
catalytic subunits in catecholaminergic cells 
As mentioned above, the region of the DAR appeared in more rostral regions 
within the right side of the NTS and its overall shape suggested that several 
anatomical subnuclei could be affected by the targeted deletion of AMPK in 
the catecholaminergic cells within them. Surprisingly, however, given the 
afferent innervations of both cardiovascular and respiratory compartments 
in the ventral medulla that originate from the vast majority of NTS subnuclei 
(see Figure 4.1), AMPK deletion and subsequent reductions in neuronal 
activity within the DAR only precipitated deficits in the respiratory response 
and did not impact on the cardiovascular responses to hypoxia (Mahmoud 
et al., 2016). Therefore, elucidating the precise subnuclear location of the 
DAR along the neuraxis of TH AMPK-α1/α2 dKO mice could lead to a better 
understanding of why only the respiratory, but not the cardiovascular 
response was affected.  
 
Overall, separating the comparisons of cFos expression between 
AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice by subnucleus of the NTS 
at each identified Bregma revealed no significant differences between 
genotypes within caudal Bregma ranging from -7.76mm to -7.60mm. 
However, excitement was sparked when significant reductions in the cFos 
expression of TH AMPK-α1/α2 dKO mice were identified relative to controls 
within specific subnuclei of the NTS located within the more rostral Bregma, 
consistent with the indications from the outcomes above (Figure 4.16, 
Appendix 2.14). Furthermore, even more thrilling was the fact that two of 
these subnuclei (hereon referred to as Nucleus A and Nucleus B) coincided 
with the approximate anatomical location of the DAR within the NTS. Both 
subnuclei showed a significant reduction within the right side of the 
brainstem (p<0.05 for Nucleus A and Nucleus B, respectively, relative to 
controls), but not the left, entirely consistent with the observed right-side 
dominance of the DAR (Figure 4.17 A, Appendix 2.15). Like most other NTS 




cardiovascular compartments of the VLM. However, Nucleus A appears to 
also innervate compartments of the ventral medulla responsible for the 
generation of respiratory rhythmogenesis, which could, at least in part, 
explain the disordered ventilatory phenotype observed in TH AMPK-α1/α2 
dKO mice, which will be further discussed in Chapter 5.  
Curiously, Nucleus A and Nucleus B were not anatomically adjacent to each 
other, so the relationship between them and the DAR was in question 
(Figure 4.17 B). In addition, a reduction in the average density of 
cFos-positive nuclei in TH AMPK-α1/α2 dKO mice was observed relative to 
controls within all of the DAR-spanning Bregma. Therefore, in order to 
determine the Bregma-specific contributions of each Nucleus to the 
formation of the DAR, various combinations of multiple Bregmas that might 
link these nuclei together were tested to see how the statistical difference 






Figure 4.16: Separation of Bregma and subnuclei revealed significant, 
right-side dominant attenuation of cFos expression following 
AMPK-α1/α2 catalytic subunit deletion in catecholaminergic cells.  
Means ± SEM of cFos counts (per 1000µm3) for the total (left panels), right 
(middle panels), and left (right panels) sides of all subnuclei (encrypted A to 
M) within the nucleus tractus solitarius (NTS) in four caudal brainstem 
Bregmas (encrypted Bregma 1 to 4) of AMPK-α1/α2 floxed (AMPK-α1/α2 
Flx, black) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red). * = p<0.05, ** = p<0.01; significance tested by 






Figure 4.17: A Bregma- and subnucleus-specific deficiency in cFos 
expression was revealed by deletion of AMPK-α1 and -α2 catalytic 
subunits in catecholaminergic cells.  
(A) Means ± SEM of cFos counts (per 1000µm3) of two specific subnuclei 
within the nucleus tractus solitarius of AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, 
black, n = 6 mice) and TH-driven AMPK-α1 and -α2 double knockout mice 
(TH AMPK-α1/α2 dKO, red, n = 7 mice). (B) Schematic representing the 
relationship of the two identified nuclei to each other and the p-values 
obtained. * = p<0.05; significance tested by Student’s t-test between 





Combinations of Nucleus A and Nucleus B across Bregma The first 
approach was to identify whether the deficit within each of the two nuclei 
within the right side of the NTS spanned more than one Bregma, as was 
suggested by the DAR. As described above, cFos expression in Nucleus A 
and Nucleus B were significantly attenuated in TH AMPK-α1/α2 dKO mice 
relative to controls in Bregma 2 (Figure 4.18 Ai, Aiv, Bi, Biv and Appendix 
2.15; Nucleus A: p=0.0154, Nucleus B: p=0.0294), but not in the next more 
caudal or rostral Bregma (Nucleus A – Bregma 1: p=0.2895, Bregma 3: 
p=0.1321, Bregma 4: p=0.2928; Nucleus B – Bregma 1: p=0.3767, Bregma 
3: p=0.1787). However, Nucleus B also exhibited significant reductions in 
cFos expression at Bregma 4 (p=0.0355), which sits at the caudal-most 
edge of the DAR-spanning Bregma along this neuraxis.  
Connecting the cFos densities across two of the four adjacent Bregma 
retained significance for Nucleus A at the rostral end (Figure 4.18 Aii, Bii and 
Appendix 2.15; Bregma 1+2: p=0.0113), but not at the others (Bregma 2+3: 
p=0.1034, Bregma 3+4: p=0.2536). However, connecting up three of the 4 
adjacent Bregmas almost retained significance in each combination (Figure 
4.18 Aiii, Biii; Bregma 1-3: p=0.042, Bregma 2-4: p=0.0508). Finally, the 
connection of all 4 identified Bregmas retained significance for the decrease 
in TH AMPK-α1/α2 dKO mice relative to controls (Bregma 1-4: p=0.0417), 
although the difference was smaller than for Bregma 2 and the combination 
of Bregma 1+2.  
For Nucleus B, combining two adjacent Bregma only retained significance 
at the caudal end, but not at the others (Figure 4.18 Av, Bv and Appendix 
2.15; Bregma 1+2: p=0.0543, Bregma 2+3: p=0.0719, Bregma 3+4: 
p=0.038). Furthermore, connecting up three of the 4 adjacent Bregmas 
revealed significance in both combinations (Figure 4.18 Avi, Bvi; Bregma 
1-3: p=0.0394, Bregma 2-4: p=0.0178), as did the combination of Nucleus B 
across all four Bregmas (Bregma 1-4: p=0.0232). Therefore, Nucleus B 
showed the greatest significant attenuation of cFos expression in TH 







Figure 4.18: The deficiency of cFos expression in mice with targeted 
deletion of AMPK-α1 and -α2 catalytic subunits spans multiple Bregma 
at each identified subnucleus.  
(A) Schematics representing which combination of the two identified nuclei 
in relation to the Bregma and each other has been tested, and the p-values 
(red) that were obtained. (B) Means ± SEM of cFos counts (per 1000µm3) 
for each Bregma combination of the two identified subnuclei within the 
nucleus tractus solitarius of AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n 
= 3-6 mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, n = 4-7 mice). * = p<0.05; significance tested by 




Additional consideration of a ‘linker nucleus’ As mentioned earlier, Nucleus 
A and B were not anatomically adjacent to each other. Therefore, the 
possibility was considered that they might be connected, on the right side of 
the NTS, by a subnucleus that sits in-between them, hereon referred to as 
Nucleus C. Nucleus C was found to span a distance that ranged from 
Bregma 1 to 3, but exhibited no statistical differences within any of these 
Bregma in its own right when TH AMPK-α1/α2 dKO mice were compared to 
controls (Figure 4.19 Ai and Bi, Appendix 2.15). However, a significant 
reduction in cFos expression in TH AMPK-α1/α2 dKO mice relative to 
controls was almost reached at Bregma 1, where p=0.056, but not at 
Bregma 2 (p=0.2139) or Bregma 3 (p=0.5727), although in each case there 
was a trend towards a reduction in cFOS expression for AMPK-α1/α2 dKO 
mice. Furthermore, linking these adjacent Bregma together did not yield any 
significant differences, regardless of whether the combinations spanned two 
Bregma (Figure 4.19 Aii, Bii; Bregma 1+2: p=0.1423, Bregma 2+3: 
p=0.2056), or all three Bregma (Bregma 1-3: p=0.2008). Unfortunately, there 
is currently no information available within the literature regarding the 
afferent innervation(s) from Nucleus C to the VLM.  
Overall, outcomes from these three nuclei would suggest that: 
1) Nucleus A showed the most severe deficit across Bregmas 1 and 2, 
2) Nucleus B showed the most severe deficit across Bregmas 2 to 4, 
and 






Figure 4.19: Assessment of the degrees of significance in attenuated 
cFos expression between genotypes within a third ‘linker’ nucleus at 
multiple Bregma.  
(A) Schematics representing which combination of the ‘linker’ subnucleus 
(Nucleus C) in relation to the Bregma has been tested, and the p-values that 
were obtained. (B) Means ± SEM of cFos counts (per 1000µm3) for each 
combination from (A) of AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black, n = 2-6 
mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, n = 4-7 mice). Significance tested by Student’s t-test 





From these findings a schematic could be predicted that is illustrated in 
Figure 4.20 Ai. While the joint combination of Nucleus A, B and C across the 
above listed Bregma resulted in a very strong statistical difference (Figure 
4.20 B, Appendix 2.15; p=0.0043), there was no anatomical connection 
apparent between Nucleus B and C that could link the DAR together. 
Therefore, another model with the addition of Nucleus B at Bregma 1 was 
considered (Figure 4.20 Aii, B). Surprisingly, this second model did not 
appear to affect the statistical differences of the first model. If anything, the 
p-value was reduced even further (p=0.0042). Finally, in order to see 
whether the anatomical connection(s) between these nuclei could be 
strengthened any further, Nucleus C at Bregma 2 was incorporated into a 
third model (Figure 4.20 Aiii, B). Despite having retained a high degree of 
statistical significance, the inclusion of Nucleus C at Bregma 2 slightly 
reduced the p-value obtained (p=0.007). This finding was unsurprising, 
given the high p-values obtained from Nucleus C alone following 
Bregma-specific combinations that included Bregma 2 (see Figure 4.19). 
Therefore, it would appear that the model that most likely corresponds to the 
area of functional neuronal deficit in TH AMPK-α1/α2 dKO mice – and 
therefore predicts the location of the DAR – is made of neurons located 
within three subnuclei of the NTS, which are highly co-localised at Bregma 
1 and span up to 4 additional Bregma, as we move caudal from Bregma 1 
(Figure 4.20 Aii). 
In summary, deficits in hypoxia-induced cFos expression in TH AMPK-α1/α2 
dKO mice revealed the location of a right-side dominant and 
hypoxia-responsive nucleus within the caudal brainstem, which is 
anatomically consistent with the location of the DAR identified by fMRI and 
shows reduced hypoxia-induced neuronal activation following deletion of 
AMPK-α1 and -α2 catalytic subunits in catecholaminergic cells. Therefore, 
this nucleus might support signal integration and thus ventilatory 
adjustments during hypoxia through AMPK-dependent pathways and thus 
protect against hypoventilation and apnoea. Moreover, it appears that the 
hypoxia-responsive neurons that shape this nucleus are interspersed 




Additional experiments are now required to elucidate the precise cellular 
characteristics of these neurons, and to confirm whether the deficit in cFos 
expression does indeed reflect a functional deficit driven by AMPK 
deficiency, through direct measurements from live preparations in vitro and 





Figure 4.20: Remodelling cFos deficient areas by degree of 
significance predicts the extent to which the DAR spans across the 
four identified nuclei.  
(A) Schematics representing combinations of the three nuclei across 
Bregmas that may shape the DAR, and the p-values that were obtained. (B) 
Means ± SEM of cFos counts (per 1000µm3) for each combination of the two 
identified subnuclei within the nucleus tractus solitarius of AMPK-α1/α2 
floxed (AMPK-α1/α2 Flx, black, n = 6 mice) and TH-driven AMPK-α1 and -α2 
double knockout mice (TH AMPK-α1/α2 dKO, red, n = 7 mice). ** = p<0.01; 





4.2.6.2 Additional nuclei with hypoxia-induced cFos deficits in mice 
with AMPK-α1 and -α2 catalytic subunit deletion in 
catecholaminergic cells 
In addition to the nuclei identified above, a few more subnuclei of the NTS 
displayed a significant Bregma-specific reduction in hypoxia-induced cFos 
expression following deletion of AMPK-α1 and -α2 catalytic subunits in 
catecholaminergic cells relative to controls (Figure 4.21, Appendix 2.14). 
However, it seemed unlikely that these nuclei form part of the DAR.  
Firstly, a deficit in cFos expression was observed within the area postrema 
(AP), but this was only apparent at one Bregma with no convincing trend 
towards a significant reduction of cFos expression in TH AMPK-α1/α2 dKO 
mice relative to controls at any other Bregma along the neuraxis (Figure 4.21 
A). It seems unlikely, therefore, that this reflects a true contribution to the 
DAR, even though it is within the range of Bregma that encompass the DAR.  
Secondly, attenuations within additional NTS subnuclei were identified, 
which were either left-side dominant (Figure 4.21 B; SolV at 
Bregma -7.64mm: p<0.05 for both sides, p<0.01 for left side alone; SolV at 
Bregma -7.44mm: p<0.05 for both sides and left side alone, but with a trend 
towards a reduction on the right side alone; SolCe: p<0.01 for the left side 
alone, with a minor trend towards a reduction for both sides together), or 
bilateral (Figure 4.21 C; 10N: p<0.01 for both sides, p<0.05 for the right and 
left sides alone), which is inconsistent with the right-side dominance 
observed for the DAR. Furthermore, the left-side dominant reductions of 
cFos expression within SolV at two spatially separated Bregmas were not 
retained throughout the neuraxis, because statistical significance was lost 
after combining cFos-positive cell counts from Bregma -7.64mm to -7.44mm 
and resulted in a comparable degree of cFos expression between genotypes 
(p=0.1257 for both sides, p=0.1941 for the right side, p=0.106 for the left 
side). However, the data for SolV and SolCe at Bregma -7.44mm should be 
interpreted with caution due to the small number of sections obtained for 
control AMPK-α1/α2 Flx (n=3) and TH AMPK-α1/α2 dKO mice (n=4). If the 
observed trend was true, the addition of further cFos-positive cell counts at 




AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice within SolV and possibly 
SolCe on the right side of the NTS, therefore resulting in a bilateral deficit. 
Either way, a contribution of the DAR remains unlikely. 
Thirdly, the anatomical location of SolV, SolCe and 10N was too lateral 
and/or ventral relative to the location of the DAR.  
All that said, the possibility that these nuclei do indeed form part of the 
hypoxia-sensitive area compromised by deletion of AMPK-α1 and -α2 
catalytic subunits cannot be excluded at this point. It is possible that 
activation of these nuclei may lie downstream of the O2-responsive nucleus 
identified above and that therefore the fMRI was unable to detect a 
significant reduction in O2 consumption during hypoxia relative to controls, 
i.e. they are not intrinsically O2-sensitive but rather they are activated 
following signal integration at DAR. Further electrophysiological in vivo and 
in vitro experiments are required in order to determine their functional role in 
response to hypoxia within control mice and those with AMPK-α1 and -α2 







Figure 4.21: Additional deficiencies of cFos expression were identified 
in mice with targeted deletion of AMPK-α1 and -α2 catalytic subunits 
in a Bregma- and subnucleus-specific manner.  
Means ± SEM of cFos counts (per 1000µm3) of additional subnuclei within 
the nucleus tractus solitarius of AMPK-α1/α2 floxed (AMPK-α1/α2 Flx, black) 
and TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 
dKO, red). AP = area postrema; SolV = ventral subnucleus; SolCe = central 
subnucleus; 10N = dorsal motornucleus of the vagus. * = p<0.05, ** = 





4.2.7 Hypoxia-induced cFos expression within catecholaminergic 
cells of the caudal brainstem 
The outcomes for cFos expression described above were assessed in terms 
of total cFos-positive counts, regardless of whether the cells were 
TH-positive or TH-negative. Because AMPK-α1 and -α2 catalytic subunit 
deletion was targeted only to catecholaminergic cells, it was important to 
identify whether hypoxic activation of these neurons specifically was 
affected in this transgenic mouse model.  
Activation of TH-positive cells in controls after exposures to severe hypoxia 
On average, approximately 70-80% of the identified TH-positive cells per 
Bregma within the NTS of control AMPK-α1/α2 Flx mice were also 
cFos-positive following exposures to 8% O2 (Figure 4.22 A, Appendix 2.16). 
This was surprising, given that such a high degree of catecholaminergic cell 
activation following hypoxia had not been previously described. Table 4.1 
directly compared outcomes from various publications regarding the 
brainstem catecholaminergic cell activation following exposures to similar 
degrees of hypoxia. A maximum of 70% activation of TH-positive cells was 
reported by Erickson & Millhorn (1994), whereas all other published reports 
suggest a drastically lower percentage. However, the total number of 
TH-positive cells counted in control AMPK-α1/α2 Flx mice was comparable 
to those obtained by others (Figure 4.22 B, Table 4.7, Appendix 2.16), 
indicating that it was unlikely that discrepancies in the number of 
catecholaminergic neurons would account for such differences.  
While variations between species and between protocols for the hypoxic 
stimulus and immunohistochemistry may explain some discrepancies 
between studies, there remains the possibility that the total number of 
catecholaminergic neurons within the rodent brainstem may have been 
grossly underestimated. In a recent study, single immunohistochemical 
staining using the DAB method aimed to simply evaluate the total numbers 
of TH-positive cells within specific parts of the brainstem, and was the first 
to date to do so in the adult mouse (Bucci et al., 2017). According to the 
authors, the total number of TH cells within the NTS was higher than any 




of this study, then it suggests that counts of TH-positive cells from previous 
studies and the amount of TH-positively labelled cells obtained in 
AMPK-α1/α2 Flx mice from my study were a gross underestimate of the true 
number of catecholaminergic cells.  
Because calculating the percentage activation of any given cell type 
depends on the successful labelling of all cells present within a given 
structure, it seems entirely possible that the high degree of TH+cFos 
co-staining observed in AMPK-α1/α2 Flx mice after exposures to 8% O2 was 
likely due to chance, given the high possibility that many cFos-negative (and 
cFos-positive, for that matter) cells remained unlabelled for TH. This 
suspicion was further strengthened by the fact that cFos expression within 
catecholaminergic cells of AMPK-α1/α2 Flx mice was also observed at an 
extremely high level after exposures to 21% and 12% O2 (Figure 4.23, 
Appendix 2.17). In fact, some Bregma revealed an up to 80% activation of 
catecholaminergic cells, which is highly inconsistent with previously reported 
findings, whereby almost none of the TH-positive cells were found to 
co-express nuclear cFos after continuously breathing room air (Smith et al., 
1995; King et al., 2012). Furthermore, no PO2-dependent increases in 
catecholaminergic cell activation were observed. Rather, the percentage of 
activated cells often appeared to slightly decrease following exposures to 
hypoxia relative to 21% O2. On the contrary, in the sections above a clear 
PO2-dependent increase of total cFos expression in AMPK-α1/α2 Flx mice 
was demonstrated, highlighting that cFos expression likely occurred in cells 
that were not labelled for TH.  
Therefore, 
1) A vast number of cFos-negative cells are expected to be TH-positive 
following exposures to 21% O2, with some, perhaps random, degree 
of TH-positive/cFos-negative labelling expected after exposures to 
8% O2, and 
2) The number of TH-positive/cFos-negative cells are expected to 
decrease following exposures to increasing intensities of hypoxia, 
whereas the number of TH-positive/cFos-positive cells is expected to 




Overall, however, it is clear that the TH-labelling achieved for AMPK-α1/α2 
Flx (and TH AMPK-α1/α2 dKO) mice was too poor to draw any conclusions 
regarding the activation of catecholaminergic cells during hypoxia and to 
subsequently assess any impact of AMPK-α1 and -α2 catalytic subunit 
deletion. That said, TH-labelling could still be used to confirm the presence 
of catecholaminergic neurons within each subnucleus of the NTS, which for 
the time being shall be the sole purpose of TH-labelling in regards to the 





Figure 4.22: The activation of catecholaminergic cells following 
exposures to 8% O2 was very high. 
Means ± SEM of (A) the percentage of catecholaminergic cells at each 
identified Bregma that co-expressed cFos (TH+/cFos+) and (B) total counts 
of catecholaminergic cells within each identified Bregma of AMPK-α1/α2 





Table 4.7: Comparison of TH-positive and cFos-positive cell counts 
following exposures to hypoxia within the literature. 































14-22% Teppema et. al., 1997 
Rabbit 10% O2  60min 
20 per 
section 70 per section 25-30% 
Hirooka et. 
al., 1997 




45-50% King et. al., 2012 





n.d. n.d. King et. al., 2015 
Mouse 21% O2  NA 
673 ± 59 per 
side  n.d. n.d. 
Bucci et. al., 
2017 
‘Section’ refers to the counts per coronal slice, ‘side’ refers to the unilateral 
counts per brainstem hemisphere. NA = not applicable; n.d. = not 
determined. ‘PVN-projecting’ refers to the authors’ approach to identify 
TH-positive cells within the dorsal brainstem by means of injecting a 






Figure 4.23: Decreasing PO2 did not result in clear increases of 
catecholaminergic cell activation. 
 Means ± SEM of the percentage of catecholaminergic cells at each 
identified Bregma that co-expressed cFos (TH+/cFos+) in AMPK-α1/α2 
floxed (AMPK-α1/α2 Flx) mice following 60min exposures to 21% O2 (light 
grey), 12% O2 (dark grey)and 8% O2 (white). Significance tested by two-way 





4.2.8 Predictive outcomes for TH-positive cell activation in control 
mice and those with AMPK-α1 and -α2 catalytic subunit deletion 
in catecholaminergic cells 
Given the large number of TH-positive cells reported by Bucci et. al. (2017), 
it seems reasonable to conclude that a significant number of the 
cFos-positive nuclei in AMPK-α1/α2 Flx mice represented unlabelled 
TH-positive neurons. Indeed, the total number of cFos-positive nuclei that 
were counted within the NTS of AMPK-α1/α2 Flx mice after exposures to 
8% O2 were 2-3 times higher than the total number of TH-positive cells 
reported by Bucci et. al. (2017) (Table 4.8). Therefore, a large proportion of 
these cFos-positive nuclei counted by me could likely belong to the 
catecholaminergic neuronal group, if one accepts the findings of Bucci et. 
al. (2017). These outcomes provided an opportunity for me to 
mathematically predict the percentages of catecholaminergic cell activation. 
However, before any outcomes could be predicted, a couple of assumptions 
needed to be made: 
- Firstly, it was not clear whether the numbers reported by the authors 
encompassed catecholaminergic cells of both hemispheres, or 
whether they were unilateral counts. Given that all representative 
images within the report were unilateral, my first assumption was that 
the reported cell counts were for one side of the brainstem only. 
- My second assumption was that all of the TH-positive cells identified 
by Bucci et. al. (2017) would have been co-labelled for cFos, given 
the up to 3-times higher cFos-positive cell counts per side in control 
AMPK-α1/α2 Flx mice. In other words, exposures to 8% O2 led to 
an activation of 100% of catecholaminergic neurons.  
Given these assumptions, in response to 60min exposures to 8% O2 a cFos 
count of 1691 ± 350 nuclei activated 100% of 673 ± 59 TH-positive cells 
(Bucci et al., 2017) (Table 4.8).  
During 60min exposures to 12% O2, a total of 979 ± 270 cFos-positive nuclei 
was obtained. Relative to the number cFos-positive nuclei obtained during 




mathematical activation of 57.9% of all catecholaminergic neurons reported 
by Bucci et. al. (2017).  
Finally, during exposures to room air (21% O2), only 196 ± 40 cFos-positive 
nuclei were detected, which would have accounted for a mathematical 
activation of approximately 11.6% of the total number of TH-positive cells.  
Given that all samples underwent the exact same staining protocol and that 
the number of TH-positive cells seemed to be unaffected upon AMPK-α1 
and -α2 catalytic subunit deletion, the same assumptions as above were 
applied to the cFos-positive cell counts obtained from TH AMPK dKO mice. 
In this case, following exposures to 8% O2 a total cFos count of 1447 ± 314 
nuclei was obtained. Applying the same calculations as above, this would 
mean that within TH AMPK-α1/α2 dKO mice a total of 85.6% of all 
catecholaminergic neurons would have been activated (Table 4.8). 
Considering the Bregma- and subnucleus-specific reductions in cFos 
expression relative to controls, a large proportion of these putative 
non-activated catecholaminergic neurons are hypothesised to lie within the 




Table 4.8: Mathematical prediction of catecholaminergic cell activation 
following exposures to hypoxia. 
Total catecholaminergic (TH) cell counts obtained from adult wild-type 
C57Bl6 mice (Bucci et al., 2017) were compared to the total dorsal brainstem 
cFos-positive cell counts per hemisphere and the percentage of activation 
calculated under the assumption that 8% O2 activated all TH-positive cells 
in control AMPK-α1/α2 Flx mice.   










8% O2 6 1691 ± 350 100%  
12% O2 6 979 ± 270 57.9% 











4.3.1 Summary of findings 
Chapter 4 revealed that dual deletion of AMPK-α1 and -α2 catalytic subunits 
in catecholaminergic (TH-positive) cells resulted in significant reductions in 
cFos expression within specific areas of the caudal brainstem. Importantly, 
the locations of these cFos-deficient areas were consistent with the 
anatomical location of the DAR, which was previously identified by fMRI and 
revealed a right-side dominant area with significantly attenuated neuronal 
activity during hypoxia in TH AMPK-α1/α2 dKO mice relative to controls. 
Combining these identified areas of attenuated cFos expression across 
several Bregma revealed the shape of a putative O2-responsive neuronal 
circuit whose activity is dependent on AMPK expression in 
catecholaminergic cells. Importantly, there was no evidence indicating loss 
of TH-positive cell numbers upon AMPK-α1/α2 deletion relative to controls, 
which was further supported by an unaltered brainstem bioamine content. 
Contrary to previous findings (Sunday Udoh, 2015; Mahmoud et al., 2016), 
I found that 10min exposures to hypoxia were of insufficient duration to 
consistently increase cFos expression within the mouse brainstem. 
Therefore the hypoxic stimulus was extended to 60min, which robustly 
induced cFos expression throughout the caudal brainstems of control 
AMPK-α1/α2 Flx mice.  
 
4.3.2 Exposures to mild and severe hypoxia preferentially induce 
increases in cFos expression of control AMPK-α1/α2 Flx mice 
within more rostral Bregma of the caudal brainstem 
My analyses of brainstem cFos expression in response to hypoxia were 
centred on the NTS because of the anatomical location of the DAR, and 
therefore the putative O2-responsive neuronal circuit. Firstly, I have shown 
that the expression of nuclear cFos within the NTS of mice increased in a 
manner proportional to the severity of hypoxia (see Figure 4.10), consistent 




1997) and rat (Erickson & Millhorn, 1994; Smith et al., 1995; Teppema et al., 
1997; Bodineau & Larnicol, 2001; Cruz Jde et al., 2010; Kline et al., 2010; 
King et al., 2012; King et al., 2013; Wakai et al., 2015).  
Surprisingly, however, while the average cFos expression of controls in 
response to exposures to mild hypoxia (12% O2) increased throughout the 
caudal brainstem, significance was only reached in the more rostral Bregma 
of the caudal NTS. This was unexpected, given the termination of carotid 
body (CB) afferent innervations within the caudal-most portions of the NTS 
(Finley & Katz, 1992). If anything, the increased afferent discharge 
frequency associated with increasing severities of hypoxia was therefore 
expected to have preferentially activated neurons at caudal Bregmas. One 
possible explanation for the lack of significant activation within the caudal 
Bregmas of the NTS could be the high degree of variability of cFos 
expression obtained following exposures to 12% O2. The sigmoidal nature 
of the CB discharge frequency in response to reductions of arterial PO2 
results in only moderate increases of the chemoafferent activation slope in 
response to mild hypoxia, whereas more severe reductions of arterial PO2 
lead to an abrupt increase in the slope and a high afferent discharge 
frequency (Kumar, 2007). Therefore, variations in the afferent discharge 
frequency during exposures to 12% O2 could have resulted in a greater 
variability of cFos expression across animals that subsequently failed to 
identify statistically significant changes in caudal Bregmas, while relay 
pathways within the NTS may have led to a more consistent activation of 
second-order neurons in more rostral Bregmas (Andresen et al., 2004). By 
contrast, the entire caudal brainstem exhibited significant activation in 
response to 8% O2, yet it appeared that once again the strongest activation 
was found within more rostral Bregma.  
Similar to the PO2-dependent increases in cFos expression across 
Bregmas, exposures to mild hypoxia appeared to increase the average 
expression of cFos in every subnucleus of the NTS, yet significance was 
only reached within the mediolateral subset of 10N, SolC, SolM, and SolCe. 
Moreover, differences were also observed in a hemisphere-specific manner, 




right side of the NTS only. These findings have not been documented or 
discussed in the literature before, so they provide the first insight into the 
response of these subnuclei to hypoxia in the mouse. Importantly, all of 
these subnuclei are known to receive afferent inputs from the CB, and in 
turn deliver inputs to the ventrolateral medulla that modulates 
cardiorespiratory responses (see Figure 4.1) (Finley & Katz, 1992; Alheid et 
al., 2011). The question remains why these specific subnuclei were 
preferentially activated in response to mild hypoxia, and whether it truly is a 
hemisphere-specific activation that occurs in the mouse, but not in other 
rodents who have shown a bilateral activation of the NTS in response to mild 
hypoxia (Smith et al., 1995; Hirooka et al., 1997; King et al., 2012).  
Exposures to severe hypoxia, on the other hand, robustly activated all 
subnuclei of the NTS in a bilateral manner. Therefore, irrespective of 
Bregma and subnucleus, severe hypoxia increases neuronal activity across 
the entire caudal brainstem, which is consistent with the findings of others 
(Erickson & Millhorn, 1994; Hirooka et al., 1997; Teppema et al., 1997; King 
et al., 2012; Joubert et al., 2016) and the robust PO2-dependent increases 
in ventilation observed in control AMPK-α1/α2 Flx and wild-type mice 
(Palmer et al., 2013; Getsy et al., 2014; Mahmoud et al., 2016).  
 
4.3.3 Ventilatory deficits of TH AMPK-α1/α2 dKO mice were not 
precipitated by reductions or loss of TH-positive neurons 
following AMPK deletion in catecholaminergic cells  
The expression and activity of AMPK is not limited to the modulation of 
metabolic homeostasis within the cell, but also extends to the cell’s fate of 
survival versus apoptosis (Mihaylova & Shaw, 2011; Merlen et al., 2014; 
Evans et al., 2015; Hardie, 2015). Importantly, AMPK activity within neurons 
has been proposed to promote survival following metabolic stress (Culmsee 
et al., 2001), and progressive loss of catecholaminergic neurons within the 
brainstem, as occurs in patients suffering from Rett syndrome, results in 
hypoventilation and apnoea which are exacerbated during hypoxia (Ide et 
al., 2005; Viemari et al., 2005; Weese-Mayer et al., 2006; Stettner et al., 




Despite the fact that mice with dual deletion of the AMPK-α1 and -α2 
catalytic subunits in catecholaminergic cells exhibited striking similarities to 
mouse models of Rett syndrome, i.e. pronounced hypoventilation which 
worsens with decreasing PO2, no deficits in the numbers of identified 
TH-positive cells were found relative to controls. Although staining for 
TH-positive cells was clearly poor and likely grossly underrepresented the 
total catecholaminergic cell population of the mouse brainstem, all samples 
for controls and TH AMPK-α1/α2 dKO mice were processed equally with 
strict adherence to the immunohistochemical protocol. This means that the 
overall ratio of TH-positive cells stained should be equal between the two 
genotypes and any significant increases or decreases in the total 
TH-positive cell numbers should have been reflected in the subsets of 
catecholaminergic cells that were positively stained. Clearly, this was not the 
case. Therefore, unlike the ventilatory deficits associated with Rett 
syndrome (Viemari et al., 2005; Stettner et al., 2007), hypoxic 
hypoventilation in TH AMPK-α1/α2 dKO mice was not precipitated by loss 
of TH-positive neurons.  
Further support for no alterations of TH-positive cell numbers came from 
measurements of the total brainstem and spinal cord bioamine content. 
Once again, the fact that no changes were found between TH AMPK-α1/α2 
dKO mice and controls highlights that the phenotype observed in our mouse 
model is determined by a functional deficit, rather than loss of 
catecholaminergic neurotransmission or hypoplasia. It is likely, therefore, 
that AMPK-dependent pathways within TH-positive cells of the brainstem 
coordinate appropriate signal integration and transduction to prompt 
ventilatory adjustments that increase the drive to breathe and retain 
ventilatory stability during periods of hypoxia.  
 
4.3.4 O2-sensitivity within the DAR is conferred by AMPK activity in 
rostral noradrenergic A2 cells  
It is important to note at this stage that the DAR was identified in our previous 
fMRI studies by way of a reductions in O2 consumption within this region of 




rationale for this investigation was two-fold: (1) In other specialised 
O2-sensing tissues, cellular O2-sensitivity is conferred, at least in part, by the 
mitochondrial electron transport chain protein cytochrome C oxidase subunit 
4 isoform 2 (COX4I2) (Fukuda et al., 2007; Zhou et al., 2016), which renders 
mitochondria exquisitely sensitive to even minor changes in O2 supply, 
because COX4I2 is not inhibited by ATP and thus O2 consumption will not 
increase as ATP levels fall. Rather, in these cells O2 consumption is 
maintained during hypoxia, leading to a fall in ATP supply and activation of 
onward signalling pathways. We hypothesised that O2-sensing cells within 
the NTS would respond in a similar way; (2) Changes in the fMRI 
Blood-oxygen-level dependent (BOLD) signal induced by peripheral pain are 
lost at ≤9% O2 (Sicard & Duong, 2005), thus removing confounding inputs 
due to vasodilation and only revealing differences in signal changes due to 
alterations in O2 consumption and hence neuronal activity. 
Given that a hypoxic stimulus of 8% O2 was used in previous experiments 
and mine, I followed up the fMRI study by using the expression of nuclear 
cFos protein as a marker for neuronal activity (Dragunow & Faull, 1989) and 
assessed differences in neuronal activation between AMPK-α1/α2 Flx and 
TH AMPK-α1/α2 dKO mice. More specifically, I sought to determine whether 
cFos expression was reduced in any of the hypoxia-responsive NTS 
subnuclei described for controls above. 
At first, no overall differences in cFos expression within the NTS ranging 
from Bregma -7.76mm to -7.44mm were identified between controls and TH 
AMPK-α1/α2 dKO mice, either when taken as a whole, or separated by each 
Bregma or subnucleus. I therefore also investigated whether there was 
bilateral asymmetry with a right-sided deficit to the cFos response of TH 
AMPK-α1/α2 dKO mice, as suggested by the fMRI. Once again, this 
revealed no differences in the total cFos counts of the right and left sides of 
the NTS per Bregma or subnucleus between TH AMPK-α1/α2 dKO mice 
and controls. However, separation of cFos counts by anatomical subnuclei 
of the NTS per Bregma identified 3 regions of significantly attenuated cFos 
expression, which were herein named nuclei A, B and C. More significant 




and by significant difference with respect to cFos expression relative to 
controls and the left-hand side of the brainstem. Aided by a subnucleus 
combination/exclusion strategy across Bregma and based on the degree of 
statistical significance by component of subnucleus included, I also 
demonstrated that the combination of nuclei A, B and C exhibited an overall 
shape that was very similar to that of the DAR across the NTS. Moreover, 
the Bregma which exhibited significant PO2-dependent increases in cFos 
expression in controls also aligned well with the rostrocaudal extent of the 
DAR (Mahmoud et al., 2016). Therefore, I predict that this identified neural 
network which spans multiple subnuclei could likely form an O2-responsive 
neuronal circuit within the dorsal medulla and through which ventilatory drive 
may be increased during hypoxia in an AMPK-dependent manner. 
Consistent with this view, the identified nuclei incorporate catecholaminergic 
neurons that receive inputs from the carotid body and project themselves to 
the ventrolateral medulla and thus the respiratory central pattern generators 
(rCPGs) (Finley & Katz, 1992; Alheid et al., 2011). However, future analyses 
of responses to hypoxia in TH AMPK-α1/α2 dKO mice and COX4I2 
expression within the NTS will be required to confirm the nature and capacity 
for O2-sensing by the DAR, and the role of signal integration by these 
neurons in mediating the HVR and apnoea genesis. 
The location of the DAR and the neural ciruit identified here is consistent 
with the location of the more rostral portion of the noradrenergic A2 cell 
group. Caudally, the A2 neurons receive the carotid body chemoafferent 
input and relay these information to other brain regions that are involved in 
the control of breathing (Andresen & Kunze, 1994; Andresen & Mendelowitz, 
1996; King et al., 2015). However, the neurons of the A2 cell group 
themselves were also reported to be hypoxia-sensitive and able to potently 
modulate ventilation during hypoxia (Buller et al., 2008; Li et al., 2008; Soliz 
et al., 2008; McGinnis et al., 2013). In light of the findings presented in this 
chapter, it may be possible that these two functions are carried out by 
spatially divided subsets of dorsal noradrenergic neurons within the NTS 
that span nuclei A, B and C. Within this subset, AMPK activity may be 




cellular metabolism, ion channel activity, neuronal firing frequency and/or 
neurotransmitter release (Lipton et al., 2001; Murphy et al., 2009; Ikematsu 
et al., 2011; Hardie, 2014), which defines a central O2-responsive neuronal 
circuit that determines – in concert with CB afferent fibre input – the overall 
degree of respiratory drive during hypoxia. Moreover, given the proposed 
hypoxia-sensitive nature of A2 cells (Andresen & Kunze, 1994; Andresen & 
Mendelowitz, 1996), one could even speculate that this O2-responsive circuit 
does not only determine the degree of the HVR, but may also underpin, at 
least partially, the ability to restore components of the HVR following CB 
resection (Davenport et al., 1947; Miller & Tenney, 1975; Bisgard et al., 
1980; Martin-Body et al., 1986; Daristotle et al., 1991; Roux et al., 2000a).  
In addition to this aforementioned proposal, the anatomical location of the 
DAR, and therefore the putative O2-responsive neuronal circuit, lies in close 
proximity to the area postrema (AP). Being the caudal-most 
circumventricular organ of the brain, the AP is a highly vascularised structure 
containing mostly fenestrated capillaries (Price et al., 2008). Moreover, the 
position outside of the blood-brain-barrier allows the AP to share 
blood-borne signals with the NTS via its unusual blood supply. Its 
fenestrated capillaries form short connecting vessels within the 
sub-postrema (SubP), which then break up again into ‘normal’ capillaries 
that supply the rest of the medulla. In this respect, fenestrations allow for 
re-entrant of venous blood into the capillary bed, which results in a relatively 
low O2 saturation within the surrounding tissue (Fodor et al., 2007; McGinnis 
et al., 2013). This already mildly hypoxic environment in turn could lead to 
an increased sensitivity to further reductions in the arterial O2 saturation, as 
would occur during periods of hypoxia, perhaps rendering a subpopulation 
of neurons sensitive to local PO2 due to COX4I2 expression, consequent 
susceptibility to deficits in mitochondrial ATP production during hypoxia, and 
thus activation of AMPK-dependent signalling pathways. 
Therefore, these findings provide further support to our hypothesis that the 
DAR is most likely made up of, at the very least, rostrally located and 





1) ‘applied metabolic stress’ (increased neuronal activity which is 
triggered by increased carotid body chemoafferent discharge that 
may be received by caudal A2 neurons, but is integrated and relayed 
by rostral A2 neurons within the DAR), and 
2) ‘local hypoxic stress’ (increased sensitivity of the neurons within the 
DAR to even minor decreases in arterial O2 saturation due to the 
already mildly hypoxic environment created by the fenestrated 
capillaries of the AP) 
 
4.3.5 Activity of additional putative non-O2-sensing regions of the 
dorsal medulla require AMPK expression in catecholaminergic 
cells 
All other nuclei within the caudal brainstem of TH AMPK-α1/α2 dKO mice 
exhibited cFos responses comparable to controls, with key exceptions. 
Against expectations, a significant reduction in cFos expression following 
AMPK deletion in catecholaminergic cells was identified within the AP (albeit 
within only a single Bregma), 10N and SolV. Importantly, their anatomical 
location within the brainstem was not consistent with the location of the DAR.  
It is possible that activity of 10N lies downstream of the O2-sensitive network 
that encompasses catecholaminergic neurons, as it has been shown to 
receive afferent inputs from the adrenergic C1 cells, which sit in the 
ventrolateral medulla and are likely candidates for VAR (see section 1.3.7 
below), as well as the dorsal C2 and C3 neurons (Hokfelt et al., 1973; Abbott 
et al., 2013; DePuy et al., 2013; Guyenet et al., 2013). 10N contains 
parasympathetic preganglionic neurons that innervate the thorax and 
abdomen (Watson et al., 2012), and bilateral projections from the 10N were 
proposed to contribute to the bradycardia and mild hypertension associated 
with the diving reflex (Panneton et al., 2014). Therefore, the cardiovascular 
regulation during periods of apnoea could be determined via motor output 
from the 10N, which in turn could be subjected to modulation via 
AMPK-dependent signalling pathways from adrenergic neurons. SolV, on 
the other hand, is one of the NTS subnuclei whose bilateral activation was 




swallowing (Wang et al., 2015). In this regard, loss of AMPK-dependent 
signalling pathways from within this subnucleus could underlie the 
pathogenesis of obstructive sleep apnoea, during which the airflow is 
obstructed by loss of laryngeal muscle tone (Panossian & Daley, 2013). 
However, further experiments are required to substantiate these 
suggestions. Either way, a contribution of these two nuclei to the 
O2-sensitivity of the DAR and modulation of ventilation seems unlikely, but 
cannot be excluded at this point. 
A very small subsection of the AP at Bregma -7.56mm also exhibited a 
marginally significant reduction of cFos expression in TH AMPK-α1/α2 dKO 
mice relative to controls. A contribution of the AP to the central O2-sensing 
neural network is plausible, because the anatomical location of the DAR, 
and therefore the putative O2-responsive neuronal circuit, lies in close 
proximity to the AP. Furthermore, noradrenergic cell bodies are also found 
within the central zone of the AP (Hermann et al., 2005), which would be 
affected by our targeted AMPK deletion strategy. As mentioned earlier, the 
AP is the caudal-most circumventricular organ of the brain and has a highly 
vascularised structure containing mostly fenestrated capillaries (Price et al., 
2008), which means it is well placed to monitor arterial PO2 centrally. In 
addition, it contains bidirectional projections to the dorsal portions of the NTS 
(van der Kooy & Koda, 1983; Shapiro & Miselis, 1985; Hermann et al., 2005), 
thus allowing for rapid communication between the AP, NTS, and VLM to 
modulate ventilation in response to changes in arterial PO2. However, a 
marginally significant reduction in cFos expression within the AP of TH 
AMPK-α1/α2 dKO mice relative to controls was only identified at one 
particular Bregma (-7.56mm). If the AP was to truly contribute to the DAR, 
then a significant attenuation of cFos expression would have been expected 
to occur at more than just one Bregma, given that the approximately 300µm 
rostrocaudal extend of the AP spans all of the analysed Bregma of the NTS 
(-7.76mm to -7.44mm), and a rostrocaudal structural subdivision of the AP 
has not been described within the literature. In fact, none of the other 
surrounding Bregma even revealed a clear trend towards a reduction in 




Bregma were only 40µm apart. Therefore, a contribution of the AP to the 
formation of the O2-sensitive neuronal circuit would be surprising, but cannot 
be ruled out at this point.  
 
4.3.6 Conclusion 
In conclusion, AMPK-dependent signalling pathways prompt increases in 
ventilation during hypoxia through the modulation of a putative 
hypoxia-responsive noradrenergic neuronal circuit located in the dorsal 
medulla oblongata in a region of close proximity to the DAR previously 
identified by fMRI. This suggests that in response to a fall in PO2, activation 
of AMPK supports increases the drive to breathe via afferent projections 
from the DAR to the respiratory network of the ventrolateral medulla, with 
AMPK activity being determined by the synergistic effects of ‘local hypoxic 
stress’ subsequent to reductions in the arterial O2 concentrations within the 
brainstem, and ‘applied metabolic stress’ subsequent to increased neuronal 
activity elicited by carotid body chemoafferent inputs. Therefore, it seems all 
the more likely that AMPK-dependent signalling pathways support 
coincidence detection and thus signal integration within a 
hypoxia-responsive circuit of the brainstem that delivers increases in the 
drive to breathe during hypoxia and therefore regulates whole-body O2 
supply. 
 
4.3.7 Limitations and future directions 
As highlighted in section 4.2.5, not all sections could be reliable allocated to 
the ‘major’ Bregma presented in the Mouse Brain Atlas (Franklin & Paxinos, 
2008). This problem is not uncommon and has been described by others 
who also did not use a matrix to block the brains, which can result in a 
dorsoventral tilt during sectioning (Llewellyn-Smith et al., 2013). However, 
creating transparent overlays of the Mouse Brain atlas which could be 
superimposed onto the photomicrographs allowed for the identification of the 
closest Bregma that would fit each individual section. Therefore, the data 




map and sat in-between two of the transparent overlays, need to be 
assessed with caution, not at least because very few numbers of sections 
were allocated to them. 
The small number of sections within the minor Bregma also limited the 
statistical analyses that could be carried out. This was particularly true for 
controls that were exposed to room air, where the total number of mice used 
was n = 4. Therefore, while sections of each major Bregma could be 
allocated for each animal, it often happened that ≤2 animals had sections 
allocated to minor Bregma, which means statistical differences could not be 
determined throughout the rostrocaudal extend.  
Lastly, the experiments presented in this Chapter focussed on the 
expression of cFos within the dorsal medulla at the level of the area 
postrema. However, it is entirely possible that the DAR extends more 
rostrally to the location of the adrenergic C2 and C3 cells. In addition, the 
fMRI study also revealed the existence of an area with deficiency of neuronal 
activity in TH AMPK-α1/α2 dKO mice relative to controls within the ventral 
medulla, which was termed the VAR (Mahmoud et al., 2016). Additional 
counts of cFos-positive cells are now required within the ventral medulla in 
order to determine whether the VAR is located within the anatomical region 
of the noradrenergic A1 and/or adrenergic C1 cells, and whether the DAR 





Chapter 5: Characterisation of the 
hypoxic apnoeic 
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5.1.1 Sighs, post-sigh apnoeas, and spontaneous apnoeas 
In mammals, eupneic breathing is periodically interrupted by the occurrence 
of augmented breaths (sighs), which are characterised by their large 
inspiratory and expiratory flows and thus much larger tidal volume compared 
to normal breaths. Sighs are an important feature of respiratory physiology 
as they prevent atelectasis, which is the occurrence of collapsed alveoli that 
create hypoventilated areas of the lungs (Nicholas et al., 1982) and they 
therefore maintain lung compliance and efficacy of gas exchange. On the 
other hand, sighs have also been proposed to promote ventilatory instability 
in subsequent breathing cycles, because they tend to be followed by apnoea 
and temporarily alter respiratory frequency (Perez-Padilla et al., 1983; 
Fleming et al., 1984; Fukumizu & Kohyama, 2004; Yamauchi et al., 2008). 
Normally respiratory rhythm is quickly restored, but sighs can be seriously 
disruptive for some individuals, for example those suffering from 
sleep-disordered breathing (Fleming et al., 1984; Hoch et al., 1998; Brown 
& Bates, 2000). The generation of sighs has been suggested to arise during 
embryogenesis within the preBötC immediately following the maturation of 
eupneic-like activity (Chapuis et al., 2014). Hypoxia in the adult increases 
the frequency of sighs and this effect has been postulated to occur via 
catecholaminergic neurotransmission and β-adrenergic receptor stimulation 
within preBötC neurons. This appears to require the additional actions of the 
neuropeptides neuromedin B and gastrin-releasing peptide, as well as input 
from vagal pulmonary C fibres that innervate the caudal NTS (Xu et al., 
2003; Bell et al., 2009; Burke et al., 2014; Li et al., 2016).  
As mentioned above, sighs are commonly followed by an apnoea. Although 
thought to arise from the preBötC neuronal network, post-sigh apnoeas 
(PSA) were found to be modulated by glutamatergic signalling within the 
pons. However, this modulation was state-dependent, as it occurred during 
rapid eye-movement (REM) sleep, but not during non-REM sleep 
(Radulovacki et al., 2001). In contrast, serotonin was found to modulate the 




2007). One prominent hypothesis as to how PSA are generated relates to 
the Hering-Breuer reflex, whereby pulmonary stretch receptors activated 
during lung inflation (sighing) lead to afferent vagal activity that inhibits 
inspiration and thus results in apnoea (Breuer, 1868). Importantly, the 
duration of the PSA appears to be directly related to the magnitude of vagal 
inhibition, and the counter balance delivered through increasing inspiratory 
excitatory input from central and peripheral chemosensors. Therefore, a 
stronger vagal inhibition will increase PSA duration, whereas increasing 
levels of CO2 during apnoeas will terminate PSA and re-initiate inspiration 
(Younes et al., 1974). Spontaneous apnoeas (SA) on the other hand appear 
to be generated by different mechanisms. The frequency of SA but not PSA 
has been correlated to the expression levels of TASK-1 potassium channels 
within the respiratory networks of the pons and medulla (Wang et al., 2008), 
and peripheral administration of serotonin was found to increase the 
generation of SA but not PSA during REM sleep (Carley & Radulovacki, 
1999a; Radulovacki et al., 2001). Therefore, PSA and SA appear to have 
distinct origins. 
 
5.1.2 AMPK deficiency in catecholaminergic cells augments the 
apnoeic phenotype during hypoxia 
Recent work on the role of AMPK within the catecholaminergic respiratory 
network has shown that deletion of the catalytic AMPK-α1 and -α2 subunits 
within tyrosine hydroxylase (TH)-positive cells (TH AMPK-α1/α2 dKO) 
precipitated more frequent and prolonged apnoeas during hypoxia 




The work on TH AMPK-α1/α2 dKO mice described above only considered 
total changes in the apnoeic responses to hypoxia during 5min exposures. 
In this chapter, I investigated the ventilatory stability of control AMPK-α1/α2 




Accordingly, mice were exposed to 10min of mild (12% O2) and severe (8% 
O2) hypoxia, as well as 60min of severe hypoxia and their ventilatory stability 
and apnoeic phenotype assessed using whole-body plethysmography. 
Moreover, I sought to determine whether AMPK deletion impacts on the 
balance of vagal and chemoafferent inputs that modulate respiratory 
stability. Therefore, sighs, post-sigh apnoeas and spontaneous apnoeas 
were separated and compared to each other in order to determine whether 







5.2.1 AMPK deletion in catecholaminergic cells increases ventilatory 
instability and disorder throughout 10min exposures to hypoxia 
Given the hypoventilation and highly disordered breathing pattern induced 
by hypoxia in TH AMPK-α1/α2 dKO mice described in section 3.2, it was of 
interest to assess and compare the overall breathing regularity and hence 
stability during 10min exposures to mild and severe hypoxia. This was 
achieved by plotting each inter-breath interval (BBn) against each 
subsequent inter-breath interval (BBn+1) for control AMPK-α1/α2 Flx and 
TH AMPK-α1/α2 dKO mice.  
Ventilatory stability of controls Example plots from single 10min exposures 
are shown in Figure 5.1 A, which compare the breathing patterns of a control 
(black) and knockout (red) mouse during 12% (left panel) and 8% (right 
panel) hypoxia. It is quite clear that control AMPK-α1/α2 Flx mice had a 
regular breathing pattern with few apnoeas evident through increases in 
inter-breath interval during mild hypoxia, which increased in number 
proportionally to the severity of hypoxia. Notably, the occurrence of apnoeas 
has been described in wild-type mice and healthy humans and is consistent 
with previous observations from this mouse model (Stettner et al., 2008; 
Ainslie et al., 2013; Mahmoud et al., 2016). These outcomes were analysed 
in more detail and quantified by comparing the standard deviations (SD) of 
BBn and BBn+1. 
Mild hypoxia: During 12% O2, the breathing variability of control 
AMPK-α1/α2 Flx mice (n = 55 exposures from 19 mice) increased slightly 
but significantly between the first and the second half of 10min exposures 
(Figure 5.1 B, left panels; 0-5min: 77 ± 2.3ms; 5-10min: 81.5 ± 2.2ms; 
p<0.05). A more detailed minute-by-minute analysis revealed that the higher 
SD of control mice during the second half of 10min exposures was due to a 
gradual increase in breathing variability over the course of the exposure to 
mild hypoxia (Figure 5.1 C, left panel; at 0-1min: 64.8 ± 2.7ms; at 5-6min: 




Severe hypoxia: Consistent with previous observations (Mahmoud, 2014; 
Mahmoud et al., 2016), the SD of AMPK-α1/α2 Flx mice during the first 5min 
of hypoxia significantly increased from 12% O2 to 8% O2 (Figure 5.1 B, right 
panel; 0-5min: 98 ± 3.7ms, p<0.0001 relative to 12% O2; n = 58 exposures 
from 25 mice). Interestingly though and contrary to mild hypoxia, the 
breathing variability of control AMPK-α1/α2 Flx mice significantly decreased 
during the second half of severe hypoxia (5-10min: 79.8 ± 3.8ms, p<0.01 
relative to 0-5min) to a level that was comparable to the second half of 
exposures to mild hypoxia (not significant relative to 5-10min of 12% O2). 
This overall decrease appeared to be due to a time-dependent decrease in 
the SD of the inter-breath intervals following a peak at 1-2min of 8% O2 
(Figure 5.1 C, right panel; at 1-2min: 108.4 ± 4.4ms; at 5-6min: 82.4 ± 4.4ms; 
at 9-10min: 77.9 ± 4.2ms). 
Ventilatory stability of knockouts Example plots of TH AMPK-α1/α2 dKO 
mice presented with very similar breathing regularities – and irregularities – 
compared to controls during mild hypoxia, where the main cluster of “regular” 
inter-breath intervals was within the same range as those of AMPK-α1/α2 
Flx mice. There were only a few breathing irregularities that could be 
attributed to the occurrence of apnoeas. In stark contrast to mild hypoxia, 
the response of TH AMPK-α1/α2 dKO mice to severe hypoxia was not only 
drastically more disordered with an overall increase in the number of 
prolonged inter-breath intervals, but individual inter-breath-intervals could be 
as long as 4s. Additionally, the main cluster of “regular” breath intervals had 
almost twice the range when compared to AMPK-α1/α2 Flx mice, indicative 
of disordered breathing and prolonged inter-breath intervals, consistent with 
the observed hypoventilation described in section 3.2.1.  
Mild hypoxia: Regarding the SD of BBn and BBn+1, the breathing variability 
of TH AMPK-α1/α2 dKO mice during 12% O2 (n = 35 exposures from 11 
mice) was indeed comparable to controls during both the first half (SD of 
73.5 ± 2.2ms, not significant) and the second half (SD of 75.1 ± 1.9ms, not 
significant relative to controls and relative to 0-5min) of 10min exposures. 
This comparable degree of breathing variability between controls and TH 




measured throughout the 10min exposures (at 0-1min: 56.6 ± 1.9ms, not 
significant; at 5-6min: 73.2 ± 2.6ms, not significant; at 9-10min: 73.7 ± 2.2ms, 
not significant). 
Severe hypoxia: In contrast to mild hypoxia, exposures to 8% O2 significantly 
increased the SD of TH AMPK-α1/α2 dKO mice (n = 46 exposures from 22 
mice) compared to controls (0-5min: 174.9 ± 6.8ms, p<0.0001; 5-10min: 
169.8 ± 10.9ms, p<0.0001; not significant relative to 0-5min), which was 
expected given the outcomes from the plots described above. The highest 
degree of breathing variability in TH AMPK-α1/α2 dKO mice was also 
observed during the second minute of severe hypoxia (1-2min: 207.7 ± 
13.6ms, p<0.0001 compared to controls). However, unlike controls, there 
was no time-dependent reduction of the SD and breathing remained 
significantly more irregular compared to controls throughout the remainder 
of the exposure, with SD of 170.3 ± 15.5ms by 5-6min (p<0.0001) and 146 
± 11ms by 9-10min (p<0.0001). 
From these plots it was obvious that increases in breathing irregularities 
were inversely related to the environmental concentration of O2, and that 
loss of AMPK-α1 and -α2 subunits in catecholaminergic cells markedly 





Figure 5.1: AMPK-α1/α2 catalytic subunit deletion in catecholaminergic 
cells precipitates breathing irregularities during severe hypoxia.  
(A) Example Poincaré plots show the inter-breath interval (BBn) versus the 
subsequent interval (BBn+1) of AMPK-α1/α2 Flx floxed (AMPK-α1/α2 Flx, 
black) and TH-driven AMPK-α1 and -α2 double knockout (TH AMPK-α1/α2 
dKO, red) mice during 10min exposures to to (i) mild hypoxia (12% O2) and 
(ii) severe hypoxia (8% O2). (B+C) Means ± SEM of the standard deviation 
(SD) of BBn and BBn+1 for AMPK-α1/α2 Flx mice (12% O2: n = 55 
exposures from 19 mice, 8% O2: n = 58 exposures from 25 mice) and TH 
AMPK-α1/α2 dKO mice (12% O2: n = 35 exposures from 11 mice, 8% O2: n 
= 46 exposures from 22 mice) for (B) 5min averages and (C) 1min averages. 
* = p<0.05, ** = p<0.01, **** = p<0.0001. Significance tested by two-way 




5.2.2 AMPK deletion in catecholaminergic cells increases the number 
and duration of apnoeas during 10min exposures to severe hypoxia 
Previous analyses of raw box flow traces revealed that the conditional 
deletion of AMPK-α1 and -α2 subunits in catecholaminergic cells 
precipitated more frequent and prolonged apnoeas during 5min exposures 
to hypoxia (Mahmoud, 2014). Figure 5.2 illustrates these findings and 
highlights the PO2-dependence of the response. Consistent with our 
previous study, apnoeas were defined as cessations of breathing ≥600ms 
(Mahmoud et al., 2016), which corresponds to the duration of two normoxic 
breaths (Nakamura & Kuwaki, 2003; Voituron et al., 2009; Peng et al., 2011).  
 
5.2.2.1 Apnoeic index 
Mild hypoxia When exposed to 10min of 12% O2, AMPK-α1/α2 Flx mice 
presented with apnoeas at a frequency of 0.8 ± 0.1 apnoeas/min (n = 55 
exposures from 19 mice) for the first, and 1 ± 0.1 apnoeas/min for the second 
5min of hypoxia (Figure 5.3 Ai). A constant number of apnoeas was also 
observed on a minute-by-minute basis, although there was a slight increase 
towards the end of the 10min exposure (Figure 5.3 Bi; apnoeas/min – at 
1-2min: 0.6 ± 0.1; at 5-6min: 0.7 ± 0.1; at 9-10min: 1 ± 0.2). 
Severe hypoxia During 8% O2, the apnoea frequency in AMPK-α1/α2 Flx 
mice was increased compared to mild hypoxia, measuring 3.1 ± 0.2 
apnoeas/min (n = 58 exposures from 25 mice) during the first half of 10min 
hypoxia, and 1.6 ± 0.2 apnoeas/min during the second half (Figure 5.3 Aii). 
Interestingly, the decline in apnoea frequency observed during the second 
half of the 10min exposure appeared to be time-dependent, as the number 
of apnoeas decreased from 4 ± 0.4 apnoeas/min by 1-2min to 2 ± 0.3 
apnoeas/min by 5-6min and 1.9 ± 0.2 apnoeas/min by 9-10min (Figure 5.3 
Bii). Thereafter, additional experiments in which the effect of 60min 
exposures to severe hypoxia (8% O2; n = 6) was investigated allowed me to 
explore whether this decrease was limited to, or extended beyond the initial 
10min measured. The 60min exposures revealed that this slow decline 




Apnoea frequency then remained stable for about 10min (25-30min: 1.3 ± 
0.2 apnoeas/min) before increasing slightly to 1.8 ± 0.1 apnoeas/min by 
35-40min. This apnoeic index was then maintained at a steady level with 
some minor fluctuations until the end of the exposure (55-60min: 1.8 ± 0.4 
apnoeas/min).  
Effect of AMPK deletion on apnoea frequency during mild hypoxia In 
contrast to previous findings (Mahmoud et al., 2016), the TH AMPK-α1/α2 
dKO mice used here (n = 35 exposures from 11 mice) produced a 
comparable number of apnoeas relative to controls during the first (0.7 ± 0.1 
apnoeas/min, not significant) and second half (0.7 ± 0.1 apnoeas/min, not 
significant) of the 10 min exposure to mild hypoxia. Further dissection of this 
response for each minute of hypoxia revealed that the numbers of apnoeas 
were indeed comparable between the genotypes throughout the hypoxic 
exposure (apnoeas/min – at 1-2min: 0.6 ± 0.1; at 5-6min: 0.9 ± 0.2; at 
9-10min: 1 ± 0.2; not significant compared to controls at any time point). 
Effect of AMPK deletion on apnoea frequency during severe hypoxia 
Consistent with previous observations, there was a much bigger increase in 
apnoea frequency in TH AMPK-α1/α2 dKO mice (n = 46 exposures from 22 
mice) compared to controls, which measured 5.9 ± 0.4 apnoeas/min 
(p<0.0001) during the first half and 4.4 ± 0.4 apnoeas/min (p<0.0001) during 
the second half of 10min exposures. This significantly augmented apnoeic 
frequency was also apparent throughout the 10min exposure (apnoeas/min 
– at 1-2min: 9.3 ± 0.8, p<0.0001; at 5-6min: 4 ± 0.5, p<0.0001; at 9-10min: 
5.5 ± 0.9, p<0.0001). In addition, not only was the frequency of apnoeas 
augmented in TH AMPK-α1/α2 dKO mice relative to controls, but the 
frequency at which apnoeas occurred oscillated with time, increasing and 
then decreasing over the course of the first 20-25min (n = 4). Thereafter, the 
frequency of apnoeas remained significantly augmented relative to controls 
between 30 and 60 min (10-15min: 7.1 ± 1.6 apnoeas/min, p<0.05; 
25-30min: 4.2 ± 0.9 apnoeas/min, p<0.05). Curiously, for the last 30min of 
60min exposures the averaged apnoeic index was generally comparable to 
controls (30-35min: 2.8 ± 0.7 apnoeas/min; 45-50min: 3 ± 1 apnoeas/min; 




analyses revealed the presence periodic “apnoeic bursts”, which were 
characterised as time-dependent phasic increases in the number of 
apnoeas, that occurred at a frequency of every 3.3 to 4.2 mHz (once every 
4-5min) and had a duration of 1min per burst. Strikingly, these bursts were 
present in each of the 4 TH AMPK-α1/α2 dKO mice analysed (Appendix 3.1) 
and were not lost upon averaging across the genotype.  
Therefore, in TH AMPK-α1/α2 dKO mice the apnoeic index was greater than 
for controls, consistent with previous outcomes. However, while control 
AMPK-α1/α2 Flx mice were able to maintain a steady number of apnoeas 
throughout prolonged exposures to hypoxia, mice with dual deletion of 
AMPK-α1 and -α2 subunits in catecholaminergic cells retained a degree of 
ventilatory instability that presented as “apnoeic bursts” at regular intervals, 
indicative of phasic disturbances of the central pattern generators (rCPGs) 






Figure 5.2: Conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells precipitates breathing instabilities that 
manifest as hypoventilation and apnoeas.  
(A) Exemplary box flow records of ventilatory activity obtained by 
plethysmography from AMPK-α1 and -α2 floxed (AMPK-α1/α2 Flx, left 
panels) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, right panels) during (i) mild hypoxia (12% O2) and (ii) 
severe hypoxia (8% O2). (B) Expanded box flow records from the same 
AMPK-α1/α2 Flx (top panel) and TH AMPK-α1/α2 dKO (bottom panel) mice 
used in (A) at an expanded time scale during (i) mild hypoxia (12% O2) and 





Figure 5.3: The precipitation of apnoeas in mice with conditional 
deletion of AMPK-α1/α2 catalytic subunits in catecholaminergic cells 
is PO2-dependent. 
Means ± SEM for the apnoeic index (apnoeas/min) during (A) the first and 
second half of 10 minute exposures and (B) for every 60 seconds of 10 
minute exposures to (i) mild hypoxia (12% O2) and (ii) severe hypoxia (8% 
O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 12% O2: n = 
55 exposures from 19 mice, 8% O2: n = 58 exposures from 25 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, 12% O2: n = 35 exposures from 11 mice, 8% O2: n = 46 exposures from 
22 mice), as well as (C) every 60s of 60min exposures to severe hypoxia for 
AMPK-α1/α2 Flx (n = 6 mice) and TH AMPK-α1/α2 dKO (n = 4 mice). * = 
p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested by 




5.2.2.2 Apnoea duration 
Mild hypoxia The duration of apnoeas for AMPK-α1/α2 Flx mice during mild 
hypoxia (12% O2) was stable during both halves of 10min exposures to 
hypoxia (Figure 5.4 Ai; 742.5 ± 17.7ms and 781 ± 15.8ms, respectively). 
That said, when looking at the average durations of apnoeas during each 
minute a minor statistically insignificant increase over time was observed 
(Figure 5.4 Bi; at 1-2min: 750.6 ± 27.4ms; at 4-5min: 787.8 ± 30.6ms; at 
9-10min: 837.6 ± 37ms).  
Severe hypoxia During 8% O2, apnoea durations were slightly greater 
relative to 12% O2 in AMPK-α1/α2 Flx mice and measured 909.7 ± 21.4ms 
during the first, and 844.4 ± 26.1ms during the second half of 10min 
exposures to hypoxia (Figure 5.4 Aii). Moreover, the duration of apnoeas 
remained fairly stable throughout the exposure, measuring 870.6 ± 19.8ms 
by 1-2min, 918.6 ± 34.6ms by 5-6min, and 869.4 ± 37.4ms by 9-10min 
(Figure 5.4 Bii) and also remained constant during prolonged exposures of 
60min hypoxia (Figure 5.4 C; 20-25min: 830 ± 20ms; 35-40min: 812 ± 28ms; 
55-60min: 906 ± 66ms).  
Effect of AMPK deletion on apnoea duration during mild hypoxia 
Unexpectedly, apnoea durations were significantly reduced in TH 
AMPK-α1/α2 dKO mice compared to controls during 12% O2, measuring 
693.7 ± 11.1ms (p<0.05) for the first and 726.5 ± 16.6ms (p<0.05) for the 
second half of 10min exposures. However, closer analyses of the durations 
for each minute revealed that apnoeas were only significantly shorter in TH 
AMPK-α1/α2 dKO mice compared to controls during the second and fifth 
minute of mild hypoxia (at 1-2min: 681.7 ± 13.9ms, p<0.05; at 4-5min: 703 
± 16.6ms, p<0.05).  
Effect of AMPK deletion on apnoea duration during severe hypoxia Under 
these conditions, TH AMPK-α1/α2 dKO mice exhibited a marked increase in 
apnoea duration compared to controls (0-5min: 1139.4 ± 39.2ms, p<0.0001; 
5-10min: 1143.6 ± 54.3ms, p<0.0001), consistent with previous 
observations. Importantly, this increase in apnoea duration was evident at 




38.9ms, p<0.0001; at 5-6min: 1185.5 ± 47.3ms, p<0.0001; at 9-10min: 
1064.2 ± 80.7ms, p<0.05). However, 60min exposures revealed that the 
significant augmentation only lasted until 25min (20-25min: 1126 ± 53ms, 
p<0.01), after which the apnoea durations decreased in TH AMPK-α1/α2 
dKO mice to the same level observed for control AMPK-α1/α2 Flx mice 
(25-30min: 920 ± 70ms; 35-40min: 950 ± 56ms; 55-60min: 926 ± 99ms; not 
significant relative to controls for any 5min block). 
Thus, deletion of AMPK-α1/α2 subunits in catecholaminergic cells 
precipitates prolonged apnoeas during severe, but not mild, hypoxia. 
Furthermore, the increase in apnoea duration observed in TH AMPK-α1/α2 
dKO mice during hypoxia relative to controls declined in a time-dependent 
manner during prolonged exposures, suggesting that these mice are able to 
“recover” normal apnoea durations and thus re-initiate inspiratory activity 






Figure 5.4: The increase in apnoea duration of mice with conditional 
deletion of AMPK-α1/α2 catalytic subunits in catecholaminergic cells 
is PO2- and time-dependent.  
Means ± SEM for the apnoea duration (ms) during (A) the first and second 
half of 10 minute exposures and (B) for every 60 seconds of 10 minute 
exposures to (i) mild hypoxia (12% O2) and (ii) severe hypoxia (8% O2) in 
AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 12% O2: n = 55 
exposures from 19 mice, 8% O2: n = 58 exposures from 25 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, 12% O2: n = 35 exposures from 11 mice, 8% O2: n = 46 exposures from 
22 mice), as well as (C) every 60s of 60min exposures to severe hypoxia for 
AMPK-α1/α2 Flx (n = 6 mice) and TH AMPK-α1/α2 dKO (n = 4 mice). * = 
p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested by 




5.2.2.3 Apnoea duration index 
Mild hypoxia As would be expected from the outcomes for apnoea frequency 
and duration, the apnoea-duration index (ADI; frequency x duration), 
remained stable in AMPK-α1/α2 Flx mice for both halves of 10min exposures 
to mild hypoxia (Figure 5.5 Ai; 0.6 ± 0.1 and 0.8 ± 0.1, respectively), but 
showed a minor increase over time when analysed as minute-by-minute 
averages (Figure 5.5 Bi; at 1-2min: 0.4 ± 0.1; at 5-6min: 0.6 ± 0.1; at 9-10min: 
1.2 ± 0.2).  
Severe hypoxia Given the stable duration of apnoeas over time in 
AMPK-α1/α2 Flx mice it was not surprising that the time-dependent changes 
in the apnoea-duration index followed a similar pattern to apnoea frequency. 
Compared to mild hypoxia, the ADI of control mice was increased in 
response to 8% O2 (Figure 5.5 Aii; 2.9 ± 0.2 and 1.5 ± 0.2, respectively) and 
showed a time-dependent decrease during 10min exposures of hypoxia 
(Figure 5.5 Bii; at 1-2min: 3.5 ± 0.3; at 5-6min: 1.9 ± 0.3; at 9-10min: 1.8 ± 
0.3) that appeared to last until 20-25min (Figure 5.5 C; 1 ± 0.2), after which 
it remained stable for the remainder of prolonged 60min exposures to 8% 
O2 (30-35min: 1.5 ± 0.2; 40-45min: 1.9 ± 0.2; 55-60min: 1.7 ± 0.3). 
Effect of AMPK deletion on ADI during mild hypoxia The outcomes for 
apnoea frequency and duration translated into an ADI of TH AMPK-α1/α2 
dKO mice that was comparable to controls in response to 12% O2, both as 
averages over 5min (0-5min: 0.5 ± 0.08, not significant; 5-10min: 0.5 ± 0.1, 
not significant), and at each time point throughout the 10min exposure (at 
1-2min: 0.4 ± 0.1; at 5-6min: 0 0.7 ± 0.2; at 9-10min: 0.8 ± 0.2; not significant 
compared to controls at any point).  
Effect of AMPK deletion on ADI during severe hypoxia By contrast, during 
8% O2, the ADI of TH AMPK-α1/α2 dKO mice was augmented compared to 
controls during both halves of 10min exposures (0-5min: 6.4 ± 0.4, 
p<0.0001; 5-10min: 5.1 ± 0.5, p<0.0001) and throughout the duration when 
measured as 1min averages (at 1-2min: 9.5 ± 0.9, p<0.0001; at 5-6min: 4.9 
± 0.7, p<0.001; at 9-10min: 5.7 ± 0.9, p<0.0001). This significantly higher 




approximately 25min (20-25min: 4.3 ± 0.7, p<0.05). Thereafter, the ADI 
declined, on average, to a level similar to controls until the end of the 
exposure (30-35min: 2.4 ± 0.6; 40-45min: 2.7 ± 0.8; 55-60min: 2.6 ± 0.5). 
However, frequency-dependent “apnoeic bursts” were still evident every 3.3 
to 4.2 mHz (once every 4-5min) when analysed on a minute-by-minute 
basis. 
Overall, while TH AMPK-α1/α2 dKO mice presented with a severely 
augmented and prolonged apnoeic phenotype in response to acute hypoxia, 
they were able to regain some ventilatory stability during more prolonged 
hypoxic exposures, especially with respect to the re-initiation of inspiration 
following an apnoea (i.e. shortened apnoea duration). Nevertheless, a 
certain degree of instability clearly remained, which oscillated rhythmically 
throughout the exposures to prolonged hypoxia. These phasic periods of 
respiratory instability were driven by phasic “bursts” of increased apnoea 
frequency, and were present in every TH AMPK-α1/α2 dKO mouse 
(Appendix 3.3). This therefore points towards periodically disrupted signal 
integration within the central pattern generators following AMPK deletion in 





Figure 5.5: The augmentation of the apnoea-duration index in 
TH-driven AMPK-α1/α2 knockout mice is PO2- dependent.  
Means ± SEM for the apnoea-duration index (frequency x duration) during 
(A) the first and second half of 10 minute exposures and (B) for every 60 
seconds of 10 minute exposures to (i) mild hypoxia (12% O2) and (ii) severe 
hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 
12% O2: n = 55 exposures from 19 mice, 8% O2: n = 58 exposures from 25 
mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, 12% O2: n = 35 exposures from 11 mice, 8% O2: n 
= 46 exposures from 22 mice), as well as (C) every 60s of 60min exposures 
to severe hypoxia for AMPK-α1/α2 Flx (n = 6 mice) and TH AMPK-α1/α2 
dKO (n = 4 mice). * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. 




5.2.3 AMPK deletion in catecholaminergic cells increases the number 
of SA and the duration of PSA during 10min exposures to severe 
hypoxia 
As mentioned in the introduction to this chapter, two types of apnoeas have 
been described, the generation of which is thought to be triggered by 
different mechanisms at the level of the brainstem (Radulovacki et al., 2001; 
Wang et al., 2008; Chapuis et al., 2014). It was therefore of interest to see 
how deletion of AMPK-α1 and -α2 subunits in catecholaminergic cells 
impacts on the occurrence of spontaneous apnoeas (SA) and post-sigh 
apnoeas (PSA) during hypoxia.  
 
5.2.3.1 Apnoeic index 
Mild hypoxia - controls During 12% O2, SA and PSA occurred at a 
comparable frequency in control AMPK-α1/α2 Flx mice (Figure 5.6 A). That 
said, there appeared to be a trend for SA to be slightly more frequent, but 
this only became statistically significant (compared to PSA) during the fifth 
and tenth minute of hypoxia (apnoeas/min for SA versus PSA – at 4-5min: 
0.7 ± 0.2 versus 0.2 ± 0.1, p<0.01; at 9-10min: 1.2 ± 0.2 versus 0.4 ± 0.1, 
p<0.0001).  
Severe hypoxia - controls Interestingly, there was a switch in apnoea 
frequency during severe hypoxia (Figure 5.6 B), whereby PSA were 
significantly more frequent in AMPK-α1/α2 Flx mice from the second to the 
seventh minute of 8% O2 (apnoeas/min for SA versus PSA – at 1-2min: 0.8 
± 0.2 versus 3.1 ± 0.3, p<0.001; at 5-6min: 0.3 ± 0.1 versus 1.7 ± 0.2, p<0.01; 
at 9-10min: 0.5 ± 0.1 versus 1.4 ± 0.2, not significant). Moreover, it seemed 
that the PO2-dependent increases of apnoea frequency of control mice 
mentioned in section 5.2.2.1 were primarily driven by increases in the 
frequency of PSA, but not SA. A closer inspection of the apnoeic profile 
during prolonged 60min exposures to 8% O2 showed that over the last 30min 
the apnoea frequencies seemed to switch back to being comparable at each 




apnoeas/min for SA versus PSA – at 30-31min: 1 ± 0.5 versus 0.5 ± 0.2; at 
45-46min: 1.2 ± 0.5 versus 0.5 ± 0.2; at 59-60min: 2.8 ± 1 versus 0.3 ± 0.2). 
Mild hypoxia - knockouts In TH AMPK-α1/α2 dKO mice, the numbers of SA 
and PSA were comparable to each other throughout the 10min exposures 
to mild hypoxia (apnoeas/min for SA versus PSA – at 1-2min: 0.2 ± 0.1 
versus 0.5 ± 0.1, not significant; at 5-6min: 0.4 ± 0.1 versus 0.5 ± 0.2, not 
significant; at 9-10min: 0.7 ± 0.2 versus 0.3 ± 0.1, not significant). 
Severe hypoxia - knockouts Unlike controls, the numbers of SA and PSA 
remained comparable in TH AMPK-α1/α2 dKO mice for most of the 10min 
of severe hypoxia. Significant differences were only seen during the second, 
third, and tenth minute of 8% O2 (apnoeas/min for SA versus PSA – at 
1-2min: 5.5 ± 0.7 versus 3.7 ± 0.3, p<0.001; at 2-3min: 1.6 ± 0.3 versus 3.1 
± 0.2, p<0.01; at 9-10min: 3.4 ± 0.8 versus 2.1 ± 0.2, p<0.05). Additionally, 
frequencies of SA and PSA also remained comparable throughout 
prolonged 60min exposures, even though it appeared that the “apnoeic 
bursts” described earlier were solely driven by periodic, oscillating increases 
in the spontaneous apnoeic index, while the numbers of PSA remained 
stable and possibly even declined over time (Figure 5.7 B; apnoeas/min for 
SA versus PSA during “apnoeic bursts” – at 28-29min: 6 ± 2 versus 1.8 ± 
0.8; at 32-33min: 4 ± 4 versus 1.3 ± 0.5; at 38-39min: 5.3 ± 3 versus 1.3 ± 
0.5; at 43-44min: 5 ± 3 versus 1.5 ± 0.3; at 49-50min: 4.8 ± 1.6 versus 0.8 ± 
0.5; at 53-54min: 6 ± 2.9 versus 0.5 ± 0.3). 
Therefore, it appears that the PO2-dependent changes in apnoea frequency 
observed in AMPK-α1/α2 Flx mice were driven by increases in PSA, 
whereas the changes observed in TH AMPK-α1/α2 dKO mice were driven 
by increases in the frequencies of both PSA and SA. Additionally, periodic 
increases in apnoeas during prolonged exposures appeared to be due to an 
increased occurrence of SA, but not PSA, which indicates that over time TH 
AMPK-α1/α2 dKO mice are able to reduce their number of PSA to the level 
observed in control AMPK-α1/α2 Flx mice. 
Effect of AMPK deletion on the frequency of SA and PSA compared to 




between AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice during either mild 
or severe hypoxia.  
By contrast, SA were significantly less frequent in TH AMPK-α1/α2 dKO 
mice at certain points during exposures to mild hypoxia (at 4-5min: p<0.01; 
at 7-8min: p<0.01), but augmented throughout the entire exposure to 10min 
of severe hypoxia (at 1-2min: p<0.0001; at 5-6min: p<0.01; at 9-10min: 
p<0.0001). Importantly, during more prolonged 60min exposures SA 
remained augmented relative to controls, particularly during the “apnoeic 
bursts” which were solely driven by augmentations in the numbers of SA. 
Although significant differences in the apnoeic index of SA between controls 
and TH AMPK-α1/α2 dKO mice were not always reached (possibly due to 
the small cohort of animals tested and the high degree of variability within 
the numbers of SA), the average numbers of SA in TH AMPK-α1/α2 dKO 
mice were at least 3 times higher than in control AMPK-α1/α2 Flx mice 
(controls versus knockouts – at 15-16min: 1 ± 1 versus 8 ± 4.6, p<0.0001; 
at 28-29min: 0.2 ± 0.2 versus 6 ± 2, p<0.01; at 32-33min: 1.3 ± 0.6 versus 4 
± 4, p>0.999; at 38-39min: 1 ± 0.4 versus 5.3 ± 3.1, p=0.266; at 43-44min: 
0.8 ± 0.5 versus 5 ± 3, p=0.322; at 49-50min: 1.2 ± 0.6 versus 4.8 ± 1.6, 
p=0.829; at 53-54min: 1 ± 0.4 versus 6 ± 2.9, p<0.05). 
This shows that because both AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO 
mice had a comparable PO2-dependent increase in the number of PSA, it 
was the additional PO2-dependent increases in the number of SA in TH 
AMPK-α1/α2 dKO mice that resulted in the significantly augmented total 
apnoeic index described during acute hypoxia (section 5.2.2.1). Moreover, 
while TH AMPK-α1/α2 dKO mice appear to recover ventilatory stability 
during prolonged exposures to severe hypoxia with respect to the 
occurrence of PSA, they clearly still suffer from periodically oscillating 






Figure 5.6: Conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells precipitates more frequent spontaneous 
apnoeas.  
Means ± SEM for the apnoeic index (apnoeas/min) for every 60 seconds of 
10 minute exposures to (A) mild hypoxia (12% O2) and (B) severe hypoxia 
(8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 12% O2: 
n = 55 exposures from 19 mice, 8% O2: n = 58 exposures from 25 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, 12% O2: n = 35 exposures from 11 mice, 8% O2: n = 46 exposures from 
22 mice), separated into post-sigh apnoeas (PSA) and spontaneous 
apnoeas (SA). Between genotypes: ** = p<0.01, *** = p<0.001, **** = 
p<0.0001; between SA and PSA: # = p<0.05, ## = p<0.01, ### = p<0.001, 
#### = p<0.0001. Significance tested by two-way ANOVA with Sidak 
post-hoc tests for apnoeic index and apnoea-duration index, multiple t-tests 





Figure 5.7: Conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells precipitates “apnoeic bursts” due to more 
frequent spontaneous apnoeas during prolonged exposures to severe 
hypoxia.  
Means ± SEM for the apnoeic index (apnoeas/min) for every 60 seconds of 
60 minute exposures severe hypoxia (8% O2) in (A) AMPK-α1 and -α2 floxed 
mice (AMPK-α1/α2 Flx, black, n = 6) and (B) TH-driven AMPK-α1 and -α2 
double knockout mice (TH AMPK-α1/α2 dKO, red, n = 4), separated into 
post-sigh apnoeas (PSA) and spontaneous apnoeas (SA). Between SA and 
PSA: # = p<0.05, ## = p<0.01, #### = p<0.0001. Significance tested by 





5.2.3.2 Apnoea duration 
Mild hypoxia - controls Similar to apnoea frequency during 12% O2, 
durations of SA and PSA were generally comparable to each other in control 
AMPK-α1/α2 Flx mice, but reached significance at the end of the 10 minutes 
with PSA being longer in duration than SA (Figure 5.8 A; SA versus PSA – 
at 8-9min: 720.3 ± 19.6ms versus 822.8 ± 47.5ms, p<0.05; at 9-10min: 759.3 
± 31.7ms versus 978.9 ± 66ms, p<0.001).  
Severe hypoxia - controls During 8% O2 (Figure 5.8 B), there was a trend 
for PSA durations of AMPK-α1/α2 Flx mice to be longer than those of SA, 
which reached significance during the second (SA: 702.5 ± 23.7ms, PSA: 
923.2 ± 25.1ms, p<0.0001), fourth (SA: 716.3 ± 51.6ms, PSA: 1008.4 ± 
31.2ms, p<0.01), fifth (SA: 745 ± 57.2ms, PSA: 939.4 ± 29.6ms, p<0.01), 
sixth (SA: 708.6 ± 41.4ms, PSA: 953.3 ± 36.2ms, p<0.01), and eighth (SA: 
701.4 ± 33.1ms, PSA: 906.1 ± 48.2ms, p<0.05) minute. This trend, albeit 
generally statistically insignificant for the number of mice tested, was also 
present throughout prolonged 60min exposures to severe hypoxia (Figure 
5.9 A; SA versus PSA – at 30-31min: 660 ± 30ms versus 1254 ± 55ms, 
p<0.05; at 44-45min: 780 ± 48ms versus 1290 ± 320ms, not significant; at 
59-60min: 777 ± 40ms versus 1846 ± 0ms, not significant).  
Mild hypoxia - knockouts Similar to controls, the durations of SA and PSA 
were also comparable to each other in TH AMPK-α1/α2 dKO mice 
throughout exposures to mild hypoxia (apart from the third minute, where 
SA: 661.1 ± 25.3, PSA: 762.1 ± 30.7, p<0.05). 
Severe hypoxia - knockouts PSA durations were significantly longer than SA 
for TH AMPK-α1/α2 dKO mice throughout exposures to severe hypoxia (SA 
versus PSA – at 1-2min: 887.2 ± 62.4ms versus 1247.6 ± 100.8ms, p<0.01; 
at 5-6min: 882.2 ± 43.9ms versus 1359 ± 63.4ms, p<0.001; at 9-10min: 
901.3 ± 67.7ms versus 1264.5 ± 99.1, p<0.05). However, as indicated in 
section 5.2.2.2, the average duration of apnoeas decreased throughout 
prolonged 60min exposures of hypoxia to a similar duration observed in 
controls. This reduction was driven by marked decreases in the duration of 




PSA – at 30-31min: 709 ± 77ms versus 752 ± 45ms; at 44-45min: 995 ± 0ms 
versus 882 ± 8ms; at 59-60min: 725 ± 0ms versus 989 ± 29ms).  
This indicates that the PO2-dependent increases of apnoea duration 
observed in both genotypes were mainly due to an augmentation in the 
durations of PSA. Moreover, deletion of AMPK in catecholaminergic cells 
further prolonged the duration of PSA during acute, but not prolonged 
hypoxia.  
Effect of AMPK deletion on the duration of SA and PSA compared to controls 
There were no differences in the durations of either SA or PSA between 
genotypes during mild hypoxia on the whole, but the durations of PSA were 
significantly shorter in TH AMPK-α1/α2 dKO mice compared to controls 
during the second (p<0.01) and tenth (p<0.05) minute of 12% O2.  
During severe hypoxia, the durations of SA were only significantly 
augmented in TH AMPK-α1/α2 dKO mice compared to controls during the 
second (p<0.01) and eighth (p<0.01) minute, whereas the durations of PSA 
were significantly longer during every minute of 8% O2 (at 1-2min: p<0.0001; 
at 5-6min: p<0.0001; at 9-10min p<0.001). However, as mentioned above, 
a time-dependent reduction on PSA duration in TH AMPK-α1/α2 dKO mice 
resulted in apnoea durations that were similarly as long as those of controls 
during prolonged 60min exposures.   
Therefore, deletion of AMPK-α1 and -α2 subunits in catecholaminergic cells 
appeared to increase the duration of apnoeas in a PO2-dependent manner 
and predominantly through the prolongation of PSA, but not SA, during 






Figure 5.8: Conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells precipitates prolonged post-sigh apnoeas.  
Means ± SEM for the apnoea duration (ms) for every 60 seconds of 10 
minute exposures to (A) mild hypoxia (12% O2) and (B) severe hypoxia (8% 
O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 12% O2: n = 
55 exposures from 19 mice, 8% O2: n = 58 exposures from 25 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, 12% O2: n = 35 exposures from 11 mice, 8% O2: n = 46 exposures from 
22 mice), separated into post-sigh apnoeas (PSA) and spontaneous 
apnoeas (SA). Between genotypes: * = p<0.05, ** = p<0.01, *** = p<0.001, 
**** = p<0.0001; between SA and PSA: # = p<0.05, ## = p<0.01, ### = 
p<0.001, #### = p<0.0001. Significance tested by two-way ANOVA with 
Sidak post-hoc tests for apnoeic index and apnoea-duration index, multiple 





Figure 5.9: Conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells precipitates “apnoeic bursts” due to more 
frequent spontaneous apnoeas during prolonged exposures to severe 
hypoxia.  
Means ± SEM for the apnoea duration (ms) for every 60 seconds of 60 
minute exposures severe hypoxia (8% O2) in (A) AMPK-α1 and -α2 floxed 
mice (AMPK-α1/α2 Flx, black, n = 6) and (B) TH-driven AMPK-α1 and -α2 
double knockout mice (TH AMPK-α1/α2 dKO, red, n = 4), separated into 
post-sigh apnoeas (PSA) and spontaneous apnoeas (SA). Between SA and 






5.2.3.3 Apnoea-duration index 
Mild hypoxia - controls Together, measurements for apnoea frequency and 
duration during 12% O2 (Figure 5.10 A) translated into an ADI that was 
generally comparable between SA and PSA for control AMPK-α1/α2 Flx 
mice (only significantly different at 4-5min and 9-10min, where SA: 0.6 ± 0.1, 
PSA: 0.2 ± 0.1, p<0.01 and SA: 0.9 ± 0.2, PSA: 0.4 ± 0.1, p<0.0001, 
respectively). 
Severe hypoxia - controls During 8% O2 (Figure 5.10 B), ADIs for PSA were 
significantly higher than for SA in control AMPK-α1/α2 Flx mice until the 
seventh minute of hypoxia (SA versus PSA – at 1-2min: 0.6 ± 0.1 versus 2.9 
± 0.3, p<0.0001; at 5-6min: 0.2 ± 0.1 versus 1.7 ± 0.2, p<0.01; at 9-10min: 
0.4 ± 0.1 versus 1.3 ± 0.2, not significant) and comparable throughout 
prolonged exposures (Figure 5.11 A; SA versus PSA – at 30-31min: 0.68 ± 
0.4 versus 0.62 ± 0.3; at 44-45min: 1.88 ± 1.1 versus 0.86 ± 0.3; at 59-60min: 
2.16 ± 0.8 versus 0.31 ± 0.3; not significant at any point).  
Mild hypoxia - knockouts No differences were found in the ADI of SA 
compared to PSA during exposures to 12% O2 in TH AMPK-α1/α2 dKO 
mice. 
Severe hypoxia - knockouts By contrast, exposures to 8% O2 significantly 
augmented the ADI of PSA in TH AMPK-α1/α2 dKO mice compared to SA 
during the third (SA: 1.2 ± 0.3, PSA: 4 ± 0.4, p<0.0001), fourth (SA: 1.5 ± 
0.4, PSA: 3.9 ± 0.3, p<0.0001), and sixth (SA: 1.5 ± 0.4, PSA: 3 ± 0.4, 
p<0.001) minute of hypoxia, but  at no other time points during 10 or 60min 
exposures. That said, the time-dependent reduction of the number of PSA 
translated into a continued decline of the ADI over the course of the 60min 
exposure. By contrast, phasic oscillations of sudden increases in the ADI of 
SA, driven by periodic “bursts” in the number of SA, were still apparent 
throughout the duration of the exposure.  
Effect of AMPK deletion on the ADI of SA and PSA compared to controls 
There were no overall differences in the ADIs of SA and PSA, respectively, 
between genotypes during exposures to mild hypoxia. The only significant 




and 7-8min, where control mice measured 0.6 ± 0.1 and 0.6 ± 0.1, 
respectively, and TH AMPK-α1/α2 dKO mice only 0.1 ± 0.05 (p<0.01) and 
0.1 ± 0.04 (p<0.01), respectively.  
During severe hypoxia, TH AMPK-α1/α2 dKO mice had significantly 
augmented ADIs of SA and PSA, respectively, compared to AMPK-α1/α2 
Flx mice at most time periods measured (SA – at 1-2min: p<0.0001; at 
5-6min: p<0.05; at 9-10min: p<0.0001; PSA – at 1-2min: p<0.001; at 5-6min: 
p<0.05; at 9-10min: not significant). However, these differences declined 
over time so that by 20min the ADIs of both SA and PSA were generally 
comparable between controls and TH AMPK-α1/α2 dKO mice for the 
remainder of the 60min exposure (Figure 5.11 B). That said, the 
frequency-dependent “bursts” in the ADI of SA were still, on average, at least 
at least 3 times higher than in control AMPK-α1/α2 Flx mice, even though 
statistical significance was only reached twice (controls versus knockouts – 
at 15-16min: 0.7 ± 0.7 versus 7.2 ± 4.2, p<0.001; 28-29min: 0.1 ± 0.1 versus 
6.7 ± 3.1, p<0.0001; at 32-33min: 1.1 ± 0.4 versus 3.7 ± 3.7, p>0.999; at 
38-39min: 0.7 ± 0.3 versus 4.6 ± 2.9, p=0.562; at 43-44min: 0.7 ± 0.4 versus 
4 ± 2.7, p=0.944; at 49-50min: 0.8 ± 0.4 versus 3.5 ± 1.2, p>0.999; at 
53-54min: 0.7 ± 0.3 versus 4.7 ± 2.3, p>0.999). 
In summary, these outcomes indicate that deletion of AMPK-α1 and -α2 
subunits in catecholaminergic cells has a contrasting effect on the two types 
of apnoeas during acute hypoxia, whereby it augments the frequency of SA 
on one hand, and the duration of PSA on the other. This translated to a 
significantly increased apnoea-duration index of both SA and PSA in mice 
with deletion of AMPK-α1 and -α2 subunits in catecholaminergic cells. 
However, over time the frequencies and durations of both types of apnoeas 
decreased to match values obtained from control mice. That said, a certain 
level of instability within TH AMPK-α1/α2 dKO mice was retained, which lead 
to periodically oscillating augmentations of SA, a phenomenon that was not 
observed for PSA or either type of apnoea in controls. Therefore, while vagal 
afferent inhibition of ventilation may be enhanced upon AMPK deletion in 
catecholaminergic cells during the early phases of hypoxia, it appeared to 




contrast, AMPK deletion precipitates unforeseen phasic disturbances of the 
rCPGs that manifest as periodic oscillations or “bursts” in the numbers of 





Figure 5.10: Conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells augments the spontaneous and post-sigh 
apnoea indexes. 
Means ± SEM for apnoea-duration index for every 60 seconds of 10 minute 
exposures to (A) mild hypoxia (12% O2) and (B) severe hypoxia (8% O2) in 
AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 12% O2: n = 55 
exposures from 19 mice, 8% O2: n = 58 exposures from 25 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, 12% O2: n = 35 exposures from 11 mice, 8% O2: n = 46 exposures from 
22 mice), separated into post-sigh apnoeas (PSA) and spontaneous 
apnoeas (SA). Between genotypes: * = p<0.05, ** = p<0.01, *** = p<0.001, 
**** = p<0.0001; between SA and PSA: # = p<0.05, ## = p<0.01, ### = 
p<0.001, #### = p<0.0001. Significance tested by two-way ANOVA with 
Sidak post-hoc tests for apnoeic index and apnoea-duration index, multiple 





Figure 5.11: The ADI of PSA and SA in mice with conditional deletion 
of AMPK-α1/α2 catalytic subunits in catecholaminergic cells is 
comparable with controls during prolonged exposures to severe 
hypoxia. 
Means ± SEM for the apnoea-duration index (frequency x duration) for every 
60 seconds of 60 minute exposures severe hypoxia (8% O2) in (A) AMPK-α1 
and -α2 floxed mice (AMPK-α1/α2 Flx, black, n = 6) and (B) TH-driven 
AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, red, n = 4), 
separated into post-sigh apnoeas (PSA) and spontaneous apnoeas (SA). 
Between SA and PSA: ### = p<0.001. Significance tested by two-way 




5.2.4 AMPK deletion in catecholaminergic cells attenuates 
PO2-dependent increases in sigh frequency during 10min exposures to 
severe hypoxia 
As described in the section above, the number of PSA increased in a 
PO2-dependent manner in both AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO 
mice. However, sighs can also occur without a proceeding apnoea 
(Yamauchi et al., 2008) and have been suggested to restore residual lung 
volume by reinflating collapsed alveoli (Chapuis et al., 2014; Li et al., 2016). 
Moreover, hypoxia has been found to increase sigh frequency dependent on 
vagal and carotid body chemoafferent activity (Bartlett, 1971). It was 
therefore of interest to compare the frequency of all sighs during hypoxia in 
control mice and those with catecholaminergic deletion of AMPK-α1 and -α2 
subunits, given that CB afferent output during hypoxia is retained in TH 
AMPK-α1/α2 dKO mice (Mahmoud et al., 2016). 
Mild hypoxia The total frequency of sighs in control AMPK-α1/α2 Flx mice 
during the first half of 10min exposures to 12% O2 measured 2.1 ± 0.07 
sighs/min (Figure 5.12 Ai; n = 55 exposures from 19 mice), which declined 
to 1.4 ± 0.07 sighs/min during the second half. More detailed analyses of 
sigh frequencies for every minute of 12% O2 revealed that this decrease was 
time-dependent (Figure 5.12 Bi), declining from 2.5 ± 0.1 sighs/min during 
the second minute, to 1.8 ± 0.1 sighs/min during the sixth minute and finally 
1.5 ± 0.1 sighs/min during the tenth minute of hypoxia.  
Severe hypoxia A very similar response was also observed during severe 
hypoxia, whereby sigh frequency declined from the first half (Figure 5.12 Aii; 
4.7 ± 0.1 sighs/min; n = 58 exposures from 25 mice) to the second half (2.8 
± 0.1 sighs/min) of the 10min exposure. Once again, this decrease was 
clearly time-dependent (Figure 5.12 Bii), declining from 6.5 ± 0.2 sighs/min 
during the second minute, to 3.4 ± 0.1 sighs/min during the sixth minute and 
finally 2.8 ± 0.2 sighs/min during the tenth minute of hypoxia. 
Effect of AMPK deletion on sigh frequency during mild hypoxia Compared 
to controls, the total number of sighs did not differ during exposures of TH 
AMPK-α1/α2 dKO mice to mild hypoxia. During the first half of 12% O2, 




mice; not significant compared to controls), which declined during the 
second half to 1.3 ± 0.1 sighs/min (not significant). A similar time-dependent 
decrease in sigh frequency was also observed, which measured 2.7 ± 0.2 
sighs/min during the second minute, 1.4 ± 0.2 sighs/min during the sixth 
minute and finally 1.3 ± 0.2 sighs/min during the tenth minute of hypoxia (not 
significant compared to controls at any time). 
Effect of AMPK deletion on sigh frequency during severe hypoxia In contrast, 
during severe hypoxia, clear differences between controls and knockouts 
were observed. Sigh frequency was significantly attenuated in TH 
AMPK-α1/α2 dKO mice (n = 46 exposures from 22 mice) compared to 
controls during both halves of 10min exposures to severe hypoxia (0-5min: 
3.7 ± 0.2, p<0.0001; 5-10min: 2.3 ± 0.1, p<0.05). However, analysis of one 
minute periods revealed that although sigh frequency was on average lower 
in TH AMPK-α1/α2 dKO mice during every minute bar the last, the difference 
only reached significance during the first half of 8% O2 compared to control 
AMPK-α1/α2 Flx mice (at 1-2min: 5.9 ± 0.3 sighs/min, p<0.05; at 5-6min: 2.5 
± 0.2 sighs/min, p<0.01; at 9-10min: 2.8 ± 0.2 sighs/min, not significant). 
These outcomes were intriguing, given that PSA are thought to be coupled 
to sighs via the Hering-Breuer reflex. A significant reduction in sighs along 
with a significant augmentation of PSA in TH AMPK-α1/α2 dKO mice relative 
to controls might be plausible if control AMPK-α1/α2 Flx mice exhibit a 
significant number of sighs without a proceeding apnoea. Therefore, the 






Figure 5.12: Conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells attenuates the number of sighs during the 
early hypoxic ventilatory response.  
Means ± SEM for the sigh frequency during (A) the first and second half, 
and (B) every 60 seconds during 10 minute exposures to (i) mild hypoxia 
(12% O2) and (ii) severe hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice 
(AMPK-α1/α2 Flx, black, 12% O2: n = 55 exposures from 19 mice, 8% O2: n 
= 58 exposures from 25 mice) and TH-driven AMPK-α1 and -α2 double 
knockout mice (TH AMPK-α1/α2 dKO, red, 12% O2: n = 35 exposures from 
11 mice, 8% O2: n = 46 exposures from 22 mice). * = p<0.05, ** = p<0.01, 
*** = p<0.001, **** = p<0.0001. Significance tested by two-way ANOVA with 





5.2.4.1 The relation between sighs and post-sigh apnoeas 
Finally, in order to understand and clearly illustrate the nature of post-sigh 
breathing behaviour, the total number of sighs was compared against the 
number of PSA in the two genotypes.  
Mild hypoxia - controls During exposures to 12% O2 (Figure 5.13 A), sighs 
were rarely followed by an apnoea in AMPK-α1/α2 Flx mice, because the 
number of sighs was significantly higher than the number of PSA at every 
time point throughout the exposure (sighs/min versus PSA/min – at 1-2min: 
2.5 ± 0.1 versus 0.2 ± 0.1, p<0.0001; at 5-6min: 1.8 ± 0.1 versus 0.3 ± 0.1, 
p<0.0001; at 9-10min: 1.5 ± 0.1 versus 0.4 ± 0.1, p<0.0001).   
Severe hypoxia - controls During 8% O2, the number of sighs remained 
significantly higher than PSA in control AMPK-α1/α2 Flx mice throughout the 
exposures (Figure 5.11 B, sighs/min versus PSA/min – at 1-2min: 6.5 ± 0.2 
versus 3.1 ± 0.3, p<0.0001; at 5-6min: 3.4 ± 0.1 versus 1.7 ± 0.2, p<0.0001; 
at 9-10min: 2.8 ± 0.2 versus 1.4 ± 0.2, p<0.0001), indicating that a large 
number of sighs still occurs without a proceeding apnoea.  
Mild hypoxia - knockouts During 12% O2, sighs were also rarely followed by 
an apnoea in TH AMPK-α1/α2 dKO mice (sighs/min versus PSA/min – at 
1-2min: 2.6 ± 0.2 versus 0.2 ± 0.1, p<0.0001; at 5-6min: 1.4 ± 0.2 versus 0.4 
± 0.1, p<0.0001; at 9-10min: 1.3 ± 0.2 versus 0.7 ± 0.2, p<0.001). 
Severe hypoxia - knockouts However, during 8% O2, sighs in TH 
AMPK-α1/α2 dKO mice were only significantly more frequent during the 
second minute of hypoxia. Thereafter, the number of sighs and PSA were 
comparable for the remainder of the exposure (sighs/min versus PSA/min – 
at 1-2min: 5.7 ± 0.3 versus 3.7 ± 0.3, p<0.0001; at 5-6min: 2.5 ± 0.2 versus 
2.1 ± 0.2, not significant; at 9-10min: 2.8 ± 0.2 versus 2.1 ± 0.2, not 
significant), suggesting that almost every sigh was coupled to a PSA.  
Effect of AMPK deletion on the frequency of sighs and PSA during mild 
hypoxia As expected, the numbers of sighs and PSA, respectively, were 
comparable between controls and TH AMPK-α1/α2 dKO mice throughout 




Effect of AMPK deletion on the frequency of sighs and PSA during severe 
hypoxia In agreement with outcomes from above, exposures to severe 
hypoxia revealed no differences in the numbers of PSA between genotypes, 
but a significant reduction in the numbers of sighs in TH AMPK-α1/α2 dKO 
mice compared to controls during the first half of 10min exposures to severe 
hypoxia (at 1-2min: p<0.05; at 5-6min: p<0.01; at 9-10min: not significant). 
Therefore, these data suggest that in AMPK-α1/α2 Flx mice, sighs occur at 
a higher rate than PSA, regardless of the hypoxic intensity. In TH 
AMPK-α1/α2 dKO mice, however, the occurrence of sighing alone appears 
to be blocked with decreasing PO2, because while a significant number of 
sighs without apnoeas was observed during mild hypoxia, almost every sigh 
was coupled to a PSA during severe hypoxia. Therefore, deletion of 
AMPK-α1 and -α2 subunits in catecholaminergic cells may alter signalling 
pathways within the brainstem respiratory network that ultimately blocks the 






Figure 5.13: During severe hypoxia, sighs are followed by apnoeas in 
mice with conditional deletion of AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells.  
Means ± SEM for the frequency of sighs and post-sigh apnoeas (PSA) 
during 10 minute exposures to (A) mild hypoxia (12% O2) and (B) severe 
hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 
12% O2: n = 55 exposures from 19 mice, 8% O2: n = 58 exposures from 25 
mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, 12% O2: n = 35 exposures from 11 mice, 8% O2: n 
= 46 exposures from 22 mice). Between genotypes: * = p<0.05, ** = p<0.01, 
*** = p<0.001, **** = p<0.0001; between sighs and PSA: ### = p<0.001, 
#### = p<0.0001. Significance tested by two-way ANOVA with Sidak 






5.3.1 Summary of findings 
Chapter 5 shows that AMPK-dependent signalling pathways within the 
central respiratory network are required not only to support ventilatory drive 
during exposures to hypoxia, but also to support ventilatory stability. In this 
respect, loss of AMPK activity within catecholaminergic cells precipitated 
irregular breathing patterns, demonstrated by large standard deviations in 
the inter-breath intervals, as well as more frequent and prolonged apnoeas. 
Interestingly, loss of AMPK activity affected the two types of apnoeas 
differently, increasing the frequency of spontaneous apnoeas (SA) on one 
hand, and the duration of post-sigh apnoeas (PSA) on the other. Moreover, 
the occurrence of sighs without apnoeas appeared to be blocked during 
acute exposures to severe, but not mild hypoxia.  
During more prolonged exposures, it appeared as though the severely 
apnoeic phenotype of TH AMPK-α1/α2 dKO observed during the initial 
phases of the response was partially compensated for by 
AMPK-independent reductions in the frequency of SA and the duration of 
PSA. Nevertheless, a clear phasic disturbance of the respiratory central 
pattern generators (rCPGs) remained apparent following AMPK deletion, 
which presented as periodic oscillations in the frequency of SA that were 
present at fairly regular intervals throughout the entire prolonged exposure 
to severe hypoxia.  
 
5.3.2 AMPK activity in brainstem catecholaminergic cells promotes 
ventilatory stability during hypoxia 
In addition to the marked reductions in respiratory drive during hypoxia 
described in Chapter 3, loss of AMPK activity in catecholaminergic cells also 
precipitated breathing irregularities associated with marked increases in the 
number and durations of apnoeas. Importantly, these were unlikely to be 
triggered by increases in catecholaminergic neurotransmission (Zanella et 




cells or the total bioamine content in TH AMPK-α1/α2 dKO mice relative to 
controls. Therefore, it appears that loss of AMPK-dependent modulation of 
the rCPGs augments ventilatory instability and the precipitation of apnoeas.  
Surprisingly, no differences in either the frequency or the duration of 
apnoeas during mild hypoxia were identified between the cohorts of controls 
and TH AMPK-α1/α2 dKO mice used here, which is in contrast to previous 
findings (Mahmoud, 2014; Mahmoud et al., 2016). However, consistent with 
those previous reports, exposures to severe hypoxia significantly 
augmented both the frequency and the duration of apnoeas. Furthermore, it 
appears that the apnoeic threshold is determined, at least in part, by PO2, 
and not solely by reductions in PCO2 as has been suggested before 
(Dempsey, 2005). This was evident because the experimental mice used 
here received a constant supply of normocapnic hypoxia (8% O2, 0.5% CO2) 
and, paradoxically, hypoventilated rather than hyperventilated, which would 
further increase central PCO2 levels. Therefore, these outcomes would be 
in agreement with other studies which have shown that the occurrence of 
periodic breathing and apnoea can be either resolved or eliminated by 
supplementation of PO2, that blunting of the HVR increases the susceptibility 
to breathing irregularities and apnoeas, and that the degree of hypocapnia 
required to trigger apnoeas can be altered by the degree of hypoxia (Lahiri 
et al., 1983; Xie et al., 2001; Adachi et al., 2006).  
Importantly, consistent with reductions in the breathing variability over time, 
control AMPK-α1/α2 Flx mice displayed a clear time-dependent reduction in 
the number of apnoeas, both of which were blocked upon AMPK deletion. It 
is currently unclear which underlying mechanism led to this reduction of the 
apnoeic index in controls over time. Perhaps AMPK-dependent pathways 
are also able to integrate and coordinate inspiratory inhibition via vagal 
afferent input during hypoxia. In that sense, deletion of AMPK could allow 
vagal afferents to temporarily inhibit ventilation in a more frequent and 
stronger manner, thereby leading to the occurrence of more frequent and 
prolonged apnoeas (Younes et al., 1974).  
In spite of a reduction in the frequency of post-sigh apnoeas in TH 




because AMPK deletion precipitated “apnoeic bursts” at regular intervals 
throughout the 60min exposure to hypoxia. These “bursts” are indicative of 
phasic disturbances of the central pattern generators during periods of 
prolonged hypoxia, which could have been affected via projections from the 
DAR to the rostral and caudal ventral respiratory groups, as well as the 
Bötzinger complex and pre Bötzinger complex (Alheid et al., 2011). Notably, 
these phasic “bursts” of increased apnoea frequency were observed in every 
experimental TH AMPK-α1/α2 dKO mouse (Appendices 3.1 to 3.3), but not 
in any of the experimental control AMPK-α1/α2 Flx mice. The fact that these 
oscillations were still apparent after averaging apnoea frequencies across 
animals highlights the high degree of synchronicity regarding the periodic 
disruptions of the central pattern generators following AMPK deletion in 
catecholaminergic cells.  
Therefore, AMPK activity in catecholaminergic cells supports ventilatory 
drive and protects against apnoea by maintaining respiratory stability during 
acute and prolonged exposures to hypoxia.  
 
5.3.3 The differential impact of AMPK deletion on the occurrence of 
spontaneous and post-sigh apnoeas 
Subdividing the two types of apnoeas into post-sigh (PSA) and spontaneous 
apnoeas (SA) revealed a differential impact of AMPK deletion, whereby it 
augmented the frequency of SA on one hand, and the duration of PSA on 
the other.  
The underlying mechanism that leads to the generation of SA has still not 
been clearly identified. Consistently across the rodent literature it seems that 
SA arise during rapid eye movement (REM) sleep, but not during non-REM 
sleep (Radulovacki et al., 1998; Carley & Radulovacki, 1999b; Radulovacki 
et al., 2001; Nakamura et al., 2003; Wang et al., 2008). However, these 
findings are in contrast to human studies, where the generation of SA 
appears to be limited to non-REM sleep and their genesis excluded during 
REM sleep (Steffen et al., 2010; Yuceege et al., 2013) unless accompanied 




(loop gain) that can trigger central apnoeas subsequent to decreases in 
PCO2 levels below the apnoeic threshold (Dempsey et al., 2010; Jouett et 
al., 2017). As mentioned earlier, however, this appears highly unlikely to be 
the case for TH AMPK-α1/α2 dKO mice, because their hypoventilatory 
phenotype would render them hypercapnic due to the reduced CO2 blow-off. 
Clearly, further investigations into the pathogenesis of SA are eagerly 
awaited, but it seems apparent from the findings presented here that 
AMPK-dependent signalling pathways in catecholaminergic cells support 
rCPGs output and protect from increases in SA during acute and more 
prolonged exposures to hypoxia. Therefore, aberrant expression and/or loss 
of AMPK signalling leads to an augmented ventilatory instability that 
presents as oscillating increases in the frequency of SA.  
Although still not fully elucidated, the genesis of sighs and PSA appears to 
be better understood. During hypoxia, an increased number of sighs is 
generated by the pre Bötzinger complex (Neubauer & Sunderram, 2004; 
Chapuis et al., 2014), which is primarily determined by hypocapnia 
subsequent to hypoxia-induced hyperventilation (Bell et al., 2009). 
Therefore, the time-dependent reduction in ventilation exhibited by control 
AMPK-α1/α2 Flx mice would have translated into gradual restoration of 
central CO2 levels, which would reduce the sigh frequency over the course 
of the 10min exposure to hypoxia. By contrast, the ventilatory response of 
TH AMPK-α1/α2 dKO mice was significantly attenuated from the beginning 
of the exposure, which could very well explain the attenuated sigh frequency 
observed relative to controls. That said, in control AMPK-α1/α2 Flx mice 
about 40-60% of sighs occurred without apnoeas, whereas almost every 
sigh in TH AMPK-α1/α2 dKO mice was coupled to a PSA. Sighing was found 
to be dependent on afferent input from vagal pulmonary C fibres that 
innervate the caudal NTS (Xu et al., 2003; Bell et al., 2009; Burke et al., 
2014; Li et al., 2016), and vagal activity has, at the same time, been 
proposed to temporarily inhibit inspiration due to activation of pulmonary 
stretch receptors during the augmented inspiration (Hering-Breuer reflex) 
(Breuer, 1868). Therefore, the question remains how AMPK-dependent 




the overall number of PSA in TH AMPK-α1/α2 dKO mice was comparable 
to controls, even though their duration was significantly prolonged at the 
beginning of the exposure to hypoxia. Therefore, vagal inhibition of 
inspiration likely occurs at a similar frequency in controls and TH 
AMPK-α1/α2 dKO mice. Moreover, both genotypes displayed a 
time-dependent reduction in the number of PSA over the course of the 60min 
exposures. Therefore, it seems likely that vagal afferent inhibition of 
post-sigh inspiration occurs independently of AMPK activity. Nevertheless, 
because the duration of PSA has been positively correlated to the strength 
of the vagal afferent input (Younes et al., 1974), it appears that 
AMPK-dependent circuit mechanisms may determine, at least temporarily, 
the susceptibility of the central respiratory network to vagal inhibition. In this 
regard, greater susceptibility conferred by AMPK deletion could explain the 
prolongation of PSA duration for TH AMPK-α1/α2 dKO mice. Apnoea-driven 
increases in PCO2 were found to re-initiate inspiration after a PSA (Younes 
et al., 1974), however it seems unlikely that AMPK deletion affected these 
pathways for two reasons: 1) as mentioned earlier, TH AMPK-α1/α2 dKO 
mice hypoventilate in response to hypoxia and therefore should exhibit 
increased PCO2 levels, and 2) the hypercapnic response of TH AMPK-α1/α2 
dKO mice is normal and hypercapnic hypoxia (8% O2, 5% CO2) rescues the 
hypoxic phenotype of these mice (Mahmoud, 2014; Mahmoud et al., 2016). 
Therefore, loss of AMPK activity most likely renders the central respiratory 
network more susceptible to inspiratory inhibition via vagal afferent input.  
Alternatively, sighs have been shown to be modulated in a state-dependent 
manner via ventral catecholaminergic C1 neurons (Burke et al., 2014; Burke 
et al., 2015) and β-adrenergic receptor stimulation within preBötC neurons 
(Viemari et al., 2013). Looking back at the phenotype of control AMPK-α1/α2 
Flx mice, a large proportion of sighs occurred on their own without preceding 
a PSA. This begs the question whether AMPK-dependent signalling 
pathways may, via adrenergic C1 neurons, determine the degree by which 
sighs trigger the Hering-Breuer reflex. In AMPK-α1/α2 Flx mice, sighs 
without apnoeas occur at a higher rate than PSA, regardless of the hypoxic 




alone appears to be blocked with decreasing PO2, because while a 
significant number of sighs without apnoeas were observed during mild 
hypoxia, almost every sigh was coupled to a PSA during severe hypoxia with 
no effect on the total number of PSA. These findings could be explained if 
sighs consisted of two types: 1) ‘weak’ sighs, possibly of a smaller amplitude 
and/or duration which do not activate stretch receptors in the lungs and 
perhaps protect from atelectasis by re-inflating collapsed alveoli (Hartland et 
al., 2014), and 2) ‘strong’ sighs of larger amplitude and/or duration which 
trigger the Hering-Breuer reflex subsequent to hyperventilation-induced 
hypocapnia. As of yet, this is the first indication of the existence of different 
types of sighs. Therefore, further experiments are critical to understand how 
AMPK-dependent signalling pathways in catecholaminergic neurons may 
impact the generation of sighs and how these are coupled to the induction 
of PSA.  
 
5.3.4 Conclusion 
In conclusion, AMPK-dependent circuit mechanisms protect against 
ventilatory instability subsequent to augmentation by hypoxia of the 
frequency of spontaneous apnoeas, and oppose prolongation of the duration 
of post-sigh apnoeas during the initial phases of the HVR. In addition, 
modulation of the respiratory network by AMPK activity appears to allow for 
the generation of sighs without apnoeas, which is blocked upon AMPK 
deletion in catecholaminergic cells. Furthermore, although there appears to 
be an AMPK-independent degree of stabilisation of ventilatory synchronicity 
over time, characterised by a reduction in apnoea frequency and duration, 
rhythmicity is still periodically lost upon AMPK deletion; which was evident 
from oscillating increases in the frequency of spontaneous apnoeas 
throughout prolonged exposures to hypoxia. Therefore, AMPK-dependent 
neural circuits are required to maintain ventilatory stability during acute and 
prolonged exposures to hypoxia in order to protect from whole-body hypoxia 






Chapter 6: Characterisation of the 
hypoxic duty cycle in 










6.1.1 Increased ventilatory drive during hypoxia is enabled through 
initiation of active expiration 
In most mammals, alterations of breathing frequency during hypoxia are 
primarily determined by changes in the inter-breath-interval (Milsom, 1991; 
Jenkin & Milsom, 2014). In mammals, this is the result of accelerated 
expiration that reduces the expiratory pause with minimal, if any, changes in 
inspiration time (Harris & Milsom, 2001; Abdala et al., 2009). Active 
expiration has several benefits: on the one hand it allows for an increased 
tidal volume by recruiting the expiratory reserve volume (Leith, 1976). On 
the other hand it creates a controllable and dynamic time constant that 
allows for a higher respiratory frequency by preventing hyperinflation of the 
lungs due to the longer time required for passive expiration (Mortola et al., 
1985).  
As already mentioned in section 1.1.2, expiratory rhythm is generated 
through excitatory inputs to respiratory motorneurons from the pFRG/RTN 
and the BötC (Smith et al., 2013), the former of which is associated with the 
production of active expiration (Feldman & Del Negro, 2006; Janczewski & 
Feldman, 2006; Pagliardini et al., 2011; Pisanski & Pagliardini, 2018). During 
quiet breathing, where expiration occurs passively, the pFRG/RTN is silent 
with respect to its neuronal firing. During the transition from quiet to active 
expiration the pFRG/RTN becomes rhythmically active and transforms into 
an additional oscillator within the ventral brainstem that modulates breathing 
via recruitment of abdominal and intercostal muscles (Pagliardini et al., 
2011; Molkov et al., 2014). Importantly, direct innervations of the RTN which 
influence the drive to breathe also arise from the catecholaminergic C1 cells 
of the ventrolateral medulla (Burke et al., 2014). In support of a role of 
catecholaminergic neurotransmission to stimulate active expiration, 
selective depletion of C1 cells was found to attenuate active expiration 
during hypoxia, but not normoxia or hypercapnia  (Malheiros-Lima et al., 




On a molecular level, the pFRG/RTN remains silent during resting conditions 
by GABAergic and glycinergic neurotransmission that has been postulated 
to originate from the medullary BötC, preBötC and NTS, as well we the KF 
and LPBr in the pons (Pagliardini et al., 2011). During metabolic demand 
and/or chemoreflex stimulation such as hypercapnia or hypoxia, the activity 
of the pFRG/RTN that generates active expiration has been suggested to 
depend on glutamatergic and serotonergic neurotransmission, because both 
of these neurotransmitters were shown to generate active expiration at rest 
and antagonists of their receptors blocked active expiration in response to 
their administration (Moraes et al., 2012b; Lemes et al., 2016; Lemes & 
Zoccal, 2016). 
 
6.1.2 AMPK deficiency in catecholaminergic cells blocks active 
expiration during hypoxia 
Previous investigations studying the effect of deleting AMPK-α1/α2 catalytic 
subunits in catecholaminergic cells on the HVR have shown that 
hypoventilation may result, in part, from a significant increase in the total 
breath time, due to prolongations in both inspiration time and expiration time. 
More importantly, the acceleration of expiration (active expiration) observed 
in control AMPK-α1/α2 Flx mice appeared to be blocked upon AMPK 
deletion, resulting in a significant increase in expiration time relative to 
normoxia and to controls (Mahmoud, 2014). 
 
6.1.3 Aims 
Following these previous outcomes on the blockage of active expiration 
during hypoxia in mice with AMPK deletion in catecholaminergic cells, I 
sought to extend these findings from 5min to 10min of exposures to mild and 
severe hypoxia in order to identify whether the augmentations of inspiration 
time and expiration time persisted, whether active expirations remained 
blocked, and how these changes impacted on the amount of air that was 






6.2.1 AMPK deletion in catecholaminergic cells prolongs breath 
duration throughout 10min exposures to hypoxia 
In order to examine the nature of the response to hypoxia in TH AMPK-α1/α2 
dKO mice compared to control AMPK-α1/α2 Flx mice in more detail, the 
inspiratory, expiratory, and total breath durations were analysed. Figures 6.1 
to 6.3 show the mean ratiometric changes (hypoxia:normoxia) for various 
ventilatory parameters of both genotypes during 10min exposures to 12% 
O2 and 8% O2, with a 2s sampling frequency. 
 
6.2.1.1 Inspiration time 
Time-dependent changes in inspiration time (Ti) were observed in both 
AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice during exposures to mild 
and severe hypoxia.  
Mild hypoxia 30s after the onset of 12% O2 (Figure 6.1 Ai), control 
AMPK-α1/α2 Flx mice (n = 37 exposures from 14 mice) responded with an 
initial reduction in Ti (0.8 ± 0.03), which returned to normoxic values after 
approximately 1min. Thereafter, Ti reached a plateau that remained stable 
not only at the 5min mark (1 ± 0.04, p<0.0001 compared to 30s) as described 
previously (Mahmoud, 2014), but right through to the end of the 10min 
exposure (0.9 ± 0.04, p<0.01 compared to 30s, not significant compared to 
5min).  
Severe hypoxia In response to 8% O2, AMPK-α1/α2 Flx mice (n = 54 
exposures from 21 mice) also displayed a reduction of inspiration time 30s 
after the onset of the exposure (Figure 6.1 Bi; 0.9 ± 0.02) which returned to 
normoxic values at around 1min. However, before reaching a plateau there 
appeared to be a secondary increase after approximately 2 minutes, which 
prolonged Ti relative to normoxia. This slower inspiration time then remained 




at 10min: 1.3 ± 0.05, p<0.0001 compared to 30s, not significant compared 
to 5min).  
Effect of AMPK deletion during mild hypoxia The overall effect of hypoxia on 
Ti in TH AMPK-α1/α2 dKO mice (n = 28 exposures from 11 mice) was very 
similar to controls. During mild hypoxia, knockouts displayed a comparable 
decrease in inspiratory duration relative to normoxia 30s following the onset 
of 12% O2 (Figure 6.1 Aii; 0.9 ± 0.03; not significant compared to controls), 
which returned to normoxic values after approximately 1min and remained 
stable at a level comparable with controls until the end of the exposure (at 
5min: 1 ± 0.04, not significant compared to controls; at 10min: 1 ± 0.04, not 
significant compared to controls).  
Effect of AMPK deletion during severe hypoxia Similar to controls, severe 
hypoxia resulted in a decrease of inspiration time in TH AMPK-α1/α2 dKO 
mice (n = 37 exposures from 15 mice) at 30s (Figure 6.1 Bii; 0.9 ± 0.03, not 
significant compared to controls), which returned to normoxic 
measurements around 1min, followed by a secondary prolongation at 
around 2min that was maintained for the duration of the exposure to hypoxia. 
It should be pointed out that the response of the TH AMPK-α1/α2 dKO mice 
fluctuated slightly from 5min onwards, at which point Ti was significantly 
longer than that of controls (1.4 ± 0.05, p<0.05 compared to controls).  
However, by 10min the duration of inspiration was once again comparable 
between the genotypes (1.4 ± 0.07, not significant compared to controls).  
Thus, TH AMPK-α1/α2 dKO mice displayed comparable changes in 
inspiration time during 12% O2 when compared to controls, but exhibited a 
significantly prolonged Ti between 5min and 10min during exposures to 
severe hypoxia. 
Overall, these data show that while both AMPK-α1/α2 Flx and TH 
AMPK-α1/α2 dKO mice responded to hypoxia with a comparable initial 
shortening of inspiration time relative to normoxia, measurements quickly 
recovered back to and remained at normoxic levels during mild hypoxia. 
During severe hypoxia, however, inspiration time was extended relative to 




duration of the exposure. This prolongation was significantly greater for 
AMPK-α1/2 dKO mice relative to controls at 5min only, returning to control 






Figure 6.1: AMPK-α1/α2 catalytic subunit deletion in catecholaminergic 
cells temporarily prolongs inspiration time during severe, but not mild 
hypoxia.  
The ratiometric changes relative to normoxia (green dotted line) of 
inspiration time during 10min exposures to (A) mild hypoxia (12% O2) and 
(B) severe hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 
Flx, black, 12% O2: n = 37 exposures from 14 mice, 8% O2: n = 54 exposures 
from 21 mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, 12% O2: n = 28 exposures from 11 mice, 8% O2: 8% 
O2: n = 37 exposures from 15 mice) are shown as means ± SEM (i) over 
time as 2s averages and (ii) at three selected time points to clearly illustrate 
differences between genotypes. ns = not significant, * = p<0.05, ** = p<0.01, 
**** = p<0.0001. Significance tested by two-way ANOVA with Sidak post-hoc 




6.2.1.2 Expiration time 
Similar to Ti, AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO mice exhibited 
time-dependent changes in expiration time (Te). 
Mild hypoxia At the onset of 12% O2 Te was markedly shortened in control 
AMPK-α1/α2 Flx mice (Figure 6.2 Ai; at 30s: 0.4 ± 0.02). This shortening 
was followed by a gradual increase in expiration time until approximately 
1-2min, after which Te plateaued. In contrast to Ti, however, Te remained 
shortened relative to normoxia, measuring 0.6 ± 0.02 after 5min (p<0.0001 
compared to 30s), and 0.6 ± 0.03 after 10min (p<0.0001 compared to 30s, 
not significant compared to 5min).  
Severe hypoxia During 8% O2 exposures Te also displayed a marked 
reduction 30s after the onset of hypoxia (Figure 6.2 Bi; 0.5 ± 0.02). 
Thereafter, a lengthening of Te occurred until approximately 2min followed 
by a secondary minor decrease and plateau, measuring 0.8 ± 0.02 by 5min 
(p<0.0001 compared to 30s) and 0.8 ± 0.03 by 10min (p<0.0001 compared 
to 30s, not significant compared to 5min). 
Effect of AMPK deletion during mild hypoxia The expiration time in TH 
AMPK-α1/α2 dKO mice also shortened initially, peaking at 30s after the 
onset of mild hypoxia, but failed to accelerate to the level that was observed 
in controls, resulting in a significantly longer Te at this time point (Figure 6.2 
Ai; 0.5 ± 0.02, p<0.01 compared to controls). As with controls, Te then 
lengthened slightly until approximately 2min, where it plateaued at a level 
that remained faster relative to normoxia. However, expiration in TH 
AMPK-α1/α2 dKO mice remained significantly prolonged when compared to 
control mice (at 5min: 0.7 ± 0.03, p<0.05 compared to controls; at 10min: 
0.7 ± 0.03, p<0.05 compared to controls).  
Effect of AMPK deletion during severe hypoxia A reduction of Te in response 
to 8% O2 was also observed in TH AMPK-α1/α2 dKO mice, measuring 0.7 
± 0.03 at 30s following the onset of hypoxia. However, as with mild hypoxia, 
the degree of acceleration was significantly lower than observed for controls 
(Figure 6.2 Bii; p<0.05). Following the nadir at 30s, Te of TH AMPK-α1/α2 




prolongation of expiration time plateaued close to normoxic values. This 
means that TH AMPK-α1/α2 dKO mice failed to maintain an accelerated 
expiration time and instead returned to and remained at Te values measured 
during normoxia, which were significantly lengthened compared to controls 
at 5min (1.1 ± 0.04; p<0.0001) and 10min (1 ± 0.04; p<0.001).  
Therefore, during mild and severe hypoxia both AMPK-α1/α2 Flx and TH 
AMPK-α1/α2 dKO mice exhibited an initial shortening of expiration time 
relative to normoxia, which slightly lengthened but generally remained below 
normoxic values throughout the duration of the exposures. Importantly, Te 
was significantly prolonged in TH AMPK-α1/α2 dKO mice and reached 
normoxic values during severe hypoxia.  
Thus, deletion of AMPK-α1 and -α2 subunits in catecholaminergic cells 







Figure 6.2: AMPK-α1/α2 catalytic subunit deletion in catecholaminergic 
cells prolongs expiration time and blocks active expiration during 
hypoxia.  
The ratiometric changes relative to normoxia (green dotted line) of expiration 
time during 10min exposures to (A) mild hypoxia (12% O2) and (B) severe 
hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 
12% O2: n = 37 exposures from 14 mice, 8% O2: n = 54 exposures from 21 
mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, 12% O2: n = 28 exposures from 11 mice, 8% O2: 8% 
O2: n = 37 exposures from 15 mice) are shown as means ± SEM SEM (i) 
over time as 2s averages and (ii) at three selected time points to clearly 
illustrate differences between genotypes. ns = not significant, * = p<0.05, ** 
= p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested by two-way 




6.2.1.3 Total breath time 
Mild hypoxia As one might expect, given the outcomes for Ti and Te, total 
breath time (To) of control AMPK-α1/α2 Flx mice was shortened relative to 
normoxia at the onset of mild hypoxia (Figure 6.3 Ai; 0.5 ± 0.02), before 
lengthening slightly and plateauing after approximately 2min. Predominantly 
driven by time-dependent reductions in Te, total breath time during mild 
hypoxia remained accelerated compared to normoxia and measured 0.7 ± 
0.02 by 5min (p<0.0001 compared to 30s) and 0.7 ± 0.03 by 10min 
(p<0.0001 compared to 30s; not significant compared to 5min).  
Severe hypoxia During severe hypoxia, total breath time was markedly 
reduced 30s following the onset of hypoxia (Figure 6.3 Bi; 0.6 ± 0.02), after 
which it increased slightly and plateaued below normoxic values, measuring 
0.9 ± 0.02 by 5min (p<0.0001 compared to 30s) and 0.9 ± 0.02 at 10min 
(p<0.0001 compared to 30s; not significant compared to 5min). 
Effect of AMPK deletion during mild hypoxia Similar to measurements 
obtained for Te, reductions in To during 12% O2 were attenuated in TH 
AMPK-α1/α2 dKO mice. Initially To fell to 0.6 ± 0.02 after 30s hypoxia, which 
once again was significantly less rapid when compared to controls (Figure 
6.3 Aii; p<0.01). Thereafter, the time-dependent prolongation and plateau of 
To was comparable to controls by 5min (0.8 ± 0.03; not significant), but this 
was not maintained until the end of the 10 min exposure, at which point To 
was significantly prolonged once more (10min: 0.8 ± 0.02; p<0.01 compared 
to controls). 
Effect of AMPK deletion during severe hypoxia During severe hypoxia, To 
initially fell to 0.7 ± 0.03 at 30s, but the prolongation of Ti and, more 
importantly, the attenuation of active expiration (Te acceleration) resulted in 
a To that plateaued slightly above normoxic values (at 5min: 1.1 ± 0.03; at 
10min: 1.1 ± 0.04). Importantly, and perhaps not surprising given the 
outcomes for Ti and Te described above, the total breath time of TH 
AMPK-α1/α2 dKO mice was significantly augmented compared to controls 
from the beginning of the exposure (Figure 6.3 Bii; at 30s: p<0.05) right 




Taken together, these data suggest that initiation of active expiration during 
hypoxia (Moraes et al., 2012a) is the main driver of the reduced breath time 
observed in control AMPK-α1/α2 Flx mice that allows for increases in 
breathing frequency. This aspect of the HVR appears to be blocked upon 
conditional deletion of AMPK-α1 and -α2 subunits in catecholaminergic 
cells, leading to an overall increase in total breath time and a subsequent 





Figure 6.3: AMPK-α1/α2 catalytic subunit deletion in catecholaminergic 
cells prolongs total breath time during hypoxia.  
The ratiometric changes relative to normoxia (green dotted line) of total 
breath time during 10min exposures to (A) mild hypoxia (12% O2) and (B) 
severe hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, 
black, 12% O2: n = 37 exposures from 14 mice, 8% O2: n = 54 exposures 
from 21 mice) and TH-driven AMPK-α1 and -α2 double knockout mice (TH 
AMPK-α1/α2 dKO, red, 12% O2: n = 28 exposures from 11 mice, 8% O2: 8% 
O2: n = 37 exposures from 15 mice) are shown as means ± SEM SEM (i) 
over time as 2s averages and (ii) at three selected time points to clearly 
illustrate differences between genotypes. ns = not significant, * = p<0.05, ** 
= p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested by two-way 




6.2.2 AMPK deletion in catecholaminergic cells attenuates the ratio of 
tidal volume to the duration of inspiration and expiration 
throughout 10min exposures to hypoxia 
In the sections above it became apparent that TH AMPK-α1/α2 dKO mice 
displayed both a reduction in tidal volume during severe hypoxia (see 
Chapter 3.2.1.2) and an increase in inspiratory and expiratory duration. In 
order to further investigate which phase(s) of the breath cycle might 
predominantly result in the attenuation of air movement, the ratios of tidal 
volume and inspiration time (Tv/Ti), expiration time (Tv/Te), and total breath 
time (Tv/To) were analysed in relation to normoxia.  
 
6.2.2.1 Tv/Ti 
As with the durations of inspiration and expiration, similar time-dependent 
changes in the Tv/Ti ratio were observed in both AMPK-α1/α2 Flx and TH 
AMPK-α1/α2 dKO mice during exposures to mild and severe hypoxia.  
Mild hypoxia 30s after the onset of 12% O2 (Figure 6.4 Ai), control 
AMPK-α1/α2 Flx mice responded with an increase in Tv/Ti from normoxia 
(1.3 ± 0.05) that slowly declined for approximately 1-2min. Thereafter, Tv/Ti 
reached a plateau slightly above normoxia that was stable not only until the 
5min mark (1.1 ± 0.05, p<0.0001 compared to 30s) (Mahmoud, 2014), but 
until the end of the exposure at 10min (1.2 ± 0.05, p<0.01 compared to 30s, 
not significant compared to 5min).  
Severe hypoxia An initial increase in Tv/Ti was also observed at 30s 
following the onset of 8% O2 (Figure 6.4 Bi; 1.2 ± 0.04), which was followed 
by a decline for approximately 2min before reaching a plateau below 
normoxic values at ≈3min. From then on, Tv/Ti remained stable until the 
5min mark (0.8 ± 0.03, p<0.0001 compared to 30s) and until the end of the 
exposure at 10min (0.8 ± 0.03, p<0.0001 compared to 30s, not significant 
compared to 5min). 
Effect of AMPK deletion during mild hypoxia For TH AMPK-α1/α2 dKO mice, 




(Figure 6.4 Aii; 1.2 ± 0.05, not significant compared to controls) before slowly 
declining. As with controls, Tv/Ti reached a plateau that was not only stable 
until the 5min mark (1 ± 0.05, not significant compared to controls), but until 
the end of the exposure at 10min (0.9 ± 0.04). However, even though both 
genotypes displayed a comparable response after 30s and 5min of 12% O2, 
TH AMPK-α1/α2 dKO mice had an attenuated Tv/Ti relative to controls by 
the end of the exposure at 10min that reached significance (p<0.05 
compared to controls).  
Effect of AMPK deletion during severe hypoxia 30s following the onset of 
severe hypoxia Tv/Ti was also initially increased in TH AMPK-α1/α2 dKO 
mice to a level that was comparable to controls (Figure 6.4 Bii; 1.1 ± 0.03, 
not significant). Unlike controls however, Tv/Ti during 8% O2 did not reach a 
plateau and continued to decline until the 5min mark (0.6 ± 0.02), after which 
values remained stable until the end of the 10min exposure (0.6 ± 0.03). The 
comparable level of ventilation observed at 30s could not be maintained over 
time and due to the delayed plateau, the remainder of the response was 
significantly attenuated when compared to AMPK-α1/α2 Flx mice (at 5min: 
p<0.0001; at 10min: p<0.0001).  
This suggests that while both AMPK-α1/α2 Flx and TH AMPK-α1/α2 dKO 
mice responded to hypoxia with a comparable initial increases of the amount 
of air moved during inspiration relative to normoxia, AMPK-α1/α2 dKO mice 
were not able to maintain a level of ventilation that is comparable to controls 
until the end of 10min exposures, resulting in less volume being moved per 






Figure 6.4: AMPK-α1/α2 catalytic subunit deletion in catecholaminergic 
cells reduces tidal volume over inspiration time during hypoxia in a 
time- and PO2-dependent manner.  
The ratiometric changes relative to normoxia (green dotted line) of tidal 
volume over inspiration time during 10min exposures to (A) mild hypoxia 
(12% O2) and (B) severe hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice 
(AMPK-α1/α2 Flx, black, 12% O2: n = 37 exposures from 14 mice, 8% O2: n 
= 54 exposures from 21 mice) and TH-driven AMPK-α1 and -α2 double 
knockout mice (TH AMPK-α1/α2 dKO, red, 12% O2: n = 28 exposures from 
11 mice, 8% O2: 8% O2: n = 37 exposures from 15 mice) are shown as 
means ± SEM (i) over time as 2s averages and (ii) at three selected time 
points to clearly illustrate differences between genotypes. ns = not 
significant,  * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. 





Similar to Tv/Ti described above, Tv/Te in AMPK-α1/α2 Flx and TH 
AMPK-α1/α2 dKO mice was highest at the onset of mild and severe hypoxia 
(Figure 6.5 Ai and Bi, respectively), followed by a time-dependent decrease 
and plateau until the end of the exposures.  
Mild hypoxia During exposures to 12% O2, Tv/Te of control AMPK-α1/α2 Flx 
mice was robustly increased to 2.5 ± 0.1 at 30s. Following a decline that 
lasted for approximately 2min, Tv/Te remained stably augmented relative to 
normoxia by 5min (1.7 ± 0.06; p<0.0001 compared to 30s), and 10min (1.8 
± 0.09; p<0.0001 compared to 30s, not significant compared to 5min).  
Severe hypoxia A robust increase in Tv/Te relative to normoxia was also 
evident during exposures to severe hypoxia, where measurements for 
control mice were 2.2 ± 0.08 at 30s, which then decreased to a nadir around 
2min before slightly increasing again and levelling at 1.4 ± 0.04 by 5min 
(p<0.0001 compared to 30s) and 1.2 ± 0.04 at 10min (p<0.0001 compared 
to 30s, not significant compared to 5min). 
Effect of AMPK deletion during mild hypoxia Similar to controls, Tv/Te of TH 
AMPK-α1/α2 dKO mice was highest 30s after the onset of mild hypoxia (1.9 
± 0.06). Unlike Tv/Ti however, the degree to which the movement of each 
volume of air was initially accelerated during expiration in TH AMPK-α1/α2 
dKO mice was significantly reduced when compared to AMPK-α1/α2 Flx 
mice (Figure 6.5 Aii; p<0.0001). This significantly attenuated Tv/Te relative 
to controls was retained throughout the exposure, measuring 1.3 ± 0.05 after 
5min (p<0.05) and 1.3 ± 0.06 after 10min (p<0.01).  
Effect of AMPK deletion during severe hypoxia As for mild hypoxia, the peak 
at 30s after the onset of severe hypoxia was significantly attenuated in TH 
AMPK-α1/α2 dKO mice compared to controls, measuring only 1.6 ± 0.09 
(Figure 6.5 Bii; p<0.0001). Thereafter, Tv/Te of TH AMPK-α1/α2 dKO mice 
quickly dropped for 2min and, unlike controls, plateaued below baseline 
values. Notably, the reduction of Tv/Te was more severe than for control 




expiration relative to normoxia by 5min (0.8 ± 0.04, p<0.0001 compared to 
controls) and 10min (0.9 ± 0.03, p<0.001 compared to controls).  
Therefore, during mild and severe hypoxia both AMPK-α1/α2 Flx and TH 
AMPK-α1/α2 dKO mice exhibited an initial increase in the volume 
transferred per unit time during expiration relative to normoxia, which then 
decreased but generally remained accelerated relative to normoxia 
throughout the duration of the exposure. Crucially, TH AMPK-α1/α2 dKO 
mice were unable to reach full capacity of air movement during expiration 
compared to controls and failed to maintain an elevated Tv/Te relative to 
normoxia during 8% O2.  
Thus, in catecholaminergic cells AMPK supports active acceleration of air 






Figure 6.5: AMPK-α1/α2 catalytic subunit deletion in catecholaminergic 
cells reduces tidal volume over expiration time during hypoxia.  
The ratiometric changes relative to normoxia (green dotted line) of tidal 
volume over expiration time during 10min exposures to (A) mild hypoxia 
(12% O2) and (B) severe hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice 
(AMPK-α1/α2 Flx, black, 12% O2: n = 37 exposures from 14 mice, 8% O2: n 
= 54 exposures from 21 mice) and TH-driven AMPK-α1 and -α2 double 
knockout mice (TH AMPK-α1/α2 dKO, red, 12% O2: n = 28 exposures from 
11 mice, 8% O2: 8% O2: n = 37 exposures from 15 mice) are shown as 
means ± SEM (i) over time as 2s averages and (ii) at three selected time 
points to clearly illustrate differences between genotypes. ns = not 
significant,  * = p<0.05, ** = p<0.01, **** = p<0.0001. Significance tested by 





As one might expect, given the outcomes for Tv/Ti and Tv/Te, the volume 
moved per total breath time (Tv/To) was highest at the onset of mild and 
severe hypoxia (Figure 6.6 Ai and Bi, respectively), and decreased to a 
plateau thereafter. 
Mild hypoxia For control AMPK-α1/α2 Flx mice the peak of Tv/To after 30s 
of 12% O2 measured 2.1 ± 0.09. Following this, Tv/To decreased and 
reached a plateau around 2min. Driven by increases in Tv/Te relative to 
normoxia, Tv/To remained above normoxic values by 5min (1.5 ± 0.05, 
p<0.0001 compared to 30s) and 10min (1.6 ± 0.07, p<0.0001 compared to 
30s, not significant compared to 5min).  
Severe hypoxia During 8% O2, Tv/To in control AMPK-α1/α2 Flx mice was 
increased to 1.8 ± 0.06 by 30s, followed by a decrease until the 2min mark. 
Thereafter it plateaued at a level just above normoxia for the remainder of 
the exposure (at 5 min: 1.2 ± 0.03, p<0.0001 compared to 30s; at 10min: 1.1 
± 0.03, p<0.0001 compared to 30s, not significant compared to 5min).  
Effect of AMPK deletion during mild hypoxia Similar to controls, Tv/To was 
highest in TH AMPK-α1/α2 dKO mice 30s after the onset of mild hypoxia 
(1.6 ± 0.04), after which Tv/To also decreased, plateaued around 2min and 
remained stable for the remainder of the exposure. However, the significant 
attenuation observed for Tv/Te at 30s also translated into a significantly 
lower Tv/To compared to controls (Figure 6.6 Aii; p<0.0001). Although TH 
AMPK-α1/α2 dKO mice were able to increase their Tv/Te relative to 
normoxia, the response remained significantly reduced compared to 
controls, measuring 1.2 ± 0.04 by 5min (p<0.05) and 1.2 ± 0.05 by 10min 
(p<0.001).  
Effect of AMPK deletion during severe hypoxia Once again, Tv/To in TH 
AMPK-α1/α2 dKO mice initially rose relative to normoxia during exposures 
to 8% O2, measuring 1.5 ± 0.06 at 30s and then declined below normoxic 
values where a plateau was quickly reached. The fact that TH AMPK-α1/α2 
dKO blocked acceleration of air movement through active expiration during 




unit time (Figure 6.6 Bii; p<0.0001 compared to controls). Additionally, the 
significant attenuations of Tv/Ti (and Tv/Te) relative to controls meant that 
overall TH AMPK-α1/α2 dKO mice shifted significantly less volume of air 
during each breath throughout the exposures, reaching values of only 0.7 ± 
0.03 by 5min (p<0.0001 compared to controls) and 0.8 ± 0.03 by 10min 
(p<0.0001 compared to controls).  
Taken together, these data suggest that less air is moved per unit time 
during every phase of the breath cycle upon deletion of AMPK-α1 and -α2 
subunits in catecholaminergic cells. This indicates that these knockout mice 
do not only breathe slower due to blocked active expiration, but also that 





Figure 6.6: AMPK-α1/α2 catalytic subunit deletion in catecholaminergic 
cells reduces tidal volume over total breath time during hypoxia.  
The ratiometric changes relative to normoxia (green dotted line) of tidal 
volume over total breath time during 10min exposures to (A) mild hypoxia 
(12% O2) and (B) severe hypoxia (8% O2) in AMPK-α1 and -α2 floxed mice 
(AMPK-α1/α2 Flx, black, 12% O2: n = 37 exposures from 14 mice, 8% O2: n 
= 54 exposures from 21 mice) and TH-driven AMPK-α1 and -α2 double 
knockout mice (TH AMPK-α1/α2 dKO, red, 12% O2: n = 28 exposures from 
11 mice, 8% O2: 8% O2: n = 37 exposures from 15 mice) are shown as 
means ± SEM (i) over time as 2s averages and (ii) at three selected time 
points to clearly illustrate differences between genotypes. ns = not 
significant,  * = p<0.05, *** = p<0.001, **** = p<0.0001. Significance tested 







6.3.1 Summary of findings 
Chapter 6 shows that the loss of both AMPK-α1 and -α2 catalytic subunits 
in catecholaminergic cells attenuates the ventilatory response to hypoxia by 
blocking acceleration of expiration time (i.e. active expiration), and reduces 
the overall volume of air that is moved during each breath, thus resulting in 
shallow breathing with an overall reduction of breathing frequency and tidal 
volume. Therefore, AMPK activity in catecholaminergic cells governs the 
maintenance of whole-body O2 supply throughout periods of acute mild and 
severe hypoxia by continuously supporting appropriate ventilatory changes 
that are aimed to restore blood PO2 levels. 
 
6.3.2 The engagement of active expiration and acceleration of air 
movement during inspiration and expiration require AMPK 
activity in catecholaminergic cells 
The attenuation of the HVR in TH AMPK-α1/α2 dKO mice described in 
Chapter 3 was mainly precipitated by significant PO2-dependent attenuation 
of increases in breathing frequency and tidal volume. The findings in this 
chapter illustrate that such attenuation was elicited by a significant 
prolongation, relative to controls, of total breath time (To), which occurred 
due to significant increases in expiration time (Te) with minimal differences 
in inspiration time (Ti). This suggests that following the Augmenting phase 
of the HVR, the respiratory central pattern generators (rCPGs) in the 
ventrolateral medulla were unable to appropriately modulate the expiratory 
phase of respiration in the manner required to promote an overall increase 
in ventilation in response to hypoxia. Important in this context, modulation of 
the rCPGs via the RTN has been suggested to depend on glutamatergic and 
serotonergic neurotransmission (Moraes et al., 2012a; Lemes et al., 2016; 
Lemes & Zoccal, 2016), and catecholaminergic neurons were shown to use 
glutamate as a neurotransmitter (Fung et al., 1994a; Fung et al., 1994b; 




selective inhibition of C1 cells was found to attenuate active expiration during 
hypoxia, but not during normoxia or hypercapnia (Malheiros-Lima et al., 
2017), which is entirely consistent with the retained hypercapnic response 
of Ti, Te and To in TH AMPK-α1/α2 dKO mice (Mahmoud, 2014).  
Therefore, AMPK-dependent afferent inputs from catecholaminergic cells – 
which likely encompass the ventrolateral C1 cell group but may also arise 
from the dorsolateral A2/C2 cell groups – appear to act on the rCPG via the 
RTN in order to engage active expiration, thus reducing the total breath time 
to accommodate increases in ventilatory frequency (Moraes et al., 2012a; 
Burke et al., 2014; Malheiros-Lima et al., 2015; Pisanski & Pagliardini, 2018).  
Additionally, loss of AMPK activity resulted in a reduction of tidal volume 
during hypoxia, which was the result of marked attenuation of the amount of 
air that was moved during every phase of the breath cycle. This indicates 
that mice with conditional deletion of the AMPK-α1 and -α2 subunits in 
catecholaminergic cells do not only breathe slower, but also that each breath 
is shallower. Therefore, AMPK-dependent signalling pathways appear to 
also be required to increase tidal volume by active expiration via recruitment 
of the expiratory reserve volume (Leith, 1976).  
 
6.3.3 Conclusion 
In conclusion, active expiration during the HVR is supported by 
AMPK-dependent signalling pathways in catecholaminergic cells. 
Therefore, AMPK activity leads to an overall decrease in the total breath time 
and increases of air movement. Thus, AMPK activity in catecholaminergic 
cells prompts increases in respiratory frequency and tidal volume in an 
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The majority of the data presented in this Chapter have been published: 
MacMillan S & Evans AM. (2018). AMPK-alpha1 or AMPK-alpha2 Deletion 
in Smooth Muscles Does Not Affect the Hypoxic Ventilatory 
Response or Systemic Arterial Blood Pressure Regulation During 





As described previously, it was demonstrated that the role of AMPK in 
metabolic homeostasis is not limited to cell autonomous pathways of energy 
supply (Ross et al., 2011), but extends to the HVR (Teppema & Dahan, 
2010; Mahmoud et al., 2016; Wilson & Teppema, 2016) and thus O2 and 
energy (ATP) supply to the body as a whole. In doing so AMPK acts to 
oppose central respiratory depression during hypoxia and thus resists 
hypoventilation and apnoea. 
However, the HVR could well be affected by AMPK deficiency in cell 
systems other than catecholaminergic neurons due to off-target AMPK 
deletion through “leakage” of Cre beyond those cells targeted by the 
conditional deletion strategy that was employed. This possibility is 
highlighted by the fact that transient developmental expression of TH occurs 
in disparate cell groups that do not express TH in the adult (Lindeberg et al., 
2004), including, for example, a subset of heart wall cells. Therefore, there 
remains the possibility that AMPK deficiency might somehow affect 
ventilatory control mechanisms through myogenic rather than neurogenic 
mechanisms.  This is evident from the fact that systemic arteries dilate in 
response to tissue hypoxemia in order to match local perfusion to local 
metabolism (Roy & Sherrington, 1890), and evidence suggests a role for 
AMPK in this response (Goirand et al., 2007; Schneider et al., 2015). With 
“leakage” of Cre, off-target deletion of AMPK in arterial myocytes could 
attenuate arterial dilation and thus impact O2 supply to the brain during 
hypoxia and the HVR. Moreover, the sympathetic outflow that regulates 
these cardiovascular responses to hypoxia is determined by neuronal 
activity within the catecholaminergic cells that were targeted by our 
TH-driven AMPK deletion (King et al., 2012; Guyenet et al., 2013; King et 
al., 2013; Burke et al., 2014; King et al., 2015) and shown to project to the 
dorsal motor nucleus of the vagus (10N), which was proposed to contribute 
to the bradycardia and mild hypertension associated with the diving reflex 
(Panneton et al., 2014) and displayed a significant reduction of cFos 
expression in response to hypoxia described in Chapter 4. Therefore, AMPK 




A further implication for off-target AMPK deficiency in cardiac myocytes 
induced by TH-Cre lies in the fact that AMPK expression in the heart has a 
protective role in the development of cardiac hypertrophy and delays the 
onset and severity of cardiac contracture during ischaemia. This in turn will 
impact on heart rate, systolic and diastolic functions and hence blood and 
O2 supply to vital organs such as the brain (Zarrinpashneh et al., 2006; 
Carvajal et al., 2007; Zarrinpashneh et al., 2008; Sung et al., 2015).  
  
7.1.1 Aims 
In order to determine whether AMPK contributes to the HVR and blood 
pressure control during severe hypoxia (8% O2) through neurogenic and/or 
myogenic mechanisms, the impact of AMPK deficiency in smooth muscles 
and catecholaminergic cells was assessed in relation to the HVR and blood 






7.2.1 AMPK deletion in smooth muscle cells does not attenuate the 
hypoxic ventilatory response 
Mice with conditional deletion of AMPK-α1 or AMPK-α2 subunits in smooth 
muscle cells (SM AMPK-α1 KO or SM AMPK-α2 KO) exhibited no obvious 
phenotype and no ventilatory dysfunction or deficiency was evident during 
normoxia (see Appendix 5.1). Most significantly in the context of the present 
investigation, no significant attenuation of the HVR relative to controls 
(AMPK-α1/α2 Flx) was identified during exposures to severe hypoxia (8% 
O2). That said, subtle differences were observed between genotypes.  
Breathing frequency Figure 7.1 A shows that both SM AMPK-α1 KO (n = 16 
exposures from 4 mice) and SM AMPK-α2 KO mice (n = 16 exposures from 
4 mice) produced increases in breathing frequency during the Augmenting 
phase (A) of the HVR that were comparable to control AMPK-α1/α2 Flx mice 
(SM AMPK-α1 KO: 61.7 ± 4%; SM AMPK-α2 KO: 68.3 ± 4.6% ; AMPK-α1/α2 
Flx: 60.8 ± 6.6%, n = 45 exposures from 12 mice). However, for SM 
AMPK-α1 KO mice alone there appeared to be an insignificant yet 
noticeable lowering, relative to controls, of breathing frequency during 
“Roll-Off” (RO; -13 ± 4.1% and 10.7 ± 4.3%, respectively) that was 
maintained for the duration of the Sustained Phase (SP; -2.2 ± 7.2% and 
11.7 ± 3.9%, respectively) of the HVR. This attenuation was not observed in 
SM AMPK-α2 KO mice which retained breathing frequencies above those 
measured during hypoxia at a level that was comparable to controls (RO: 
7.5 ± 5.6%; SP: 20 ± 4.2%).  
Tidal volume By contrast, in both SM AMPK-α1 KO and SM AMPK-α2 KO 
mice larger increases in tidal volume were observed relative to controls 
(Figure 7.1 B), which were comparable across all three genotypes during 
the Augmenting phase (AMPK-α1/α2 Flx: -3.2 ± 2.3%; SM AMPK-α1 KO: 
11.6 ± 1.4%; SM AMPK-α2 KO: 10.3 ± 2.2%), but reached significance for 
SM AMPK-α1 KO mice relative to controls at the peak of “Roll-Off” 




AMPK-α2 KO: 10.3 ± 2.2%, not significant). This significance was lost again 
during the sustained phase, where tidal volume responses were comparable 
across the three genotypes tested (AMPK-α1/α2 Flx: -2.1 ± 9%; SM 
AMPK-α1 KO: 21.5 ± 5.3%; SM AMPK-α2 KO: 11.4 ± 1.2%).  
Minute ventilation Increases in minute ventilation during hypoxia also 
showed a tendency to be greater for SM AMPK-α1 KO and SM AMPK-α2 
KO mice than for control AMPK-α1/α2 Flx mice. However, this only reached 
significance during the initial Augmenting Phase of the HVR (Figure 7.1 C; 
AMPK-α1/α2 Flx: 53.2 ± 5.9%; SM AMPK-α1 KO: 79.1 ± 6.6%; SM AMPK-α2 
KO: 84.3 ± 7.3%, p<0.05 compared to controls), which primarily results from 
increases in carotid body afferent input responses (Day & Wilson, 2007; 
Teppema & Dahan, 2010; Wilson & Teppema, 2016). Thereafter, minute 
ventilation was comparable across the three genotypes both at the peak of 
“Roll-Off” (AMPK-α1/α2 Flx: 8.5 ± 5.6%; SM AMPK-α1 KO: -0.5 ± 3.6%; SM 
AMPK-α2 KO: 19.3 ± 5.8%) and during the Sustained Phase (AMPK-α1/α2 
Flx: 7.8 ± 5.1%; SM AMPK-α1 KO: 15.9 ± 5.4%; SM AMPK-α2 KO: 32.6 ± 





Figure 7.1: The hypoxic ventilatory response is not attenuated by 
conditional deletion of AMPK-α1 or AMPK-α2 catalytic subunits in 
smooth muscle cells. 
Bar charts show mean ± SEM for changes in (A) respiratory frequency, (B) 
tidal volume, and (C) minute ventilation for AMPK-α1/α2 floxed mice (Flx; 
black, n = 45 exposures from 12 mice), and for mice with AMPK-α1 (orange; 
n = 16 exposures from 4 mice) and AMPK-α2 (green; n = 16 exposures from 
4 mice) deletion in smooth muscles (transgelin expressing cells) during the 
peak of the Augmenting phase (A), after approximately 100s of Roll Off (RO) 
and the plateau of the Sustained Phase (SP) of the response to severe 
hypoxia (8% O2). * = p<0.05. Significance tested by two-way ANOVA with 





7.2.2 AMPK deletion in smooth muscle cells has no effect on the 
apnoeic phenotype during severe hypoxia 
Perhaps most striking was the fact that deletion of neither AMPK-α1 nor 
AMPK-α2 catalytic subunits in smooth muscle cells had any discernible 
effect on hypoxia-evoked apnoeas (Figure 7.2), when compared to controls 
(AMPK-α1/α2 Flx). This was evident from the fact that there were no 
difference in either the apnoea frequency (Figure 7.2 A; AMPK-α1/α2 Flx: 
3.1 ± 0.5 apnoeas/min; SM AMPK-α1 KO: 3.4 ± 0.6 apnoeas/min; SM 
AMPK-α2 KO: 2.4 ± 0.8 apnoeas/min), duration (Figure 7.2 B; AMPK-α1/α2 
Flx: -928.9 ± 38.5ms; SM AMPK-α1 KO: 1021 ± 64.6ms; SM AMPK-α2 KO: 
863.9 ± 92.4ms) or apnoea duration index (Figure 7.2 C; AMPK-α1/α2 Flx: 
2.9 ± 0.4; SM AMPK-α1 KO: 3.4 ± 0.6; SM AMPK-α2 KO: 2.3 ± 0.9) in mice 
lacking the AMPK-α1 or AMPK-α2 subunits in smooth muscle cells. 
The aforementioned findings are therefore in complete contrast to previous 
observations on mice with AMPK-α1 deletion in catecholaminergic neurons 
(driven by TH-Cre), which exhibited marked attenuation of the HVR and 
pronounced increases in apnoea frequency, duration and apnoea duration 





Figure 7.2: Deletion of AMPK-α1 or AMPK-α2 catalytic subunits in 
smooth muscle cells does not affect apnoea frequency or duration 
during hypoxia.  
Bar charts show mean ± SEM for the (A) apnoeic index (per minute), (B) 
apnoea duration (ms), and (C) apnoea duration index (frequency x duration) 
of AMPK-α1/α2 floxed mice (Flx; black, n = 45 exposures from 12 mice), and 
for mice with AMPK-α1 (orange; n = 16 exposures from 4 mice) and 
AMPK-α2 (green; n = 16 exposures from 4 mice) deletion in smooth muscles 
(transgelin expressing cells). Significance tested by  t-tests between 





7.2.3 Cardiovascular responses to hypoxia remain unaltered 
following deletion of AMPK-α1 and AMPK-α2 in smooth muscle 
or catecholaminergic cells 
Next, the effect of AMPK deficiency on cardiovascular function was 
assessed during severe hypoxia by monitoring changes in systemic blood 
pressure. Deleting either AMPK-α1 KO or SM AMPK-α2 KO subunits in 
smooth muscle (SM) cells or both AMPK-α1/α2 subunits in 
catecholaminergic (TH) cells had little or no effect on resting blood pressure 
(Fig 7.3 A, Table 7.1). Furthermore, neither smooth muscle AMPK-α1 
nor -α2 deficiency affected hypoxia-evoked falls in systemic blood pressure 
in mice (Fig 7.3 B and C), which were comparable to the range of responses 
reported previously (Mahmoud et al., 2016). By contrast, hypoxia-evoked 
falls in blood pressure appeared to be significantly larger in TH AMPK-α1/α2 
dKO mice than for control AMPK-α1/α2 Flx mice (mean: p<0.01; systolic: 
p<0.05; diastolic: p<0.05). This could, however, be caused by the higher 
pre-hypoxic blood pressures of TH AMPK-α1/α2 dKO mice measured during 
normoxia on the experimental days. In fact, all measures of systemic blood 
pressure responses during 8% O2 were comparable between controls and 
TH AMPK-α1/α2 dKO mice (Figure 7.3 B), showing that dual AMPK-α1/α2 
deletion in TH-positive cells did not lead to hypoxic hyper- or hypotension 
that could explain the hypoventilatory phenotype observed in Chapter 3. 
Additional analyses of heart rates during hypoxia showed no differences 
between any of the genotypes tested (Figure 7.4). That said, the heart rate 
of SM AMPK-α1 KO mice was significantly lower compared to controls both 
during normoxia (controls: 702 ± 16 beats/min; SM AMPK-α1 KO: 628 ± 24 
beats/min, p>0.05) and 8% O2 (controls: 718 ± 21 beats/min; SM AMPK-α1 
KO: 638 ± 37 beats/min, p>0.05). However, this was most likely be due to 
the small sample size, as measurements of 2 out of 3 SM AMPK-α1 KO mice 
were within the same range as controls and SM AMPK-α2 KO mice. 
Moreover, there was no difference observed during recovery and % changes 
between all genotypes were identical. It should, however, be pointed out that 




advises against the use of tail pulse oximetry to obtain heart rate 
measurements (Kent, 2012).  
That comparable levels of arterial hypoxia were achieved in all mice was 
confirmed by pulse oximetry, which demonstrated significant and similar falls 
in SpO2 for all genotypes (Figure 7.5, Table 7.1). Moreover, there were no 
differences with respect to post-hypoxic recovery of arterial SpO2 upon 





Figure 7.3: Deletion of AMPK-α1 and AMPK-α2 subunits in smooth 
muscle cells or catecholaminergic cells has no effect on systemic 
arterial blood pressure during normoxia or hypoxia.  
(A) Bar charts show (mean ± SEM) the mean, systolic and diastolic blood 
pressure of control AMPK-α1/α2 floxed (Flx; black; n = 6) mice, those with 
AMPK-α1 (orange; n = 4) and AMPK-α2 (green; n = 4) deletion in smooth 
muscles (transgelin expressing cells) and AMPK-α1/α2 double KO in 
catecholaminergic cells (TH AMPK-α1/α2 dKO, red, n = 5). (B) Bar charts 
show the same measures of blood pressure during normoxia (N), after 
10min of hypoxia (H; 8% O2) and following recovery to normoxia (R). (C) Bar 
charts show the percentage change in blood pressure measured during 





Figure 7.4: Heart rate during hypoxia was unaffected by AMPK-α1/α2 
catalytic subunit deletion in smooth muscle or catecholaminergic 
cells.  
(A) Bar charts show mean ± SEM for the heart rate (beats/min) during 
normoxia (room air), after 10 min of hypoxia (8% O2) and following recovery 
to normoxia, and (B) shows mean ± SEM for percentage change in heart 
rate in AMPK-α1/α2 floxed (Flx; black, n = 12 exposures from 5 mice), 
smooth muscle AMPK-α1 KO (orange, n = 8 exposures from 3 mice), 
smooth muscle AMPK-α2 KO mice (green, n = 15 exposures from 4 mice) 
and catecholaminergic AMPK-α1/α2 double KO (TH AMPK-α1/α2 dKO, red, 
n = 12 exposures from 6 mice). Between genotypes: * = p<0.05; compared 
to normoxia: $ = p<0.05, $$ = p<0.01; compared to hypoxia: ## = p<0.01; 
### = p<0.001. Significance tested by two-way ANOVA with Sidak post-hoc 






Figure 7.5: Deletion of AMPK-α1/α2 catalytic subunit deletion in 
smooth muscle or catecholaminergic cells did not affect falls in arterial 
oxygen saturation during exposures to severe hypoxia. 
(A) Bar charts show mean ± SEM for the arterial oxygen saturation (SpO2) 
during normoxia (room air), after 10 min of hypoxia (8% O2) and following 
recovery to normoxia, and (B) shows mean ± SEM for percentage change 
in SpO2 in AMPK-α1/α2 floxed (Flx; black, n = 12 exposures from 5 mice), 
smooth muscle AMPK-α1 KO (orange, n = 8 exposures from 3 mice), 
smooth muscle AMPK-α2 KO mice (green, n = 15 exposures from 4 mice) 
and catecholaminergic AMPK-α1/α2 double KO (TH AMPK-α1/α2 dKO, red, 
n = 12 exposures from 6 mice). **** = p<0.001. Significance tested by 





Table 7.1: Means ± SEM of values obtained by tail cuff blood pressure 
measurements and percentage changes in arterial SpO2 before, 
during, and after exposures to hypoxia (8%O2) across all genotypes. 




















































































7.3.1 Summary of findings 
In this chapter I demonstrated that deletion of AMPK-α1 or AMPK-α2 
subunits in smooth muscle cells had very little to no effect on the control of 
the cardiorespiratory system. Firstly, there were no differences in minute 
ventilation or blood pressure during normoxia. However, increases in minute 
ventilation during severe hypoxia (8% O2) were, if affected at all, augmented 
by smooth muscle cell AMPK-α1 and AMPK-α2 deletion – despite the fact 
that hypoxia (8% O2) evoked falls in arterial SpO2 comparable with controls. 
Moreover, these mice exhibited no differences in heart rate or in systolic, 
diastolic or mean arterial blood pressure during hypoxia. In addition, 
cardiovascular responses to hypoxia were also unaffected by dual deletion 
of AMPK-α1 and AMPK-α2 subunits in catecholaminergic (TH) cells, 
therefore supporting our hypothesis that neurogenic mechanisms 
dependent on AMPK activity in TH-positive cells support the HVR. 
 
7.3.2 AMPK activity within catecholaminergic cells modulates 
respiratory, but not cardiovascular responses to hypoxia 
In previously reported findings, AMPK-α1 deficiency in catecholaminergic 
neurons (driven by TH-Cre) markedly attenuated the HVR and precipitated 
hypoventilation and apnoea during hypoxia (Mahmoud et al., 2016). These 
outcomes led to the proposed model of central oxygen-sensing by 
catecholaminergic neurons of the brainstem respiratory network (see 
section 3.1.1).  Outcomes presented in this chapter provide further detail for 
this model, given the consideration that the modulation of sympathetic 
outflow during hypoxia is supposedly orchestrated by the same 
catecholaminergic network within the brainstem that adjusts ventilatory 
responses (King et al., 2012; Guyenet et al., 2013; King et al., 2013; Burke 
et al., 2014; King et al., 2015). So far, studies have shown that activation of 
dorsal A2/C2 and ventral A1/C1 neurons modulates both ventilatory and 




of AMPK within the catecholaminergic network (driven by TH-Cre) which 
affects all of these neuronal groups was found to only alter the respiratory 
responses (see also Chapter 3), and not those of the cardiovascular system. 
This suggests that we may have uncovered a split in the dependency of 
AMPK activity within the catecholaminergic network that might separate 
these two systems, which could be anatomically inseparable and therefore 
so difficult to isolate and identify. Furthermore, there is a possibility that this 
effect could be co-dependent on serotonergic signalling, because serotonin 
receptor activation within the commissural (SolC) and medial (SolM) 
subnuclei of the NTS has been shown to decrease central respiratory output 
via phrenic nerve activity with no alteration of heart rate, arterial pressure, 
or sympathetic nerve activity (Ostrowski et al., 2014). This is highly relevant, 
as the anatomical location of SolM is adjacent to the area of cFos deficiency 
uncovered in Chapter 4, and serotonin has been found to inhibit neuronal 
AMPK activity in other model organisms (Cunningham et al., 2012; 
Cunningham et al., 2014).  By contrast, the proposed role of 10N to 
contribute to the bradycardia and mild hypertension associated with the 
diving reflex (Panneton et al., 2014) appears to not translate to the 
modulation of cardiovascular responses to hypoxia. Despite exhibiting a 
bilateral deficiency in hypoxia-induced cFos expression within 10N, which 
was proposed to receive afferent input from the adrenergic subset of 
brainstem catecholaminergic neurons (Hokfelt et al., 1973; Abbott et al., 
2013; DePuy et al., 2013; Guyenet et al., 2013), the systemic cardiovascular 
responses to hypoxia remained unaltered upon deletion of AMPK-α1/α2 
catalytic subunits in catecholaminergic cells. 
Therefore, AMPK activity may modulate signalling pathways within 






7.3.3 AMPK-dependent hypoxic vasodilation is system-specific and 
does not translate to systemic blood pressure responses or the 
HVR 
Additional significance of the present findings lies in the fact that reduced 
cerebral arterial dilation could affect O2 supply to the brain during hypoxia 
and thus the HVR through consequent respiratory depression, because the 
activity of brainstem respiratory networks is ultimately reliant on O2 delivery 
via the vasculature that could be modulated systemically and locally through 
myogenic responses. Such system-specific responses could well be 
affected by a number of mechanisms through which AMPK has been 
proposed to regulate myocyte function, rendering outcomes susceptible to 
off-target AMPK deletion due to “leakage” of Cre beyond those cells targeted 
by conditional deletion strategies. This was a distinct possibility, given that 
transient developmental expression of TH occurs in disparate cell groups 
that do not express TH in the adult (Lindeberg et al., 2004), including, for 
example, a subset of heart wall cells. However, the data presented here 
showed that TH-driven deletion of AMPK did not affect heart rate during 
normoxia or hypoxia.  
The outcomes of this investigation further indicate that while AMPK has been 
shown to mediate ex vivo arterial dilation in some circumstances (Goirand 
et al., 2007; Schneider et al., 2015), neither the expression of AMPK-α1 nor 
AMPK-α2 catalytic subunits in smooth muscles is a pre-requisite for in vivo 
arterial dilation during hypoxia sufficient enough to impact systemic arterial 
blood pressures. These findings do not, however, rule out a role for AMPK 
in maintaining resting vascular tone locally, or in governing organ- and/or 
tissue-specific perfusion and oxygen supply. Indeed, studies on other 
vascular beds have already revealed that AMPK might adjust local perfusion 
during hypoxia. For example, AMPK may mediate hypoxic pulmonary 
vasoconstriction (Evans et al., 2005a; Evans, 2006; Moral-Sanz et al., 
2018), and thus assist ventilation-perfusion matching by diverting blood from 
oxygen deprived to oxygen rich areas of the lung (Bradford & Dean, 1894; 
von Euler & Liljestrand, 1946). Furthermore, evidence suggests that AMPK 




arteries, at the level of smooth muscles that may counter tissue hypoxaemia 
(Schneider et al., 2015; Moral-Sanz et al., 2016). Accordingly, AMPK has 
also been implicated in the regulation of uterine artery reactivity during 
hypoxia (Skeffington et al., 2016), perhaps linking maternal metabolic and 
cardiovascular responses during pregnancy and governing oxygen and 
nutrient supply to the foetus.  
The mechanisms involved in systemic arterial dilation during hypoxia include 
AMPK-dependent activation of SERCA and BKCa channels in systemic 
arterial myocytes (Schneider et al., 2015), while AMPK exerts its effects on 
pulmonary smooth muscle cells, at least in part, through direct 
phosphorylation and inhibition of the voltage-gated potassium channel KV1.5 
(Moral-Sanz et al., 2016). Significant to the context of this study, KV1.5 
availability has been proposed to impact cerebral myogenic responses 
(Koide et al., 2018), which could equally well be affected by loss of capacity 
for AMPK-dependent activation of SERCA and BKCa channels. Either way, 
the data presented here argue strongly against the possibility that the HVR 
is influenced by AMPK-dependent mechanisms within smooth muscles that 
might affect local myogenic responses, irrespective of the tissue- and 
circulation-specific function they might impact. Nevertheless, it would be 
interesting to determine whether AMPK contributes to local autoregulatory 
mechanisms in the cerebral vasculature during hypoxia.  
 
7.3.4 Conclusion 
In conclusion, neither AMPK-α1 nor AMPK-α2 are required in smooth 
muscle or catecholaminergic cells for the regulation of systemic arterial 
blood pressure during hypoxia. Thus, AMPK likely supports the HVR through 
neurogenic but not myogenic mechanisms as previously proposed, by 
supporting increased respiratory drive (Mahmoud et al., 2016) and perhaps 
functional hyperaemia (Bucher et al., 2014), each of which may be 






7.3.5 Limitations of the study 
The experiments described above compared outcomes of single AMPK-α1 
and AMPK-α2 deletion in smooth muscle (SM) cells with those where both 
catalytic AMPK-α subunits were deleted in tyrosine hydroxylase-positive 
cells. Ideally, a double knockout of both AMPK-α1 and AMPK-α2 subunits in 
SM cells (SM AMPK-α1/α2 dKO) should be used for this comparison. 
However, such a genetic modification resulted in mice that were only viable 
for 8-10 weeks and therefore died before reaching a breeding age. 
Moreover, only very few SM AMPK-α1/α2 dKO could be generated from 
heterozygous breeding pairs which in other experiments carried out in our 
research group have not been observed to survive exposures to severe 
hypoxia for more than 2min, making comparisons of 5min and 10min 
exposures of hypoxia impossible. That said, blood pressure measurements 
taken under resting conditions showed no differences compared to control 







Chapter 8: Characterisation of the 
hypoxic ventilatory 
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8.1.1 The control of cardiorespiratory responses to hypoxia by 
adrenergic neurons of the brainstem 
Located within the caudal portions of the brainstem are the noradrenergic 
(dopamine β-hydroxylase-expressing) A1 and A2 cell groups, which are 
heavily implicated in the receipt of peripheral chemoafferent fibre input and 
the control of breathing, as well as the modulation of other emotional and 
cognitive processes such as satiation, behavioural stress responses, 
addictive drug dependence, or emotional learning (Finley & Katz, 1992; 
Rinaman, 2011). The rostral portion of the brainstem on the other hand 
contains the adrenergic (Phenylethanolamine N-methyltransferase 
(PNMT)-expressing) C1, C2, and C3 cell groups, which are best known for 
the control of sympathoexcitatory responses and the stimulation of 
breathing. The vast majority (>70%) of PNMT-positive neurons is made up 
of the neuronal C1 group, which are located bilaterally in the ventral medulla 
(Minson et al., 1990). The primary synaptic connections made by the C1 
neurons are glutamatergic and therefore excitatory, and projections have 
been found to innervate several higher brainstem structures (for example 
the paraventricular nucleus of the hypothalamus), the dorsal motor nucleus 
of the vagus (10N) and the respiratory centres of the brainstem, as well as 
sympathetic preganglionic neurons in the spinal cord (Guyenet et al., 2013). 
The anatomical location of the adrenergic C1 neurons in close proximity to 
the respiratory central pattern generators (rCPG) and the “pressor and 
depressor areas”  - which control changes in arterial pressure - of the rostral 
and caudal ventrolateral medulla (respectively) make the connections 
between C1 neurons and the control of cardiorespiratory responses 
immediately obvious (Willette et al., 1983; Burke et al., 2014). Indeed, the 
contribution of C1 neurons to the baroreflex has already been well 
established, whereby the regulatory influence of the arterial baroreceptors 
activates bulbospinal C1 neurons, which then modulate arterial blood 
pressure and heart rate via vaso- and cardiomotor sympathetic efferents 




2013). In this context, targeted optogenetic and hypoxic activation of 
exclusively C1 neurons provided conclusive evidence that it is indeed the 
adrenergic cell population of the ventral medulla that determines the 
cardiovascular changes in the rat (Burke et al., 2014).  
In addition to its control of cardiovascular responses, stimuli that activate C1 
neurons such as nociception, hypoxia, and hypotension also activate 
breathing, and targeted optogenetic stimulation of C1 cells has been shown 
to increase breathing frequencies in conscious mice (Abbott et al., 2013) 
and rats (Burke et al., 2014). The effects of C1 cell activation on the control 
of breathing have been proposed to be mostly mediated through direct 
projections to the retrotrapezoid nucleus (RTN), which in turn modulates 
respiratory output through innervations of the rCPG (Abbott et al., 2009; 
Burke et al., 2014; Burke et al., 2015). However, the hypoxia-induced 
modulation of breathing by the C1-RTN signalling pathways does not always 
translate to increases in ventilation. Hypoxia-evoked hyperventilation, which 
is primarily determined and maintained by excitatory input from the carotid 
bodies, leads to overall reductions of CO2 levels known as respiratory 
alkalosis (Foster et al., 2001). This in turn has been shown to silence 
neurons of the RTN, even during exposures to mild hypoxia (12% O2). 
Silencing of the RTN reduces the ventilatory drive during hypoxia through 
reductions in breathing frequency and tidal volume. Notably, additional 
optogenetic inhibition of the RTN during hypoxia did not lead to further 
reductions in breathing frequency unless the hypoxic stimulus was 
supplemented with 3% CO2 or pharmacological agents that led to blood 
re-acidification (Basting et al., 2015). Although the involvement of the 
adrenergic C1 neurons in the response to respiratory alkalosis was deemed 
unlikely, it could not be excluded. Therefore, the possibility remains that the 
release of inhibitory neuropeptides (such as enkephalin or neuropeptide Y) 
or signalling pathways involving GABAergic interneurons could, at least in 
part, involve the ventral adrenergic C1 neurons in the response 







Insofar, it has been demonstrated that loss of AMPK-α1/α2 catalytic subunits 
in catecholaminergic cells precipitates hypoventilation and apnoea during 
hypoxia (Mahmoud, 2014; Mahmoud et al., 2016). Because the deletion 
strategy employed by TH Cre-driven AMPK deletion encompassed both the 
noradrenergic and adrenergic cell groups of the brainstem, it was impossible 
to determine whether the effect of AMPK deletion was synergistic or cell-type 
specific.  
In this chapter, I aimed to further investigate the circuit mechanism by which 
AMPK deficiency impacts the HVR. More specifically, I sought to identify 
whether the attenuation of the HVR and augmentation of the apnoeic 
phenotype observed in TH AMPK-α1/α2 dKO mice was predominantly 
precipitated by AMPK deficiency in noradrenergic cells, adrenergic cells, or 
the combined effect of both cell types. Accordingly, AMPK-α1/α2 Flx mice 
were crossed with mice that express Cre recombinase under the control of 
the Pnmt gene. From these crosses, mice with dual deletion of the 
AMPK-α1/α2 catalytic subunits in PNMT-expressing cells were generated 
and exposed to 10min of severe hypoxia. Their ventilatory and apnoeic 






8.2.1 The generation of mice with dual deletion of the AMPK-α1/α2 
catalytic subunits in adrenergic cells 
As a result of a generous donation from Prof Steven Ebert (University of 
Central Florida), mice expressing Cre recombinase under the PNMT 
promoter (Ebert et al., 2004) were crossed with AMPK-α1/α2 Flx mice, 
thereby generating PNMT-driven AMPK-α1/α2 dKO mice. However, a 
couple of limitations needed to be considered in advance of any 
experimental work and interpretation of outcomes.  
Firstly, the insertion of Cre recombinase was targeted to exon 1 of the Pnmt 
gene, and homozygous insertion of Cre disrupted the functional expression 
of the PNMT protein. As might be expected, the absence of the enzyme that 
converts noradrenaline to adrenaline led to undetectable levels of adrenaline 
and increases in the concentration of noradrenaline in adrenal extracts. 
However, mice with heterozygous insertions of PNMT Cre did not exhibit 
any changes of noradrenaline and adrenaline concentrations, respectively 
(Ebert et al., 2004). Therefore, in order to avoid any phenotypic side effects 
due to the absence of adrenaline, all experimental mice used in this chapter 
were exclusively heterozygous for the expression of Cre. Importantly, 
heterozygous Cre expression was shown to be sufficient for the cell-specific 
excision of both of the floxed AMPK-α1 and -α2 subunits (Mahmoud, 2014).  
The second limitation was that the gifted PNMT Cre mice were bred on a 
CD1 background strain, whereas all our previously assessed 
catecholaminergic and smooth muscle AMPK knockout mice were bred on 
a C57Bl6 background strain. Genetic differences between background 
strains of mice are known to influence the ventilatory responses to hypoxia 
(Tankersley et al., 1994; Tankersley et al., 2000; Adachi et al., 2006; Ward 
et al., 2007; Ivy & Scott, 2017). Therefore, the donated CD1 PNMT Cre mice 
had to be back-crossed onto a C57Bl6 background to allow for comparisons 
with our previous mouse models. In order to determine whether the 




background-specific differences in their ventilatory responses to hypoxia, all 
outcomes from the newly bred control PNMT Cre mice were also directly 
compared to control AMPK-α1/α2 Flx mice. 
 
8.2.2 AMPK deletion in adrenergic cells augments ventilation 
throughout 10min exposures to hypoxia 
Deletion of AMPK-α1/α2 catalytic subunits in adrenergic cells (PNMT 
AMPK-α1/α2 dKO) was found to have no effect on normoxic baseline 
breathing relative to control PNMT Cre mice (Appendix 5.1), but augmented 
the HVR during severe hypoxia. Example records of changes in breathing 
frequency (Figure 8.1 Ai and Aii), tidal volume (Figure 8.1 Bi and Bii) and 
minute ventilation (Figure 8.1 Ci and Cii) illustrate the responses of PNMT 
Cre and PNMT AMPK-α1/α2 dKO mice to 10min exposures of 8% O2. 
Whereas control PNMT Cre mice responded to hypoxia with robust 
increases in ventilation which later stayed slightly above or returned to 
baseline values, PNMT AMPK-α1/α2 dKO mice retained an augmented 
ventilatory phenotype which appeared not only to have a more regular 
inter-breath interval, but also contained slightly fewer apnoeas. 
 
8.2.2.1 Breathing frequency 
5min exposures – controls As depicted in Figure 8.1 Aiii, control PNMT Cre 
mice responded to hypoxia (8% O2) with robust increases in breathing 
frequency. Following the onset of hypoxia, values reached 66.5 ± 4.6% 
relative to normoxia (n = 32 exposures from 8 mice) during the peak of the 
Augmenting phase (A) and then declined during ventilatory Roll-Off (RO) to 
4.2 ± 2.6%. On average, this level of ventilation was slightly increased during 
the Sustained Phase (SP), where breathing frequency measured 13.6 ± 
2.9%. Importantly, each of these responses was comparable to outcomes 
from control AMPK-α1/α2 Flx mice described in Chapter 3. 
10min exposures – controls Comparable breathing frequencies between 




exposures to hypoxia (Figure 8.2 Ai). Measures taken at each full minute of 
hypoxia showed that breathing frequencies of PNMT Cre mice during severe 
hypoxia were increased relative to normoxia to a level that was comparable 
to AMPK-α1/α2 Flx mice at each time point measured (Figure 8.2 A; at 1min: 
19.1 ± 2.7%; at 5min: 13.6 ± 2.9%; at 10min: 11.1 ± 3.4%).  
Effect of AMPK deletion during 5min exposures PNMT AMPK-α1/α2 dKO 
mice (n = 32 exposures from 8 mice) also responded with robust increases 
in breathing frequency during the Augmenting phase of 5min exposures to 
severe hypoxia (8% O2, 64.2 ± 3.4% relative to normoxia), which were 
comparable to the responses of both AMPK-α1/α2 Flx and PNMT Cre mice. 
However, breathing frequencies of PNMT AMPK-α1/α2 dKO mice remained 
slightly elevated at a level that was significantly increased relative to PNMT 
Cre mice during RO (20.5 ± 3.8%, p<0.05 relative to PNMT Cre, not 
significant relative to AMPK-α1/α2 Flx), and relative to AMPK-α1/α2 Flx mice 
during the SP (25.8 ± 4.4%, not significant relative to PNMT Cre, p<0.05 
relative to AMPK-α1/α2 Flx).  
Effect of AMPK deletion during 10min exposures Analyses of breathing 
frequencies at each full minute of hypoxia revealed that PNMT AMPK-α1/α2 
dKO mice displayed, on average, an augmentation of breathing frequency 
relative to both AMPK-α1/α2 Flx and PNMT Cre mice at each time point 
measured. However, this only became statistically significant during the fifth 
minute of hypoxia relative to AMPK-α1/α2 Flx mice (at 1min: 29.3 ± 3.4%, 
not significant relative to either control; at 5min: 25.9 ± 4.4%, p<0.05 relative 
to AMPK-α1/α2 Flx, not significant relative to PNMT Cre; at 10min: 15.1 ± 
3.2%, not significant relative to either control). Given this on average 
augmented response in PNMT AMPK-α1/α2 dKO mice relative to either 
control, the entire 10min exposure was also analysed as a whole. This 
showed that the breathing frequency was significantly augmented in PNMT 
AMPK-α1/α2 dKO mice (Figure 8.2 Aii; 23.4 ± 1.6%) relative to both PNMT 
Cre mice (13.4 ± 0.9%; p<0.0001) and AMPK-α1/α2 Flx mice (13.9 ± 1.9%; 
p<0.001). 
Therefore, changes in breathing frequencies of PNMT AMPK-α1/α2 dKO 




TH AMPK-α1/α2 dKO mice, which exhibited significant attenuations of 
breathing frequency relative to controls during both 5min and 10min 
exposures to severe hypoxia (see Chapter 3). By contrast, PNMT 
AMPK-α1/α2 dKO mice retained a hyperventilatory phenotype and did not 
show any signs of a ventilatory deficit. In fact, it appeared as if deletion of 
AMPK in adrenergic cells augmented breathing frequencies relative to 
controls.  
Therefore, the opposite effects of AMPK-α1 and -α2 catalytic subunit 
deletion in catecholaminergic cells compared to only adrenergic cells 
indicate that AMPK-dependent modulations of noradrenergic  signalling 
pathways protect from hypoventilation by supporting hypoxia-induced 
increases in ventilatory frequency, whereas AMPK-dependent modulations 
of adrenergic signalling pathways appear to provide a mild inhibitory input to 
the central pattern generators that reduces ventilatory frequency during 
hypoxia. These reductions may help to reduce the degree of respiratory 
alkalosis that occurs through hypoxia-induced hyperventilation (Foster et al., 
2001). 
 
8.2.2.2 Tidal volume 
5min exposures – controls In marked contrast to the hypoxia-induced 
increases in breathing frequency, only marginal changes in tidal volume 
were observed. During severe hypoxia (Figure 8.1 Biii), measurements for 
tidal volume of PNMT Cre mice were -2.7 ± 2.4% relative to normoxia during 
the Augmenting phase, 4.5 ± 2.4% during RO, and -3.3 ± 1.7% during the 
SP. Importantly, these values were similar to those obtained in AMPK-α1/α2 
Flx mice at each point measured. 
10min exposures – controls During slightly longer exposures to hypoxia, 
tidal volume of control PNMT Cre mice was also slightly attenuated relative 
to normoxia and showed a mild reduction over time, which was comparable 
to AMPK-α1/α2 Flx mice at every time point measured (Figure 8.2 Bi; at 




Effect of AMPK deletion during 5min exposures Compared to both controls, 
highly similar outcomes for tidal volume in response to hypoxia were 
observed in PNMT AMPK-α1/α2 dKO mice, measuring (relative to 
normoxia) -0.9 ± 2.6% during the Augmenting phase, 3.1 ± 2.5% for RO, 
and -0.3 ± 1.9% during the SP (not significant compared to either control at 
any point).  
Effect of AMPK deletion during 10min exposures Changes in tidal volume of 
PNMT AMPK-α1/α2 dKO mice measured at each full minute of hypoxia were 
minimal compared to normoxia and did not differ significantly from the 
changes in tidal volume observed in either cohort of control mice (at 1min: 
6.3 ± 2.5%; at 5min: -0.2 ± 1.9%; at 10min: -0.5 ± 2.2%; not significant 
compared to either control at any time point). However, when considering 
the entire 10min exposure as a whole, the smaller reduction of tidal volume 
relative to normoxia in PNMT AMPK-α1/α2 dKO mice translated into a 
significantly attenuated change (i.e. reduction) in tidal volume relative to 
AMPK-α1/α2 Flx mice (Figure 8.2 Bii; PNMT AMPK-α1/α2 dKO: 0.4 ± 0.7%; 
AMPK-α1/α2 Flx: -2.9 ± 1%, p<0.01; PNMT Cre: -1.3 ± 1%, not significant).  
Therefore, the minimal changes in tidal volume of PNMT AMPK-α1/α2 dKO 
mice during severe hypoxia were once again in marked contrast to those 
observed in TH AMPK-α1/α2 dKO mice, which exhibited significant 
attenuations of tidal volume relative to normoxia and controls during 5min 
and 10min exposures to severe hypoxia. By contrast, PNMT AMPK-α1/α2 
dKO mice exhibited minimal reductions in tidal volume relative to normoxia 
that only on the whole were augmented relative to controls.  
Therefore, AMPK-dependent modulation of noradrenergic signalling 
pathways also supports the HVR through maintenance of tidal volume, 
whereas AMPK-dependent modulation of adrenergic signalling pathways 
does not appear to make a significant contribution to the changes in tidal 





8.2.2.3 Minute ventilation 
5min exposures – controls Adjustments of minute ventilation in PNMT Cre 
mice followed a similar trend to breathing frequency. During hypoxia (Figure 
8.1 Ciii), control PNMT Cre mice responded similar to control AMPK-α1/α2 
Flx mice by increasing minute ventilation to 60.6 ± 6.6% relative to normoxia 
during the Augmenting phase, which then declined to 7.7 ± 3.2% during RO 
and 8.8 ± 3.3% for the SP (not significant relative to AMPK-α1/α2 Flx at any 
point).  
10min exposures – controls Not surprisingly perhaps, given the 10min 
outcomes for breathing frequency and tidal volume during hypoxia described 
above, minute ventilation of control PNMT Cre mice was increased relative 
to normoxia and similar to control AMPK-α1/α2 Flx mice at each time point 
measured during 10min exposures to hypoxia (Figure 8.2 Ci; at 1min: 25.3 
± 3.3%; at 5min: 8.8 ± 3.3%; at 10min: 4.1 ± 3.7%, not significant at any 
point).  
Effect of AMPK deletion during 5min exposures Relative to controls, 
measurements of minute ventilation in PNMT AMPK-α1/α2 dKO mice during 
hypoxia were highly comparable to both PNMT Cre and AMPK-α1/α2 Flx 
mice during the Augmenting phase (61.6 ± 5.4%, not significant relative to 
either control). However, despite not reaching statistical significance, PNMT 
AMPK-α1/α2 dKO mice displayed a reduced ventilatory decline that lead to 
higher averages of minute ventilation during RO (22.9 ± 4.9%, p=0.17 
relative to PNMT Cre and p=0.27 relative to AMPK-α1/α2 Flx) and the SP 
(24.2 ± 4.7%, p=0.16 relative to PNMT Cre and p=0.09 relative to 
AMPK-α1/α2 Flx).  
Effect of AMPK deletion during 10min exposures In addition to the findings 
described above, the changes in minute ventilation of PNMT AMPK-α1/α2 
dKO mice were, on average, augmented relative to both controls at every 
time point measured throughout 10min exposures to 8% O2. However, this 
only reached significance relative to AMPK-α1/α2 Flx mice alone during the 
fifth and ninth minute of hypoxia (at 1min: 36.4 ± 4.6%, not significant relative 




not significant relative to PNMT Cre; at 9min: 17.1 ± 4.5%, p<0.05 relative 
to AMPK-α1/α2 Flx, not significant relative to PNMT Cre; at 10min: 14.9 ± 
4.1%, not significant relative to either control). Nevertheless, as might be 
expected, considering the 10min exposure as a whole revealed a 
significantly augmented minute ventilation in PNMT AMPK-α1/α2 dKO mice 
(Figure 8.2 Cii; 22.8 ± 2.2%) relative to both PNMT Cre mice (10.9 ± 1.9%; 
p<0.0001) and AMPK-α1/α2 Flx mice (10.3 ± 3%; p<0.0001). 
Overall, the outcomes for breathing frequency and tidal volume of PNMT 
AMPK-α1/α2 dKO mice during severe hypoxia translated into changes of 
minute ventilation that were again in marked contrast to those observed in 
TH AMPK-α1/α2 dKO mice, which exhibited significant attenuations of 
minute ventilation relative to controls during 5min and throughout 10min 
exposures. By contrast, PNMT AMPK-α1/α2 dKO mice retained a breathing 
frequency-driven hyperventilatory phenotype and did not show signs of a 
ventilatory deficit at any point. Instead, deletion of AMPK in adrenergic cells 
appeared to augment the HVR relative to controls. Therefore, AMPK-α1 
and -α2 catalytic subunit deletion in adrenergic cells did not contribute the 
ventilatory deficit observed in TH AMPK-α1/α2 dKO mice in response to 
severe hypoxia, which in light of these findings was most likely precipitated 
by loss of AMPK-dependent signalling pathways in the noradrenergic subset 
of catecholaminergic cells. Accordingly, these findings are in agreement with 
and further support the conclusions drawn in Chapter 4, which predicted the 
location of a hypoxia-responsive neuronal circuit within the noradrenergic 
population of catecholaminergic cells that supports the HVR via 
AMPK-dependent pathways.  
Thus, whereas AMPK-dependent modulation of noradrenergic signalling 
pathways lead to increases in the ventilatory drive that shape the classical 
HVR, AMPK-dependent modulations of adrenergic signalling pathways may 
provide an inhibitory input to the central pattern generators during hypoxia 
that aim to protect from hyperventilation-induced hypocapnia (respiratory 





Figure 8.1: AMPK-α1/α2 catalytic subunit deletion in adrenergic cells 
augments the hypoxic ventilatory response to 5min exposures of 
severe hypoxia through increases in breathing frequency. 
Left and middle panels show raw example records of breathing (A) 
frequencies (breaths/min), (B) tidal volume (ml) and (C) minute ventilation 
(ml/min) during 10 minute exposures to severe hypoxia (8% O2) from (i) a 
mouse expressing Cre under the Phenylethanolamine N-methyltransferase 
reporter (PNMT Cre) and (ii) a PNMT-driven AMPK-α1 and -α2 double 
knockout (PNMT AMPK-α1/α2 dKO) mouse with a 2s sampling frequency. 
Dotted green lines indicate pre-hypoxic baseline frequency, dashed lines the 
artefacts induced by gas exchange. Right panels (iii) show means ± SEM 
for percentage changes of minute ventilation during the peak of the 
augmenting phase (A, approximately 30s), the nadir of the Roll-Off (RO, 
approximately 100s), and the plateau of the sustained phase (SP, at 300s) 
of the HVR in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, n = 54 
exposures from 21 mice), PNMT Cre mice (blue, n = 32 exposures from 8 
mice) and PNMT AMPK-α1/α2 dKO mice (purple, n = 32 exposures from 8 
mice). * = p<0.05. Significance tested by two-way ANOVA with Sidak 





Figure 8.2: AMPK-α1/α2 catalytic subunit deletion in adrenergic cells 
augments the hypoxic ventilatory response to 10min exposures of 
severe hypoxia.  
Means ± SEM for percentage changes relative to normoxia (green dotted 
line) of (A) breathing frequency (breaths/min), (B) tidal volume (ml), and (C) 
minute ventilation (ml/min) during (i) every 60s of and (ii) the entirety of 10 
minute exposures to severe hypoxia (8% O2) in AMPK-α1 and -α2 floxed 
mice (AMPK-α1/α2 Flx, black, n = 58 exposures from 21 mice),  mice 
expressing Cre under the Phenylethanolamine N-methyltransferase reporter 
(PNMT Cre, blue, n = 32 exposures from 8 mice) and PNMT-driven 
AMPK-α1 and -α2 double knockout mice (PNMT AMPK-α1/α2 dKO, purple, 
n = 32 exposures from 8 mice) measured at each full minute of hypoxia. * = 
p<0.05, ** = p<0.01. Significance tested by two-way ANOVA with Sidak 




8.2.3 AMPK deletion in adrenergic cells increases ventilatory stability 
throughout 10min exposures to hypoxia 
Given the augmented hypoxic ventilatory phenotype of PNMT AMPK-α1/α2 
dKO mice relative to controls it was of interest to further assess and compare 
the overall breathing regularity and hence stability during 10min exposures 
to severe hypoxia. As before, this was achieved by plotting each inter-breath 
interval (BBn) against each subsequent inter-breath interval (BBn+1) for 
PNMT Cre and PNMT AMPK-α1/α2 dKO mice.  
Example plots from single 10min exposures are shown in Figure 8.3 A, 
which compare the inter-breath intervals of a control (blue) and knockout 
(purple) mouse during 8% hypoxia. It is quite clear that control PNMT Cre 
mice had a regular breathing pattern with some apnoeas, evident through 
increases in inter-breath interval. In comparison, it appeared that apnoeas 
were slightly less prevalent in PNMT AMPK-α1/α2 dKO mice, indicated by 
the smaller and possibly fewer increases in the inter-breath intervals. These 
outcomes were further analysed by comparing the standard deviations (SD) 
of BBn and BBn+1. 
Ventilatory stability of controls Minute-by-minute analyses revealed that 
increases in the SD of the breathing pattern in control PNMT Cre mice (n = 
32 exposures from 8 mice) were most prevalent during the second and third 
minutes of hypoxia (Figure 8.3 B; at 0-1min: 69.5 ± 3.4ms; at 1-2min: 104.2 
± 4.4ms; at 2-3min: 97.5 ± 8.7ms). Thereafter, breathing became more 
regular again and the SD declined back to the level observed during the first 
minute of hypoxia, which then remained constant throughout the remainder 
of the exposure (at 3-4min: 74.6 ± 4ms; at 5-6min: 72.4 ± 4.5ms; at 9-10min: 
70.7 ± 3.6ms). Importantly, these time-dependent changes are similar to 
observations from control AMPK-α1/α2 Flx mice (see Chapter 5). 
Ventilatory stability of knockouts Consistent with the observations from the 
plots described above, the breathing pattern of PNMT AMPK-α1/α2 dKO 
mice (n = 32 exposures from 8 mice) did indeed exhibit a less variable SD 
of the inter-breath intervals relative to controls during the first three minutes 
of hypoxia (at 0-1min: 52.1 ± 2.6ms, p<0.05; at 1-2min: 75.8 ± 3.8ms, 




Thereafter, the SD of PNMT AMPK-α1/α2 dKO mice was on average slightly 
lower but statistically comparable to control PNMT Cre mice for the 
remainder of the exposure (at 3-4min: 59.9 ± 3.4ms; at 5-6min: 63 ± 4.1ms; 
at 9-10min: 63.8 ± 3.8ms; not significant relative to PNMT Cre mice at any 
time point).   
From these plots it was apparent that loss of AMPK-α1 and -α2 subunits in 
adrenergic cells did not precipitate increases in breathing irregularities, 
which is in stark contrast to the results obtained following AMPK deletion in 
all catecholaminergic cells, inclusive of the adrenergic population. In fact, 
adrenergic AMPK deletion appeared to do the opposite and stabilised 
breathing patterns during the first few minutes of hypoxia by reducing 
variabilities within the inter-breath intervals (see also Appendix4.2).  
Therefore, AMPK-dependent modulations of noradrenergic signalling 
pathways seem to support ventilatory stability during periods of increased 
hypoxia-induced ventilatory drive, whereas the earlier suggested inhibitory 
input from AMPK-dependent modulations of adrenergic signalling pathways 
likely leads to disruptions of ventilatory rhythmicity at the beginning of the 
hypoxic exposure, possibly until respiratory drive from the carotid bodies and 
mild respiratory inhibition through silencing of the RTN may have reached 





Figure 8.3: Mice with deletion of AMPK-α1/α2 catalytic subunits in 
adrenergic cells exhibit reduced breathing variability.  
(A) Example Poincaré plots show the inter-breath interval (BBn) versus the 
subsequent interval (BBn+1) of mice expressing Cre under the 
Phenylethanolamine N-methyltransferase reporter (PNMT Cre, blue) and 
PNMT-driven AMPK-α1 and -α2 double knockout mice (PNMT AMPK-α1/α2 
dKO, purple) mice during 10min exposures to severe hypoxia (8% O2). (B) 
Means ± SEM of the standard deviation (SD) of BBn and BBn+1 for PNMT 
Cre mice (n = 32 exposures from 8 mice) and PNMT AMPK-α1/α2 dKO mice 
(n = 32 exposures from 8 mice) for 1min averages of 10min exposures to 
hypoxia. * = p<0.05, **** = p<0.0001. Significance tested by two-way 




8.2.4 AMPK deletion in adrenergic cells reduces apnoeas throughout 
10min exposures to hypoxia 
The above described augmentation of ventilation and the reduction in 
breathing variability during hypoxia opened the possibility that deletion of 
AMPK-α1 and -α2 subunits in adrenergic cells may also have an effect on 
the number of apnoeas during 10min exposures to hypoxia. Accordingly, the 
apnoeic phenotype of control PNMT Cre PNMT AMPK-α1/α2 dKO mice was 
assessed.  
 
8.2.4.1 Apnoeic index 
Control mice When exposed to 10min of 8% O2, control PNMT Cre mice 
presented with apnoeas at a frequency of 2.7 ± 0.3 apnoeas/min (n = 32 
exposures from 8 mice) for the first, and 1.6 ± 0.2 apnoeas/min for the 
second 5min of hypoxia (Figure 8.4 Ai), which was comparable to the 
number of apnoeas observed in AMPK-α1/α2 Flx mice. Furthermore, a 
time-dependent decline in apnoea frequency was observed in PNMT Cre 
mice during minute-by-minute analyses of apnoea frequency, which 
measured 3.3 ± 0.4 apnoeas/min by 1-2min, 1.8 ± 0.3 apnoeas/min by 
5-6min, and 1.9 ± 0.3 apnoeas/min by 9-10min (Figure 8.4 Aii). This 
reduction in apnoea frequency over time was entirely consistent with 
outcomes observed in AMPK-α1/α2 Flx mice at each time point measured.  
Effect of AMPK deletion on apnoea frequency Interestingly, the apnoea 
frequency measured in PNMT AMPK-α1/α2 dKO mice (n = 32 exposures 
from 8 mice) was, on average, lower during the first half of hypoxia 
compared to both controls (1.9 ± 0.3 apnoeas/min) and reached significance 
relative to AMPK-α1/α2 Flx mice (p<0.01). During the second half of 
hypoxia, only a minor reduction in the apnoea frequency was observed in 
PNMT AMPK-α1/α2 dKO mice relative to the first half, measuring 1.2 ± 0.2 
apnoeas/min. As just stated above, both controls exhibited a higher number 
of apnoeas during the first half of hypoxia. However, a pronounced decrease 




over time meant that during the second half of 10min exposures, the average 
numbers of apnoeas were comparable between the three genotypes. 
However, an on average reduced apnoeic frequency relative to controls was 
still apparent throughout the 10min exposure, but this became only 
significant during the second and third minute of hypoxia (apnoeas/min – at 
1-2min: 1.8 ± 0.4, p<0.0001 compared to AMPK-α1/α2 Flx, p<0.01 
compared to PNMT Cre; at 2-3min: 2.5 ± 0.4, p<0.05 compared to PNMT 
Cre only; at 5-6min: 1.5 ± 0.2, not significant relative to either control; at 
9-10min: 1.3 ± 0.2, not significant relative to either control). Despite 
exhibiting an attenuated number of apnoeas per minute relative to controls, 
PNMT AMPK-α1/α2 dKO mice still presented with a time-dependent 
decrease of the apnoeic index following a peak at 2-3min. However, given 
the already low number of apnoeas at the beginning of the exposure, this 
decrease was not as pronounced as it was for AMPK-α1/α2 Flx or PNMT 
Cre mice.  
Overall, the effect of PNMT-driven deletion of AMPK is once again entirely 
opposite to the effect of TH-driven deletion of AMPK. Whereas TH 
AMPK-α1/α2 dKO mice exhibited marked and sustained increases in the 
apnoeic index relative to controls throughout exposures to severe hypoxia 
(see Chapter 5), PNMT AMPK-α1/α2 dKO mice presented with a slight 
reduction in the number of apnoeas relative to controls. Moreover, while the 
time-dependent decline of apnoea frequency was absent in TH AMPK-α1/α2 
dKO mice, it was retained in PNMT AMPK-α1/α2 dKO mice. Therefore, 
AMPK-dependent modulation of noradrenergic signalling pathways appears 
to protect from apnoeas during hypoxia, whereas AMPK-dependent 
adrenergic signalling pathways may indirectly contribute to the generation of 
apnoeas.  
 
8.2.4.2 Apnoea duration 
Control mice The durations of apnoeas for PNMT Cre mice in response to 
8% O2 were fairly stable during both halves of 10min exposures to hypoxia 




apnoea durations were significantly shorter in PNMT Cre mice compared to 
AMPK-α1/α2 Flx mice during the first half of 10min exposures (p<0.05). 
Thereafter, the second half of hypoxia was comparable between the two 
control groups. Considering the average durations of apnoeas during each 
minute of hypoxia revealed minimal changes over time (Figure 8.4 Bii; at 
1-2min: 850 ± 24.5ms; at 4-5min: 825.9 ± 30.8ms; at 9-10min: 798.1 ± 
41.7ms). Each of these values was generally comparable to apnoea 
durations of AMPK-α1/α2 Flx mice, yet a significantly lower apnoea duration 
in PNMT Cre mice was observed during the fourth minute of hypoxia 
(p<0.05).  
Effect of AMPK deletion on apnoea duration Like controls, apnoea durations 
of PNMT AMPK-α1/α2 dKO mice were significantly lower compared to 
AMPK-α1/α2 Flx mice during the first half of 8% O2 (0-5min: 778.7 ± 35.7ms, 
p<0.05), but comparable to PNMT Cre mice. Furthermore, apnoea durations 
of PNMT AMPK-α1/α2 dKO mice remained stable during the second half of 
hypoxia (5-10min: 799.7 ± 27.5ms), during which period the durations were 
similar across all three genotypes. Closer analyses of the durations for each 
minute revealed that apnoeas were indeed stable throughout the 10min 
exposures (at 1-2min: 819.4 ± 52.5ms; at 4-5min: 760.4 ± 27.4ms; at 
9-10min: 853.4 ± 43.8ms), and significant differences relative to controls 
were only found during the third (750.8 ± 24.6ms, p<0.05 relative to 
AMPK-α1/α2 Flx, p<0.05 relative to PNMT Cre), fourth (719.6 ± 25.5ms, 
p<0.05 relative to AMPK-α1/α2 Flx only), and fifth (760.4 ± 27.4ms, p<0.05 
relative to AMPK-α1/α2 Flx only) minute of hypoxia. 
Therefore, PNMT-driven deletion of AMPK did not appear to have a major 
effect on the overall duration of apnoeas relative to controls. However, minor 
differences between PNMT AMPK-α1/α2 dKO mice and controls did 
occasionally occur, where the average apnoea duration in knockouts was 
significantly decreased. Once again, this is entirely opposite to the effect of 
AMPK deletion in TH-positive cells, where apnoea durations were 
augmented relative to controls throughout the exposure to hypoxia. This 
suggests that AMPK-dependent modulation of noradrenergic signalling 




re-initiating inspiration and hence terminating an apnoea, whereas 
AMPK-dependent modulations of adrenergic signalling pathways may 
indirectly contribute to the prolongation of apnoeas at the onset of the 
hypoxic exposure. 
 
8.2.4.3 Apnoea duration index 
Control mice Given the reduction of apnoea frequency over time with stable 
apnoea durations, it was not surprising that the apnoea-duration index (ADI) 
of PNMT Cre mice followed similar time-dependent changes to the apnoeic 
index. During the first half of hypoxia, the ADI measured 2.3 ± 0.3, which 
declined to 1.3 ± 0.2 during the second half of 10min exposures (Figure 8.4 
Ci). Moreover, like apnoea frequency, the ADI of PNMT Cre mice was 
comparable to that of AMPK-α1/α2 Flx mice. A time-dependent decrease of 
the ADI driven by reductions in apnoea frequency was also observed during 
more detailed analyses of 10min exposures of hypoxia. In that respect, the 
ADI of PNMT Cre mice measured 2.8 ± 0.4 by 1-2min, 1.5 ± 0.2 by 5-6min, 
and 1.6 ± 0.3 by 9-10min (Figure 8.4 Cii). Importantly, each of these time 
points was comparable to the ADI of AMPK-α1/α2 Flx mice, even though the 
average ADI was often lower in PNMT Cre mice. 
Effect of AMPK deletion on the apnoea duration index The outcomes for 
apnoea frequency and duration of PNMT AMPK-α1/α2 dKO mice translated 
into an ADI that was comparable to PNMT Cre during the first half of hypoxia, 
but significantly attenuated relative to AMPK-α1/α2 Flx mice (0-5min: 1.5 ± 
0.2, p<0.0001). During the second half of 10min exposures, however, the 
ADI was once again comparable across the three genotypes (5-10min: 1 ± 
0.1, not significant relative to either control). Minute-by-minute analyses 
revealed that attenuations of apnoea frequency and duration translated into 
a reduction of the ADI in PNMT AMPK-α1/α2 dKO mice relative to controls, 
which was significant during the second (1.4 ± 0.3, p<0.0001 relative to 
AMPK-α1/α2 Flx, p<0.01 relative to PNMT Cre), third (1.9 ± 0.3, p<0.01 
relative to AMPK-α1/α2 Flx, p<0.01 relative to PNMT Cre), and fourth (1.3 ± 




minute of 8% O2. In addition, following a peak at 2-3min of hypoxia, PNMT 
AMPK-α1/α2 dKO mice exhibited a time-dependent and apnoea 
frequency-driven decrease of the ADI, which apart from the third minute was 
comparable to both controls (5-6min: 1.2 ± 0.2; 7-8min: 0.9 ± 0.2; 9-10min: 
1.1 ± 0.2). 
Overall, PNMT-driven deletion of AMPK-α1 and -α2 subunits reduced the 
ADI relative to controls during 10min exposures to severe hypoxia (8% O2). 
These findings are opposite to the effect of TH-driven AMPK deletion, which 
significantly increased the ADI relative to controls throughout the duration of 
the 10min exposure. Moreover, while a time-dependent decline of ADI was 
absent in TH AMPK-α1/α2 dKO mice, it was retained in PNMT AMPK-α1/α2 
dKO mice. Therefore, AMPK-dependent modulations of noradrenergic 
signalling pathways protect from apnoeas during hypoxia, likely by 
supporting the generation of respiratory rhythm and re-initiation of inspiration 
during apnoea. By contrast, AMPK-dependent modulations of adrenergic 
signalling pathways may limit and indirectly periodically inhibit respiration in 
response to respiratory alkalosis triggered by hypoxic hyperventilation, and 
thus aid to restore CO2 levels in the most rapid and efficient way (Basting et 





Figure 8.4: AMPK deletion in adrenergic cells reduces apnoeas during 
10min exposures to severe hypoxia.  
Means ± SEM for the (A) apnoeic index (apnoeas/min), (B) apnoea duration 
(ms), and (C) apnoea-duration index during (i) the first and second half and 
(ii) for every 60 seconds of 10 minute exposures to severe hypoxia (8% O2) 
in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, n = 58 exposures 
from 25 mice), mice expressing Cre under the Phenylethanolamine 
N-methyltransferase reporter (PNMT Cre, blue, n = 32 exposures from 8 
mice) and PNMT-driven AMPK-α1 and -α2 double knockout mice (PNMT 
AMPK-α1/α2 dKO, purple, n = 32 exposures from 8 mice). * = p<0.05, ** = 
p<0.01, **** = p<0.0001. Significance tested by two-way ANOVA with Sidak 
post-hoc tests for apnoeic index and apnoea-duration index, and multiple 






8.3.1 Summary of findings 
Chapter 8 shows that AMPK activity within the adrenergic subset of 
catecholaminergic cells exerts completely opposing effects to the combined 
effect of all catecholaminergic cells regarding the respiratory response to 
hypoxia. Whereas loss of AMPK activity in all catecholaminergic cells 
precipitated severe hypoventilation, ventilatory instability and significant 
increases in the apnoeic phenotype, deletion of AMPK-α1 and -α2 catalytic 
subunits in the adrenergic subset of catecholaminergic cells mildly 
augmented the HVR, stabilised respiratory rhythmicity at the beginning of 
the hypoxic exposure, and mildly attenuated the apnoeic phenotype. 
Therefore, these findings are in complete contrast to those obtained in 
Chapter 3, and clearly point towards differential roles of noradrenergic and 
adrenergic input in the regulation of the HVR and thus the maintenance of 
whole-body O2 supply.  
 
8.3.2 AMPK activity in brainstem adrenergic cells likely protects from 
respiratory alkalosis during hypoxia-induced hyperventilation 
Firstly, the ventilatory responses of control PNMT Cre mice were 
comparable to those of control AMPK-α1/α2 Flx mice. This shows that if any 
CD1 background strain-specific responses of the HVR remained after the 
back-crosses, then these were minimal and did not differ significantly from 
the inbred C57Bl6 background (see also Appendices 5.1 to 5.8). Therefore, 
outcomes obtained from PNMT AMPK-α1/α2 dKO mice could be reliably 
compared to both controls.  
Strikingly, and in stark contrast to the HVR of TH AMPK-α1/α2 dKO mice, 
each component of the HVR of PNMT AMPK-α1/α2 dKO mice was 
augmented relative to controls. This was surprising at first, given that the 
adrenergic and thus PNMT Cre positive ventrolateral C1 neurons have been 
proposed to form an integral part of the neural circuit that drives increases 




Burke et al., 2014). Instead, the augmentation of the ventilatory responses 
to hypoxia following AMPK deletion in adrenergic cells was suggestive of 
the provision of an AMPK-dependent inhibitory input from the C1 and/or C2 
neurons to the rCPGs. Given that AMPK deletion in all catecholaminergic 
cell types precipitated severe hypoventilation, this strongly suggests that 
noradrenergic signalling inputs act to increase ventilation to a degree that 
could quickly lead to reductions in central PCO2 levels and thus respiratory 
alkalosis (Foster et al., 2001). It seems quite plausible, therefore, that 
AMPK-dependent adrenergic inputs might act to limit the degree of 
hyperventilation and thus protect from severe hypocapnia. Respiratory 
alkalosis silences neurons of the RTN, and a role of C1 neurons in this 
pathway could not be excluded (Basting et al., 2015). Thus, the possibility 
remains that silencing of the RTN could be mediated by AMPK-dependent 
release of inhibitory neuropeptides (such as enkephalin or neuropeptide Y) 
or signalling pathways involving GABAergic interneurons incorporating, at 
the very least, ventral adrenergic C1 neurons that are known to express 
inhibitory neurotransmitter (Stornetta et al., 1999; Pilowsky et al., 2008) and 
could therefore oppose hypoxia-induced respiratory alkalosis.  
In this regard, it would also be interesting to determine whether selective 
deletion of AMPK in only noradrenergic cells would further exacerbate the 
ventilatory deficit observed in TH AMPK-α1/α2 dKO mice. If so, then such 
findings would provide additional, strong support for the predicted location 
of the hypoxia-responsive neuronal circuit called DAR (see Chapter 4) within 
the noradrenergic population of catecholaminergic cells that supports, in a 
manner dependent upon the expression of AMPK, the degree of the HVR.  
Currently, the possibility remains that the DAR may encompass the 
adrenergic neuronal network to some extent, given the indication from our 
previous fMRI study that the DAR continues in Bregma that are rostral to the 
predicted boundaries of the noradrenergic neuronal network (Rinaman, 
2011; Mahmoud et al., 2016). However, if this was the case then clearly 
AMPK-dependent pathways in noradrenergic and adrenergic cells must act 




stimulation must clearly outweigh adrenergic ventilatory inhibition during 
hypoxia.  
Further indications of an inhibitory role of adrenergic inputs came from the 
fact that AMPK deletion decreased the variability of inter-breath intervals 
during the first three minutes of the hypoxic exposure. It is possible that 
during the Augmenting Phase of the HVR, respiratory drive from the carotid 
bodies and central hypoxia-responsive noradrenergic neurons may act in 
concert with a mild respiratory inhibition through silencing of the RTN in 
order to reach an equilibrium of optimal balance between O2 intake through 
hyperventilation and protection from respiratory alkalosis. Consistent with 
this, AMPK deficiency in adrenergic cells appeared to reduce the frequency 
of apnoeas relative to controls at the beginning of the hypoxic exposure. 
Complete cessation of ventilation may thus be the most rapid and efficient 
way to restore central CO2 levels during periods of intense respiratory effort 
(Dempsey, 2005). However, after approximately four minutes of hypoxia, 
which coincides with the Sustained Phase of the HVR, the balance of 
inspiratory drive from the carotid bodies and noradrenergic neurons, and 
inhibitory drive from the adrenergic neurons may keep hyperventilation and 
apnoea frequency at a level that maintains adequate CO2 levels during 
periods of hypoxia. One question that remains is whether AMPK-dependent 
signalling pathways are the primary determinant of the increased frequency 
of spontaneous apnoeas observed in TH AMPK-α1/α2 dKO mice, or whether 
they impact on the duration of post-sigh apnoeas as well through modulation 
of inspiratory inhibition via vagal afferent input. However, vagal inhibition is 
received and interpreted by the caudal portion of noradrenergic cells (Kubin 
et al., 2006), indicating that it is unlikely that rostral adrenergic cells 
contribute to the generation of post-sigh apnoeas.  
 
8.3.3 Conclusion 
In conclusion, it appears that AMPK-dependent signalling pathways within 
noradrenergic and adrenergic cells serve different roles in determining the 
ventilatory responses to hypoxia. While noradrenergic AMPK activity most 




carotid bodies, activity of AMPK in adrenergic cells may instead limit the 
extent of respiratory frequency and protect from central hypocapnia and thus 
respiratory alkalosis. In this respect, adrenergic cells may induce ventilatory 
instability via increases in apnoea frequency during the Augmenting Phase 
of the HVR, which after a few minutes may normalise and reach an 
equilibrium with the ventilatory drive that come from the periphery and the 
caudal noradrenergic neurons. Overall, this delicate interplay may not only 
aim to restore and maintain whole-body O2 supply, but may also protect from 
the hypocapnia-induced manifestation of ‘pins and needles’ in the 
extremities, chest discomfort, or light-headedness via reductions in cerebral 
blood flow that can lead to further tissue hypoxaemia (Madias & Adrogué, 
2014). 
 
8.3.4 Limitations and future directions 
To date, the dual deletion of the AMPK-α1 and -α2 catalytic subunits in 
adrenergic cells has only been assumed following genotype analysis, which 
confirmed the presence of AMPK-α1fl/fl, AMPK-α2fl/fl, and PNMT Cre+/- alleles 
(Appendix 5.9). Unfortunately there is no homogeneous population of 
adrenergic cells within any tissue, but the adrenal medulla is reportedly 
made up of 50-98% adrenergic cells (Norris & Carr, 2013). Therefore, 
attempts have been made to use single cell laser microdissection in order to 
extract the nuclear content from individual nuclei of the adrenal medulla of 
PNMT Cre and PNMT AMPK-α1/α2 dKO mice. However, to this point the 
results have been inconclusive and could not definitively show that the 
AMPK-α1 and -α2 catalytic subunits have been successfully excised. 
Obtaining such evidence will be crucial in order to confirm the findings and 
support the conclusions drawn above. Nevertheless, laser microdissection 
of multiple adrenal medulla cells with subsequent RNA extraction and 
end-point qPCR indicated a reduced expression of the AMPK-α1 and -α2 
catalytic subunits in PNMT AMPK-α1/α2 dKO mice relative to PNMT Cre 
controls (Appendix 5.10), which at the very least provides support for an 




significantly different ventilatory response to hypoxia relative to both controls 
would have been unlikely.  
Further additional experiments on PNMT AMPK-α1/α2 dKO mice would be 
required to analyse the blood gas composition after 10min exposures to 
severe hypoxia in order to determine whether AMPK activity in adrenergic 
cells indeed protects from respiratory alkalosis. Moreover, analyses of the 
duty cycle would be beneficial to establish whether initiation of active 
expiration during hypoxia is mediated by glutamatergic signalling from 
noradrenergic, or indeed adrenergic cells, as was suggested in Chapter 6 
(Fung et al., 1994a; Fung et al., 1994b; Stornetta et al., 2002; Rinaman, 
2011; DePuy et al., 2013; Malheiros-Lima et al., 2015).  
As mentioned above, AMPK activity in adrenergic cells appeared to mildly 
increase the numbers of apnoeas. It was speculated that spontaneous 
apnoeas would be the main driver of the augmented apnoea index, due to 
the generation of post-sigh apnoeas via vagal inhibition of inspiration that 
terminates within the noradrenergic portion of catecholaminergic cells (see 
Chapter 5). Analyses of spontaneous versus post-sigh apnoeas would be 
required to corroborate or reject this hypothesis.  
Another very important aspect of the response to hypoxia modulated by 
adrenergic neurons is that of the cardiovascular system. Ventrolateral C1 
neurons have been heavily implicated in the control of the baroreflex, 
whereby the regulatory influence of the arterial baroreceptors activates 
bulbospinal C1 neurons, which then modulate arterial blood pressure and 
heart rate via vaso- and cardiomotor sympathetic efferents (Ross et al., 
1984; Dampney et al., 2002; Guyenet, 2006; Guyenet et al., 2013). 
Measurements of heart rate and blood pressure during exposures to hypoxia 
have been carried out by pulse oximetry and tail cuff, respectively, but 
results remained inconclusive. For both PNMT Cre and PNMT AMPK-α1/α2 
dKO mice, the cardiovascular responses during hypoxia exhibited 
sometimes increases in blood pressure, sometimes decreases, and 
sometimes no response at all. Importantly, these outcomes were not 
sex-specific, as both male and female mice exhibited these variations 




method of sampling blood pressure and heart rate is required, such as 
telemetry, in order to evaluate the effects of AMPK deletion in adrenergic 
cells on the cardiovascular system. However, given that no changes in heart 
rate or blood pressure during normoxia and hypoxia were identified upon 
AMPK deletion in all catecholaminergic cells (MacMillan & Evans, 2018), no 









9.1 Summary of findings 
During periods of acute hypoxia, appropriate modulations of the drive to 
breathe are crucial in order to optimise O2 uptake by increasing ventilation. 
Ventilatory drive is mediated by the respiratory central pattern generators 
(rCPGs) of the ventrolateral medulla, which are continuously modulated by 
specialised peripheral and central chemoreceptors to adjust ventilation 
according to changes in arterial PO2, PCO2, and pH levels. Regarding 
changes in arterial PO2, catecholaminergic O2-sensing cells of the carotid 
body and the brainstem are vital, as they are able to sense reductions in O2 
supply and trigger increases in ventilation. However, the underlying 
molecular mechanism(s) within O2-sensing cells by which afferent output 
modulates respiratory adjustments during acute hypoxia still remain 
controversial. The findings presented in this thesis show that the ventilatory 
response to hypoxia requires the activity of AMPK within the central 
catecholaminergic neuronal network of the medulla oblongata, which likely 
forms a noradrenergic hypoxia-responsive neuronal circuit that integrates 
peripheral and central chemosensory information and determines – via 
projections to the rCPGs in the ventral medulla – the degree of ventilatory 
drive. 
Initially, I set out to determine whether AMPK deficiency in 
catecholaminergic cells precipitates ventilatory deficits even during more 
prolonged exposures to acute hypoxia, or whether alternative 
AMPK-independent pathways would lead to an at least partial recovery of 
the HVR. By using the previously described mouse model of dual AMPK-α1 
and -α2 catalytic subunit deletion targeted to catecholaminergic (tyrosine 
hydroxylase [TH]-expressing) cells (Mahmoud, 2014; Mahmoud et al., 
2016), I showed in Chapters 3, 5 and 6 that TH-driven AMPK-α1/α2 double 
knockout (dKO) mice were unable to recover ventilatory efforts and 
remained in a hypoventilatory state relative to normoxia, as well as relative 
to control AMPK-α1/α2 floxed (Flx) mice, for hypoxic durations that lasted 
up to an hour. Hypoventilation in TH AMPK-α1/α2 dKO mice was primarily 
driven by blocked active expiration and the inability to accelerate the 




addition, ventilatory instability was pronounced and retained throughout the 
exposure to hypoxia, which during more prolonged periods manifested as 
periodically oscillating “bursts” in the frequency of spontaneous apnoeas. 
Importantly, I have shown in Chapter 4 that the hypoxic ventilatory 
deficiencies of TH AMPK-α1/α2 dKO mice were not precipitated by loss of 
neuronal cell numbers or catecholaminergic neurotransmission per se, but 
rather resulted from a functional deficit subsequent to an attenuated 
neuronal activation within a specific area of the caudal dorsal brainstem. 
This area is likely to harbour a hypoxia-responsive neuronal circuit which, in 
an AMPK-dependent manner, may integrate and coordinate peripheral and 
central chemoafferent input with the modulation of the ventrolateral rCPGs 
and thus ventilation and O2 supply at the level of the whole body. Moreover, 
the herein identified putative hypoxia-responsive neuronal circuit was 
consistent with the location of the DAR that was previously identified by 
fMRI, and proposed to be located within the noradrenergic population of 
brainstem catecholaminergic cells. Nevertheless, the possibility remains that 
this hypoxia-sensitive circuit may also encompass a subset of the adrenergic 
cell population.  
In further support for a functional role of AMPK-dependent signalling 
pathways in specifically mediating the HVR, I showed in Chapter 7 that the 
cardiovascular responses to hypoxia were retained in TH AMPK-α1/α2 dKO 
mice. This was surprising, given that hypoxia appears to simultaneously 
activate the same neurons of the brainstem that subsequently determine the 
HVR and the cardiovascular response. Therefore, these findings may 
provide the first evidence of a separation of these two physiological 
responses in a manner that is determined by AMPK activity within central 
catecholaminergic neurons. In addition, Chapter 7 revealed that 
cardiorespiratory adjustments during hypoxic exposures were also 
unaffected by deletion of either AMPK-α1 or -α2 subunits targeted to arterial 
smooth muscle (SM) cells. The retention of a normal cardiorespiratory 
response to hypoxia in SM AMPK-α1 KO and SM AMPK-α2 KO mice thus 
further supported the conclusion that the ventilatory deficits observed in TH 




activity and function, rather than alterations in cerebral hypoxia-induced 
vasodilation and thus O2 supply via the vasculature, or off-target effects via 
“leakage” of Cre.  
Finally, in Chapter 8 my findings corroborated a role for AMPK activity within 
noradrenergic cells to deliver ventilatory drive, because when conditional 
dual deletion of AMPK-α1/α2 catalytic subunits was targeted to adrenergic 
(Phenylethanolamine N-methyltransferase [PNMT]-expressing) cells, an 
increased ventilatory phenotype during hypoxia relative to controls and 
stabilisation of ventilation subsequent to reductions in the apnoeic 
phenotype at the beginning of the hypoxic exposure were observed. Clearly, 
these outcomes were in stark contrast and completely opposite to the 
outcomes following deletion of AMPK-α1/α2 in all catecholaminergic cells. 
Therefore, it appeared that AMPK-dependent signalling pathways within the 
catecholaminergic network of the brainstem differentially modulate the HVR 
in noradrenergic and adrenergic cells, whereby it augments respiratory drive 
in the former, but mildly inhibits it in the latter.  
 
9.2 The modulation of respiratory drive during hypoxia by 
AMPK activity within brainstem catecholaminergic cells 
Within the majority of the scientific field, it is believed that the carotid body 
(CB) is the primary peripheral chemoreceptor which solely determines acute 
increases in ventilation during hypoxia through increased afferent discharge 
and modulation of the rCPGs via the catecholaminergic network of the dorsal 
brainstem (Guyenet, 2000; Prabhakar, 2000; Kumar, 2007; Guyenet, 2014). 
However, the responsiveness of central neurons to hypoxia has been 
suggested repeatedly over the decades (Dampney & Moon, 1980; Smith et 
al., 1993; Sun & Reis, 1993; Curran et al., 2000; Hill et al., 2011) and a 
variety of mammalian animal studies have demonstrated that the HVR can 
be either partially or completely restored after either denervation or surgical 
removal of the CB (Davenport et al., 1947; Miller & Tenney, 1975; Bisgard 
et al., 1980; Martin-Body et al., 1986; Daristotle et al., 1991; Roux et al., 




site within the brainstem remains ongoing. Moreover, recent findings from 
our laboratory showed that targeted deletion of the AMPK-α1/α2 catalytic 
subunits in catecholaminergic cells attenuated the HVR and precipitated 
hypoventilation and apnoea during brief exposures to acute hypoxia, despite 
retaining normal increases in CB chemoafferent fibre discharge in response 
to hypoxia (Mahmoud, 2014; Mahmoud et al., 2016). Therefore, it appears 
that a component of the HVR arises centrally within the catecholaminergic 
neurons of the brainstem, and that within this catecholaminergic network 
AMPK activity may govern the integration and onward relay of peripheral 
and possibly central chemoafferent input during periods of reduced O2 
availability. 
 
9.2.1 The ongoing search for a central respiratory oxygen sensor 
The search for a central O2-sensitive site has been under investigation for 
several decades, but the continuous failure to concretely identify such a 
structure or cell population still generates considerable disagreement and 
doubt within the field. However, it now seems that the use of anaesthesia 
may have been a potential confounding factor in suppressing a central 
stimulatory component of the HVR, because the majority of studies that 
reported recovery of the HVR following CB denervation were undertaken in 
awake, and therefore unanaesthetised, animals (Davenport et al., 1947; 
Miller & Tenney, 1975; Bisgard et al., 1980; Martin-Body et al., 1986; 
Daristotle et al., 1991; Roux et al., 2000a; Roux et al., 2000b). Moreover, 
one particular study directly compared the HVR of CB denervated rats in the 
awake state and during urethane-induced general anaesthesia. It was found 
that during anaesthesia, the robust HVR observed in the awake state was 
dramatically reduced, therefore suggesting that anaesthetic agents inhibit 
the signalling mechanisms of central O2-sensitive neurons (Angelova et al., 
2015). In this respect it is important to note that in response to hypoxia, a 
~30% increase in respiratory frequency was also reported in CB denervated 
sleeping dogs, suggesting that a degree of central O2-sensitivity is retained 




Certain proponents of the central respiratory O2 sensor hypothesis have 
recently suggested that this mechanism may not be neuronal in nature, but 
rather determined by ATP-releasing glial cells (Gourine & Funk, 2017). 
Hypoxia was found to induce exocytosis of ATP-containing vesicles in 
astrocytes, which was proposed to potently excite ATP-sensitive neurons of 
the pre-Bötzinger complex (preBötC) (Gourine et al., 2005). However, at 
least within the human brainstem, glial numbers were estimated to outweigh 
neurons in a ratio of 11.35/1 (Azevedo et al., 2009; Lent et al., 2012; 
Herculano-Houzel, 2014), which means their high density and wide spread 
across the brainstem make them unlikely candidates to specifically activate 
the rCPGs. Rather, it would seem more likely that the increased and 
sustained activity of central O2-sensitive neurons during hypoxia is 
supported by ATP-releasing astrocytes, and in direct support of this it was 
found that the metabolic stress-induced activity of catecholaminergic 
neurons in the murine brainstem is dependent on purinergic signalling from 
astrocytes via P2 receptors  (Rogers et al., 2018). In this respect, a role for 
catecholaminergic neurons has long been prominent (Roux et al., 2000a; 
Neubauer & Sunderram, 2004), not at least because other O2-sensing cells 
that are able to potently modulate ventilation are also catecholaminergic 
(Nurse, 2014; Nurse et al., 2018). 
 
9.2.2 The activation of a putative hypoxia-responsive neuronal 
network within the dorsal brainstem is dependent on AMPK 
activity in catecholaminergic cells 
The first direct evidence showing that AMPK-dependent signalling pathways 
in catecholaminergic neurons support the HVR through central neuronal 
activation during hypoxia was obtained by examining the brainstem function 
of TH AMPK-α1/α2 dKO mice by functional magnetic resonance imaging. 
These experiments identified key areas within the dorsal and ventral 
brainstem that exhibited reduced O2 consumption during hypoxia relative to 
controls, indicative of reduced neuronal activity. These regions were 
subsequently termed the ‘dorsal active region’ (DAR) and ‘ventral active 




of cFos expression corroborated these findings and revealed an area of 
significant right-side dominant reductions in neuronal cFos expression within 
the dorsal brainstem, which spanned three subnuclei of the NTS and was 
entirely consistent with the predicted shape, anatomical location and 
rostrocaudal extend of the DAR.  
It seems entirely possible that the DAR forms a hypoxia-responsive neuronal 
circuit within the dorsal medulla through which ventilatory drive is increased 
during hypoxia in an AMPK-dependent manner. In support of this view, its 
anatomical location lies in very close proximity to the area postrema (AP), 
which is highly vascularised and shares blood-borne signals with the NTS 
via its unusual blood supply of highly fenestrated capillaries (Price et al., 
2008). In this respect, the DAR would be strategically placed to monitor 
arterial PO2 centrally. Furthermore, the fenestrated capillaries of the AP 
create a relatively low O2 saturation within the surrounding tissue (Fodor et 
al., 2007; McGinnis et al., 2013), which means that within the neuronal 
population that forms the DAR, this mildly hypoxic environment could result 
in increased afferent output in response to even minor reductions in the 
arterial O2 saturation. Additional O2-sensitivity could be conferred via 
expression of COX4I2 (as has been observed in other O2-sensitive cells 
such as pulmonary arterial smooth muscle cells and CB type I cells) 
(Huttemann et al., 2001; Zhou et al., 2016), consequent susceptibility to 
deficits in mitochondrial ATP production during hypoxia, and thus activation 
of AMPK-dependent signalling pathways to increase O2 uptake via 
enhanced ventilatory effort. However, future analyses of responses to 
hypoxia in TH AMPK-α1/α2 dKO mice and COX4I2 expression within the 
NTS will be required to confirm the nature and capacity for O2-sensing by 
the DAR, and the role of signal integration by these neurons in mediating 
ventilatory output.  
The position of the DAR is also consistent with the location of the rostral 
portion of the noradrenergic A2 cell group, but an involvement of the more 
rostrally located adrenergic C2 cell group could not be excluded at this point. 
Recent studies on laser microdissected A1/A2 and C1/C2 neurons have 




cell groups, and that its activity increases in response to metabolic stress 
(Shrestha et al., 2014). Caudally, the A2 neurons receive chemoafferent 
input from the carotid body and relay these information to other brain regions 
that are involved in the control of breathing (Andresen & Kunze, 1994; 
Andresen & Mendelowitz, 1996; King et al., 2015). Although these afferent 
inputs may not directly innervate the regions encompassing the DAR, relay 
pathways within the NTS lead to the activation of second-order NTS neurons 
in more rostral Bregmas (Andresen et al., 2004), which includes the 
rostrocaudal extend of the DAR. Accordingly, AMPK availability in these 
catecholaminergic neurons may be of primary importance to mediate the 
appropriate response to ‘applied metabolic stress’ during exposures to acute 
hypoxia, and ultimately support the HVR and whole-body O2 homeostasis. 
Moreover, signalling inputs to the DAR could also be received from the AP, 
which contains bidirectional projections to and from the dorsal portion of the 
NTS (van der Kooy & Koda, 1983; Shapiro & Miselis, 1985; Hermann et al., 
2005) and therefore allows for rapid communication between brainstem 
structures within and outside of the Blood-Brain-Barrier. In this respect, the 
DAR could form a ‘central integration hub’ which receives information from 
the periphery as well as the cerebral vasculature and could determine – in 
an AMPK-dependent manner – the degree to which a ventilatory response 
is initiated. Consistent with our proposed model of action (see Figure 9.1), 
the capacity of AMPK activation within the DAR may therefore be 
determined by the co-action of ‘local hypoxic stress’ within the brainstem 
that increases the AM(D)P:ATP ratio via decreases in ATP supply (Hardie, 
2014), coupled to ‘applied metabolic stress’ via intense neuronal activation 
following inputs from peripheral and central afferent projections and thus 
increases in ATP usage. 
The reception and relay of chemoafferent inputs aside, the neurons of the 
A2 cell group themselves have also been reported to be hypoxia-sensitive 
and able to potently modulate ventilation during hypoxia (Andresen & Kunze, 
1994; Andresen & Mendelowitz, 1996; Buller et al., 2008; Li et al., 2008; 
Soliz et al., 2008; McGinnis et al., 2013). In light of the identification of the 




determine the degree of the HVR, but may also offer an explanation as to 
how in some species components of the HVR could be, at least partially, 
restored following CB resection (Davenport et al., 1947; Miller & Tenney, 
1975; Bisgard et al., 1980; Martin-Body et al., 1986; Daristotle et al., 1991; 
Roux et al., 2000a). A direct modulation of ventilation originating from 
hypoxia-responsive A2 neurons and/or the DAR is possible due to the 
afferent projections from the NTS that terminate within the respiratory 
compartments of the ventrolateral medulla and thus the respiratory central 
pattern generators (rCPGs). When taken as a whole, the NTS sends afferent 
projections to each distinct compartment of the ventral respiratory column 
(VRC). However, more detailed analyses of the dorsal to ventral 
innervations revealed that the projections from the individual nuclei of the 
NTS innervate the compartments of the VRC differentially (Alheid et al., 
2011). Importantly, the NTS subnuclei that I proposed to form the DAR 
appear to strongly innervate the rostral and caudal ventral respiratory groups 
which contain bulbospinal projections to motoneurons that facilitate 
inspiration and expiration, respectively, as well as the rostral and caudal 
ventrolateral medulla which contain pre-sympathetic catecholaminergic C1 
neurons implicated in the control of the baroreflex (Ross et al., 1984; Ross 
et al., 1985; Aicher et al., 1996; Dampney et al., 2002; Guyenet, 2006; 
Guyenet et al., 2013). Moreover, at least one of the anatomical nuclei that 
forms part of the DAR was also found to strongly innervate the preBötC and 
Bötzinger complex (BötC), which are important autonomic oscillators that 
are required and sufficient for the rhythmogenesis of inspiration and 
expiration, respectively (Janczewski & Feldman, 2006; Smith et al., 2007; 
Koizumi et al., 2013; Anderson & Ramirez, 2017). Therefore, the activity of 
O2-responsive neurons within the DAR may be sufficient to elicit a ventilatory 
response to hypoxia, even in the absence of increased chemoafferent input.  
Overall, this is the first proposal of an anatomically well-defined central 
hypoxia-responsive neuronal network, which is hypothesised to determine 
the degree of the HVR centrally and whose activity is dependent on 





9.2.3 Ventilatory drive during the hypoxic ventilatory response is 
differentially regulated by AMPK activity within brainstem 
noradrenergic and adrenergic cells 
Dual deletion of the AMPK-α1/α2 catalytic subunits in catecholaminergic 
cells of the brainstem, and thus loss of neuronal activity within the DAR, 
significantly impacted the ventilatory response to hypoxia in mice. When 
both noradrenergic and adrenergic cell groups were targeted by our deletion 
strategy that was dependent on the expression of TH, hypoxia evoked 
severe hypoventilation, ventilatory instability and increases in the frequency 
and duration of apnoeas. Importantly however, components of the classical 
biphasic HVR were retained in TH AMPK-α1/α2 dKO mice, albeit in an 
attenuated manner. These outcomes are consistent with the view that – 
despite the fact that carotid body chemoafferent input responses remained 
unaffected – AMPK-α1/α2 deletion in catecholaminergic neurons blocked 
the HVR beyond the initial ventilatory augmentation during hypoxia for which 
peripheral afferent inputs may be responsible (Teppema & Dahan, 2010; 
Mahmoud et al., 2016; Wilson & Teppema, 2016). That said, the attenuation 
of the Augmenting phase, particularly at 8% O2, indicates that while 
chemoafferent inputs were most likely received within the brainstem, the 
appropriate physiological responses could not be executed sufficiently in the 
absence of AMPK activity within central catecholaminergic cells. This is 
entirely consistent with the proposal that AMPK-dependent signalling 
pathways within brainstem catecholaminergic cells and/or the neuronal 
network of the DAR continuously support signal integration and thus 
modulation of ventilatory output during acute and more prolonged periods of 
hypoxia via modulation of the respiratory central pattern generators (rCPGs) 
(Evans et al., 2016; Mahmoud et al., 2016; Evans, 2018). 
Initially, the possibility remained that TH AMPK-α1/α2 dKO mice could enter 
a hypometabolic state in order to, at least partially, compensate for the fall 
in O2 supply (Guppy & Withers, 1999). This possibility was particularly 
evident from the fact that these mice enter a ‘torpor-like state’ during 
hypoxia, during which the animal lies down and exhibits minimal body 




comprising the catecholaminergic cells of the peripheral carotid body and 
NTS are still immature at birth (Bissonnette, 2000; Teppema & Dahan, 2010; 
Koos & Rajaee, 2014), also exhibit a ventilatory response to hypoxia that is 
characterised by a reduced augmentation phase and a quick decline into 
hypoventilation – similar to the hypoxic ventilatory pattern of TH 
AMPK-α1/α2 dKO mice. However, the depressed neonatal HVR is, at least 
partially, compensated for by a rapid decrease in metabolism and hence O2 
demand (Mortola & Maskrey, 2011). In contrast, no differences in the 
metabolic status between TH AMPK-α1/α2 dKO mice and controls were 
identified, despite exhibiting severe ventilatory deficiencies and ‘torpor-like 
behaviour’ for up to 60min of hypoxia. Therefore, these animals truly enter 
a hypoventilatory state, from which AMPK-dependent signalling pathways 
within central catecholaminergic cells protect.  
A crucial component in the postnatal adaptation to extra-uterine life has been 
suggested to be the release of adrenaline during birth (Padbury et al., 1982; 
Padbury et al., 1987; Hillman et al., 2012), given that the peripheral 
chemoreceptors are poorly developed and initially silenced in the perinatal 
and neonatal periods (Wasicko et al., 1999; Donnelly, 2000; Lavezzi & 
Matturri, 2008). If adrenaline secretion from neonatal adrenal medullary 
chromaffin cells (nAMCs) is truly the developmental trigger, then it appears 
that this event is not dependent on AMPK-dependent signalling pathways. 
This was clear from the fact that dual deletion of the AMPK-α1/α2 catalytic 
subunits in PNMT-expressing adrenergic cells – which includes nAMCs – 
had no effect on the ventilatory phenotype during normoxia and did not result 
in any attenuation of the HVR. In fact, ventilatory frequencies of PNMT 
AMPK-α1/α2 dKO mice were significantly augmented during exposures to 
10min of severe hypoxia relative to controls, suggesting that 
AMPK-dependent signalling pathways in adrenergic cells may to contribute 
an inhibitory input to the HVR in the adult. This was surprising, given that 
adrenergic – and thus PNMT Cre-positive – ventrolateral C1 neurons have 
been proposed to form an integral part of the neural circuit that drives 
increases in breathing frequency during hypoxia in mice and rats (Abbott et 




upon AMPK-α1/α2 catalytic subunit deletion in both adrenergic and 
noradrenergic neurons. It may be possible, therefore, that AMPK-dependent 
signalling pathways within noradrenergic and adrenergic cells serve different 
roles in determining the ventilatory responses to hypoxia. While 
noradrenergic AMPK activity most likely supports hyperventilation along with 
chemoafferent inputs from the carotid bodies, activity of AMPK in adrenergic 
cells may instead indirectly limit the extent of respiratory frequency and thus 
protect from hyperventilation-induced central hypocapnia and therefore 
respiratory alkalosis (Foster et al., 2001). Alternatively, several studies have 
demonstrated that afferent projections from the adrenergic C1 cell group 
also terminate within the thalamus and pons (Haselton & Guyenet, 1990; 
Phillipson & Bohn, 1994; Otake et al., 1995; Abbott et al., 2012; Burke et al., 
2014), which in turn provide an inhibitory input to the rCPGs (Martin-Body, 
1988; Kramer et al., 1999). Therefore, innervations from the C1 cells to the 
rCPGs and pons could determine respiratory drive and inhibition, 
respectively, whereby afferent input to the rCPGs dominates and is perhaps 
determined by the sub-cellular localisation and activity of AMPK (Ross et al., 
2016). 
Further indications that support an inhibitory role of adrenergic signalling – 
be it direct or indirect – came from the fact that AMPK-dependent signalling 
pathways within adrenergic cells appear to contribute to the genesis of 
apnoeas and thus ventilatory instability during the initial Augmenting phase 
of the HVR. By contrast, AMPK-dependent signalling pathways within 
noradrenergic cells seemed to protect from frequent and prolonged apnoeas 
throughout the hypoxic exposure, because deletion of AMPK-α1/α2 catalytic 
subunits in all catecholaminergic cells precipitated highly irregular breathing 
patterns, as well as more frequent spontaneous and prolonged post-sigh 
apnoeas, the former of which were retained as periodically oscillating 
“bursts” evident throughout even prolonged exposures to hypoxia. This 
suggests that AMPK activity within the DAR is required to protect from 
phasic disturbances of the central pattern generators during periods of 




respiratory groups, as well as the Bötzinger complex and pre-Bötzinger 
complex (Alheid et al., 2011).  
On the whole, it is therefore possible that during the Augmenting Phase of 
the HVR respiratory drive is jointly determined by chemoafferent input from 
the carotid bodies, the DAR, and/or central hypoxia-responsive 
noradrenergic neurons that may act in concert with a mild respiratory 
inhibition originating from central adrenergic neurons which may reduce 
ventilation through silencing of the RTN until an equilibrium of optimal 
balance between O2 intake through hyperventilation and protection from 
respiratory alkalosis has been reached (Basting et al., 2015). In this respect, 
complete cessation of ventilation during the Augmenting phase may thus be 
the most rapid and efficient way to restore central CO2 levels during periods 
of intense respiratory effort (Dempsey, 2005). However, after approximately 
four minutes of hypoxia, which coincides with the Sustained Phase of the 
HVR, the balance of inspiratory drive from the carotid bodies, the DAR 
and/or central hypoxia-responsive noradrenergic neurons, and inhibitory 
drive from the adrenergic neurons and/or pons may keep hyperventilation 
and apnoea frequency at a level that maintains adequate CO2 levels during 
periods of hypoxia.  
Roughly coinciding with the end of the Augmenting phase, expiration time 
remains accelerated during hypoxia relative to normoxia due to the initiation 
of active expiration, which is determined by the modulation of the rCPGs via 
activity of the RTN (Feldman & Del Negro, 2006; Janczewski & Feldman, 
2006; Pagliardini et al., 2011; Pisanski & Pagliardini, 2018). This modulation 
appears to be dependent on glutamatergic and serotonergic 
neurotransmission (Moraes et al., 2012b; Lemes et al., 2016; Lemes & 
Zoccal, 2016), and catecholaminergic neurons were shown to use glutamate 
as a neurotransmitter (Fung et al., 1994a; Fung et al., 1994b; Stornetta et 
al., 2002; Rinaman, 2011; DePuy et al., 2013). The fact that active expiration 
appeared to be blocked upon AMPK-α1/α2 catalytic subunit deletion in 
catecholaminergic cells may therefore not be entirely surprising. Importantly, 
selective inhibition of C1 cells was found to attenuate active expiration during 




2017). Moreover, each of the NTS nuclei identified as the DAR also project 
densely to the RTN (Alheid et al., 2011).  Together, this indicates that 
AMPK-dependent afferent inputs from catecholaminergic cells – which likely 
encompass the ventrolateral C1 cell group but may also arise from the DAR 
and/or dorsolateral A2/C2 cell groups – appear to act on the rCPG via the 
RTN in order to engage active expiration, thus reducing the total breath time 
to accommodate increases in ventilatory frequency (Moraes et al., 2012a; 
Burke et al., 2014; Malheiros-Lima et al., 2017; Pisanski & Pagliardini, 2018).  
 
9.2.4 Similarities between the breathing irregularities in the AMPK 
double knockouts and Rett syndrome 
As observed in our TH-driven AMPK knockout model, patients with Rett 
syndrome also exhibit hypoventilation with PO2-dependent increases in the 
frequency of apnoeas. In 60-90% of cases, Rett syndrome is caused by a 
loss-of-function mutation in the methyl-CpG binding protein 2 (MECP2) 
(Amir et al., 1999; Shahbazian & Zoghbi, 2001), which has been strongly 
associated with the progressive degeneration of central catecholaminergic 
neuromodulatory systems (Ide et al., 2005). As previously mentioned, A1/C1 
and A2/C2 catecholaminergic neurons have been proposed to project and 
modulate the rCPGs during hypoxia in a manner dependent on 
chemoafferent input from the carotid body in order to maintain physiological 
PO2 and PCO2 at the whole-body level (Smith et al., 1995; Li et al., 2008; 
King et al., 2012; King et al., 2013). Thus, respiratory instability, 
hypoventilation and increased apnoea frequency appear to occur following 
reductions and loss of catecholaminergic neurotransmission from the A1/C1 
and A2/C2 catecholaminergic neurons to the rCPGs, which could rely on 
AMPK-dependent signalling pathways.  
By contrast, breathing irregularities and apnoeas during hypoxia were also 
shown to be triggered by increases in noradrenergic neurotransmission 
(Zanella et al., 2014). Therefore, appropriate neuromodulation of the rCPGS 
appears to especially depend on precise noradrenergic signalling outputs 




subtle changes in synaptic transmission can have dramatic consequences 
at the whole respiratory network level.  
Given that AMPK deletion was targeted to all catecholaminergic neurons 
and that these mice exhibit breathing irregularities similar to those 
manifested with Rett syndrome or increased noradrenergic 
neurotransmission, AMPK-dependent signalling pathways appear to be 
crucial within these neurons to determine catecholaminergic 
neuromodulation and therefore ventilatory responses during hypoxia. 
However, in contrast to the underlying pathology of Rett syndrome, TH 
AMPK-α1/α2 dKO mice did not appear to exhibit any alterations in the 
number of catecholaminergic neurons within the brainstem. As discussed 
previously, the success of TH-labelling may have been limited in my studies, 
however my overall cell counts were in line with those previously reported in 
the rabbit and rat (Hirooka et al., 1997; Teppema et al., 1997; King et al., 
2015). Moreover, analyses of brainstems and spinal cords of AMPK 
knockouts and controls identified no differences or alterations in the total 
bioamine contents. Therefore, ventilatory deficiencies subsequent to loss of 
catecholaminergic AMPK-dependent signalling pathways were not 
precipitated by alterations in the number of catecholaminergic neurons or 
their bioamine content, but the possibility remains that they could be affected 
by reductions or loss of AMPK-mediated exocytosis (Puljak et al., 2008) and 
subsequent disturbances of onward signalling pathways to the rCPGs. For 
example, noradrenaline was shown to stabilise inspiratory rhythmogenesis 
of the preBötC by stimulation of both the strength and frequency of 
inspiratory bursts (Viemari & Ramirez, 2006; Viemari et al., 2011). Thus, the 
possibility remains that hypoventilation was, at least in part, subsequent to 
loss of noradrenergic neuromodulation of the rCPGs following AMPK 





9.3 AMPK activity in brainstem catecholaminergic neurons 
separates respiratory from cardiovascular responses to 
hypoxia 
In concert with the modulation of respiratory effort, hypoxia also 
synergistically regulates well-defined responses of the cardiovascular 
system via activation of sympathetic efferents. While increased ventilation 
aims to maximise O2 uptake, the cardiovascular response to hypoxia 
ensures that O2 delivery and perfusion are optimised. Within the mouse, this 
translates to progressive decreases in heart rate and blood pressure 
(Campen et al., 2004; Campen et al., 2005a; Campen et al., 2005b). The 
hypotensive effect of acute exposure to hypoxia in mice would be consistent 
with direct vasodilating effects of hypoxia on systemic vessels that may 
override sympathetically mediated increases in systemic vascular resistance 
(Prabhakar & Kumar, 2010; Kulandavelu et al., 2015). In this respect, the 
cardiovascular responses of the mouse are in contrast to other species such 
as rats, cats, pigs, dogs and humans, where hypoxia either maintains or 
increases blood pressure (Bower & O'Donnell, 1991; Hedner et al., 1992; 
Bao et al., 1997; Chen et al., 1998; Schneider et al., 2000). 
 
9.3.1 Cardiorespiratory signal integration at the level of the brainstem 
Peripheral chemoafferent fibre inputs from the CB terminate within the 
caudal NTS, and the vast majority of NTS subnuclei that are innervated by 
these chemoafferents were shown to project to both the respiratory, as well 
as the cardiovascular centres of the ventrolateral medulla (see also Figure 
4.1) (Finley & Katz, 1992; Alheid et al., 2011). In addition, extensive overlap 
exists between the termination sites of chemoafferent input and 
baroreceptor feedback from the vasculature, because both of these 
peripheral sensors densely project to the medial subnucleus of the NTS 
(SolM) (Mendelowitz et al., 1992). Therefore, the integration of these two 
peripheral inputs within the same anatomical structure of the dorsal 
brainstem and the simultaneous onward projections from SolM to the rCPGs 




ventrolateral medulla (RVL and CVL, respectively) directly or via 2nd-order 
NTS neurons make a separation of the individual signalling pathways 
mediating the cardiorespiratory responses to hypoxia nearly impossible. 
Moreover, recordings of sympathetic activity from pre-sympathetic neurons 
of the RVL and CVL have shown that the majority of them are subjected to 
rhythmic respiratory modulation (Numao et al., 1987; Dick et al., 2004; 
Moraes et al., 2017), further highlighting that cardiorespiratory homeostasis 
is maintained and modulated by appropriate changes in both systems.  
However, despite the synaptic connectivity and strong central convergence 
of the cardiorespiratory signalling pathways (Spyer & Gourine, 2009), my 
data supports the existence of an area within the dorsal brainstem where 
AMPK-dependent signalling pathways appear to separate the 
cardiorespiratory control by solely modulating the HVR, but not the 
cardiovascular responses to hypoxia.  
 
9.3.2 Separation of respiratory and cardiovascular responses to 
hypoxia following AMPK deletion in catecholaminergic neurons 
As previously stated, deletion of the AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells resulted in a severely attenuated HVR and the 
identification of the DAR by means of fMRI and cFos expression analysis. 
Subsequently, the DAR was proposed to be crucial in supporting hypoxia-
evoked increases in ventilation in an AMPK-dependent manner. However, 
the cardiovascular responses in mice with AMPK deletion were unaffected, 
as both changes in heart rate and blood pressure during hypoxia were 
comparable to controls, which means a role for the DAR in mediating the 
cardiovascular responses to hypoxia seems unlikely. 
One possible explanation for this separation could be the existence of 
distinct 2nd-order NTS neuronal ‘integration hubs’ within the dorsal 
brainstem, which integrate and regulate the respiratory and cardiovascular 
responses to hypoxia, respectively, by different signalling pathways and/or 
receptor expression profiles. For example, in rhythmically active medullary 




populations is delivered via serotonergic neuromodulation (Ramirez et al., 
1997; Telgkamp & Ramirez, 1999; Thoby-Brisson & Ramirez, 2000; Neff et 
al., 2004; Evans et al., 2005b; Pena & Ramirez, 2005; Hill et al., 2011). 
However, while serotonin activates 5-HT3 receptors on cardiac vagal 
efferents, neuromodulation of respiratory rhythmogenesis via neurons of the 
preBötC involves 5-HT2A receptors (Pena & Ramirez, 2002; Tryba et al., 
2008; Dergacheva et al., 2009). Similarly, variable receptor expression 
profiles of particular neurons within the NTS could lead to signal divergence 
following integration in the caudal portions of SolM and onward relay of 
cardiovascular activity by AMPK-independent pathways.  
Alternatively, it may be possible that the activity and signalling output of a 
subset of catecholaminergic cells may be AMPK-independent. The 
involvement of the ventrolateral catecholaminergic C1 neurons in mediating 
the baroreflex during normoxia and exposures to hypoxia has been well 
established, whereby hypoxia activates bulbospinal C1 neurons, which then 
modulate arterial blood pressure and heart rate via vaso- and cardiomotor 
pre-sympathetic efferents (Ross et al., 1984; Sun & Reis, 1994a; Dampney 
et al., 2002; Guyenet, 2006; Guyenet et al., 2013; Burke et al., 2014). It may 
be possible that this pathway is, at least within a subset of C1 neurons, 
independent on AMPK activity, because fMRI analysis of TH AMPK-α1/α2 
dKO mice during hypoxia revealed an area with significant reductions in 
ventral neuronal activity (i.e. the VAR) that was predominantly consistent 
with the anatomical location and rostrocaudal extend of the noradrenergic 
A1 cells (Mahmoud et al., 2016). Importantly, while the rostral border of the 
VAR appeared to include caudal-most portion of the C1 cells, it appears as 
though the majority of more rostrally located ventral adrenergic cells were 
unaffected and thus retained their neuronal activity during hypoxia. Clearly, 
these assumptions still need to be corroborated by analysis of cFos 
expression. However, given the proposed direct contribution of the C1 cells 
to the ventilatory drive during hypoxia (Burke et al., 2014), it seems likely 
that the sympathetic pathways that control cardiovascular responses to 





9.4 Future experiments 
Clearly, a lot of questions about the role of AMPK signalling in mediating the 
HVR, but not the cardiovascular responses to hypoxia, still remain 
unresolved. Firstly, in order to determine the full anatomical shape and 
extent of the DAR, counts of nuclear cFos expression and TH-labelling need 
to be completed for the more rostral parts of the NTS that harbour the C2/C3 
adrenergic cell populations. At the same time, assessment of the ventral 
regions of the brainstem encompassing the rCPGs and A1/C1 neuronal 
network are crucial to determine the degree by which ventilations during 
hypoxia might be compromised by the VAR, and could give further insight 
into the cardiovascular control by the C1 neurons in relation to AMPK 
activity. Moreover, extending these counts to the pontine regions will 
address whether AMPK activity within noradrenergic A5/A6/A7 neurons 
affected signalling outputs from the pontine respiratory group.  
Once the areas with reduced neuronal activation following AMPK deletion 
have been anatomically defined, their individual and joint contributions to the 
HVR could be tested by means of viral injections into the target regions. This 
can be achieved by injecting a fluorescently tagged recombinant Cre-
recombinase carrying virus vector into the target brainstem regions of 
AMPK-α1/α2 Flx mice. Accordingly, AMPK deletion will only be targeted to 
the injected region and the mice can be examined for their ventilatory 
phenotype during hypoxia. Immunofluorescent studies on perfused and 
fixed brain sections can then be performed to identify the injection site and 
viral spread, and hence the ratio of infected catecholaminergic versus 
non-catecholaminergic neurons. Alternatively, brain slices could be freshly 
dissected and neuronal activity and/or neurotransmitter release of the 
identified target regions recorded ex vivo during normoxic and hypoxic 
conditions by whole-cell patch clamping. However, it is very important to 
consider the local PO2 of various regions within the brainstem, because the 
physiologically normoxic PO2 of certain brainstem areas can be very low and 
perfusion of a higher O2 concentration could therefore lead to silencing of 
hypoxia-responsive neurons and therefore impact on data interpretation of 




In addition to the electrophysiological experiments during exposures to 
normoxia and hypoxia, the proposed hypoxia-sensitivity of the DAR and 
other putative hypoxia-responsive sites could be tested by expression 
analysis of genes that confer O2-sensitivity in other cells types. Accordingly, 
quantitative PCR or RNA sequencing could be carried out to test for the 
expression of NDUFA4L2 and, more importantly, COX4I2, which would 
confirm whether or not the mitochondria within these neuronal circuits are 
exquisitely sensitive to reductions in O2 availability or not.  
 
9.5 Conclusion  
In conclusion, AMPK-dependent signalling pathways in central 
catecholaminergic neurons are not only critical for appropriate ventilatory 
adjustments during acute hypoxia, but also during prolonged periods of low 
O2 availability in order to protect against hypoventilation, respiratory 
instability, and apnoeas. Crucially, AMPK is required to continuously deliver 
increases in the drive to breathe via activation of a putative 
hypoxia-responsive neuronal circuit located in the dorsal brainstem called 
the DAR. Within this neuronal network, the activation of AMPK may be 
determined by peripheral chemoreceptor inputs and brainstem hypoxia, and 
couples those inputs to increased ventilatory drive via signalling outputs to 
the respiratory central pattern generators (Figure 9.1). Therefore, 
AMPK-dependent signalling pathways are not only important to maintain 
cellular energy homeostasis, but have also evolved to regulate O2, and thus 
energy supply, at the whole-body level. Given these indications, it seems 
plausible that aberrant expression levels of AMPK may underlie ventilatory 
pathophysiologies such as sleep-disordered breathing related to the 
metabolic syndrome (Chau et al., 2012; Ruderman et al., 2013), high altitude 
sickness (Ainslie et al., 2013), or sudden infant death syndrome (Nakamura 
& Kuwaki, 2003) and could therefore offer new opportunities for the 






Figure 9.1: Proposed model for the delivery of respiratory drive during 
hypoxia mediated by AMPK dependent signalling pathways in central 
catecholaminergic neurons of the brainstem. 
Ventilatory output during hypoxia, and therefore the degree of HVR, is 
proposed to be mediated by AMPK-dependent signalling pathways within, 
at the very least, dorsal noradrenergic cell of the brainstem which underpin 
the hypoxia-responsiveness of the DAR. During periods of reduced O2 
availability, AMPK activity is hypothesised to be determined by the coaction 
of (1) applied metabolic stress via increased neuronal activity (increased 
ATP consumption) from peripheral and central afferent inputs, and (2) the 
central effect of hypoxia (decreased ATP production). (3) Signalling outputs 
from the DAR innervate and modulate the ventral respiratory central pattern 
generators of the ventrolateral medulla, which in concert provide the efferent 
signals for (4) increased ventilatory output to optimise O2 uptake. Omitted 
for clarity are projections from and to the pons, between the rCPGs, 
additional projections from the NTS to the rCPGs, and neuronal circuits 
regulating cardiovascular responses to hypoxia. AP = area postrema; NTS 
= nucleus tractus solitarius; 7N: facial nucleus, RTN: retrotrapezoid nucleus, 
NA: nucleus ambiguus, BötC: Bötzinger complex, preBötC: pre Bötzinger 
complex, rVRG: rostral ventral respiratory group, cVRG: caudal ventral 
respiratory group, RVL: rostral ventrolateral medulla, CVL: caudal 







Supplementary material for Chapter 3 
 
 
Appendix 1.1: Differences in the pre-hypoxic baselines between 
experimental mice.  
Bar charts show mean ± SEM for (A) ‘raw’ baselines and (B) baselines 
normalised for weight that were selected prior to exposures to mild hypoxia 
(12% O2, left panels) or severe hypoxia (8% O2, right panels) for AMPK-α1 
and -α2 floxed (AMPK-α1/α2 Flx, black, 12% O2: n = 37 exposures from 14 
mice, 8% O2: n = 54 exposures from 21 mice) and TH-driven AMPK-α1 
and -α2 double knockout mice (TH AMPK-α1/α2 dKO, red, 12% O2: n = 28 
exposures from 11 mice, 8% O2: n = 49 exposures from 21 mice). ** = 
p<0.01, **** = p<0.0001. Significance tested by t-tests between genotypes 





Appendix 1.2: Ventilatory deficiency of mice with dual deletion of 
AMPK α1/α2 catalytic subunits in catecholaminergic cells in response 
to mild hypoxia is also apparent in the ‘raw’ experimental data. 
Bar charts show mean ± SEM of values computed by the FinePointe 
software for (A) breathing frequency, (B) tidal volume (normalised for 
weight), and (C) minute ventilation (normalised for weight) during 10 minute 
exposures to mild hypoxia (12% O2) for analysis (i) of the HVR at the peak 
of the augmenting phase (A), the nadir of Roll-Off (RO), and the plateau of 
the sustained phase (SP), (ii) at each full minute of hypoxia, and (iii) whole 
minute averages in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 
n = 37 exposures from 14 mice) and TH-driven AMPK-α1 and -α2 double 
knockout mice (TH AMPK-α1/α2 dKO, red, n = 28 exposures from 11 mice). 
* = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested 






Appendix 1.3: Ventilatory deficiency of mice with dual deletion of 
AMPK α1/α2 catalytic subunits in catecholaminergic cells in response 
to severe hypoxia is also apparent in the ‘raw’ experimental data. 
Bar charts show mean ± SEM of values computed by the FinePointe 
software for (A) breathing frequency, (B) tidal volume (normalised for 
weight), and (C) minute ventilation (normalised for weight) during 10 minute 
exposures to severe hypoxia (8% O2) for analysis (i) of the HVR at the peak 
of the augmenting phase (A), the nadir of Roll-Off (RO), and the plateau of 
the sustained phase (SP), (ii) at each full minute of hypoxia, and (iii) whole 
minute averages in AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 
n = 55 exposures from 21 mice) and TH-driven AMPK-α1 and -α2 double 
knockout mice (TH AMPK-α1/α2 dKO, red, n = 40 exposures from 18 mice). 
* = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Significance tested 






Appendix 1.4: The hypoxic ventilatory response to mild and severe 
hypoxia is significantly attenuated in mice with dual deletion of AMPK 
α1/α2 catalytic subunits in catecholaminergic cells when analysed as 
whole minute averages.  
Bar charts show mean ± SEM for the % changes of 60 second averages in 
(A) breathing frequency, (B) tidal volume, and (C) minute ventilation during 
10 minute exposures to (i) mild hypoxia (12% O2) and (ii) severe hypoxia 
(8% O2) for AMPK-α1 and -α2 floxed mice (AMPK-α1/α2 Flx, black, 12% O2: 
n = 37 exposures from 14 mice, 8% O2: n = 55 exposures from 21 mice) and 
TH-driven AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, 
red, 12% O2: n = 28 exposures from 11 mice, 8% O2: n = 40 exposures from 
18 mice). * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. 











Appendix 2.1: Means ± SEM of dorsal (counts per 1000µm3) and ventral 
(counts per sections) tyrosine hydroxylase (TH)-positive cells for the 
whole brainstem of AMPK-α1/α2 Flx (n = 16) and TH AMPK-α1/α2 dKO 
(n = 11) mice.  
 











Dorsal 0.0023 ± 0.00035 0.0016 ± 0.00027 ns
Ventral 16 ± 1.1 17 ± 0.99 ns
Right side
Dorsal 0.001 ± 0.00016 0.0009 ± 0.0001 ns
Ventral 8.3 ± 0.58 8.5 ± 0.6 ns
Left side
Dorsal 0.0009 ± 0.00015 0.0007 ± 0.0001 ns




Appendix 2.2: Means ± SEM of dorsal (counts per 1000µm3) tyrosine 
hydroxylase (TH)-positive cells for the whole NTS of AMPK-α1/α2 Flx 
and TH AMPK-α1/α2 dKO mice at each Bregma.  
 
ns = not significant; significance tested by multiple t-tests with Holm-Sidak 
post-hoc test. 
Appendix 2.3: Means ± SEM of dorsal (counts per 1000µm3) tyrosine 
hydroxylase (TH)-positive cells for the whole brainstem of AMPK-α1/α2 
Flx (n = 16) and TH AMPK-α1/α2 dKO (n = 11) mice for each subnucleus 
of the NTS.  
 














 - 7.76 mm 0.001 ± 0.0003n = 10
0.001 ± 0.0002








n = 10 ns
 - 7.70 mm 0.002 ± 0.0004n = 6
0.001 ± 0.0001








n = 4 ns
 - 7.64 mm 0.001 ± 0.0002n = 15
0.001 ± 0.0002








n = 11 ns
 - 7.60 mm 0.001 ± 0.0001n = 4
0.001 ± 0.0001








n = 4 ns
 - 7.56 mm 0.0008 ± 0.0001n = 13
0.0006 ± 0.0001








n = 11 ns
 - 7.50 mm 0.0009 ± 0.0002n = 11
0.0005 ± 0.0001








n = 8 ns
 - 7.48 mm 0.0006 ± 0.0001n = 16
0.0005 ± 0.0001








n = 11 ns
 - 7.44 mm 0.0001 ± 0.0001n = 8
0.0006 ± 0.0003









n = 4 ns













SubP 0.0002 ± 0.00007 0.00002 ± 0.00002 ns 0.0002 ± 0.00009 0 ± 0 ns 0.0001 ± 0.00006 0.0001 ± 0.00005 ns
10N 0.0004 ± 0.0001 0.0016 ± 0.00027 ns 0.0005 ± 0.0002 0.0005 ± 0.0002 ns 0.0003 ± 0.00008 0.0003 ± 0.00008 ns
SolC 0.00008 ± 0.00003 0.00012 ± 0.00006 ns / / / / / /
SolM 0.0006 ± 0.0001 0.0007 ± 0.0001 ns 0.0006 ± 0.0001 0.0007 ± 0.0001 ns 0.0006 ± 0.0001 0.0006 ± 0.0001 ns
SolDM 0.0002 ± 0.0001 0.0001 ± 0.0001 ns 0.00009 ± 0.00006 0 ± 0 ns 0.0002 ± 0.0001 0.0002 ± 0.0001 ns
SolDL 0.0003 ± 0.00007 0.0002 ± 0.00005 ns 0.0003 ± 0.00009 0.0003 ± 0.00008 ns 0.0002 ± 0.00008 0.0002 ± 0.00005 ns
SolI 0.0009 ± 0.0003 0.0006 ± 0.0001 ns 0.001 ± 0.0005 0.001 ± 0.0003 ns 0.0005 ± 0.0002 0.0002 ± 0.0001 ns
SolIM 0.003 ± 0.0004 0.002 ± 0.0004 ns 0.003 ± 0.0005 0.002 ± 0.0004 ns 0.002 ± 0.0004 0.002 ± 0.0005 ns
SolV 0.002 ± 0.0003 0.002 ± 0.0003 ns 0.002 ± 0.0003 0.001 ± 0.0003 ns 0.002 ± 0.0004 0.002 ± 0.0004 ns
SolVL 0.002 ± 0.0004 0.001 ± 0.0002 ns 0.002 ± 0.0005 0.001 ± 0.0003 ns 0.002 ± 0.0004 0.001 ± 0.0002 ns
SolL 0.0005 ± 0.0002 0.0003 ± 0.0001 ns 0.0007 ± 0.0003 0.0003 ± 0.0002 ns 0.0001 ± 0.00008 0.0002 ± 0.00011 ns
SolCe 0.003 ± 0.0004 0.002 ± 0.0003 ns 0.002 ± 0.0006 0.003 ± 0.0005 ns 0.002 ± 0.0005 0.002 ± 0.0003 ns




Appendix 2.4: Means ± SEM of ventral (counts per sections) tyrosine 
hydroxylase (TH)-positive cells in AMPK-α1/α2 Flx (n = 16) and TH 
AMPK-α1/α2 dKO (n = 11) mice. ns = not significant, * = p<0.05; 




Appendix 2.5: Means ± SEM of bioamine contents in the brainstem and 
spinal cords of AMPK-α1/α2 Flx (n = 11) and TH AMPK-α1/α2 dKO (n = 
12) mice. 
 
L-DOPA: L-3,4-dihydroxyphenylalanine, NA: noradrenaline, 5-HT: 
serotonin, 5-HIAA: 5-hydroxyindoleacetic acid. ns = not significant; 







A1 18 ± 1.1 20.1 ± 1.2 ns
A1/C1 16.9 ± 1.3 16.6 ± 1.2 ns
C1 12.6 ± 1 15 ± 1.3 ns
Right side
A1 9.4 ± 0.5 9.7 ± 0.8 ns
A1/C1 8.9 ± 0.8 8 ± 0.6 ns
C1 5.7 ± 0.6 8.3 ± 0.9 *
Left side
A1 8.7 ± 0.7 10.4 ± 0.8 ns
A1/C1 8 ± 0.9 8.6 ± 0.9 ns









L-DOPA 670 ± 97 ng/g 700.5 ± 110.5 ng/g ns 1221 ± 138 ng/g 990 ± 198.5 ng/g ns
NA 2399 ± 192 ng/g 2090 ± 162 ng/g ns 1605 ± 185 ng/g 1662 ± 227 ng/g ns
5-HT 826 ± 48 ng/g 790 ± 35 ng/g ns 551 ± 35 ng/g 617 ± 46 ng/g ns






Appendix 2.6: Means ± SEM of total cFos counts (per 1000µm3) for each 
Bregma of the total, right, and left NTS in AMPK-α1/α2 Flx mice 




Appendix 2.7: Means ± SEM of total cFos counts (per 1000µm3) for each 
subnucleus along the length of the total, right, and left NTS in 
AMPK-α1/α2 Flx mice following exposures to 21% O2 (n = 4), 12% O2 (n 
= 6), and 8% O2 (n = 6). 
 
 
21% O2 12% O2 8% O2 21% O2 12% O2 8% O2 21% O2 12% O2 8% O2 

















 - 7.70 mm / 0.059 ± 0.028n = 2
0.073 ± 0.008















































































































Both sides Right side Left side
21% O2 12% O2 8% O2 21% O2 12% O2 8% O2 21% O2 12% O2 8% O2 
AP 0.004 ± 0.002 0.037 ± 0.008 0.073 ± 0.014 / / / / / /
SubP 0.002 ± 0.0006 0.023 ± 0.0078 0.052 ± 0.0069 0.002 ± 0.002 0.024 ± 0.008 0.059 ± 0.009 0.003 ± 0.001 0.021 ± 0.007 0.045 ± 0.008
10N 0.011 ± 0.002 0.052 ± 0.007 0.082 ± 0.009 0.012 ± 0.003 0.052 ± 0.006 0.076 ± 0.008 0.01 ± 0.002 0.052 ± 0.009 0.087 ± 0.011
SolC 0.003 ± 0.0005 0.021 ± 0.0051 0.039 ± 0.0044 / / / / / /
SolM 0.006 ± 0.0007 0.058 ± 0.0149 0.09 ± 0.0102 0.004 ± 0.0006 0.058 ± 0.0152 0.085 ± 0.0082 0.007 ± 0.001 0.057 ± 0.015 0.094 ± 0.013
SolDM 0.003 ± 0.0008 0.034 ± 0.0128 0.061 ± 0.0105 0.003 ± 0.0004 0.036 ± 0.0179 0.068 ± 0.012 0.003 ± 0.002 0.033 ± 0.01 0.056 ± 0.01
SolDL 0.005 ± 0.001 0.045 ± 0.013 0.083 ± 0.009 0.005 ± 0.0009 0.041 ± 0.0117 0.09 ± 0.011 0.006 ± 0.001 0.048 ± 0.014 0.078 ± 0.009
SolI 0.011 ± 0.002 0.051 ± 0.009 0.118 ± 0.021 0.012 ± 0.002 0.049 ± 0.011 0.125 ± 0.029 0.009 ± 0.003 0.053 ± 0.013 0.111 ± 0.014
SolIM 0.016 ± 0.002 0.076 ± 0.017 0.126 ± 0.016 0.017 ± 0.005 0.075 ± 0.015 0.125 ± 0.015 0.014 ± 0.0009 0.077 ± 0.0191 0.128 ± 0.0174
SolV 0.024 ± 0.002 0.043 ± 0.009 0.086 ± 0.008 0.028 ± 0.004 0.049 ± 0.011 0.086 ± 0.011 0.02 ± 0.002 0.037 ± 0.009 0.086 ± 0.006
SolVL 0.013 ± 0.002 0.04 ± 0.01 0.079 ± 0.01 0.016 ± 0.005 0.04 ± 0.007 0.078 ± 0.013 0.01 ± 0.001 0.04 ± 0.013 0.08 ± 0.008
SolL 0.013 ± 0.004 0.034 ± 0.013 0.073 ± 0.007 0.012 ± 0.003 0.029 ± 0.009 0.069 ± 0.006 0.014 ± 0.005 0.039 ± 0.016 0.08 ± 0.01
SolCe 0.015 ± 0.002 0.077 ± 0.014 0.118 ± 0.016 0.016 ± 0.002 0.066 ± 0.011 0.118 ± 0.015 0.015 ± 0.003 0.087 ± 0.017 0.119 ± 0.018






Appendix 2.8: cFos expression at Bregma -7.76mm increases with 
decreasing PO2.  
Means ± SEM of cFos-positive cell counts per 1000μm3 in AMPK-α1/α2 
floxed mice after 60min exposures to 21% O2 (n = 4 mice), 12% O2 (n = 6 
mice), or 8% O2 (n = 6 mice). * = p<0.05, ** = p<0.01; significance tested by 





Appendix 2.9: cFos expression at Bregma -7.64mm increases with 
decreasing PO2.  
Means ± SEM of cFos-positive cell counts per 1000μm3 in AMPK-α1/α2 
floxed mice after 60min exposures to 21% O2 (n = 4 mice), 12% O2 (n = 6 
mice), or 8% O2 (n = 6 mice). * = p<0.05, ** = p<0.01; significance tested by 





Appendix 2.10: cFos expression at Bregma -7.56mm increases with 
decreasing PO2.  
Means ± SEM of cFos-positive cell counts per 1000μm3 in AMPK-α1/α2 
floxed mice after 60min exposures to 21% O2 (n = 4 mice), 12% O2 (n = 6 
mice), or 8% O2 (n = 6 mice). * = p<0.05, ** = p<0.01; significance tested by 





Appendix 2.11: cFos expression at Bregma -7.48mm increases with 
decreasing PO2.  
Means ± SEM of cFos-positive cell counts per 1000μm3 in AMPK-α1/α2 
floxed mice after 60min exposures to 21% O2 (n = 4 mice), 12% O2 (n = 6 
mice), or 8% O2 (n = 6 mice). * = p<0.05, ** = p<0.01, *** = p<0.001; 




Appendix 2.12: Means ± SEM of cFos counts (per 1000µm3) for each 
Bregma of the whole, right, and left side of the NTS in AMPK-α1/α2 Flx 
and TH AMPK-α1/α2 dKO mice.  
 
ns = not significant; significance tested by multiple t-tests with Holm-Sidak 
post-hoc test. 
Appendix 2.13: Means ± SEM of cFos counts (per 1000µm3) for each 
subnucleus along the length of the total, right, and left NTS in 
AMPK-α1/α2 Flx (n = 6) and TH AMPK-α1/α2 dKO (n = 7) mice for each 
subnucleus of the NTS.  
 














 - 7.76 mm 0.073 ± 0.008n = 3
0.071 ± 0.012








n = 6 ns
 - 7.70 mm 0.071 ± 0.011n = 4
0.072 ± 0.017








n = 3 ns
 - 7.64 mm 0.087 ± 0.012n = 5
0.066 ± 0.013








n = 7 ns
 - 7.60 mm 0.07 ± 0.022n = 2
0.062 ± 0.037








n = 2 ns
 - 7.56 mm 0.078 ± 0.011n = 4
0.06 ± 0.012








n = 7 ns
 - 7.52 mm 0.086 ± 0.013n = 4
0.075 ± 0.016








n = 5 ns
 - 7.48 mm 0.086 ± 0.009n = 6
0.065 ± 0.013








n = 7 ns
 - 7.44 mm 0.1 ± 0.007n = 3
0.06 ± 0.014








n = 4 ns













AP 0.073 ± 0.014 0.049 ± 0.009 ns / / / / / /
SubP 0.052 ± 0.007 0.03 ± 0.005 ns 0.059 ± 0.009 0.029 ± 0.005 ns 0.045 ± 0.008 0.03 ± 0.005 ns
10N 0.082 ± 0.009 0.06 ± 0.01 ns 0.076 ± 0.008 0.059 ± 0.011 ns 0.087 ± 0.011 0.062 ± 0.009 ns
SolC 0.039 ± 0.004 0.025 ± 0.006 ns / / / / / /
SolM 0.09 ± 0.01 0.074 ± 0.018 ns 0.085 ± 0.008 0.076 ± 0.018 ns 0.094 ± 0.013 0.072 ± 0.018 ns
SolDM 0.061 ± 0.01 0.037 ± 0.01 ns 0.068 ± 0.012 0.042 ± 0.014 ns 0.056 ± 0.01 0.034 ± 0.008 ns
SolDL 0.083 ± 0.009 0.056 ± 0.012 ns 0.09 ± 0.011 0.061 ± 0.012 ns 0.078 ± 0.009 0.052 ± 0.013 ns
SolI 0.118 ± 0.021 0.086 ± 0.013 ns 0.125 ± 0.029 0.091 ± 0.012 ns 0.111 ± 0.014 0.081 ± 0.015 ns
SolIM 0.126 ± 0.016 0.111 ± 0.025 ns 0.125 ± 0.015 0.113 ± 0.026 ns 0.128 ± 0.017 0.108 ± 0.024 ns
SolV 0.086 ± 0.008 0.06 ± 0.012 ns 0.086 ± 0.011 0.061 ± 0.011 ns 0.086 ± 0.006 0.059 ± 0.013 ns
SolVL 0.079 ± 0.01 0.064 ± 0.008 ns 0.078 ± 0.013 0.065 ± 0.007 ns 0.08 ± 0.008 0.064 ± 0.01 ns
SolL 0.073 ± 0.007 0.062 ± 0.006 ns 0.069 ± 0.006 0.056 ± 0.004 ns 0.08 ± 0.01 0.069 ± 0.011 ns
SolCe 0.118 ± 0.016 0.1 ± 0.018 ns 0.118 ± 0.015 0.104 ± 0.018 ns 0.119 ± 0.018 0.096 ± 0.019 ns




Appendix 2.14: Means ± SEM of cFos counts (per 1000µm3) for 
subnuclei of the NTS at each Bregma between AMPK-α1/α2 Flx and TH 
AMPK-α1/α2 dKO mice.  
 
 
ns = not significant, * = p<0.05, ** = p<0.01, *** = p<0.001; significance 


























Nucleus A 0.077 ± 0.013
n = 3
0.052 ± 0.013












n = 7 ns
Nucleus B 0.063 ± 0.021
n = 3
0.033 ± 0.004












n = 7 ns
Nucleus C 0.075 ± 0.023
n = 3
0.023 ± 0.008








n = 5 ns / / /
Nucleus D 0.107 ± 0.007
n = 3
0.049 ± 0.010












n = 7 ns
Nucleus E 0.063 ± 0.022
n = 3
0.062 ± 0.024












n = 7 ns
Nucleus F 0.088 ± 0.011
n = 3
0.061 ± 0.02












n = 7 ns
Nucleus G 0.105 ± 0.013
n = 3
0.131 ± 0.041












n = 7 ns
Nucleus H 0.15 ± 0.005
n = 3
0.103 ± 0.041












n = 7 ns
Nucleus I 0.114 ± 0.015
n = 3
0.051 ± 0.012












n = 7 ns
Nucleus J 0.095 ± 0.011
n = 3
0.08 ± 0.019












n = 7 ns
Nucleus K 0.083 ± 0.006
n = 3
0.063 ± 0.014












n = 7 ns
Nucleus L 0.146 ± 0.015
n = 3
0.094 ± 0.023












n = 7 ns
Nucleus M 0.103 ± 0.031
n = 3
0.061 ± 0.013












n = 7 *


























Nucleus A 0.064 ± 0.026
n = 2
0.047 ± 0.038












n = 6 ns
Nucleus B 0.045 ± 0.023
n = 2
0.039 ± 0.027












n = 6 ns
Nucleus C / / / / / / / / / / / /
Nucleus D 0.066 ± 0.013
n = 2
0.065 ± 0.03












n = 6 ns
Nucleus E 0.023 ± 0.011
n = 2
0.032 ± 0.009












n = 6 ns
Nucleus F 0.074 ± 0.033
n = 2
0.049 ± 0.034












n = 6 ns
Nucleus G 0.061 ± 0.005
n = 2
0.082 ± 0.033












n = 6 ns
Nucleus H 0.104 ± 0.037
n = 2
0.102 ± 0.06








n = 3 ns / / /
Nucleus I 0.073 ± 0.012
n = 2
0.046 ± 0.027












n = 6 ns
Nucleus J 0.065 ± 0.012
n = 2
0.092 ± 0.052












n = 6 ns
Nucleus K 0.075 ± 0.01
n = 2
0.059 ± 0.026
n = 2 ns / / / / / / / / /
Nucleus L 0.085 ± 0.031
n = 2
0.093 ± 0.067












n = 6 ns
Nucleus M 0.101 ± 0.021
n = 2
0.045 ± 0.029












n = 6 ns





























Nucleus A 0.089 ± 0.013
n = 3
0.066 ± 0.014












n = 7 ns
Nucleus B 0.056 ± 0.028
n = 3
0.031 ± 0.009












n = 7 *
Nucleus C 0.092 ± 0.027
n = 3
0.029 ± 0.01








n = 5 ns / / /
Nucleus D 0.105 ± 0.007
n = 3
0.049 ± 0.012












n = 7 ns
Nucleus E / / / / / / / / / / / /
Nucleus F 0.089 ± 0.01
n = 3
0.066 ± 0.024












n = 7 ns
Nucleus G 0.106 ± 0.022
n = 3
0.142 ± 0.041












n = 7 ns
Nucleus H 0.15 ± 0.015
n = 3
0.1 ± 0.045












n = 7 ns
Nucleus I 0.113 ± 0.008
n = 3
0.054 ± 0.019












n = 7 ns
Nucleus J 0.106 ± 0.022
n = 3
0.09 ± 0.021












n = 7 ns
Nucleus K 0.082 ± 0.011
n = 3
0.049 ± 0.011












n = 7 ns
Nucleus L 0.145 ± 0.008
n = 3
0.103 ± 0.036












n = 7 ns


























Nucleus A 0.068 ± 0.037
n = 2
0.045 ± 0.035












n = 6 ns
Nucleus B 0.039 ± 0.02
n = 2
0.049 ± 0.037












n = 6 ns
Nucleus C / / / / / / / / / / / /
Nucleus D 0.059 ± 0.019
n = 2
0.07 ± 0.03












n = 6 ns
Nucleus E / / / / / / / / / / / /
Nucleus F 0.075 ± 0.031
n = 2
0.049 ± 0.025












n = 6 ns
Nucleus G 0.051 ± 0.004
n = 2
0.068 ± 0.008












n = 6 ns
Nucleus H 0.112 ± 0.04
n = 2
0.085 ± 0.037








n = 3 ns / / /
Nucleus I 0.072 ± 0.014
n = 2
0.053 ± 0.013












n = 6 ns
Nucleus J 0.071 ± 0.011
n = 2
0.115 ± 0.06












n = 6 ns
Nucleus K 0.101 ± 0.022
n = 2
0.04 ± 0.015
n = 2 ns / / / / / / / / /
Nucleus L 0.105 ± 0.032
n = 2
0.084 ± 0.061












n = 6 ns







































Nucleus A 0.074 ± 0.015
n = 3
0.038 ± 0.02












n = 7 ns
Nucleus B 0.07 ± 0.02
n = 3
0.036 ± 0.009












n = 7 ns
Nucleus C 0.063 ± 0.029
n = 3
0.029 ± 0.006








n = 5 ns / / /
Nucleus D 0.11 ± 0.013
n = 3
0.048 ± 0.009












n = 7 ns
Nucleus E / / / / / / / / / / / /
Nucleus F 0.088 ± 0.013
n = 3
0.056 ± 0.017












n = 7 ns
Nucleus G 0.105 ± 0.003
n = 3
0.099 ± 0.052












n = 7 ns
Nucleus H 0.15 ± 0.016
n = 3
0.106 ± 0.038












n = 7 ns
Nucleus I 0.114 ± 0.024
n = 3
0.046 ± 0.011












n = 7 ns
Nucleus J 0.086 ± 0.002
n = 3
0.072 ± 0.021












n = 7 ns
Nucleus K 0.085 ± 0.003
n = 3
0.086 ± 0.02












n = 7 ns
Nucleus L 0.174 ± 0.009
n = 3
0.085 ± 0.015












n = 7 ns


























Nucleus A 0.06 ± 0.013
n = 2
0.049 ± 0.041












n = 6 ns
Nucleus B 0.059 ± 0.028
n = 2
0.022 ± 0.008












n = 6 ns
Nucleus C / / / / / / / / / / / /
Nucleus D 0.073 ± 0.008
n = 2
0.061 ± 0.03












n = 6 ns
Nucleus E / / / / / / / / / / / /
Nucleus F 0.072 ± 0.034
n = 2
0.049 ± 0.042












n = 6 ns
Nucleus G 0.07 ± 0.012
n = 2
0.092 ± 0.067












n = 6 ns
Nucleus H 0.095 ± 0.034
n = 2
0.122 ± 0.088








n = 3 ns / / /
Nucleus I 0.073 ± 0.011
n = 2
0.042 ± 0.037












n = 6 ns
Nucleus J 0.06 ± 0.013
n = 2
0.073 ± 0.045












n = 6 ns
Nucleus K 0.056 ± 0.001
n = 2
0.073 ± 0.03
n = 2 ns / / / / / / / / /
Nucleus L 0.069 ± 0.03
n = 2
0.1 ± 0.072












n = 6 ns




Appendix 2.15: Means ± SEM of cFos counts (per 1000µm3) for three 
subnuclei of the NTS and combinations of them that showed 
hemisphere- and Bregma-specific differences between AMPK-α1/α2 
Flx (n = 6) and TH AMPK-α1/α2 dKO (n = 7) mice.  
 
ns = not significant, * = p<0.05, ** = p<0.01; significance tested by unpaired 



















A 0.09 ± 0.013 0.051 ± 0.006 * 0.093 ± 0.014 0.051 ± 0.008 * 0.087 ± 0.016 0.05 ± 0.012 ns
Nucleus




























































































































































n = 7 **
Combination 1 Combination 2 Combination 3
Nucleus A Nucleus B Nucleus C




Appendix 2.16: Means ± SEM of dorsal tyrosine hydroxylase 
(TH)-positive cell activation (in %) and total cell counts for each 
Bregma of the whole brainstem in AMPK-α1/α2 Flx mice. 
 
Appendix 2.17: Means ± SEM of PO2-dependent changes in dorsal 
tyrosine hydroxylase (TH)-positive cell activation (in %) for each 







 - 7.76 mm 73.55 ± 12.9n = 3
15.67 ± 3.93
n = 3
 - 7.70 mm 83.6 ± 5.67n = 4
17.25 ± 5.15
n = 4
 - 7.64 mm 73.67 ± 7n = 5
14.2 ± 5.62
n = 5
 - 7.60 mm 83.15 ± 5.74n = 2
24.5 ± 6.5
n = 2
 - 7.56 mm 82.41 ± 12.17n = 4
15.75 ± 5.48
n = 4
 - 7.52 mm 67.66 ± 13.54n = 5
14.17 ± 4.72
n = 6
 - 7.48 mm 74.37 ± 9.27n = 6
12.33 ± 3.34
n = 6
 - 7.44 mm 100n = 1
0.5 ± 0.5
n = 2
21% O2 12% O2 8% O2 





 - 7.70 mm 86.16 ± 7.59n = 2
83.6 ± 5.67
n = 4


































Supplementary material for Chapter 5 
 
Appendix 3.1: Dual deletion of the AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells precipitates “bursts” of apnoea frequency at 
regular intervals during prolonged 60min exposures to severe hypoxia.  
Line charts show the mean apnoea index (AI, apnoeas/min) over a 60min 
period of severe hypoxia (8% O2) of all experimental TH-driven AMPK-α1 
and -α2 double knockout mice (TH AMPK-α1/α2 dKO, n = 4) at the top and 





Appendix 3.2: The apnoea duration declines and stabilises over time 
in mice with dual deletion of the AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells during prolonged 60min exposures to severe 
hypoxia.  
Line charts show the mean apnoea duration (AD, ms) over a 60min period 
of severe hypoxia (8% O2) of all experimental TH-driven AMPK-α1 and -α2 
double knockout mice (TH AMPK-α1/α2 dKO, n = 4) at the top and each 






Appendix 3.3: Dual deletion of the AMPK-α1/α2 catalytic subunits in 
catecholaminergic cells precipitates “bursts” of the apnoea duration 
index at regular intervals during prolonged 60min exposures to severe 
hypoxia.  
Line charts show the mean apnoea duration index (ADI, AI x duration) over 
a 60min period of severe hypoxia (8% O2) of all experimental TH-driven 
AMPK-α1 and -α2 double knockout mice (TH AMPK-α1/α2 dKO, n = 4) at 











Appendix 4.1: Dual deletion of the AMPK-α1/α2 catalytic subunits in 
arterial smooth muscle cells does not alter resting blood pressure 
values.  
Bar charts show mean ± SEM of the mean, systolic and diastolic blood 
pressures of control AMPK-α1/α2 floxed (Flx; black; n = 6) mice, those with 
AMPK-α1 (orange; n = 4) and AMPK-α2 (green; n = 4) deletion in arterial 
smooth muscles (transgelin expressing cells) and AMPK-α1/α2 double KO 







Supplementary material for Chapter 8 
 
 
Appendix 4.1: Differences in the pre-hypoxic baselines between the 
genotypes tested.  
Bar charts show mean ± SEM for (A) ‘raw’ baselines and (B) baselines 
normalised for weight that were selected prior to exposures to severe 
hypoxia (8% O2) for AMPK-α1 and -α2 floxed (AMPK-α1/α2 Flx, black, n = 
54 exposures from 21 mice), mice expressing Cre under the 
Phenylethanolamine N-methyltransferase reporter (PNMT Cre, blue, n = 32 
exposures from 8 mice) and PNMT-driven AMPK-α1 and -α2 double 
knockout mice (PNMT AMPK-α1/α2 dKO, purple, n = 32 exposures from 8 
mice). * = p<0.05, ** = p<0.01. Significance tested by one-way ANOVA 





Appendix 4.2: The inter-breath intervals during exposures to severe 
hypoxia are attenuated in the first half of the exposure in mice with 
dual deletion of the AMPK α1/α2 catalytic subunits in adrenergic cells.  
Bar charts show mean ± SEM for the standard deviations (SD) of the 
inter-breath intervals in mice expressing Cre under the Phenylethanolamine 
N-methyltransferase reporter (PNMT Cre, blue, n = 32 exposures from 8 
mice) and PNMT-driven AMPK-α1 and -α2 double knockout mice (PNMT 
AMPK-α1/α2 dKO, purple, n = 32 exposures from 8 mice) for (A) the entire 
10min and (B) the first and second half of 10min exposures to severe 
hypoxia (8% O2). * = p<0.05, **** = p<0.0001. Significance tested by (A) 





Appendix 4.3: Ventilatory differences in the response to severe 
hypoxia are also apparent in the ‘raw’ experimental data. 
Bar charts show mean ± SEM of values computed by the FinePointe 
software for (A) breathing frequency, (B) tidal volume (normalised for 
weight), and (C) minute ventilation (normalised for weight) during 10 minute 
exposures to severe hypoxia (8% O2) for analysis (i) of the HVR at the peak 
of the augmenting phase (A), the nadir of Roll-Off (RO), and the plateau of 
the sustained phase (SP), and (ii) as whole minute averages for AMPK-α1 
and -α2 floxed mice (AMPK-α1/α2 Flx, black, 12% O2: n = 37 exposures 
from 14 mice, 8% O2: n = 55 exposures from 21 mice), mice expressing Cre 
under the Phenylethanolamine N-methyltransferase reporter (PNMT Cre, 
blue, n = 32 exposures from 8 mice) and PNMT-driven AMPK-α1 and -α2 
double knockout mice (PNMT AMPK-α1/α2 dKO, purple, n = 32 exposures 
from 8 mice).  * = p<0.05, ** = p<0.01, **** = p<0.0001. Significance tested 





Appendix 4.4: Pre-hypoxic baselines are comparable for C57Bl6 and 
CD1 background controls.  
Bar charts show mean ± SEM for (A) ‘raw’ baselines and (B) baselines 
normalised for weight that were selected prior to exposures to severe 
hypoxia (8% O2) for wild-type C57Bl6 mice (black checked, n = 20 exposures 
from 5 mice), and CD1 mice expressing Cre under the Phenylethanolamine 
N-methyltransferase reporter (PNMT Cre – CD1, blue checked, n = 8 
exposures from 2 mice). Significance tested by one-way ANOVA between 





Figure 4.5: The hypoxic ventilatory response to 5min of severe hypoxia 
is background strain-specific. 
Left and middle panels show raw example records of breathing (A) 
frequencies (breaths/min), (B) tidal volume (ml/min) and (C) minute 
ventilation (ml/g/min) during 10 minute exposures to severe hypoxia (8% O2) 
from (i) a wild-type C57Bl6 mouse and (ii) a CD1 mouse expressing Cre 
under the Phenylethanolamine N-methyltransferase reporter (PNMT Cre – 
CD1) with a 2s sampling frequency. Dotted green lines indicate pre-hypoxic 
baseline frequencies, dashed lines the artefacts induced by gas exchange. 
Right panels (iii) show means ± SEM for percentage changes during the 
peak of the augmenting phase (A, approximately 30s), the nadir of the 
Roll-Off (RO, approximately 100s), and the plateau of the sustained phase 
(SP, at 300s) of the HVR in C57Bl6 mice (black checked, n = 20 exposures 
from 5 mice) and PNMT Cre – CD1 mice (blue checked, n = 8 exposures 
from 2 mice). * = p<0.05, ** = p<0.01, *** = p<0.001. Significance tested by 





Figure 4.6: The hypoxic ventilatory response to 10min of severe 
hypoxia is background strain-specific.  
Means ± SEM for percentage changes relative to normoxia (green dotted 
line) of (A) breathing frequency (breaths/min), (B) tidal volume (ml), and (C) 
minute ventilation (ml/min) during 10 minute exposures to severe hypoxia 
(8% O2) in wild-type C57Bl6 mice (black checked, n = 20 exposures from 5 
mice) and CD1 mice expressing Cre under the Phenylethanolamine 
N-methyltransferase reporter (PNMT Cre – CD1, blue checked, n = 8 
exposures from 2 mice) measured at each full minute of hypoxia. * = p<0.05, 






Appendix 4.7: Background strain-specific differences in the ventilatory 
response to severe hypoxia are also apparent in the ‘raw’ experimental 
data.  
Bar charts show mean ± SEM of values computed by the FinePointe 
software for (A) breathing frequency, (B) tidal volume (normalised for 
weight), and (C) minute ventilation (normalised for weight) during 10 minute 
exposures to severe hypoxia (8% O2) for analysis (i) of the HVR at the peak 
of the augmenting phase (A), the nadir of Roll-Off (RO), and the plateau of 
the sustained phase (SP), and (ii) as whole minute averages for wild-type 
C57Bl6 mice (black checked, n = 20 exposures from 5 mice) and CD1 mice 
expressing Cre under the Phenylethanolamine N-methyltransferase reporter 
(PNMT Cre – CD1, blue checked, n = 8 exposures from 2 mice) * = p<0.05, 
** = p<0.01, *** = p<0.001. Significance tested by two-way ANOVA with 





Appendix 4.8: The precipitation of apnoeas during 10min exposures to 
severe hypoxia is background strain-specific.  
Means ± SEM for the (A) apnoeic index (apnoeas/min), (B) apnoea duration 
(ms), and (C) apnoea-duration index during (i) the first and second half and 
(ii) for every 60 seconds of 10 minute exposures to severe hypoxia (8% O2) 
in wild-type C57Bl6 mice (black checked, n = 20 exposures from 5 mice) and 
CD1 mice expressing Cre under the Phenylethanolamine 
N-methyltransferase reporter (PNMT Cre – CD1, blue checked, n = 8 
exposures from 2 mice). * = p<0.05, ** = p<0.01, *** = p<0.001. Significance 
tested by two-way ANOVA with Sidak post-hoc tests for apnoeic index and 
apnoea-duration index, and multiple t-tests with Holm-Sidak post-hoc for 





Appendix 4.9: Genotype analysis confirms the expression of PNMT Cre 
and AMPK-α1fl/fl and AMPK-α2fl/fl catalytic subunits.  
The products of targeted gene amplification obtained by polymerase chain 
reaction were run on a 2% agarose gel and visualised. The first lane was 
loaded with a 1kb DNA ladder, followed by 12 ear clip samples obtained 
from PNMT AMPK-α1/α2 dKO pups. NTC contains a no-template control, 
WT an ear clip sample from a wild-type C57Bl6 mouse, and Het/Hom was 
loaded with a sample from a mouse with heterozygous genetic modification 
of the PNMT gene and a homozygous genetic modification of the AMPK-α1 
and -α2 subunits. The yellow boxes highlight three mice that were confirmed 






Appendix 4.10: End-point PCR analysis of RNA extracted from the 
adrenal medullae of PNMT AMPK-α1/α2 dKO mice indicates reduced 
expression of the AMPK-α1 and -α2 subunits relative to PNMT Cre 
mice.  
The products of targeted gene amplification obtained by end-point 
quantitative polymerase chain reaction following RNA extraction and cDNA 
conversion from laser dissected adrenal medullae were run on a 2% agarose 
gel and visualised. The first lane was loaded with a 1kb DNA ladder, followed 
by 4 samples obtained from PNMT AMPK-α1/α2 dKO mice and 4 samples 
obtained from PNMT Cre mice. NTC contains a no-template control. The 
yellow boxes highlight three mice that were confirmed as PNMT Cre-driven 
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